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Abstract
Introduction: Ethnic differences exist in the UK regarding the cardiovascular diseases
(CVD). But despite a growing population of Iranian migrants there are relatively few
health related studies on them and none in the UK.
Aims: To develop methods, gain experience and to acquire estimates to inform full scale
future cardiovascular health survey, Iranian subjects in Edinburgh were compared in a
pilot study with Edinburgh's White and Tehran's population.
Methods: Two preliminary systematic reviews were conducted to make decisions about
useful recruitment methods of Iranian migrants and also on the pilot study variables.
Based on the MOOSE guidelines (Meta Analysis of Observational Studies in
Epidemiology) nine databases were searched and identified articles were assessed for
their quality. A multi-method recruitment strategy was applied to recruit 72 Iranian
migrants in Edinburgh. For comparison purposes based on one to many (variable)
matching design five controls for each of the recruited people were selected randomly
from the databases of an exemplar study in Scotland (Scottish Health Survey 2003) and
also in Iran (Tehran Lipid and Glucose Study 2001). Prevalence rate ratio and mean
difference were calculated with 95% confidence interval. Analysis of variance and
conditional logistic regression were applied for data analysis where appropriate.
Results: In the first systematic review from 31 relevant articles 17 unique studies met
the inclusion criteria with considerable heterogeneity in the methodologies used. A wide
range ofparticipation rates was observed. Participation rate in studies that used snowball
sampling ranged from 19.0% with postal questionnaires and 99.0% with telephone
interview. Participation rates were in the range of 33.3-57.0% in studies with
convenience sampling method and 21.3-68.1% in studies with random sampling
methods. Given the small number of studies on this ethnic minority and the diversity of
methodologies it was not possible to analyse them statistically. The limited data
available suggest that application of a multi-method recruitment approach and
translation of the study questionnaire may increase participation rate.
In the second systematic review from 104 relevant articles 28 unique studies met the
inclusion criteria, ofwhich 25 were reports of original cross sectional prevalence studies
I
in Iran and three were studies on Iranians living abroad. Meta-analysis was performed to
calculate overall summary data from eligible studies. According to the results 32.9%
(95%CI: 26.6-39.9%) of Iranian men and 32.5 % (95%CI: 26.3-39.5%) of women were
overweight. Obesity was seen among 22.6% (95%CI: 14.2-34.1%) of the women and
7.7% (95%CI: 4.5-12.9%) of the men. Self-reported smoking rate was prevalent among
1.3% (95%CI: 0.6-2.4%) of women and 17.7% (95%CI: 10.2-28.8%) of Iranian men.
The lowest reported smoking rate for Iranian women abroad was 10.5% (95%CI: 7.2-
15.1%).
Findings of the pilot study indicated that only 8.2% (95%CI: 3.2-19.2%) of Iranian
men and 21.7% (95%CI: 9.7-41.9%) of women in Edinburgh had moderate or vigorous
physical activity level. Overweight or obesity was prevalent among 79.6% (95%CI:
66.4-88.5%) of the Iranian men and 60.8% (95%CI: 40.8-77.8%) of the women. Self
reported smoking rate was 30.6% (95%CI: 16.8-49.0%) among the Iranian men and
13.0% (95%CI: 3.4-39.3%) among the women. Having an abnormally low level of high
density lipoprotein (HDL-C) was considerably more prevalent among Iranians in
Edinburgh than the Edinburgh White population and prevalence rate ratio in the male
subgroup was 3.5 (95%CI: 1.4-8.9) and in the female subgroup was 9.9 (95%CI: 2.3-
43.2).
Discussion: The systematic reviews indicated considerable gaps in the evidence base
and so importance of a future large scale study on Iranian Diaspora. Findings of the pilot
study indicate the extent of the prevalence of CVD risk factors in the Iranian Diaspora
and important methodological issues that must be considered in any future health related
studies. Bearing in mind probability of selection bias, the results indicated added risks
among the recruited Iranian migrants in Edinburgh with regard to some of the CVD risk
factors such as smoking and low physical activity level compared to Edinburgh's White
population. Due to differences between the studies, such comparisons must be
interpreted with extreme caution. To have a precise picture about the CVD status of
Iranian migrants, data from a representative sample ofUK Iranians is needed.
Conclusion: This is the first study of its kind ever undertaken in the UK and its findings
can help efforts to control CVD in Iranians living in the UK and similar European
II
countries. This pilot study shed light on one of the important but least talked aspect of
health needs in a relatively sizeable subgroup of ethnic minorities in the UK and other
European countries. The findings revealed that conducting of a future large scale study
on Iranian migrant population is feasible.
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Glossary of terms *
Body mass index (BMI): individual's body weight in kilogram divided by the square of
his/her height in metre.
Cardiovascular disease (CVD): also known as heart and circulatory disease refers to
the class of diseases that affect the heart and circulatory system.
Coronary heart disease (CHD): a gradual build up of fatty deposits on the walls of
coronary arteries which leads to narrowing of arteries and thus difficulty in supplying
heart muscle with blood and oxygen.
Edinburgh White population: those people from White Scottish, White Irish, White
British or any other White backgrounds who were resident of Edinburgh when Scottish
Health Survey 2003 was conducted.
Ethnicity: The social group a person belongs to, and either identifies with or is
identified with by others, as a result of a mix of cultural and other factors including
language, diet, religion, ancestry, and physical features traditionally associated with
race.
Healthy life expectancy: The number of years a person can expect to live in good
health and free from disease at a given age.
HDL-C: high density lipoprotein or good cholesterol is one of the major groups of
lipoproteins which enable lipids like cholesterol and triglycerides to be transported
within the blood stream.
Indigenous: This term is usually used to mean a person who belongs naturally to a place
in the sense of long term family origins.
Iranian: those who were born from a native Iranian mother and/or father and considered
themselves as being an Iranian.
Ischaemic heart disease (IHD): characterised by reduced blood supply to the heart
muscle usually due to coronary artery disease.
* Ethnicity related terms explained by Professor Raj S. Bhopal in his article titled "Glossary of
terms relating to ethnicity and race: for reflection and debate" (1) were applied where
appropriate.
XX
LDL-C: low density lipoprotein or bad cholesterol is one of the major groups of
lipoproteins that transport cholesterol and triglycerides from the liver to peripheral
tissues.
Life expectancy: The average expected lifespan of a person at a given age.
Oral glucose tolerance test (OGTT): is performed to identify diabetic patients or those
with impaired fasting glycaemia 2 hours after a 75 gram oral glucose load in subjects
who should fast before test for at least 14 hours.
Race: The group a person belongs to as a result of a mix of physical features such as
skin colour and hair texture, which reflect ancestry and geographical origins, as
identified by others or, increasingly, as self identified.
Very low density lipoproteins (VLDL): is one of the major groups of lipoproteins
made by the liver that enable fats and cholesterol to move within the blood stream.
White-coat effect: refers to a physiological reaction in patients caused by anxiety and is




ABP: Ambulatory Blood Pressure
AHA: American Heart Association
AIDS: Acquired Immuno-Deficiency Syndrome
ADA: American Diabetes Association
BC: Before Christ
BHS: British Hypertension Society
BMI: Body Mass Index
CAC: Coronary Artery Calcium
CCS: Conventional Cluster Sampling




DHI: Dietary History Interview
DXA: Dual Energy X-ray Absorptiometry
EBR: Evidence-Based Research
ESC: European Society of Cardiology
ESH: European Society ofHypertension
EU: European Union
FBS: Facility-Based Sampling
FFQ: Food Frequency Questionnaires
FPG: Fasting Plasma Glucose
GATT: General Agreement on Tariffs and Trade
GDM: Gestational Diabetes Mellitus
GPAQ: Global Physical Activity Questionnaire
HALE: Healthy Life Expectancy at birth
HDL-C: High Density Lipoprotein Cholesterol
XXII
IDF: International Diabetes Federation
IFCC: International Federation of Clinical Chemistry and Laboratory Medicine
IFWS: Indigenous Field Worker Sampling
IMT: Intima-Media Thickness
IPAQ: International Physical Activity Questionnaire
LE: Life Expectancy
LDL-C: Low Density Lipoproteins Cholesterol
MI: Myocardial Infraction
OGTT: Oral Glucose Tolerance Test
PICO: Population, Intervention, Comparison and Outcome
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses
QFQ: Quantity Frequency Questionnaire
RDS: Respondent-Driven Sampling
SAD: Supine Sagittal Abdominal Diameter
SAT: Subcutaneous Abdominal Adipose Tissue
SIDS: Sudden Infant Death Syndrome






NHS: National Health System
VAT: Visceral Adipose Tissue
VLDL: Very Low Density Lipoproteins
WC: Waist Circumference
WHR: Waist to Hip Ratio
WHO: World Health Organisation
WTCRF: Wellcome Trust Clinical Research Facility
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Chapter one: Dilemmas in research on ethnic minorities with
special focus on the Iranian Diaspora
1.1 Introduction
Equity in health and access to health care are emphasised in many international
mandates as a pivotal element of human rights. Even so substantial disparities still exist
in the health of people with diverse ethnic background in several countries. Further to
disparities in health of ethnic populations also there is inequity in the inclusion of ethnic
minorities in research on health and health care.
A significant number of Iranians live in the United Kingdom (UK) including Scotland
but we know very little about the prevalence of cardiovascular disease (CVD) risk
factors in this population.
This chapter outlines the debates surrounding the issue of equity of health and access
to health care for ethnic groups and reviews the international policy mandates in this
regard. Main objectives of this study and its importance in sustaining of equity in health
and access to health care for all subgroups of population in the UK and other European
countries are also provided. Background information about Iran, its geography,
population and economy and recent pattern of Iranians' emigration are also provided to
support the rationale behind selection of the study topic.
1.2 Equity of health and access to health care for ethnic groups:
international policy mandates
Healthy living is a universal desire regardless of biological, demographic, social or
cultural background of human beings. Definitions of health and well-being may vary
amongst communities and even individuals living an identical community based on the
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perceived definition of health or cultural and social beliefs. Even so equal right of
everyone to be healthy and have access to health care is emphasised in prominent
international agreements. In the Article 25 of the Universal Declaration of Human
Rights (2) for instance having a standard level of living adequate for the health and well-
being, access to medical care and necessary social services clearly is addressed and
therefore it is incorporated as a sine qua non in other international legislation and policy
mandates. The following few examples reflect the efforts made by the international
community towards translating these rights into regulations:
- United Nations (UN) International Convention on the Elimination of All Forms
of Racial Discrimination (January 1969). (3)
Commonwealth Racial Discrimination Act 1975. (4)
UK Race Relations Act 1976. (5)
Race Relations (amendment) Act 2000. (6)
- Human Rights Act 1998. (7)
- NHS Department of Health Race Equality Scheme: 2005-2008. (8)
Canadian Charter of Rights and Freedoms (incorporated as part of the
Constitution of Canada in 1982). (9)
European Union (EU) Race Equality Directive (2000/43/EC). (10)
United States (US) Healthy People 2010 plan (document of the US Department
of Health and Human Services, January 2000). (11)
It is commonly accepted that equity of health and access to health care does not exist
for people with diverse ethnic background across countries. (12) Even in the developed
world, the burden of diseases and their consequences is considerably varying among
ethnic groups. Some of these variations are unavoidable and originated from divergences
in the gene pool of different ethnic populations. Thus there is an international debate to
explain the distinctions as an issue of natural biological phenomenon or simply as a
social injustice that affect quality of health care for ethnic minorities. (13) In the former
case it was argued that deficiencies in health care systems and inadequacy of health
services in serving diverse target population should be scrutinised. It is a widely
accepted value for a health care system to deliver equal health services regardless of
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people's sex, age, race or ethnicity. That being the case, a person's ethnicity should not
affect his/her chance to receive proper health services. Otherwise disparities in health
between ethnic groups and indigenous populations can reflect major deficiencies of
health care systems as a failure or presence of an institutionalised discrimination against
ethnic groups in the given communities. Such a conclusion was highlighted properly in
the recommendation of the European Union (EU) Committee of Ministers (8th
November 2006) to the member states that"...inequalities with regard to health care
affecting ethnic groups are linked to problems of access, the lack ofculture competence
in health care providers, lack of essential provisions, all of which may be structural
barriers to quality care...". (14) All these discussions imply that ethnicity is a rising
issue in the arena of health and health care provision and should be investigated in the
associated scientific literature. But without an extensive shift in our approaches toward
ethnicity and race neither local nor international ethical codes can prevent the
consequences of so mentioned inequalities. (15)
1.3 Dilemmas in research on ethnic minorities
Easily understandable and internationally accepted criteria do not exist to label non-
native people living in a designated host community. Therefore differing terminology
was utilised in the literature to classify these people and their offspring within last
decades. Terms like migrants, immigrants, ethnic minorities or settlers are widely used
although their application may cause confusion from one country to another. (14) This
variation has partly evolved from the complexity in labelling of our own group identity
and with the same token from confusions in the assignment of group identity to others.
For instance, we sometimes use cultural or biological factors equivalently to distinguish
a group identity by a given label. (16)
Lack of consensus on a widely adoptable guideline to apply when incorporating
ethnicity related terminology in health studies imposes certain challenges. (1) Race and
ethnicity as a criterion to categorise population groups are sometimes employed in the
literature synonymously. While race refers to biological attributes which generally
distinguish a population with anatomical features, ethnicity mostly reflects cultural
characteristics of a group. Having a common language or a set of traditions are popular
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probes for ethnicity but with current pace of expansion in the cross-cultural marriages or
extra marital relationships it will be very difficult to label successors of these mixed-
culture families. Moreover offspring of migrants who are brought up in the host
communities generally are more homogenous culturally with the indigenous population
since they adopt the cultural norms, values, attitudes and behaviours of these
communities from very early ages. Thus we may face individuals with biological
features of one group and cultural characteristics of another group in a single
community. As Braun et al. (17) have announced classification of ethnic groups in a
stereotypical way when they are actually genetically or socio-culturally homogeneous
will cause major bias in biomedical research. Many people may have their own
subjective categorisation of ethnicity which is mainly shaped by connection between
anatomical features, culture and socio-economic status. Therefore classification of ethnic
groups by labels selected by a researcher may be considered to be inaccurate, offensive
or even racist by people who may participate in a study. This could be a major barrier in
collection of sound data about health of ethnic groups regardless of the place they are
living. In addition there is a widespread concern about socio-political sensitivity of
ethnic labelling to prevent stigmatising or endangering groups that are in the greater risk
of illness. (18)
As a matter of fact there is now a mounting evidence about genetic homogeneity of
human beings and that we are more like each other than many other species in the world.
This implies that our genetic identity is derived from same ancestors. Interestingly the
study by King et al. (19) has shown the hidden African ancestry of White men in
Yorkshire. All these verifications indicate that cultural and social expressions should be
applied in studies on ethnic groups rather than merely place of birth or biological
features.
Despite these debates about precise classification of ethnic identity, it is commonly
accepted that ethnicity could be an important variable to identify population variations in
health related studies. (20) With such a background, cross-cultural medicine was
introduced as a new approach in the medical science to highlight the interplay ethnicity
has on health and wellbeing of different populations.
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Yet, there are many unanswered questions posed by inequities in the health of
divergent ethnic populations and it seems absurd to ignore this legitimate descriptor of
health inequities in the research on health components. Furthermore in addition to
disparities in health of ethnic populations there is also inequity in the inclusion of
ethnicity in research on health and health care. This is partly entrenched in ambiguities
in definition and classification of ethnicity and also more importantly in the lack of
comprehensive knowledge about consequential effect of ethnic background on health.
Institutionalised discrimination against ethnic minorities in some countries may also
have effect on their lower representation in health research, divergent access to health
cares or exposure to health risks. But in the absence of such a structural barrier and with
current rigorous body of research evidence all population based studies on health should
reflect diversity of the population to assure equitable provision of health care. This only
will be achieved through the precise investigation of health needs within the divergent
communities. (18)
1.4 Iran: A country profile
In this section general information about Iran's history, geography, population and
economy were summarised using the several facets provided in the corresponding
references. Later it was discussed that how these background characteristics affected
shape and size of the Iranian minority groups in different countries of the world.
1.4.1 History
Iran has a diverse population and cultural structure which is rooted in its history.
Until 21st of March 1935 Iran was known as Persia which is originated from the name of
a region in the south of this country (Pars). Iran's history goes back to about 559 BC
when Cyrus the Great established the first Iranian unified empire (Achaemenian Empire,
559-330 BC). (21, 22) He was the mastermind of Cyrus Cylinder known as the first
statement of human rights, which is now in the British Museum of London. (23) Iranian
empire under the rule of Cyrus the Great and his successor Darius the Great reached to
its highest accomplishment as one of the largest and most powerful empires in human
history. Thus one of the world's oldest civilisations was developed. This empire was
destroyed by Alexander III ofMacedon in 330 BC. (21, 22)
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Iran in its later history was ruled by Parthian (247 BC-224 AD) and Sassanian (224-
651 AD) dynasties. During the Sassanian period the last great Iranian empire was
formed and its rich cultural heritage were expanded out virtually beyond the
neighbouring countries. (21, 22)
Arab tribes invaded Iran in 637 AD and conquered it after several great battles in 651.
During these battles some of the remarkable symbols of Iranian civilisation were
destroyed. Zoroastrianism was the state religion before the seizure of Arabs but
afterwards Iranians gradually converted to Islam. Even with drastic sabotage of the
country's civilisation symbols, many of the Iran's achievements that time were adopted
by Arab invaders. Therefore Persian Empire in the Sassanian period is believed to have
major contribution to the Muslim world and global civilisation. (21, 22)
Iran was invaded by the Mongol leader Genghis Khan in the 13th century and
subsequently Mongol dynasties ruled Iran for nearly two centuries. Safavieh Dynasty
eventually created again a centralised Persian Empire in 1501. Shia Islam was
established as the official religion of the Iran under the rule of this dynasty (Shias
believe that after Prophet Muhammad the political leader of the Muslim world should be
descended by one of infallible member of his family but according to the Sunni Islam
the leader must be elected by Muslims). Iran was ruled by the Qajar Dynasty from 1796
until 1925 and after that by the Pahlavi Dynasty from 1925 to 1979. (24) The Pahlavi
dynasty was overturned by an Islamic revolution which also was an end to the
constitutional monarchy ruling system in this country.
1.4.2 Geography
Iran is situated in Southwest Asia bordering with Armenia, Azerbaijan, and
Turkmenistan in North (including almost 650 kilometres of water along the southern
shore of Caspian Sea), Turkey and Iraq in West, Afghanistan and Pakistan in East and
the Persian Gulf and Gulf ofOman in South. Iran is the 18th largest country in the world
with an area of 1,648,195 km2 of which 12 000 km2 is water (including a dozen islands
in the Persian Gulf of them Abu Musa, Farsi, Hendurabi, Hormuz, Kharg, Kish, Lavan,
Qeshm, Greater and lesser Tunbs are prominent). (24) Iran has a variable climate. In the
northwest mountainous provinces (Ardabil, East & West Azerbaijan and Kurdestan),
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winters are generally cold with heavy snowfall and freezing temperatures ideal for the
region's ski resorts. In the south, winters are mild and the summers are very hot
(temperature exceeding 40° Celsius) accompanied by high humidity. About one-tenth of
the country is forested which are mostly scattered in the North and North West region.
(21)
1.4.3 Population
Iran has a population of almost 69.6 million (25) and according to the latest
available data annual population growth rate is 1%. (25) About 68% (26) of Iran's
population is living in urban areas. This country is amongst the most receptive countries
in the world with hosting an estimated 2.1 million refugees, 1.85 million of whom were
from Afghanistan and 220,000 from Iraq. (27) Iran has a young population since about
29% of its population is under 15. (26) The overall life expectancy was reported to be
70.0 years: 68 years for men, 72 years for women in 2004. (28) Adult mortality rate was
190 (per 1000) for males and 118 (per 1000) for females in 2004 and according to the
provided statistics ischaemic heart disease was the leading cause (21%) of death in 2002.
(28) Under five mortality rate (per 1000 live births) was 38 in 2004 and maternal mortality
rate (per 100000 live births) was reported to be 76 in 2000. (28) Total fertility rate and
annual population growth rate was 2 and 1% respectively in 2004. (25)
As discussed earlier Iran is a multi-ethnic and multicultural country. Persian language
is official spoken language not only in Iran but also in Afghanistan and Tajikistan and is
prevalently spoken in other countries like Uzbekistan and Bahrain. Historically the term
"Persians" has used to label all groups of people having origin in the Iranian Plateau.
Therefore, this term includes all subgroups of Iranians even with various regional
languages or dialects. (21, 22) These sub-groups are identified primarily with their
distinctly Iranian language, and/or culture but they also can be labelled by their
secondary ethnic, religious, linguistic, or regional backgrounds. The main ethno-
linguistic minority groups in Iran are: Fars 51%, Azeri 24%, Gilaki and Mazandarani
8%, Kurd 7%, Arab 3%, Lur 2%, Baloch 2%, Turkmen 2%, other 1%. (21, 22) All of
these groups speak Persian as the national language but have their own languages and
cultures as their sub-identity and as an asset for their ancient civilisation. Thus as
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Professor Richard Frye stated "... the mosaic ofpeoples living in Iran today reflects the
central geographical situation ofthe country throughout history, frequently described as
a crossroads ofEurasia." (29)
1.4.4 Economy
Iran is one of the main oil exporters in the Middle East region with possessing
almost 10% of the world's total proven petroleum reserves. This country also has the
second greatest natural gas reserves after Russia. With this background the country's
economy is heavily dependant on oil and gas industry. Even so, major progresses have
taken place in the car, textile, metal manufacturing and food processing industries in
recent years. (30, 31) Despite having such a substantial potential, Iran's economy suffers
from a chronic inefficiency due to the improper economic policies. Distribution of fuel
and other energy carriers in heavily subsidised rates or deficient income tax system are
only examples of strains in the country's economy. General government expenditure on
health was estimated to be 9.6% in 2004. (26)
1.5 Iranian Diaspora: Past, present and future
Migration of Iranians is deeply entrenched in the history of this country. Turbulence
in the political, economic and social status following the replacement of central
governments or major wars all were main causes of migration from Iran. For instance a
group of Iranians (mostly follower of Zoroastrianism) migrated to western India to save
their lives and possessions after invasion of the Arab tribes in 637 AD. They are now
called Parsis (originated from Persia the old name of Iran) and form one of the major
ethnic groups in India. (32, 33)
In more recent decades there was a gradual shift in the composition, size and the
motivation of Iranian migrants. Some of the Iranian high profile intellectuals left the
country following the tribulations leading to the Constitutional Revolution in the late
19th century (1905-1911). (34) After this period two major waves of emigration have
happened in Iran. The first one started from 1950 and continued until 1979 during which
youngsters mostly from middle and higher class families were sent abroad for higher
education. This was consequence of the country's gradual economic recovery and
rocketing revenues due to rise in oil prices. The number of Iranian students reached its
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highest peak in the late 1970s and according to the official sources about 100,000
Iranians were studying abroad in 1977-1978 academic year, of which 36,220 were
enrolled in the United States and rest of them mainly in the United Kingdom, West
Germany, France, Austria and Italy. (35) It is estimated that the number of Iranian
students that time was greater than the number of students from any other country in the
United States. (35) Many of these students remained in the destination countries with
their families and created the first sizable Iranian ethnic groups in these host countries.
The second wave of the Iranians' emigration started in early 1979 and accelerated
following the start of an eight year war between Iran and Iraq in 1980. This twist in the
history of emigration from Iran is undoubtedly regarded as the largest collective
migration of Iranians from their country.
According to the US Census Bureau, there were approximately 283,225 foreign-born
Iranians living in the United States in 2000. (35) The number of admitted Iranian
immigrants to the United States was reported to be 192510 people from 1990-2005. (36)
According to the Office of Immigration Statistics (OIS) overall 356,642 Iranian-born
immigrants were admitted to the United States from 1970 to 2004. Approximately half
of these migrants are living in the state of California with more concentration in Los
Angeles and San Francisco. (35) The number of admitted Iranian immigrants was 21150
in the UK from 1991-2005, (37) 18034 in Sweden from 1992-2003, (38) 2095 in
Norway from 1999-2001, (39) 14784 in Netherlands from 1995-2002, (40) 63295 in
Germany from 1994-2003, (41) 8505 in Denmark from 1980-89, (42) 89191 in Canada
from 1990-2004, (43) 7814 in Austria from 1996-2001, (44) 11008 in Australia from
1991-2005, (45). Thus with adding all these numbers together, about 592518 Iranians
have migrated to these countries during the mentioned period of times. The number
obviously excludes many other countries and time periods for which reliable data was
not provided. Moreover these numbers do not include offspring of Iranians within the
host communities. Thus while a considerable and growing population of Iranian
migrants has shaped throughout the world we know very few about their health in
general and their cardiovascular risk status specifically.
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The diversity of Iran's original population and its cultural heterogeneity is reflected in
the socio-cultural features of the Iranian ethnic groups living abroad. So their first
language, culture, life style and even motivation to migrate can be different. Cross
cultural marriages also added further to this complexity. The heterogeneity along with
the extent of territories in the ancient Persian Empire had also impact on the variety of
names and family names Iranian possess. On this account it is difficult to spot an Iranian
migrant by his/her name or family name. Some of Iranian migrants especially those who
fled the country due to political reason depending on their legal status or political
affiliation may not want to make known their identity to their counterparts. Ultimately
while migrants in general are considered to be hard-to-reach population, lack of
cohesion among the Iranian migrants will warrant careful application of recruitment
strategies when doing population based research in this ethnic group.
1.6 Focus, aims and objectives of this research
Cardiovascular disease (CVD) is a major cause of death and morbidity throughout
the world and ranks as the leading cause of death in many countries. Almost 7.2 million
people (46) have died globally in 2002 as a result of coronary heart disease (CHD) and
5.5 million (46) as a result of stroke which are the consequences of disruption in the
blood vessels supplying the heart muscle or brain.
Findings of several studies in the developed countries have indicated that the
prevalence of CVD risk factors among migrants is different from the general population
and also from the population of the country of origin. (47-51)
As explained previously Iran with a population of over 69 million (25) is changing
rapidly towards industrialisation. Although a sizable number of Iranians reside across
the UK (37) including Scotland we know very little about the prevalence of CVD risk
factors in this population.
This thesis reports findings of a pilot population-based research on the prevalence of
conventional CVD risk factors amongst Iranians living in Edinburgh as the first study of
its kind ever undertaken in the UK. The thesis also outlines main findings of the two
conducted systematic reviews. As a preliminary work a systematic review was carried
out to provide a comprehensive tabulation of available data on recruitment methods that
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have been used successfully in studies on the Iranian minority groups living abroad. It
was based on the findings of this systematic review that a decision about useful
recruitment methods in this pilot study was made. Another systematic review with meta¬
analysis also was implemented on the prevalence studies of CVD risk factors amongst
Iranians in order to have a reliable estimate on the prevalence of these risk factors and
also to decide on the study variables. Findings of this pilot study will be important to
develop methods, gain experience and to acquire estimates to inform a larger future
study. In the same way these findings will help efforts to control CVD in Iranians living
in the UK and similar European countries. A future full scale study in this subject could
be enlightening for health care policy makers and will be influential in decision making
about efficient allocation of resources to control CVD risk factors.
1.7 The layout of the thesis
In this chapter the issue of equity of health and access to health care for ethnic
groups was reviewed in the context of international policy mandates. Main objectives of
the study and its importance in sustaining of equity in health and access to health care
for all subgroups of population in the UK and other European countries were also
provided. Summary information about Iran, its geography, population and economy and
recent pattern of Iranians' emigration were also discussed to support the rationale behind
selection of the study topic.
Chapter two focuses on the global burden of cardiovascular diseases, diversities in
cardiovascular health among migrant population and methodological considerations in
epidemiological studies ofmajor cardiovascular risk factors. Techniques to recruit hard-
to-reach populations and role of systematic reviews and meta-analysis in practising
evidence based approach when doing research on health issues are also discussed.
Chapter three illustrates protocol and results of a systematic review on the methods
and themes of health-related research on the Iranian Diaspora as one of the preliminary
works carried out to gain experiences to apply in this pilot study and also in the future
planned epidemiological researches.
Chapter four indicates protocol and results of another systematic review implemented
to have an overall estimate from the prevalence of major CVD risk factors among
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Iranians. This review also attempts to assess accuracy and the quality of the methods
used in possibly all studies on the prevalence ofCVD risk factors among Iranians.
Chapter five outlines the processes and methods carried out to achieve the aims of the
pilot study, i.e. the study questionnaires, the research design and the analysis plan.
Chapter six describes the results of the fieldwork including the demographic
characteristics of the study sample and the prevalence of the major cardiovascular risk
factors in this group. Participants' ideas about the study and the applied questionnaires
are also demonstrated in this chapter.
Chapter seven displays comparatively the prevalence of major CVD risk factors among
Iranians in Iran, Iranians in Edinburgh and Edinburgh's White population.
Chapter eight as the final chapter in context of the study aims gives an extensive
overview about what this study added to the scientific literature in relation to the health
of Iranian ethnic minorities throughout the world and also about implications this study
may have on the ways any future large scale study on Iranian migrants can be
conducted.
1.8 Summary
There is mounting evidence to confirm that ethnicity is a rising issue in the arena of
health and health care provision and should be scrutinised in the associated scientific
literatures. It is commonly accepted that equity of health and access to health care does
not exist for people with diverse ethnic background across countries. Equitable provision
of health care will be achieved only through the precise investigation of health needs
within the divergent communities.
Findings of several studies in the developed countries have indicated that the
prevalence of CVD risk factors among migrants is different from indigenous population
and also from the population of the country of origin. A significant number of Iranians
reside across the UK including Scotland but we know very little about their health and
the prevalence of CVD risk factors in this population. While migrants in general are
considered to be hard-to-reach populations, lack of cohesion among the Iranian migrants
will warrant application of more efficient recruitment strategies when doing population
based research in this ethnic group.
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This thesis reports about a pilot population-based study about the prevalence of major
CVD risk factors amongst Iranians living in Edinburgh as the first study of its kind ever
undertaken in the UK. The findings will be important to develop methods, gain
experience and to acquire estimates to inform a larger future study. In the same way
these findings will help efforts to control CVD in Iranians living in the UK and similar
European countries. In the next chapter global burden of cardiovascular diseases and
methodological considerations in epidemiological studies of major cardiovascular risk
factors are discussed. Techniques to recruit hard-to-reach populations and the role
evidence based approach can play in extending boundaries of our current knowledge are
also outlined.
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Chapter two: Literature review: important considerations in
epidemiological studies of cardiovascular risk
factors, recruitment of hard-to-reach populations
and use of scientific evidence to inform research
2.1 Introduction
Despite considerable progress in the detection and treatment of cardiovascular
diseases (CVD) in recent decades, still more people are losing their lives from CVD than
any other disease in many parts of the world. There are many unanswered questions
about the pattern of morbidity and mortality from cardiovascular disease. Major
disparities have been reported to exist between different countries and even among
subgroups of populations within a defined geographical region. In the previous chapter
issues of equity of health and access to health care for ethnic groups were discussed.
Diversities in cardiovascular health among migrant population and dilemmas in research
on ethnic minorities also were outlined. This chapter focuses on diversities in
cardiovascular health of migrants with special emphasis on the methodological issues
surrounding the study of major cardiovascular risk factors. Recruitment methods of
migrants as generally one of the hard-to-reach populations and importance of applying
an evidence based approach in research on health issues are also reviewed.
2.2 Global burden of cardiovascular diseases
Our knowledge about determinants and consequences of cardiovascular diseases
(CVD) have extensively improved in recent years but still CVD takes lives of more
people than any other disease in several countries of the world. (52) About 16.7 million
individuals (46) from those who develop heart attacks, strokes or other types of CVD die
each year while many of these deaths are preventable. Putting proper measures into
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action to lower prevalence of predisposing factors such as hypertension, diabetes,
smoking, high blood lipids or physical inactivity have contributed to a sharp decline of
CVD related mortality in some developed countries, but CVD nevertheless remains the
leading cause of death and morbidity in the developed world and also in many other
developing countries. (52) Thus CVD extended beyond geographic and socio-economic
boundaries for instance by taking lives of almost 267 individuals per 100000 within the
countries of European Union (EU) every year. (53) According to the data available for
2002 (54) France (118) and Spain (137) had lowest CVD related age-adjusted mortality
rate and Czech Republic (315) with Greece (258) the highest rate per 100000 of
population. In the Middle East region where major oil rich countries with high income
rates are located, age-adjusted CVD related mortality is even higher than most of the
European countries and in 2002 it was reported to be 369 for United Arab Emirates, 309
for Kuwait, 405 for Saudi Arabia and 466 for Iran per 100000 of their population. (54)
All these figures are illuminating the scope of trouble CVD created to the civil societies
regardless of the socio-economic status.
Even though CVD caused almost a third of global deaths yet about 80% of these
deaths (55) have occurred in developing countries. According to the World Health
Organisation's predictions CVD will be the leading cause of death in developing
countries by 2010, (56, 57) whilst many developing countries already have reached this
level.
Economic transitions have precipitated urbanisation and lifestyle changes in the
developing countries which are triggering, in turn, poor behavioural patterns.
Unfortunately unhealthy consequences of globalisation such as fast food epidemic have
reached into developing world very much faster than the favourable aspects. For
instance global trade and taxation laws such as the General Agreement on Tariffs and
Trade (typically abbreviated GATT) have made access to harmful products like tobacco
very easy in these countries. Tobacco use has precipitated about 6% of all global
mortality at 1990. Tobacco related mortality was 4.9 million in 2001 and is estimated to
reach 10 million by 2020. (56) These figures show how important can be health burden
of economic policies in addition to other consequences. Tobacco industry generates
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substantial amounts of profits and tax revenues for producer and importer countries but
in developing countries this is not comparable with the direct and indirect burden of
tobacco use. Thus CVD control programmes can be potentially hampered by
controversial policies of other sectors especially in developing countries where there are
a background inadequacy of health system infrastructure and shortage of resources.
Overall cost of CVD was estimated to be about €168757 million for EU and €36550
million for UK in 2003. (58) Economic impact of CVD in low and middle income
countries can be complicated and even worsen their fragile health condition due to
competing health priorities. (59) Therefore without critical reassessment of policies in
all community sectors considerable progress in control of CVD epidemic can not be
achievable. CVD can significantly affect both healthy life expectancy at birth (HALE:
the number of years a person can expect to live in good health and free from disease)
and life expectancy (LE) due to abrupt death following a myocardial infraction or stroke.
Thus without revising of current general and public health policies in these groups of
countries quality of life for mostly deprived and poor people will be worse than current
conditions due to growing pattern of CVD pandemic. Consequently, many people will
pay cost of defective international and national policies with their lives.
2.3 Diversity in cardiovascular health among migrant populations:
few examples to highlight magnitude of the problem
While cardiovascular disease still is the leading cause of death and morbidity in
many part of the world but considerable achievements have been made in reduction of
CVD mortality since the 1980s. Major part of this success is due to the relative progress
in recognition of high risk groups and also implementation of interventional programmes
to control the contributing risk factors. But this reduction has not occurred equally in
countries across the world and even within an individual country. (60) CVD mortality
and morbidity currently is higher in developing countries than the developed world and
it is predicted that the gap will be extended beyond the present levels in the future. (57)
But currently in the both groups of countries such a gap is seen between population sub
groups too. This disparity was attributed in the literature to genetic, differences in the
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associated risk factors and the variations in the socio-economic or environmental
features. However; a considerable amount ofuncertainty still remains to be resolved.
With recent accelerated pace ofmigration from developing world a sizeable number of
ethnic groups were formed in the developed countries. Most importantly distinct
divergences in CVD mortality and morbidity rates have been reported in the immigrant
population of these countries. (61) Differing genetic characteristics, exposure to variety
of predisposing factors in their country of origin along with maintaining of a certain
cultural beliefs and customs are considered to be main contributing factors for the
observed variation.
Dotevall et al. (62) in their study on the immigrant population (those from Finland and
those originated from other regions of the world including the Balkans and Turkey,
Middle East, Central/Eastern Europe and Western Europe) of Sweden have reported that
they have a worse CVD risk profile than Swedes owing to higher levels of predisposing
risk factors such as body mass index (BMI), waist to hip ratio (WHR), low density
lipoprotein (LDL-C) and smoking rate. According to the findings of this study Finnish
immigrants had higher blood pressure than Swedes. Finnish men also had a higher level
of total and LDL-cholesterol but in non-Finnish immigrants of both genders level of
HDL-cholesterol reported to be significantly lower while level of triglycerides
significantly was higher. Another study in Sweden by Gadd et al. (63) have revealed that
foreign born migrants (classified in 12 subgroups according to their country of origin)
have higher risk of CVD and coronary heart disease (CHD) than the indigenous
population regardless of education level and employment status. For instance according
to the findings of this study Iranian migrants even after adjusting for age, education and
employment status indicated a higher risk of coronary heart disease (CHD) compared to
Swedes in both gender. Gadd et al. (61) also suggested in another study that the majority
of immigrant groups (coming from Denmark, Norway, Finland, Germany, Southern
Europe, Chile, Poland and Hungary) have lower all-cause mortality risk of CHD in
Sweden than their original countries. Hedlund et al. (64) reported that foreign born
immigrants in Sweden (born in Finland, other Nordic countries, Poland, Turkey, Syria
and South Asia) have higher incidence of first myocardial infraction (MI) than the
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indigenous population which persist even several years after immigration. They have
concluded that this pattern is not explainable by differences in the socio-economic
status.
Cappuccio (65) has shown that mortality from stroke is high amongst black migrants
to UK (both Caribbeans and West Africans) while CHD mortality is low in this group
(compared to general White population). He discussed that such a pattern might be
associated mostly with high prevalence of hypertension and diabetes since other
conventional CVD risk factors like smoking and hypercholesterolaemia are less
prevalent in this group. Thus he addressed genetic susceptibility and gene-environment
interplays in his paper which should be considered when studying ethnic groups
especially when we also see a consistent pattern of the disease in subsequent generations
of the migrants across the world.
Brindle et al. (66) indicated in their study on seven British Black and ethnic groups
that 10-year risk of CHD and CVD for non-smoking people aged over 50 years with a
systolic blood pressure of 130 mmHg and a total cholesterol to high density lipoprotein
cholesterol ratio of 4.2 were highest for Pakistani and Bangladeshi men and CHD risk
were lowest in Caribbean men. According to the findings of this study CVD risk was
lowest in Chinese.
Notwithstanding with the findings of the study was conducted by Cappuccio (65)
(which indicated a high CHD and stroke mortality among South Asians settled in the
UK), Bhopal et al. (67) discussed South Asians' risk status in detail. In this article the
authors explained that South Asians consisting of Indians, Pakistanis and Bangladeshis
are not homogenous with regard to the risk of coronary heart disease. Bangladeshis were
reported in this article to have the lowest socio-economic status. Accordingly it was
shown that they have the highest concentrations of triglycerides and fasting blood
glucose. Pakistanis also were reported in this study to be in greater risk of CHD due to
high prevalence of contributing risk factors in comparison to Indians and indigenous
population. The sex-specific standardised mortality ratio due to circulatory disease
which was estimated by Wild et al. (68) (using deaths data from 2001 onwards) for
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Bangladeshis and Pakistanis confirms higher overall CVD related mortality rate in the
both ethnic groups.
All these examples are suggesting that migrant population in many countries of the
world have considerably diverse cardiovascular health compared to indigenous
population. They are also implying that such a gap should mostly be attributed to
variations in the contributing risk factors within migrant population.
2.4 Major cardiovascular risk factors and their measurement
methods in epidemiological studies
Existence of multiple definitions and standards for measuring CVD risk factor has
caused confusion and impeded comparison of the results from different research papers.
Thus, trends of cardiovascular risks over time in many countries and merits of
interventional programmes to control influential constituents of the pathologic
phenomenon are not provable precisely. Heterogeneity of the applied measurement
protocols in the CVD related health studies and the types of studied CVD markers may
also cause major biases in the calculation of overall summary measures and thus distort
the policies that will be sought upon the findings. Therefore it is crucial to base CVD
studies on a sound methodology and take into account all possible confounding factors
in measurement of the conventional CVD risk factors. In the absence of internationally
agreed guidelines to investigate epidemiological attributes of CVD, findings from
scattered studies will not contribute thoroughly to the disease control and prevention.
Major studied CVD risk factors and important recommendations to be considered in
their measurement are discussed below.
2.4.1 Hypertension
Hypertension is one of the major predictors for an important group of
cardiovascular incidents which can precipitate critical conditions in several organs of the
body. Therefore accurate measurement of blood pressure is the basis for control and
management of cardiovascular disease and other related complications. Imprecise
measurement of blood pressure can cost lives and despite its wide application for more
than a century still there are important debates about reliability of blood pressure
measurements. (69) Inferior standardisation of blood pressure measurement techniques,
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lack of harmony amongst different guidelines and on the other hand existence of major
discrepancies between present guidelines and training of medical profession in the
educational institutions all have raised concerns in efforts to control hypertension. (70)
While using of a reliable device is a basic prerequisite for an accurate blood pressure
measurement other influential factors are measurement circumstances like time,
position, location, temperature and frequency, patient related characteristics e. g. age,
race, use of tobacco or alcoholic drinks, having meals or exercise, pain or bladder
distension, patients' emotions and finally measurer related factors e. g. scale of
proficiency, precision and implicit bias. (71) The following are the main
recommendations to lower measurement bias based on internationally proven practice
guidelines to measure blood pressure accurately:
White-coat effect: Refers to a physiological reaction caused by anxiety and is
commonly seen in the hospitals or outpatient departments when measuring of a
frightened or anxious patient's blood pressure. Anxiety can increase blood pressure as
much as 30 mmHg (72) in a normotensive or hypertensive individual. Thus the level of
measured blood pressure will be greater than the blood pressure values obtained outside
the medical environment. Therefore all attempts should be made to reduce fear and
anxiety of individuals before measuring their blood pressure. Selecting of cosy room to
measure blood pressure in a comfortable and relaxed position, talking non medical
issues for a few minutes before starting measurement could lessen this fear. (71)
Attitude and posture of subject: To have a reliable blood pressure measurement
subjects should be encouraged to relax and be advised not to talk shortly before and
during the measurement. Blood pressure values slightly decline from lying to sitting or
standing positions. (72) In order to standardise posture, in practice it is recommended to
measure blood pressure in the sitting position with back support, legs uncrossed and the
arm supported at heart level (positioning arm below heart level overestimates and rising
it above heart level underestimates the systolic and diastolic blood pressure). It is also
suggested to ask subjects to remain for 5 minutes in their sitting position before doing
the measurements. (72) The task force for the management of arterial hypertension of
the European Society of Hypertension (ESH) and of the European Society of Cardiology
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(ESC) published guidelines (2007) recommend taking of at least two measurements
spaced by 1-2 minutes, and an additional measurements if the two first measurements
were considerably different. (73) Due to inter-arm differences of systolic and diastolic
blood pressure it is also recommended to measure it in both arms at first visit and take
the higher value as the reference. If the differences be greater than 20 mmHg for systolic
and 10 mmHg for diastolic pressure on consecutive readings to detect possible
peripheral vascular disease, subjects should be referred to a specialised centre. (72, 73)
The cuff and bladder: In the conventional Riva-Rocci/Korotkoff technique to
measure ambulatory blood pressure (ABP) majority of applicable devices are dependent
on an elastic cloth containing an inflatable rubber bladder that encircles the arm. A
standard cuff size is 12-13 cm long and 35 cm wide according to ESH and ESC
guidelines (73) however; the standards given by the British Hypertension Society (BHS)
(74) and the American Heart Association (AHA) (75) are different. Relative to the
subjects' arm circumferences it is also possible to use a shorter (e.g. for children) or
longer cuff (e. g. for obese people). Too narrow or short bladder could cause
overestimation and too wide or long bladder could cause underestimation in blood
pressure measurement. (72) The cuff should be placed 2-3 cm over the arterial pulsation
after palpation of the brachial artery in the ante-cubital fossa on the subjects' bare upper
arm. It is also should be noticed that the sleeve not be rolled up in a way that has a
tourniquet effect above the cuff. The tubing from the device to the cuff must be of
sufficient length (70 cm or more) and the cuff must be inflated to at least 30 mmHg
above the point at which the radial pulse disappears. The rate of cuff deflation is
recommended to be 2 to 3 mmHg per second. (75)
Blood pressure conventional measurement devices: Accurate measurement of
blood pressure is highly dependent on the equipment used. Mercury sphygmo¬
manometers were routine devices in measuring blood pressure until recently but
automated sphygmomanometers are replacing very rapidly on the basis of concerns
about the toxicity of mercury, error inherent in the oscillometric method and need to
repeated and expensive training of health care professionals. Even so still there are
debates on usefulness of automated devices in clinical settings to measure blood
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pressure accurately. The fact that available devices are giving systematically different
results than those obtained by mercury sphygmomanometers and especially their
limitations to measure reliable blood pressure in patients with arrhythmias have retained
mercury sphygmomanometers as a gold standard for many. (72) On the other hand most
of the available epidemiologic data are based on the measurements taken by mercury
sphygmomanometer which makes their comparison with the data coming from
automated devices-very difficult. Therefore it is recommended to use same measurement
method if the main objective of a research is to make comparisons with other studies.
(76) Advantages of automated devices such as being easy to use even in conditions not
favourable to good practice and reduction of measurer bias (due to systemic error,
terminal digit preference or observer prejudice) have led many researchers and health
care providers to switch from application of mercury sphygmomanometers to automated
devices. But right decision will be made only with contemplating of the instruments'
usefulness in differing circumstances and noticing the main objectives of blood pressure
measurement in practice. (76)
Other important issues to consider for a reliable blood pressure measure: In
addition to the discussed tips to have a reliable blood pressure measure there are a
number of other recommendations in the literature to be applied in CVD studies. A
phenomenon called masked hypertension refers to a state in which individuals with
normal clinic blood pressure show an elevated value at home. (77-80) It is reported that
about 1 in every 7-8 subjects with normal blood pressure in clinic may fall into this
category. (79) Another issue is the influence of physical and mental stressors on blood
pressure. For instance it has been shown that physical activity (dynamic or static
exercise) or mental engagement (due to a problem of daily life or with technical and
decisional nature) may increase blood pressure. (73) Thus riding of a bike or climbing
stairs before attending a clinic for CVD risk assessment may raise up blood pressure.
Other stressors like outdoor (causing seasonal variation) or room temperature (81-83)
and performing a painful procedure before measurement of blood pressure all will have
same effect on blood pressure. (84)
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2.4.2 Smoking
Smoking is one of the major risk factors for CVD and accounted as a precipitating
constituent for about 20% of CVD cases worldwide through mostly damaging the
endothelium lining of the arteries, increasing the cholesterol plaques, intensifying
clotting, elevating low density lipoprotein (LDL-C) and reducing high density
lipoprotein level and also by promoting coronary artery spasm. (46) Tobacco use was
estimated to be main cause of death of more than five million people in 2008 which is
more than the total number of deaths due to AIDS, malaria and tuberculosis together.
(85) Mathers and Loncar (86) predicted that total tobacco-attributable mortality will rise
from 5.4 million in 2005 to 8.3 million and according to the pessimistic scenario to 9.7
million in 2030. They also have envisaged that in 2015 smoking will be accountable for
10% of all deaths worldwide and kill 50% more people than AIDS (Acquired
Immunodeficiency Syndrome). By that time it is anticipated that deaths caused by
smoking will double from current 3.4 million to 6.8 million in low and middle income
countries. (86) Thus while about 75% of the world's tobacco market is controlled by just
four companies based in the developed world, (87) smokers in the developing countries
will ensure profits of these corporations with their lives.
Based on the World Health Organisation standardised guidelines for measurement of
smoking (88) people can be categorised into main groups and within each group into
number of subgroups. Smokers and non-smokers are the main classifying labels.
A smoker is a person who smokes any tobacco product on a daily basis (at least once a
day) or occasionally (not every day). Occasional smokers themselves can be a reducer
(used to smoke daily but currently smoke occasionally), continuing occasional smoker
(has never smoked on the daily basis but has smoked at least 100 cigarettes or the
equivalent of tobacco) and experimenter (has smoked fewer than 100 cigarettes or the
equivalent of tobacco). (88)
A non-smoker is a person who does not smoke at the time of questioning but he/she
can be an ex-smoker (formerly a daily smoker who has stoped smoking), ex-occasional
smoker (formerly an occasional smoker who has never been a daily smoker but has
smoked 100 or more cigarettes or the equivalent amount of tobacco in his/her lifetime)
23
or never smoker (a person who has never smoked or has smoked less than 100 cigarettes
or the equivalent amount of tobacco in his/her lifetime). (88)
Self reporting and biochemical measurement are two main data gathering methods that
are being applied in many studies to clarify smoking habits in different population.
There are several reports suggesting the underreporting of smoking (89-91) which
generally is believed to be the result of socio-cultural desirability of non-smoking or
presence of a stigma with smoking which inhibits people to explore their smoking
behaviour accurately. If self reporting will be chosen as the proxy for smoking status it
is recommended that the questions should include starting age and age of stopping (if
smoking stoped), type of smoking (manufactured or hand made cigarette, pipe, cigar or
hubble-bubble) and the quantity used. (76) Also questions about passive smoking should
be asked if the study targets CVD and its risk factors.
Amount of carbon monoxide in breath also can be measured as a biomarker of
smoking in CVD studies. This method is a very cheap and simple technique and
applicable by using a portable monitor. Thiocyanate levels in serum, urine or saliva and
cotinine levels in plasma or urine are other biomarkers of smoking. Thiocyanate levels
are prone to unusually high cyanide content of diet (is found in cabbage or cassava).
Cotinine levels in plasma are sensitive to all source of smoking (passive smoking,
chewing or sniffing tobacco) however; its application is very much expensive than the
other methods. So it is suggested that measurement of carbon monoxide in breath can be
as accurate as other methods in detecting smokers from non-smokers and there is no
indication to apply other expensive methods in population based prevalence studies. (76)
2.4.3 Physical inactivity
Physical inactivity is a global health concern and as an independent risk factor for
many chronic illnesses it is estimated to be the main precipitating factor of 1.9 million
deaths globally. (92) Intensity and frequency of our daily physical activities play a key
role in our body's energy balance and so have a pivotal role in weight control and
consequences of being overweight. Thus it is suggested that adequate physical activity
can reduce the risk of coronary heart disease, type II diabetes, colon cancer and breast
cancer in women in addition to its beneficial effect on mental health. (93) Different
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intensity and amount of physical activity is required in order to maintain a healthy life.
WHO suggests that at least 30 minutes of regular physical activity with moderate
intensity in five days of the week reduce the risk of CVD and diabetes, colon and breast
cancer but more activity is needed for weight control. (93)
Several questionnaires are generally being used to assess level of physical activity in
populations whereas a standardised approach does not exist. In response to the need for
developing of an international standard tool to measure physical activity different
versions of physical activity questionnaires were developed in recent years. International
Physical Activity Questionnaire (IPAQ) (94) and Global Physical Activity Questionnaire
(GPAQ) (95) are routinely used questionnaires worldwide. Main determinants of these
questionnaires are queries about levels of activity at work, during travel to and from
places, frequency and intensity of recreational activities and also sedentary behaviour.
The main objectives of applying these questionnaires in the population level are to
estimate total energy expenditure and extent of vigorous activity. (76) The major
concern in application of these self report or recall questionnaires is their reliability and
validity on different populations. IPAQ has been tested in 12 countries and its reliability
and validity was verified. (96) GPAQ also has been validated in nine countries
(CPAQvl). (97) There are also other questionnaires to assess physical activity level in
population based studies (e.g. physical activity module in Health Surveys for England
and Scottish Health Survey 2003) (98) but they are not validated to be applicable
internationally.
Accurate and reliable assessment of physical activity by application of even validated
questionnaires is not straightforward. Remembering activities with low intensity or those
not done routinely generally are not easy for respondents. So it is argued that questions
about physical inactivity may provide more information than the questions about
activities in the past. (76) Over reporting of the activities' frequency or their intensity are
another challenges in utilisation of self report questionnaires. There is a tendency among
respondents generally to present themselves in a positive light by giving socially
desirable answers. (99) This phenomenon can potentially affect validity of self report
questionnaires to describe pattern of physical activity in a community. Other methods
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developed for measurement of physical activity have their own limitations. For instance
motion sensors (e.g. pedometers) are expensive and are not easily applicable in large
population based studies. Heart rate monitors that should be used for at least 5 days to
obtain average energy expenditure are also expensive and their use is not recommended
in population based studies. The double labeled water technique in which the production
of carbon dioxide is estimated from the rates at which stable isotopes of hydrogen and
oxygen are replaced in the body water space is also expensive and can not be used in
large scale population based studies. (76)
Sociocultural characteristics and the economic status of a given society may have
substantial effect on the extent of physical activity therefore all these prominent factors
should be considered in addition to the reliable assessment technique to investigate
pattern of physical activity.
2.4.4 Hyperlipidaemia
Hyperlipidaemia refers to an abnormality which is characterised by raised serum
lipid profiles. Such an elevation may occur in total cholesterol (TC), low-density
lipoprotein cholesterol (LDL-C) or triglycerides (TGs). Also the term dyslipidaemia is
widely used in the literature to explain this phenomenon. However, the later term
generally covers a broader range of irregularities in serum lipids including abnormally
low level of high-density lipoprotein cholesterol (HDL-C). Lipids are insoluble in water
and to be transported around the body they bind with protein molecules and form water
soluble lipoproteins. These lipoprotein complexes are categorised into different classes
with respect to their size and density. Starting with larger and less dense chylomicrons
other classes in descending order are very low density lipoproteins (VLDL),
intermediate-density lipoproteins (IDL), low density lipoproteins (LDL), high density
lipoproteins (HDL) and lipoprotein a [LP(a)] which is a complex of LDL-C and an
apoprotein B-100. (100) As the constituents of the plasma lipoproteins there are also
lipid-binding proteins called apoproteins which transfer dietary lipids through the
bloodstream from the intestine to the liver, and endogenously synthesised lipids from the
liver to tissues. Acting as an enzyme co-factor, receptor ligand and lipid transfer carrier
lipoproteins regulate the intravascular metabolism of lipoproteins and their target tissue
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uptake. Based on their function in different lipoproteins, apoproteins are classified into
six main classes and several subclasses. The main classes and subclasses of apoproteins
are: A (apo A-I, apo A-II and apo A-IV), B (apo B48 and apo B100), C (apo C-I, apo C-
II and apo C-III), D, cholesterol ester transfer protein (CETP) and apoproteins E. (101)
The relationship between plasma lipids and CVD is well established in many studies
but the exact mechanism of this interrelation is still the subject of intense research. (102)
The question to be asked is whether the disease process should be assessed by measuring
the lipoproteins or the lipids carried within them. With the development of a method to
analyse lipoproteins which is called nuclear magnetic resonance (NMR) it is now
possible to measure their size and quantity in every individual subject. (103) This
landmark technological progress has produced distinct improvements in our knowledge
about the role of different lipoproteins in the development of CVD. It was indicated for
instance that LDL-C values do not accurately reflect the number of circulating LDL
particles and the risk of associated coronary artery disease. (102) It was also argued that
the extent of atherosclerotic disease and its consequent CVD vary substantially between
individuals with similar lipid profiles. (100) Nuclear magnetic resonance lipoprotein
profiling has displayed that all LDL-C or EIDL-C particles are not same and their size
and quantity may vary from subject to subject. (103-110)
With considering all these in mind a measured LDL-C level may or may not be a
reliable indication to concern unless the number of LDL particles carrying the
cholesterol is markedly increased. (103) LDL-Cs are a heterogeneous group of particles
with variable size and density. LDL-C i is the largest and least dense particle with greater
amount of cholesterol, LDL-C2 is the intermediate and LDL-c3 is the smallest and most
dense particle with lower amount of cholesterol in this group. All LDL-C particles have
a apolipoprotein B in their molecule irrespective of their cholesterol content. It has been
shown that between two subjects with the same LDL-C level, the one which has
predominantly higher level of LDL-C3 will be in greater risk ofCVD. (100, 111))
Therefore it is suggested in some studies (112-116) that apolipoproein B or ratio of
apolipoproein B to apolipoproein A-I can be measured as a predictor for CVD. They do
not need to be measured in fasting status and it is recommended that apolipoproein B
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measurement have a better predictive value than LDL-C or non-HDL-C alone. It is also
argued that TC loses its predictive value in people over 70 years but apolipoproein B or
ratio of apolipoproein B to apolipoproein A-I is even applicable in this age group. (115)
In addition where LDL-C level is in the normal range apolipoproein B can be used to
predict a fatal myocardial incident. Thus those people who have normal concentration of
LDL-C but concurrently high level of apolipoproein B are in greater risk of CVD than
people who have higher level of LDL-C but low concentration of apolipoproein B.
(115)
It is believed that disruption in the normal physiology of lipids in human body can lead
to excessive accumulation of LDL-C in the arterial walls which in turn is the primary
stimuli for atherosclerotic lesions. Accumulated LDL-Cs in the arterial wall transfer
into the monolayer endothelial cells that is concurrent with their modest oxidation inside
the cells. Such a change in the arterial endothelium cells can activate an inflammatory
reaction that proves inflammatory nature of atherosclerosis. (100) Thus C-reactive
protein (CRP) as an inflammatory marker (is produced in the liver in response to a
systemic inflammation) is regarded to be a powerful predictor for future CVD. (117-
119)
Other important issues to consider for a reliable blood lipids measurement:
There is some evidence supporting seasonal variations of selected biomarkers of CVD
including lipid profiles. (120-124) Kelly in his review of the relevant literature has
concluded that irrespective of the age, sex, ethnicity and baseline lipid levels in the
studied subjects a robust winter/summer variation exists with highest total cholesterol
and LDL-C levels in winter. (120) Nazir et al. (124) have reported a significant
reduction in TC, HDL-C, LDL-C, and apoprotein A-I during summer months while
Ockene et al. (123) described such a variations in TC and HDL-C levels during summer
in both sexes and reduction of LDL-C only in women. The rationale for such a variation
needs to be studied in the future but the outcome can provoke major biases in the
interpretation of the findings from epidemiological research implemented in dissimilar
seasons or in the meta-analysis of the data from divergent studies to estimate an overall
mean of lipids or prevalence rate of hyperlipidaemia within the targeted population.
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There is also some debate in the literature regarding the effect of other factors, such as
subject's posture or use of tourniquet on the lipoproteins level but validity of these
hypotheses needs to be evaluated rigorously in the future. (125-127)
2.4.5 Elevated blood glucose
Despite our progress in the understanding of mechanisms and physiology of
glucose homeostasis from the time diabetes mellitus was first described in 1552 BC,
(128) it is still one of the major health concerns we are facing in the 21st century. Since
its discovery in the 1920s, insulin was viewed as the unique hormonal regulator of
glucose level in the circulation and so insulin deficiency was regarded as the centrepiece
of hypotheses to describe aetiology of this mono-hormonal disorder. However with
recognition of other influential glucoregulatory hormones our knowledge about diabetes
and its contributing factors has expanded in recent years so that we consider it as a
multi-hormonal disease.
Wild et al. (129) have argued that diabetes epidemic will continue to expand during
the forthcoming decades due to increasing prevalence of obesity especially among urban
population of the world. Most common type II diabetes imposed 98 billion dollar to the
US economy in 1992 and it accounts for about 10% of the UK national health budget.
(130) Additionally, it was indicated that impairment in glucose metabolism is associated
with increased CVD. Levitzky et al. (131) for instance have indicated that CVD risk in
women may be elevated at a lower glucose level compared to men. Faeh et al. (132) also
have shown relationship between impaired glucose regulation and both major CVD risk
factors and carotid/femoral intima-thickness. Proper measurement of glucose tolerance
and determination of the epidemic's scale in several regions of the world therefore is
pivotal in the CVD prevention programmes.
Since type II diabetes and its complications may start several years before the clinical
diagnosis and thus many diabetics may remain undiagnosed, fasting (at least 8 hours
overnight) plasma glucose (FPG) level can be applicable for screening purposes in the
epidemiological studies. (131)
To have a reliable measure of blood glucose level major considerations should be
taken into account. Glycolysis decreases glucose concentrations in the drawn whole
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blood sample in vitro with time which could be inhibited by use of reagents such as
sodium fluoride. Glycolysis rate in the first hour of sample collection in tubes with or
without sodium fluoride is almost identical. So its use is unnecessary if glucose level is
planned to be measured within the first hour after sampling otherwise, use of sodium
fluoride can preserve glucose concentration in a stable level for up to three days.
It is possible to measure glucose level in whole blood, serum or plasma but plasma
glucose level is recommended for diagnostic purposes. The molality of glucose in
plasma is about similar with whole blood but almost 5% lower than the serum. (131,
133)
Another test to identify diabetics is oral glucose tolerance test (OGTT) which is
performed 2 hours after a 75 gram oral glucose load in subjects who should fast before
test for at least 14 hours. (76) There are controversies about use of this test as a
diagnostic procedure. While International Diabetes Federation (IDF) and World Health
Organisation (WHO) suggests its use, (131, 134) American Diabetes Association (ADA)
(131) and Joint British Societies' guidelines (135) does not recommend its routine use in
the general population to diagnose either type I or type II diabetes. Even so both ADA
and WHO agree with the use of OGTT as a diagnostic tool for gestational diabetes
mellitus (GDM), neither of them recommend 3-5 hours glucose tolerance test as a
routine procedure. (131) The rationale behind OGTT not to be recommended by ADA is
having of an almost identical sensitivity with FPG and existing of questions surrounding
its repeatability, feasibility and cost. (136)
The glycated haemoglobin (as HbAlc) measurement to distinguish chronic glycaemia
has been utilised for over two decades but there are major concerns about its sensitivity
to diagnose diabetes. (137, 138) International Federation of Clinical Chemistry and
Laboratory Medicine (IFCC) in an effort to standardise HbAlc measurement have
developed a new method (measure of ultra-pure synthetic fragment of glycated
haemoglobin rather than a mixture of glycated haemoglobins) and suggested that the
results be provided in correct units (mmol/1) rather than a percent of haemoglobins with
attached glucose. (138, 139) But despite advent of these methodological
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recommendations more attempts still are needed to be done for its worldwide standard
application as a screening or diagnostic test for diabetes.
Other important issues to consider for a reliable blood glucose measurement:
There is evidence of circadian variation of blood glucose level (140-143) and its
implications for the diagnosis of abnormalities in glucose metabolism. But contributory
factors affecting this variation are still poorly understood and need to be investigated in
future studies. Therefore drawing of blood samples from all subjects in almost identical
time of the day is the only practical way of control for this potential confounding factor.
2.4.6 Adiposity
Obesity is a well known risk factor for a number of CVD related complications
including hypertension, diabetes and atherosclerotic disorders. (144) Several methods
have been invented to assess adiposity but there are discussions about reliability of each
method. Body Mass Index (BMI), Waist Circumference (WC) and Waist to Hip Ratio
(WHR) are amongst the widely used markers of obesity in recent years. There are some
debates about reliability of these markers in reflecting the precise magnitude of
pathologic complications caused by obesity. BMI was suggested to be a useful indicator
of overall adiposity however; pattern of body fat deposition was also indicated to be
influential in the onset of differential CVD disorders. (145) With the same token
although WC is easily obtainable but it was suggested to be an imprecise measure of
abdominal adiposity since it reflects both the subcutaneous adipose tissue (SAT) and
visceral adipose tissue (VAT) compartments. (144) This is while different fat depots
have varying potential pathogenic effect for instance increase of VAT creates greater
risk than increase of SAT. (146) As a disadvantage to this marker assessment of VAT
requires imaging with radiographic techniques such as computed tomography (CT) or
magnetic resonance imaging (MRI) which are potentially expensive, even so they have
been used in several studies. (144, 145, 147-151) Findings of these and other similar
studies are not convergent with regard to the sensitivity of the sophisticated techniques
in predicting CVD risk in comparison to the simpler traditional techniques.
It was recommended in the study by Lee et al. (149) that WHR is not a reliable
predictor of insulin sensitivity in either men or women and instead abdominal fat mass
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which can be determined by dual energy X-ray absorptiometry scans (DXA) was
introduced as the best sex independent predictor of insulin sensitivity index.
Notwithstanding, Sierra-Johnson et al. (150) have shown that WC has almost identical
predictive information with DXA in men. This is while Onat et al. (151) have introduce
WC as the best surrogate marker of VAT and its related CVD across a wide age range
among the other applied measures such as computed tomography (CT) and abdominal
sagittal diameter. Application of WC as a valid marker of VAT and consequent
complications also was approved by Edwards et al. (152) Simpson et al. (153) have
compared sensitivity of different adiposity measures (WHR, WC, BMI, fat mass and
percentage of fat estimated by bioelectric impedance analysis) to predict all cause
mortality associated with obesity. They have concluded that WHR may be used to
predict the outcome in both sexes but WC only in men. They also have suggested that
the use of bioelectric impedance analysis to estimate body fat mass and percentage of
body fat will not add to the information provided by the traditional measures. Findings
from the study by Menke et al. (154) have revealed that WC maintains strongest
association with CVD risk factors than other measures of adiposity such as BMI, total
body fat, body fat percentage and skinfold thickness. Same recommendation was given
by Stamatelopoulos et al. (155) in relation to application ofWC as best marker to predict
atherosclerosis in young and middle aged healthy adults.
Chen et al. (156) have recommended that WHR is more useful than BMI or WC in the
identification of subjects predicted to be at greater risk of CVD. The study by Dalton et
al. (157) have also shown that WHR is the most useful measure of obesity (comparing to
BMI and WC) and thus the identification tool of those who are in added risk ofCVD.
Supine sagittal abdominal diameter (SAD) which is anteroposterior diameter of the
abdomen or simply abdominal height in centimetre has been described as a potential
marker of VAT. (158-162) Ohrvall et al (159) have suggested that SAD is a stronger
predictor of CVD risk than other routine anthropometric variables like WC, WHR and
BMI. Inter and intra-observer precision of SAD by anthropometry to predict VAT in
comparison to WC, WHR and SAD computed by CT was discussed in the study by
Zamboni et al. (158) This study confirmed precision of SAD by anthropometry and its
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usefulness to predict VAT. Iribarren et al. (163) have used standing SAD to predict
coronary heart disease (CHD) in their cohort study. They have concluded that standing
SAD is a strong predictor of CHD independent of BMI. Despite these recommendations
resulting from successful application of supine or standing SAD to predict CVD and its
related disorders Mukuddem-Petersen et al. (164) have indicated that use of supine SAD
has no advantages over simpler and commonly used anthropometric measures such as
WC, WHR or BMI in elderly people.
In summary SAD might be worth studying in future clinical and epidemiological
studies on VAT and CVD as an important assessment tool but obviously standardisation
of its measurement should also be considered in the anthropometric measurement
guidelines in order to base our judgements on reliable and sound data. Currently from a
public health perspective it may be advisable to use the simplest, practical and precise
anthropometric measure in population based studies to predict prospective pattern of
CVD.
2.4.7 Unhealthy dietary habits
Unhealthy dietary pattern which was some times referred to Western dietary
pattern in the literature is characterised by high intakes of refined grains, processed
meat, fried foods and red meat. (165, 166) The association between having an unhealthy
diet and a cluster of CVD related disorders is well documented. (167-170) Accurate
estimation of habitual dietary intake for specific food groups and nutrients however, is a
major concern in epidemiological studies. (171) The underlying objective of dietary
assessment, whether for an individual or for a group is to determine dietary patterns or
quantify nutrient intake. Dietary assessment methodology is therefore a crucial
constituent of studies that are being aimed to identify the relationships between diet,
health and illnesses. Information about diet may be collected by self report or by report
from relatives and family members (especially in children and elderly people). In this
case food frequency questionnaires (FFQ) or interviews (retrospective method) and food
records (prospective method) are used. (172) Another option is to apply recovery
biomarkers such as doubly-labelled water which is used to calculate almost accurately
the dietary total energy intake. Currently reliable recovery biomarkers (urinary nitrogen
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as a marker of protein intake and urinary potassium as a marker of dietary potassium
intake) are only available for a few dietary factors and their utilisation in practice is very
expensive. (173)
Each of these methods has its own merits, associated errors and constraints for use in
different studies. Thus in most epidemiological studies use of self-report techniques will
be the best, although imperfect available method to obtain dietary data. This technique
however, reflects the amounts of energy and nutrients found in food and not necessarily
the amounts available for the physiologic metabolism. (172) Therefore it is only
applicable to measure average use of foods during a defined time period. Variability of
subjects' habitual intake levels on the other hand is a reality and so dietary behaviour
can not be measured without errors. Consequently the random measurement errors may
decrease the statistical power of studies. (171) The precision of the dietary assessment
technique have produced great concern in recent years and the "flattened-slope
phenomenon" in which subjects with higher levels of food intake tend to underreport
and those with lower food consumption tend the over report their dietary intake is very
common in population based studies. (174, 175) Findings from application of FFQ in
comparison to the recovery biomarkers have elucidated significant differences. (176,
177) Therefore to have reliable data about dietary behaviours it is very important to
consider reliability and validity of various available FFQs according to the particular
research needs and select an appropriate instrument that has been validated in the target
population whenever possible. Even with application of such a questionnaire accuracy of
dietary data will depend on the quality of instructions to the respondents, their amount of
learning and readiness to answer the questions precisely.
2.4.8 Use of alcoholic drinks
Some evidence from observational studies implicated that moderate alcohol
consumption which is defined as one standard drink per day (14 g of alcohol) have
beneficial effect to reduce CVD through increasing ofHDL-C and decreasing of LDL-C
(170, 178-179). But what is not approved with certainty is whether the pattern of
consumption has a role beyond the amount of consumed alcohol alone. Tolstrup (181)
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in their recent article have discussed for instance that drinking frequency probably is
more strongly associated with abdominal obesity than the amount of alcohol intake.
Mukamal et al. (182) in their study on roles of drinking pattern and type of consumed
alcohol in occurrence of coronary heart disease among men have indicated that
consumption of alcohol at least three to four days per week was inversely associated
with the risk of myocardial infarction and neither the type nor the proportion of
consumed beverage with meals substantially altered this association. Baglietto et al.
(183) have shown that type of alcoholic beverage is important in all cause mortality and
wine drinkers have a lower death risk comparing to beer drinkers or spirits consumers.
They also have argued that benefits from phenolic acids and polyphenols which
generally exist in vegetables and fruits probably be correct for wine and thus some of the
protective effect of wine consumption at low doses may stem from fruit ingredient of
wine rather than from alcohol per se. This is while Djousse et al. (184) have
demonstrated that alcohol consumption is associated with a lower prevalence of
metabolic syndrome irrespective of the type of alcoholic beverage taken. In the study of
Mukamal et al. (185) on alcohol consumption and risk of coronary heart disease (CHD)
in older adults it was concluded that intake of 14 or more drinks per week irrespective of
the beverage type is associated with the lowest risk of CHD. However Mukamal et al.
(186) in another article have questioned the absolute benefit of moderate alcohol
drinking in populations with healthy lifestyle. They have recommended that even with
moderate consumption of alcoholic drinks there are potential health risks such as breast
cancer in women and acceleration of cirrhosis in patients with hepatitis C and thus both
possible benefits and risks should be considered when discussing alcohol intake.
Furthermore in studies to investigate effects of moderate drinking on CVD, they have
argued that control of other confounders can be difficult because of CVD multi-factorial
nature (187) and also small effect size of moderate alcohol consumption relative to other
CVD risk factors. They also have highlighted synergistic effect of combinations ofCVD
risk factors and difficulties of assessing all such combinations for effect modification.
With such an ethical dilemma for the public health communities and in the absence of
randomised controlled trials to study precise effect of moderate alcohol consumption
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they have suggested that public health guidelines should not recommend initiation of
alcohol drinking for health reasons. Consistent with this suggestion in another study
Mukamal et al. (188) have illustrated that moderate alcohol drinking had not proven to
prevent CVD and hence argued that the observational studies may be susceptible to
uncontrolled confounding.
Furthermore there are important concerns regrading the use of current alcohol
measurement methods. For instance Koppes et al. (189) have argued validity of the
quantity-frequency questionnaire (QFQ) versus the dietary history interview (DHI) in
their study and concluded that serious questions may arise in relation to the validity and
precision of alcohol consumption measurements based on the QFQ alone. Thus they
have suggested that with incorporating questions on the type of consumed beverage and
also drinking patterns form DHI questionnaire accuracy of QFQ questionnaire may be
improved. In another study on the application of alcohol measurement methodology in
epidemiological research (190) it was discussed that use of different self-report alcohol
measurement methods may result in widely different alcohol prevalence rates. It was
also suggested in this study that self-report methods to measure alcohol consumption
where there is no particular sensitivity to alcohol use can provide reliable results but
when there are cultural or religious concerns this may lead to under-reporting. Based on
the findings of their study Wurst et al. (191) suggested that use of a complementary
biological marker such as ethyl glucuronide (EtG) which is a direct metabolite of ethanol
and can be detected in various body fluids, tissues and hair may lead to major
improvement in the accuracy of alcohol consumption self-reports. Wurst at al. (192) in
another study on a population-based sample of Swedish pregnant women and based on
measurement of direct ethanol metabolites in urine and hair samples indicated that only
about 14% of those who were highly suspicious for heavy alcohol drinking (according to
their hair sample analysis) admitted to have ongoing alcohol consumption.
Referring to the debates surrounding effect of moderate alcohol consumption on CVD
and methodological issues hampering interpretation of the studies' results, further
research based on valid and precise measures of alcohol intake and its pattern need to be
conducted to clarify the role alcohol may have on CVD risk.
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2.4.9 Medical history
In large population based CVD risk factors studies information about pre-existing
CVD conditions and CVD risk factors is generally gathered by self-report
questionnaires. While this method of data gathering is relatively inexpensive compared
to physical examination and biochemical measurements, its reliability to collect valid
data is often disputed as it may provoke systematic errors. Among many possible
prominent factors on the accuracy of self-reported data participants' knowledge, their
understanding of the relevant information, ability to recall events and their willingness to
comply with questioner are pivotal. (193) Thus the rate of biased reporting can vary
from one study to another. Molenaar et al. (194) have recommended including
biometrical measurements in studies on the prevalence of hypertension and diabetes to
ensure the validity of data.
Agreement between self-report data and medical record on the other hand for diabetes,
hypertension, myocardial infarction and stroke was reported substantial by Okura Y et
al. (195) but trivial for heart failure. Glintborg et al. (196) have argued that self-report is
reliable for recent use of cardiovascular and anti-diabetic drugs. St Sauver et al. (197)
pointed out to the inaccuracy of data about CVD conditions and CVD risk factors which
are collected through self-report. By the same token Klungel et al. (198) have
recommended using of information from other resources e.g. medical records as a
complementary constituent of data in the population-based studies on CVD and its risk
factors. Johansson et al. (199) have raised the issue of gender differences in accuracy of
CVD risk factor self-reporting and also have pointed out to the differences they found in
the accuracy of self-reporting for the different risk factors. All these findings support the
view that adding biomedical data from other sources to the information derived from
self-reports does markedly enhance the accuracy of data about medical history in the
population based CVD studies. (194) But since accuracy of self-reporting differs
between subgroups of population and from one risk factor to another the magnitude of
the added precision will depend on the condition of interest and characteristics of the
population under investigation. Therefore when self-reporting is the sole source of
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information systemic errors may occur and to prevent it application of multiple data
gathering techniques should be contemplated.
2.4.10 Family history
The association between family history of CVD and the presence of
conventional CVD risk factors is well documented. (200-207) Wright et al. (200) have
reported greater diastolic blood pressure reactivity and poorer systolic and diastolic
blood pressure recovery from the stressors in individuals with family history of
cardiovascular disease independent of baseline cardiovascular activity, body mass index,
waist to hip ratio and smoking status. Carr et al. (201) have indicated that family history
of type 2 diabetes increases the risk of CVD in women with gestational diabetes
mellitus.
Juonala et al. (202) have illustrated the increased arterial vulnerability to metabolic
risk factors among young adults with family history of coronary heart disease. Study
conducted by Ford et al. (203) have not shown any association between family history of
diabetes and C-reactive protein concentration in an representative population of the
United States after adjusting for age, gender, ethnicity, education etc. Glowinska et al.
(204) in their study on children with obesity, hypertension and diabetes have concluded
that they often originate from families with CVD history. Leander et al. (205) have
demonstrated that family history of coronary heart disease is not only a strong risk factor
for myocardial infarction in both sexes but they also referred to its synergistic effect
with other CVD risk factors. Thus Williams et al. (206) have recommended CVD family
history collection as a validated and inexpensive tool for identifying high risk people in
the population-based preventive programmes and research. Based on this background a
rapidly growing field in cardiovascular genetic medicine is emerged to identify and
understand cardiovascular conditions resulting from genetic mechanisms that are
inherited. (207) But even with the accelerating pace of progress still family history
merits further investigation as a public health tool which might save millions of lives
and improve quality of life for many more.
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2.4.11 Socio-economic factors
CVD and its related risk factors show a clear socio-economic (SES) gradient and
highest prevalence of several CVD risk factors has been indicated to be found in those
groups of population which have low socio-economic status (SES). (208-212) Different
hypothesis have been formulated to explain this variation but the causal pathway itself
requires further investigation to determine the contribution of SES determinants in
shaping health status. This ambiguity in theoretical backbone of the findings should not
only lead us to ignore SES as an independent co-factor in population based studies on
the prevalence of CVD but it gives rise to concern that the gap between high and low
SES sections of population should be filled. Alder et al. (213, 214) suggested that SES
may affect health status through three pathways: health care, environmental exposure,
and health behaviour. In order to work out effective strategies to combat CVD it is very
important to determine which groups of population are in added risk of CVD and to
what extent the higher risk is related to the values, attitudes and motivations and to what
degree it is linked to lower standards of health care in the deprived groups of a
population.
Socio-economic status generally is included in epidemiologic studies as a background
variable but difficulties of collecting sound data in different communities and also
interpretation of available data may restrict reliability of the study findings. (215) There
are some discussions about applicability of different SES indicators in optimal
prediction of health outcomes. (216, 217) Daly et al. (217) have argued in a longitudinal
study that economic indicators of SES can be applicable as effectively as other SES
conventional indicators like education and occupation to predict probability of mortality.
Such a conclusion is consistent with the findings of the study conducted by Metcalf et al.
(218) They have suggested according to their study results that household income is
more strongly associated with the cardiovascular disease and diabetes risk factors than
the individual's occupation or level of education per se. In another study by Metcalf et
al. (219) it has been shown that raised blood pressure was associated with level of
education and prevalence of diabetes mellitus with income. Bringing in mind all these
complexities there is also some evidence (220, 221) which posits that adding ethnic
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classification to the equation of SES may further hinder interpretation of findings in
population based studies. Acheson (222) and Marmot (223) for instance have raised the
issue of socio-economic differences between ethnic minorities and White population in
the UK. In the Acheson's report (222) for instance, while just under a third of White
households were indicated to live in poverty it was suggested that a third of Chinese,
two-fifths of African Caribbean and Indian households and four-fifths of Pakistani and
Bangladeshi households to have less than half of the average households' income.
Referring to the findings of this and other similar studies Marmot (223) have suggested
that more attention should be on setting targets and policies for reduction of health
inequalities rather than repeatedly emphasizing the magnitude of health inequalities.
Therefore, irrespective of practical difficulties which may occur in determining SES of a
specified population group and regarding the overall role of SES in the epidemiology of
CVD all initiatives should be targeted on understanding the socio-economic pattern of
CVD and thus on reducing inequities between advantaged and disadvantaged groups in
all countries.
2.4.12 Diversity in cardiovascular health among ethnic minorities:
examples of new ideas in the context of possible contributing CVD
risk factors
In addition to the conventional CVD risk factors major efforts have been made in
recent years to study possible effect of genetic or mixtures of environmental factors in
the observed diverse CVD risk profiles among ethnic minorities. Therefore, several
hypotheses developed to explain the reported variations in cardiovascular health among
ethnic populations. But the ongoing debates to justify such differences and lack of a
widespread consensus among the researchers represent the ambiguities that need to be
clarified.
Some researchers suggested that genetically mediated anatomical differences are key
factors in the reported variations of CVD profile among ethnic groups. Sniderman et al.
(224) have suggested that the smaller superficial subcutaneous adipose tissue
compartment might be influential in south Asians to develop the metabolic
complications of upper body obesity at lower overall masses of adipose tissue compared
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to the European White population. Natori et al. (225) have referred in their study to
lower values of left ventricle (LV) mass and volumes among Asian-Americans
compared to general White, African-Americans and Hispanics after adjustment for
body surface area. They have discussed that lower values of LV mass and volumes can
be regarded as a subclinical cardiovascular risk factor which may predict progression of
a symptomatic CVD in the later stages of life. Kronmal et al. (226) have suggested that
coronary artery calcium (CAC) progression as a predictor for CVD is more prevalent in
White American than the Blacks, Hispanics and Chinese. In this study low creatinine
was associated with higher risk of incident CAC. Creatinine is a breakdown product of
creatine phosphate with an important energy store role in skeletal muscle. It is usually
produced at a fairly constant rate by the body and filtered mainly by the kidney. If the
filtering of the kidney is deficient, the blood levels rise. (227)
Markus et al. (228) have discussed possible influence of genetic factors in the
development of stroke and indicated that the Black patients with stroke were
significantly younger and had higher prevalence of hypertension, diabetes and obesity.
They have highlighted the major differences in the distribution of stroke subtypes
between Black and White patients. Based on the findings they have concluded that the
stroke resulting from small vessel disease was markedly prevalent in Black patients
whereas large vessel disease stroke was more common amongst White population. They
have suggested that these differences can not be fully explained by differences in the
conventional CVD risk factors.
Lear et al. (229) in their study to explore association between visceral adipose tissue
(VAT) and carotid atherosclerosis have suggested that influence of obesity (defined by
body mass index of >30 kg/m2) on CVD might be mediated through VAT. They have
suggested that increase of VAT reduces insulin sensitivity and supplies free fatty acids
into the hepatic circulation and thus stimulates the release of apolipoprotein B (the
primary component of low density lipoproteins that can cause atherosclerosis). (230-
232) Lear et al. (229) have measured in their study the extent of coronary calcification
and carotid artery intima-media thickness (IMT) using ultrasound scans. They also have
used a computerised tomography scanner (CT) to measure VAT and subcutaneous
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abdominal adipose tissue (SAT). Thus they have concluded that having a low VAT but
high waist circumference may not be an excess risk for atherosclerosis. Accordingly
they have suggested that while VAT represents only 10% of adipose tissue in women
but accounts for 20% in men at a given age, greater amount of SAT in younger women
may also have a protective effect. They also have discussed that with age VAT of
women tends to increase and reach to the levels of men. Through highlighting the
relation between VAT and growth factors that may affect artery wall thickening, they
also have suggested that VAT may have a greater role in IMT than the development of
atherosclerotic plaque. According to the findings of this study the association between
VAT and IMT is independent of waist circumference and waist-to-hip ratio. Release of a
number of pro-inflammatory cytokines which stem from adipose tissue in the absence of
acute inflammation was also suggested to lead to CVD in the literature. (233, 234) All
these findings support the idea that with increased VAT even regardless of BMI,
probability of developing CVD will increase. Moreover findings from a number of
studies have verified that even with a BMI level in the normal range an increased waist
circumference or waist-to-hip ratio may cause CVD. (235, 236) According to the
findings of these studies neither waist circumference nor waist to hip ratio can reflect the
total amount of CVD risks in a person or community. Therefore, variations in
susceptibility of different ethnic groups to develop CVD must be scrutinised further not
only by focusing on their life style but also more precisely by investigating physio-
anatomical characteristics of divergent ethnic groups. Thus, even widely used cut off
points for clinical and para-clinical indices such as BMI, waist circumference, waist to
hip ratio, blood pressure levels and lipid profiles need to be validated for ethnic
minorities as recommended by Razak et al. (237) and Stein et al. (238) Otherwise
detection and reporting bias will affect our conclusions and thus policy making will be
encumbered to provide equal access to health and health care for ethnic groups.
Genetically mediated variations in the blood biochemical factors also were suggested
to explain ethnic diversities in CVD risk profile. Reynolds et al. (239) have raised in
their study the issue of substantial lower Cortisol concentrations in South Asians
compared to Europeans. A positive association was found in this study between morning
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Cortisol levels and presence of cardiovascular risk factors in both South Asians and
Europeans. According to the findings of this research, among South Asian subgroups,
Bangladeshis have highest Cortisol concentrations.
Jerrard-Dunne et al. (240) have discussed ethnic differences in markers of
thrombophilia and suggested that the Black Africans have significantly lower protein S
(a vitamin K-dependent plasma glycoprotein which is synthesised in the liver and has a
major role in the anti coagulation pathway) (241), protein C (a vitamin K-dependent
enzyme with a major physiological anticoagulant effect) (242) and anti-thrombin III (a
glycoprotein which is produced by the liver and can inactivate several enzymes of the
coagulation system) (243) compared to indigenous White population. They have
concluded that these variations may explain the excess stroke risk in Black Africans.
Kanaya et al. (244) have indicated racial differences of serum adiponectin (a bioactive
peptide which is secreted by adipose tissue and can influence inflammation, coagulation,
and endothelial function as well as glucose and lipid metabolism) in Black and White
Americans. Adiponectin levels was shown to be positively correlated with lipoprotein
lipase activity and as an indication of lipase genes variations among the races, Kanaya et
al. (244) have concluded that Black Americans have higher lipoprotein lipase activity
and reduced hepatic lipase activity compared to Whites. They also have suggested that
while this variation should contribute to the favorable plasma lipoprotein profile and
lower level of visceral fat but on the other hand possible role of the high-molecular-
weight form of adiponectin in lipase activity should not be disregarded. Thus they have
discussed that Black Americans may have lower proportions of the high molecular-
weight adiponectin relative to the total circulating adiponectin concentrations. As a
consequence, they have argued that regulation of lipoprotein lipase activity slows down
among Black Americans which in turn decreases favorable lipoprotein profile and
consequently increases risk of coronary heart disease. Concurrent with these results Lu
et al. (245) also have indicated significant variations of adiponectin levels between
African-Americans and Caucasians. African-Americans in this study had lower levels of
the adiponectin which is similar to the findings from another study conducted by Hanley
et al. (246) to compare this ethnic group with Hispanics.
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Race/ethnicity effect on the interaction between serum leptin (an adipose tissue
originated hormone) concentration and myocardial infarction was also studied recently.
(247) Moreover serum level of C-reactive protein (CRP) (a marker of inflammation
which is produced by the liver and also by the smooth muscle cells of coronary arteries
in response to an inflammatory episode) was indicated to be influenced by race and
ethnicity and therefore suggested to be applicable in predicting future CVD risk. (248,
249)
Differences in lipoprotein particle sizes have been introduced as another hypothesis to
justify racial variations in CAC which is not convergent with the results of the study
carried out by Aiyer et al. (250)
Homocysteine is a sulphurated amino acid and a natural by-product of a chemical
reaction in blood which can prohibit production of collagen and elastin, two main
structural proteins in arteries. (251) It is suggested in the literature that deficiencies of
folic acid (B9), pyridoxine (B6), cyanocobalamin (B12) or a pre-existing atherosclerosis
and diabetes can lead to high homocysteine levels which is believed to be a risk factor
for CVD. (252-254) Albert et al. (255) on their study on women without a history of
CVD have indicated that homocysteine is lower in Asian women comparing to Whites,
Hispanic and Black American women. Even so Cappuccio et al. (256) reported that
Indians have significantly higher levels of homocysteine than Whites, West Africans and
Caribbeans residing in UK. These heterogeneous results are indicating insufficiency of
studies to investigate race/ethnic variation of homocysteine level and other blood
biochemical markers. Hence, more studies needed to be done to prove the association.
Possible effect of some behavioural and environmental factors like using toilet in
squatting posture, vitamin D deficiency, infection and the combined impact of smoking
and tobacco chewing among South Asians to have higher risk of stroke were suggested
by Bhopal et al. (257).
Other aspect of diversity in cardiovascular health of ethnic groups can be explained by
implicit race/ethnicity bias (unconscious) in unequal accessibility of preventive health
measures or proper treatment ofCVD patients belonging to a certain ethnic group. Such
a bias in favour of White American patients to receive thrombolysis was reported by
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Green et al. (258) and Jha et al. (259) Similar failure also was seen in the equal treatment
of Black Caribbean patients in the UK to reduce blood pressure, total cholesterol and
haemoglobin Ale (HbAlc is a glycosylated haemoglobin molecule) level. (260) A part
of this bias may emanate from race/ethnic CVD awareness gap (261) or lack of thorough
knowledge of the health care providers about existing diversities in the CVD
predisposing factors among ethnic groups. This deficient knowledge itself was
represented well in the unequal number of cardiovascular studies on original White
American or European population in comparison to ethnic populations settled in these
continents from decades ago. (262)
To summarise, all above discussed hypotheses are based on ethnic variations in:
Superficial subcutaneous adipose tissue compartment (221)
Values of left ventricle mass and volumes (225)
Coronary artery calcium (CAC) progression (226)
Cortisol concentrations (239)
Protein S, protein C and anti-thrombin III levels (240)
Serum adiponectin levels (244, 245)
Serum leptin levels (247)
C-reactive protein levels (CRP) (248, 249)
Homocysteine levels (255)
Vitamin D levels (257)
Obviously more work need to be done on these and other possible hypotheses before
their practical application in interventional initiatives. But whether the observed
differences were provoked by unconscious bias, behavioural and environmental factors
or due to real genetic differences among ethnic minorities, their presence indicates a
failure to follow best practice standards both in our research and health care delivery
systems.
2.5 Techniques to recruit hard-to-reach populations
Hard-to-reach population is a term used to describe those sub-groups of the
population that are difficult to reach or involve in research or public health programmes
due to their physical and geographical location (e.g. in mountains, forests or deserts) or
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their social and economic situation. (263) An alternative term 'hidden population'
sometimes used in the literature especially to refer to those who do not wish to be found
or contacted (illegal drug users or migrants, homeless people etc). (264) Application of a
single term to call these sub-sections of populations implies a homogeneity within the
distinct groups which does not exist necessarily. (265) Hard-to-reach populations may
also actively try to conceal their group identity (266) due to fear of confrontation with
legal authorities (e.g. drug users) or simply because of social pressure they feel from
other members of the broader community. Hard-to-reach populations may be
characterised by a group of disadvantage attributes such as illiteracy or being
uncooperative but this is not the case in all circumstances and for all hard-to-reach
populations. In addition, even with distinguishing hard-to-reach populations by these
underprivileged features we should try to avoid stigmatising of this terminology.
It is suggested that faith based communities and newly arrived residents are among the
hard-to-reach populations. Over-consulted people also have been suggested to be
generally reluctant to participate in research. People who feel are disconnected from the
mainstream political process also were added to the list of hard-to-reach groups. (267)
Migrants are also among world's most hard-to-reach people due to their clustering on
the host communities, living in temporary camps, cultural separateness or simply
because of difficulties an outsider may experience to access the social network of an
special migrant group. (263)
The degree of compliance with a study by a certain hard-to-reach group depends on
the characteristics of that group, recruitment method used and the subject of interest. A
group may be hard-to-reach in some extents and locations and not in all circumstances.
(267) Even when studies are explicitly designed to reach socially excluded groups
researchers generally face with challenges in recruiting enough number of study
participants in practice. (268) Cultural, economic and social factors or lack of a sampling
frame can raise barriers to access a special subgroup of a population. Different sampling
techniques were introduced so far to recruit hard-to-reach populations. Widely applied
techniques, their advantages and disadvantages were summarised below using views of
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the authors in the corresponding references. My overall judgement about the discussed
techniques is provided in section 2.5.8.
2.5.1 Snowball sampling
Snowball sampling is a non-probability method used when the desired sample
characteristic is rare or when the studied population is broader and more heterogeneous
than that can be easily accessible through other more reliable sampling methods. (269)
It is not always possible to undertake a probability method of sampling when for
example there is not a complete or easily accessible sampling frame which is common
for certain groups of population including migrants. (270) In these circumstances it can
be very difficult or expensive to recruit study subjects. In the snowball sampling method
reliance is based on referrals from initial known subjects to recruit new additional
subjects. This method is often used when population under investigation is hard-to-reach
due to their special characteristics or sensitivity of the study subject. (271) The known
cases may be contacted to acquire needed data. If these known cases mutually agree to
participate in the study they will be asked to nominate and facilitate introductions to
other people whom they know according to the interpersonal relations and connections
between people. Accordingly the introduced nominee will be contacted and invited to
participate in the study and if consent he or she is asked to introduce other people who
fulfil the study inclusion criteria. (269, 271)
This strategy is regarded as a solution to the problems which generally arise when
sampling concealed populations. (264) Basic assumption in the snowball sampling is
that a link exists between the initial known subjects and others in the same target
population. If this assumption is accurate it will allow a chain of acquaintance to be
created originating from primary contacts. (264) Main value of the snowball sampling is
its usefulness where some degree of trust is needed to initiate study subjects' recruiting
process. Limited validity of data resulting from selection bias is the most important
consideration for snowball sampling. Therefore findings from data gathered through
snowball sampling were suggested not to be generalisable to the whole population. It is
also discussed that in snowball sampling emphasis is on the inter-relationships which
isolates those who are not connected to any social network and thus are under-
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represented in the sample. The problem of selection bias is recommended to be solved
relatively through selection of large sample and also by replication of results. (264)
2.5.2 Respondent-driven Sampling (RDS)
As Heckathorn et al. (272) stated main criticism about chain-referral or snowball
sampling is bias toward recruiting more cooperative subjects and masking which is
protecting close friends or relatives by not referring them when specially there is a
strong privacy concern associated with the subject of the study. It is also suggested that
those with extended personal networks to be over-sampled and isolated people to be
excluded in the study.
Developed by Heckathom (273) in 1997, RDS is a form of chain-referral sampling that
was designed to eliminate above mentioned sources of bias that are not inherent in the
method. In order to lengthen recruitment procedure three mechanisms were suggested to
be employed in RDS. These are; use of recruitment incentives (payment for participation
and also for recruiting peers), limiting the number of recruits permitted per participant
and not violating participants' confidentiality by letting them decide whether to become
known to researcher or not (respondents should be recruited by their peers rather than by
researchers). (272) RDS combines snowball sampling with a mathematical model that
weights the sample to compensate for the fact that the sample was collected non-
randomly. (273) But still many open questions remain with RDS including bias which
can emerge from variable recruitment success rate by different types of people in an
individual study. (274)
2.5.3 Indigenous field worker sampling (IFWS)
In this sampling method instead of using formal trained interviewer, interviewers
are selected from local community. Then they undergo special training relevant with
objectives of the study including interview skills and fieldwork protocol. The selected
people should have privileged access to the study target population. (275, 276) It is
believed that use of this technique can reduce masking, volunteer bias and under¬
reporting of socially undesirable behaviours. (277, 278)
The indigenous fieldworkers track down individuals known to them within the target
area and recruit them into the study. Interview takes place in the community setting
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separate from the rest of research team. An incentive is given to participants and they are
asked to introduce their peers to the interviewer. To insure wide coverage of the target
population use of multiple sites and recruitment networks is recommended.
Interviewers' safety and steady progress of recruitment process are main reported
concerns. (275)
2.5.4 Facility-based sampling (FBS)
Facility-based sampling refers to recruiting members of target population from a
variety of facilities including correctional and drug treatment centres, sexually
transmitted diseases clinics or general health centres and hospitals in certain sub-urban
areas. (279) Each of these facilities can be used to recruit individuals from hidden
population but similar biases may occur due to under-sampling of those who are
reluctant to seek and obtain services especially when their behaviours are stigmatised.
Other limitation for this sampling method is that in many part of the world particularly
in less developed countries dedicated services to high risk groups are not common and
even where provided; equal access to them by deprived sub-groups of population is not
guaranteed. (279)
2.5.5 Targeted sampling (TS)
Targeted or purposive sampling method has been developed to overcome the
limitation of snowball sampling when we would like to include specific pre-defined
subgroups of population in our sample. (279, 280) This sampling method generally
includes an initial assessment aimed at identifying the various subgroups that might exist
in the population of interest. The identified subgroups are then regarded as sampling
strata which should have a pre-defined quota in the final sample. The magnitude of
success in this sampling method depends mainly on thoroughness of the initial
assessment and to some extend the time and resources available for its undertaking.
(279) Application of this method can reach readily accessible subgroups very quickly
(281) but on the other hand reaching isolated people will be very time consuming and
therefore expensive.
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2.5.6 Time-location (space) sampling (TLS)
Some members of hidden populations e.g. migrant workers tend to gather at
certain types of location within the community and therefore time-location sampling is
used to recruit these groups of hard-to-reach populations at locations where they may be
found. (279, 282) Generally TLS begins with a formative phase of mapping different
venues and establishments where individuals from hidden groups are known to
congregate. The mapping generates a sampling frame of venues and time periods
through which recruitment of individuals from a specific group of a hidden population
will be possible. (283, 284) At later stage the sampling frame is divided into venue-day¬
time increments that form the unit of random sampling. (283) These steps are necessary
to ensure inclusion of individuals with varying venue and time attendance patterns. (284)
It is suggested that bias due to masking and chain-referral selection of study
participants is eliminated in TLS (282) however, unless a high percent of venues where
members of hidden populations gather are identified and a very high percent of members
from target population visit such locations, TLS also can suffer from potentially
considerable bias. Isolated people for instance who do not visit such locations will be
under-represented in the sample. (279)
2.5.7 Conventional cluster sampling (CCS)
Conventional cluster sampling can be applied in limited circumstances to recruit
hard-to-reach population. Cluster sampling is reasonable when there is no list of people
to be selected but a good list of locations where individuals from hard-to-reach group are
gathered. Primary presumption for use of this sampling method is that the distribution of
the variable of interest is similar between locations (clusters). (279, 285) Clusters then
are randomly selected for data gathering and thus recruitment costs will be minimised
since the number of locations from which recruitment take place reduces. Clusters can
be perinatal clinics, drug treatment centres, restaurants or health centres. Other
requirement to be met in using this method is the possibility of ready access to all
individuals from the population of interest in the clusters; otherwise cluster sampling
will be an infeasible option to reach hidden populations.
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2.5.8 Recruitment of hard-to-reach populations: a holistic approach
beyond techniques
To sum up and irrespective of potential advantages or limitations of the discussed
techniques, their successful use depend mainly upon our knowledge about specific
characteristics of a target subgroup within a larger population. Without having such
essential information it is very difficult to clarify which method will work best to recruit
different hard-to-reach populations in varying settings and circumstances. Moreover our
current knowledge about the recruitment techniques is based on their application in a
wide range of topics and mostly within socially, culturally or behaviourally homogenous
population subgroups. People belonging to a specific ethnic minority may be classified
socially and culturally in a wider spectrum and are not necessarily homogenous. Thus in
line with attempts to expand the current boundaries of our knowledge about recruitment
techniques and their applications in varying situations, we should also focus on possibly
all contributing factors which may have an impact on participation rate within a defined
ethnic minority group.
2.6 Interpersonal access to the data: issues and barriers
Studies on hidden populations raise a number of issues which are usually less
important when doing research involving known populations. Hard-to-reach populations
are generally floating populations and socially invisible thus gaining access to them
poses major barriers for their recruitment. (286) Sensitivity of the variables under study
also adds to the potential difficulties a researcher may face when working with hard-to-
reach groups. Even after reaching and recruiting an individual from a hidden population
actual or perceived threat from legal authorities when doing research on stigmatised or
illegal behaviours can increase probability of concealing identity, a particular behaviour
or characteristic.
People may not agree to cooperate in a study if they feel their anonymity may be
violated by their participation. Even after consent to be a participant he/she may refrain
from giving correct answer to the questions. In order to overcome these difficulties use
of peer interviewers (an insider vs. an outsider) (287) and also being very careful and





An insider can generally better understand para-verbal (the way people say the words)
and nonverbal (body language) messages in addition to the language hard-to-reach
people apply when talking about their status. Cultural differences in beliefs towards
health and health related practices also can be more understandable for a peer
interviewer than an outsider.
2.7 Evidence based research: dilemmas and debates
Evidence based research (EBR) in health and medicine is a methodological
approach to make research proposals based on an intimate knowledge in order to
maximise efficacy of the investments to answer research questions or investigate
scientific hypotheses. Therefore the ultimate goal of EBR is to improve health care and
policies. Ubiquity of error in health care settings and unjustifiable variations in practice
are indications of challenges we are still facing in this field. (288)
EBR focuses attention on the consequences of unsystematic research planning as
grounds for decision-making in public health. In the absence of a sound foundation,
public health policies lack scientific credibility which is vital for their successful
implementation. (289) Planning of an evidence based research involves identification,
evaluation and application of scientific evidence which was produced based on previous
works in the field. This process of reviewing and evaluating the scientific literature was
called systematic review which aims at evaluating and interpreting all relevant evidence
available to answer a particular question. (290)
Lack of this comprehensive approach to find and include all available evidence in
research and consequently in decision making about health policies can delay important
and useful developments in science and thus necessary revisions in health delivery
systems. As an example more than 50000 babies in Europe have died due to sudden
infant death syndrome (SIDS) from the 1950's into the 1990's following an advice given
in a best-selling book to put babies to sleep on the prone position. (291) While even that
time there was sufficient research evidence from scattered studies suggesting adverse
effect of the recommended sleeping position on SIDS.
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2.8 Systematic review and meta-analysis: prerequisite to evidence
based research
Evaluation of scientific literature can range from narrative reviews which are very
subjective and prone to major biases to highly formal syntheses of best available
evidence. In a systematic review previous studies of interest are identified, assessed for
quality and synthesised to investigate the consistency of an overall outcome measure.
(290) Major difference of a systematic review with a narrative review is its transparency
with regard to the identification, appraisal and synthesis steps.
With current increase in the number of conducted and published studies it is extremely
crucial to make research steps very clear to the audiences. Otherwise two reviews on the
same topic may come to divergent conclusions without any chance for readers to realise
the perpetrating reason(s). In systematic reviews explicit and rigorous methods are
employed to clarify the whole truth about a scientific phenomenon and not a part of truth
which can be confusing and misleading. A reliable systematic review will be invaluable
for us to keep up to date and realise boundaries of current knowledge. (292)
Statistical synthesis of pooled data from studies that have attempted to answer same
questions is called meta-analysis. It is an analytical method to integrate different studies
together and pool their results into a single common result. (293) Two basic models can
be applied to integrate different studies in a meta-analysis: fixed effect model in which
homogeneity of the studies are assumed and random-effects model which avoids the
homogeneity assumption. (294) Mixed effect model is the combination of fixed and
random effects model which is also applicable when dealing with subgroup analysis in a
meta-analysis. (295)
A rational decision can not be made without having in depth information about
possibly every aspect of health issues. Therefore systematic review and meta-analysis
are considered to be the fundamental scientific activity in practising EBR. Development
of the Campbell and Cochrane collaborations to prepare and maintain systematic
reviews of research on health related issues reflects the surge of interest in systematic
review and meta-analysis internationally. (296)
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In this chapter it has been indicated that CVD is a global threat despite considerable
development of our knowledge about its aetiology and prognostic implications. It is also
discussed that a widespread diversity exists among different population groups regarding
CVD and its contributing risk factors. Such a gap between migrant and general
population in destination countries was the subject of attention in recent years.
Complexity in measurement of CVD risk factors and lack of standard methods that can
be applicable in socially and culturally divergent groups have created a list of
unanswered questions that need to be scrutinised. Moreover difficulties in recruitment of
migrants into population based CVD studies even added further discussion on this topic.
With such a background and to gain experience and leam lessons from other
population-based studies on Iranians living abroad a systematic review has been
conducted on the recruitment methods and health related themes of research. The
ultimate goal of the systematic review was to aid planning and implementation of
reliable, new population-based studies on Iranians overseas. The protocol and results of
this systematic review is provided in the next chapter.
2.9 Summary
Our knowledge about determinants and consequences of cardiovascular diseases
(CVD) have extensively improved in recent years but still CVD takes lives of more
people than any other disease in several countries of the world. With recent accelerated
pace of migration from developing world a sizeable number of ethnic groups were
formed in the developed countries. Distinct divergences in CVD mortality and morbidity
rates have been reported in the immigrant population of these countries. This disparity
was attributed in the literature to genetic, differences in the associated risk factors and
the variations in the socio-economic or environmental features. However; a considerable
amount of uncertainty still remains to be resolved.
Migrants are among the world's most hard-to-reach people due to their clustering on
the host communities, living in temporary camps, cultural separateness or simply
because of difficulties an outsider may experience to access the social network of a
special migrant group. Complexity in measurement of CVD risk factors and lack of
standard methods that can be applicable in socially and culturally divergent groups have
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created a list of unanswered questions that need to be scrutinised. To make health
policies based on an intimate knowledge and to maximise efficacy of the investments to
answer research questions, employment of evidence based research (EBR) approach in
research is vital. In the absence of a sound foundation, public health policies lack
scientific credibility which is crucial for their successful implementation.
To gain experience and learn lessons from other population-based studies on Iranians
living abroad to aid planning and implementation of reliable, new population-based
studies on Iranians overseas a systematic review has been conducted on the recruitment
methods and health related themes of research. The protocol and results of this
systematic review is provided in the next chapter.
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Chapter three: A systematic review of the methods and themes
of health-related research on the Iranian
Diaspora *
3.1 Introduction
In the previous chapter global burden of cardiovascular disease and diversities in
cardiovascular health among migrant populations were discussed. It was also indicated
that migrants are among hard-to-reach population and thus researchers generally face
with challenges in recruiting them into health studies. It was suggested that a growing
number of Iranian migrants dispersed within the general population mostly in the
European countries and North America. The research evidence on which to base health
care planning and provision decisions for the Iranian Diaspora is, however, very limited.
This chapter describes the protocol and results of a systematic review that was carried
out on methods used in population-based health research on Iranians abroad in order to
learn lessons to apply to future planned epidemiological researches.
3.2 Background
Researchers are, through studying ethnic groups as discrete communities,
endeavouring to improve health status and reduce health inequalities, as mandated by
health policies and equal opportunities legislation. They are however frequently
encountering problems in the implementation stages, this is notably manifesting as a
failure to identify and recruit the planned number ofparticipants.
* Findings of this systematic review were published earlier as an article (see appendix
one). (297) Professor Raj S. Bhopal, Professor Aziz Sheilch and Dr Farshid Namdaran
had a major contribution in drafting of this article.
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There are many potential explanations for this, including lack of knowledge about the
sociocultural features of each individual ethnic group. A rigorous look at recruitment
strategies and sociocultural attributes of potential participants is therefore extremely
important in the planning phase of research on ethnic minority groups.
There is an enlarging Middle Eastern Diaspora and as stated in chapter one Iranians
are one of the major subgroups. Iranian migrants are generally wealthy and educated
comparing to the source population or to the population of other minorities e.g.
Caribbean, Bangladeshi and Pakistani groups in destination countries. According to the
statistics given by official resources at least 428,386 Iranians (36-45) migrated to the
Australia, Austria, Canada, Denmark, Germany, Netherlands, Norway, Sweden, UK and
United State during 1990-2005. However, the actual number ofmigrants having Iranian
origins is likely to be more than official reports since these figures do not represent
asylum seekers and illegal immigrants. Yet the number of population-based health
studies on Iranians abroad is small. Iranians are dispersed within the general population
in the destination countries and have no easily identifiable names or surnames, these
factors possibly contributing to the dearth of such studies. Iran itself is a multi-ethnic
and multi-cultural country and this background diversity is reflected in the language,
lifestyle and living conditions of Iranian migrants overseas. Conducting population-
based studies on this minority group is therefore challenging.
The lack of studies on Iranian migrant population is believed by some researchers to
reflect a lack of willingness of Iranians to participate in research for reasons including
fear of being identified, particularly among political migrants. (298, 299) There is
however no reliable summary of the empirical literature to substantiate this assertion.
Based on the recommended structure (PICO: Population, Intervention, Comparison and
Outcome) explained by Glasziou et al. (290) the study question was framed in a
systematic review to provide sound evidence about any possible reservation
(phenomena) Iranian migrants (population) may have to participate (outcome) in health
studies. The review aimed to gain experience and leam lessons about successful
recruitment methods of Iranian migrants into population based health studies. Result of
this systematic review can aid planning and implementation of reliable, new population-
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based studies on Iranians overseas. The review focuses on sample size and recruitment
strategies and also assesses the range of topics covered and hence both the range of
themes already studied and those that remain unstudied. The main question of this
review is how other researchers have reached and recruited Iranian migrants into
population based health studies. Ultimately the review aims to help treat Iranian origin
minorities equally in relation to research and access to health and health care. To the best
of current knowledge, this systematic review is the first review of the recruitment
methods in this population.
3.3 Methods
3.3.1 Types of studies
The protocol of this systematic review was planned based on the MOOSE (Meta
Analysis of Observational Studies in Epidemiology) guidelines. (300) The MOOSE
guidelines include a checklist summarising recommendations for reporting meta¬
analyses of observational studies. All population based quantitative studies, qualitative
researches and social surveys on free-living Iranians (not those living in institutions)
residing abroad (settled in a permanent base, so excluding students overseas) were
eligible if they were:
- Published in English or Persian.
- Reported sample recruitment strategy, sample size and data collection technique.
Systematic reviews of observational studies usually exclude qualitative studies.
Although qualitative studies may not contribute to synthesis of quantitative
epidemiological studies, in view of the suggestion that the lack of studies on Iranian
migrant population may reflect a lack ofwillingness of Iranians to participate in research
for reasons including fear of being identified, particularly among political migrants, it
was judged that qualitative studies on Iranians could be a rich source of understanding
about their possible reluctance to participate in research and highlight methodological
barriers to recruiting Iranians overseas into population-based studies. Thus such studies
were included.
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3.3.2 Types of data
Types of collected data included the following:
- Demographic characteristics of studied sample (age, sex, status of residency
and current place of living)
- Sampling approaches in the eligible studies (sample size and recruitment
strategy, sampling methods, sampling frame)
- Study features (researcher, study subject and type, data collection technique and
study implementation year)
3.3.3 Types of outcome sought
Topics covered by studies.
- Number of studies on Iranians living abroad by country.
- Number of studies having good quality information on methods (sample size,
sampling method, sampling frame and recruitment criteria of subjects).
- Type of recruitment strategies.
- Response rates.
- Main lessons from eligible studies that may help planning of future studies on
Iranians abroad.
3.3.4 Search strategy
The free text and MeSH (Medical Subject Headings) indexing terms (Appendix
two) were used to search the following databases that were considered to be most
relevant in terms of this systematic review's objectives:
- AMED (Allied and Complementary Medicine) (1985 to April, 2006).
- CINAHL (Cumulative Index to Nursing & Allied Health Literature) (1982 to
March week 5, 2006).
- EMBASE (1980 to week 13, 2006).
- Ovid MEDLINE(R):
- (1950 to 1965).
- (1966 to April 07, 2006).
In-Process & Other Non-Indexed Citations (April 06, 2006).
- CAB Abstracts (1973 to March 2006).
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- Global Health (1973 to March 2006).
- Index to theses (A comprehensive listing of theses with abstracts accepted for
higher degrees by universities in Great Britain and Ireland since 1716) (1716 to
March 06, 2006).
- National Research Register (UK).
- International Bibliography of the Social Sciences 1951 to April week 01, 2006).
Other electronic resources such as web pages of ethnicity related organisations or
official health organisations of countries known as having a fair number of Iranians and
potentially pertinent Internet sites (Google) were searched for unpublished materials.
The review was limited to English and Persian language studies published between
1950 up to April week 01, 2006. The titles and abstracts of all retrieved records were
checked to distinguish relevant articles. Articles were excluded on initial screening if the
title and the abstract showed that they were not reporting population-based studies on
Iranians. When a title or abstract could not be rejected with certainty, the full text of the
article was acquired for further assessment. For those studies that were potentially
relevant, full papers were secured. References of relevant articles were inspected. Studies
were recognised through serendipitous discovery also included in this systematic review.
Researchers (Dr. Sirous Momenzadeh, Dr. Freidoon Khavarpour, Professor Haakon
Meyer) well known to do work on Iranian ethnic groups were contacted for references.
Reference manager software (version 10) was utilised and the duplicate entries were
deleted. A data extraction sheet was used for summarising included studies (Appendix
three). These studies were also assessed for their quality according to the internal and
external validity criteria (Appendix four).
3.3.5 Data extraction
All relevant data in the articles were extracted into the data extraction form. A
description of the problems encountered by the researcher(s) in recruiting the study
sample or recommendations to increase participation rate were also derived.
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3.3.6 Data presentation
Data were tabulated chronologically by country of study and presented in
descriptive form. Response rate was calculated as percent of participants in the study in
relation to those intended to participate by the researcher.
3.4 Results
QUOROM (Quality of Reporting of Meta-Analyses) statement (300, 301) which is
renamed later as PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-
Analyses) (302, 303) was used to report results of this systematic review. 310 studies
(including duplicates) were identified mainly from AMED (1 article), CINAHL (11
articles), EMBASE (83 articles), MEDLINE (1966 to 07 April 2006) (109 articles),
CAB (1973 to March 2006) (35 articles), Global Health (1973 to March 2006) (29
articles) and International Bibliography of the Social Sciences (1951 to February week
01, 2006) (42 articles) (Figure 3.1).
Review of the titles of these studies identified 70 potentially pertinent articles. Review
of the abstracts lead to 24 studies (298, 299, 304-325) which met the inclusion criteria.
Full texts of these articles were obtained and 20 studies (298, 299, 304-321) met the
initial criteria.
A further 56 candidate articles (326-381) were identified by reviewing the references
of these 20 articles and 9 had potential for inclusion. (382-390) One study also resulted
from serendipitous discovery of unpublished work presented in the Sixth International
Conference on Preventive Cardiology at Foz do Iguagu, Brazil in 21-25 May of 2005.
Findings of this study published later in the European journal of cardiovascular
prevention and rehabilitation 2006. (391) Thus 30 articles were fully assessed.
An internal report from the Institute for Social Anthropology in the University of
Bergen, Norway (382) was not obtainable (the request was sent to the email address have
been given on the institute website). In six other studies (383-388) Iranians were a part of
study sample but they had been categorised in the group of "immigrants from other
countries'''' and not analysed separately. One article (389) was on college students but
since it was not clear from the full text whether these students were spending a length of
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Figure 3.1 The PRISMA flow diagram: number and status of the identified articles in the
systematic review of the methods and themes of health-related research on
the Iranian Diaspora
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Correspondence with other researchers did not add to the list of relevant studies. From
22 (17.3%) articles that met the inclusion criteria (298, 300, 304-321, 390, 391) seven
(306-309, 311, 312, 314) were publications from the Immigrant Survey of Living
Conditions in four minority groups of Sweden. Two studies from Australia, (305, 315)
two from Netherlands (310, 317) and two from Norway (318, 391) were also
publications based on data from same studies.
Since methodologies for sampling, recruiting and participation rate in several
publications from same study are identical it was decided to include one sample study
from each group of these publications. Thus 17 studies were excluded (Table 3.1) from
the list of retrieved studies and only 13 studies were the focus of this review as shown in
Table 3.2.
3.4.1 Studies reporting data
The topics included dental health, cardiovascular risk factors, sex roles, cultural
identity and acculturation, healthy behaviour, mental health, vitamin deficiency and
research methods.
Eight studies (298, 304, 305, 313, 316, 319, 320, 390) were implemented by authors
with Iranian names. They took place in six countries: Australia with two (15.4%),
Canada with one (7.7%), Netherlands with one (7.7%), Norway with one (7.7%),
Sweden with two (15.4%) and United States with six (46.1%) studies. In the Canadian
study methods for creating a list of Iranians through linking specific surnames and given
names were described. Sample size among the other twelve studies was in the range of
10-413. Convenience sampling, (298, 299, 304) snowball sampling method, (305, 313,
319, 321) inclusive sampling (318) and random sampling method (307, 317, 320, 390)
had been used. Participation rate in studies that used snowball sampling ranged from
19% with postal questionnaires and 99% with telephone interview. The participation rate
in studies with convenience sampling method were 33.3-57% and in studies with random
sampling methods in the range of 21.3-68.1%. This rate in studies where inclusive
sampling was used was reported to be 38.8%. (318)
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The data collection technique, study site, use of translated or original questionnaires and
language in the interview is provided in Table 3.3. Postal questionnaire and face to face
interview were used simultaneously in 3 studies (298, 304, 321) (25%). In five studies
(41.7%) only face to face interview was used. (299, 307, 313, 317, 319) Telephone
interview was used in one study (305) (8.3%). Self administered questionnaires along
with clinical examination and para-clinical tests were applied in two studies (16.7%).
(318, 320) In one study (8.3%) only a postal questionnaire (390) was used.
Place for data collection among eight studies using face to face interview was not
reported in two (25%) articles, (298, 321) in four studies (50%) it was the participants'
homes (307, 313, 317, 319) while in two studies (25%) both participants' homes and
researchers' offices were used. (299, 304)
In two studies (16.7%) clinical data were collected (318, 320). Of six studies (50%)
where postal or self administered questionnaire were used (298, 304, 318, 320, 321, 390)
three (50%) did not refer to translated questionnaires. (298, 304, 390) In the remaining
three studies (318, 320, 321) translated questionnaire were applied.
Telephone or face to face interview was reported in nine (75%) studies (specifically or
in combination with other methods). In three (33%) studies (299, 307, 321) both original
and translated set of questions (optional) were used; and in one (313) only an English
version of a questionnaire was used during interviews. To answer interview questions,
interviewees in one study (313) used Persian, in four (299, 305, 319, 321) (44.4%)
Persian and English, in one (317) (11.1%) Persian and Dutch and in one (307) Persian
and Swedish. In two studies (298, 304) authors did not refer to the language of interview.
3.4.2 Studies on research methods on Iranians
Three studies (299, 305, 316) discussed methodological aspects of doing research
on Iranians abroad, as summarised in Table 3.4.
Rissel and Khavarpour (305) referred to obstacles to use more reliable sampling
methods among Iranian migrants e.g. being a small dispersed community within the
original population, not having ethnically identifiable names or surnames and sensitivity
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of study subject (e.g. sexual behaviour or illegal drug use). They recruited four bilingual
interviewers born in Iran representing different sub-groups of Iranians. Interviewers then
contacted eligible persons via telephone to encourage them to answer study questions
and to give telephone numbers of up to four adult friends or relatives (not immediate
family members) with a parent born in Iran. To avoid selection bias the number of
contacts each participant could suggest was limited. The project was also publicised
through the local Iranian radio station. The response rate was 99% (417/428). Interviews
took place in Persian in 90% and the remaining in English. The sample was similar in
regard to sex and age to residents born in Iran in the 1991 census of the Sydney
Statistical Area. The snowball sampling method generated a more educated and wealthy
sample than the population of migrants from Iran to Australia.
Higgins' review (299) referred to studies which indicate high educational and
economic status of Iranian migrants. She stated that residing in the same area does not
guarantee researchers contact with Iranians and that the offer of paying people for their
time is unlikely to increase participation. She reported strong suspicion among Iranians
of strangers asking questions and that only those with strong ties to the community can
be successful in research on this ethnic group. She referred to studies which reflected
participants' cooperation and eagerness to participate. Factors like appeals to national or
ethnic pride, choice of language and place of interview were helpful in convincing
Iranians to participate. She reported finding only one study where a formal informed
consent procedure was followed. In several studies a tendency among Iranian migrants to
present oneself, one's family and one's community in the best possible light had been
observed.
Higgins used a list of Iranian families' names, phones and addresses provided by
school administrators or Iranian networks to send letter or make a telephone call to
recruit Iranians. She consented of 101 families to participate, which was only one third
of the eligible families. She permitted the study participant to choose the language of
interview and between a non-Iranian and an Iranian interviewer. Most interviews were in
the family home but interviewer's office, participants' place of work and coffee shops
also were used. Participation rate reported to be one third of eligible families.
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Higgins concluded that Iranians were not over-sensitive, sceptical or cynical and were
typical of the Iranian community in the area. The commonest reason for refusal was lack
of time. She recommended that personal contacts and snowball sampling were the most
effective ways of recruiting Iranian migrants.
Yavari et al. (316) identified Iranians in British Columbia (BC), Canada. They listed
common Iranian surnames and given names from a local residential telephone book and
the Screening Mammography Program of BC database. They linked this list with the BC
Cancer Agency to identify Iranians who had been diagnosed with cancer. Sensitivity of
this approach to detect Iranians was reported to be up to 97% for surnames.
3.4.3 Population based studies on Iranian minority group: additional key
points from identified papers
In three studies (30%) only females were included (304, 320, 390). Two studies
(20%) were among Iranian refugees and asylum seekers, (317, 319) other studies were
on Iranian migrants. Iranians were studied in five studies with other migrants in a
collective sample. (307, 317-320)
Hanassab in her study (304) on Iranian women in Los Angeles, USA used a postal
questionnaire. There was selection of better educated persons from higher socio¬
economic backgrounds. Socio-economic difference between respondents and non-
respondents also was found to be a methodological limitation of the research by Wandell
et al. (306) Hjern and Grindefjord (307) reported that Iranians had the highest level of
education among migrants. They identified higher dropout rate in the minority sample as
one of their study's limitations.
The study of Wiking et al. (308) about self reported health among immigrants (including
Iranians) in Sweden revealed that people in older age groups, females and those living in
small cities are over represented in the study group. Among Iranian non-respondents
21% reported no income while in the respondents group it was 7%. Higher non-response
rate among immigrant groups than the Swedish control group was a stated limitation in
this study.
Iranian migrants residing around Iowa City, USA were sent a postal questionnaire or
interviewed in a study by Chaichian (298) Response rate to postal questionnaires was
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57% and participation rate for interview was 17.14%. Iranians who participated were
highly educated compared to the larger urban concentrations of Iranians.
Mahdi (390) mailed a questionnaire with 113 questions to a number of Iranian
families residing in 41 states of USA. The study target group included Iranian females
randomly drawn from address list of one cultural and two scholarly associations in the
US. Response rate in this study was 21.3% (excluding returned questionnaires due to
incorrect address). The sample was biased towards a more educated and professional
sample.
Barnes and Almasy (319) studied refugees' perceptions of healthy behaviours.
Overall participation rate for the study sample (including Iranians) was reported as 91%.
The study researchers suggested not including refugees from various parts of the world
in one sample without separating the data according to the similarities and differences
between groups.
In a qualitative study by Momenzadeh and Posner (313) snowball sampling was used
to recruit Iranians from different socioeconomic backgrounds in Australia. An English
version of the questionnaire was used but interviewees were asked to respond to
questions in Persian.
Lipson et al. (321) sent English and Persian (translated and back translated) versions
of a standard questionnaire to 200 selected Iranians of which only 19% were returned.
She suggested that this poor response rate could have resulted from distaste for written
surveys, a preference for face to face interview or mistrust of research among Iranians in
the San Francisco area.
3.5 Discussion
This is the first systematic review of recruitment methods in health studies of
Iranians living abroad. Relatively few studies were found but considerable heterogeneity
in the methodologies used. From 22 relevant articles, 13 unique studies met the inclusion
criteria. One reported methodology of linking two databases of names and surnames to
find Iranians. (316) In four articles there was missing information about important
aspects of the methodology. Place of data collection (298, 321) or application of
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translated versus original questionnaires (298, 304, 390) and language of interviews
(298, 304) had often not been declared.
The wide range of participation rates from 19% to 99% most likely represents both
differing recruitment and study methods. No single method of recruitment can be
considered a gold standard. Similar methods in varying circumstances lead to differing
results. For instance a random sampling method to recruit Iranian women resulted in
participation rate of 21% in one study (390) and 79% in another. (320) Snowball
sampling was reported to be a successful way to recruit Iranians. To avoid selection bias
where marginalised people are less likely to be nominated, researchers should limit the
number of contacts each participant could introduce. Snowball sampling generated a
more educated and wealthy sample than the general population of Iranian migrants in a
number of studies. Participation rate where snowball sampling was used to recruit
Iranian males and females (321) was reported to be as low as 19% and as high as 99%.
(305) In the study by Hjern and Grindefjord (307) face to face interview method in the
participants' home resulted in participation rate of 68% but in the study by Gerritsen et
al.(317) the participation rate was 53%. Factors at play in these variations include time
and place of study (country, city, district etc), migration status, level of education,
subject of the research and measurements made in each individual study.
It is vital to understand the factors persuading or inhibiting participation by Iranians
living abroad. Given the small number of studies on this ethnic minority and the
diversity ofmethodologies it is not possible to analyse these results statistically, but they
can help other researchers. Based on these results, it can be concluded that Iranians have
high levels of education and economic status in comparison with the other ethnic
minority groups, that those participating have higher socio-economic status than those
not doing so, but that useful studies are achievable for a variety of settings, countries and
topics.
To increase participation of Iranians factors suggested included: application of a multi
method approach to recruit Iranians; translation of the study questionnaire, brochure and
declaration of consent in the respondents' language; emphasising anonymity; choice of
interviewer (examiner), language, time and place of interview; contacting of respondents
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by letter and in person; using an oral informed consent procedure; publicising the study
through the local Iranian radio station; and giving financial incentives. (299, 305, 313,
317)
There was discussion about distaste for written surveys, strong suspicion of strangers
asking questions among Iranian migrants and that only those with strong ties to the
community can be successful in research on this ethnic group. (293, 307) One study
(309) avoided distributing a formal consent form to prevent participants being reminded
of earlier confrontations with legal authorities but in most studies no hesitance was seen
among Iranian migrants in giving consent. Overall, however, there was evidence
reflecting Iranians cooperation and eagerness to participate in research. Lack of
engagement on the part of Iranians is unlikely to be a barrier to research: institutional
barriers are likely to be more important.
The limited data available suggest that the majority of Iranian migrants will speak the
language of their adoptive countries and relatively few will require translation services.
In this review literature written in English or Persian language was searched but a
sizeable number of Iranians are living in countries where other languages are used and
articles or reports may be published in local languages (France, Denmark, Germany,
Norway, Sweden). For this reason probably some articles or reports were missed from
these countries. Searching procedure in this systematic review was limited to the
websites written in English or Persian while there are many other websites (non English)
in which potentially relevant articles could be found. In the future researchers should try
to expand the search domain to the non English/Persian language through collaboration
with other researchers internationally who read these other languages.
To the best of current knowledge, there is no available published systematic review
on the methods and themes of health-related research on the Iranian Diaspora. This
systematic review has been undertaken to establish a baseline to inform future studies on
Iranian migrants. The findings fill the knowledge gap and can help researchers to meet
the challenges may rise in doing research On Iranian ethnic group.
There is now a considerable and growing population of Iranian migrants throughout
the World. Iranian culture will transfer from the migrant generation to the offspring born
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in the receiving country. However it will be affected by the culture of host countries
concurrently. Study of determinants of health and quality and quantity of health care in
this ethnic minority is now important in international health. This review shows that such
studies are sparse (none in the UK), needed and feasible. This review shows that wide
span of topics can be studied. Heart disease, stroke, diabetes, cancer and mental illness
are a few of the major health problems of Iranians overseas (and in Iran). No studies on
diabetes, stroke and cancer were found and only meagre work on the other topics was
retrieved. In the interests of equity of health care, and in response to health policies and
legislation promoting equality, research is mandatory. Results of this systematic review
call on the research community to take head of the needs and opportunities identified
here.
3.6 Research update: Studies published since the date of this
systematic review
Literature search in this systematic review was conducted in April 2006 to provide
baseline information needed for planning of a population based pilot study on Iranian
migrant population in Edinburgh. To check whether any relevant study has been carried
out since the date of this systematic review a rigorous search was performed in Feb
2009. Thus 18 additional potential publications (392-409) were found to report studies
that were conducted on Iranian Diaspora in different countries (one in Australia, (400)
three in Canada, (392, 394, 397) three in Norway, (393, 404, 407) eight in Sweden (398,
401-403, 405, 406, 408, 409) and three in the United States (395, 396, 399)). Among the
retrieved articles (393, 400, 404, 405, 407) only five were written by non-Iranians
authors. Nine articles (392, 394, 396, 399, 404-407, 409) were excluded since they were
not reporting a population based study.
Nasseri (396) has attempted in his study to create and validate a list of common
Middle Eastern surnames for epidemiological research. He used place of birth and
surnames already present in the various lists in the United States to construct the
proposed list. Then he applied the created list on the California Cancer registry to find
accuracy of the list in finding the surnames from different countries in the Middle East.
The accuracy of the list to find Iranian surnames for instance was reported to be 94.63
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%. Thus he concluded that while the Middle East consists of a mosaic of countries with
different cultures and languages, construction of a surname list that can identify different
ethnic subgroups originating from the region is possible with reasonable accuracy.
Five studies (393, 398, 402, 403, 408) were publications of same studies conducted in
Norway (393) and Sweden (398, 402, 404, 408). Due to use of an identical methodology
in multiple publications, one sample article was included from each group of the
publications. The article by Kumar et al (393) was another publication based on the data
from Oslo Immigrant Health study. Since an earlier publication (391) was already
included in the systematic review so this article was excluded. The articles were
published by Daryani et al (398, 402) were different publications from a same study on
first-generation immigrant women born in the Middle East in Uppsala, Sweden. By the
same token since an earlier publication (320) of the study was included in the systematic
review these two articles were excluded too. Three articles (401, 403, 408) were
different publications from a study was conducted in the township ofKista in Stockholm
of Sweden. Thus only one of the articles (401) was decided to be scrutinised further
according to the objectives of this systematic review.
Therefore from a total of eighteen identified studies which were published since the
date of this systematic review only four studies (395, 397, 400, 401) were eligible for
further assessment.
In the study of Shirazi et al (395) snowball sampling has been used to recruit Iranian
women aged 30-75 years in California, the United States. From those who were invited
(520 people) by letter or verbally (2003) to be assessed by a questionnaire for breast
cancer self examination practices only 361 accepted to participate yielding a 69.4%
response rate. In this study the investigators have used a multi-method recruitment
strategy (contacting community centres, Iranian schools, women's group and mosques
along with publicising the study in the community newsletter and Persian news websites,
attending the Iranian's informal gatherings in several events) to provide broad socio¬
economic participation. The study respondents have been offered a free T-shirt for their
voluntary participation. About 65.7% of those consented to participate in the study had
at least college degree which may be an indication of selection bias or as it was stated in
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other studies (298, 299, 304) reflection of Iranians overall higher education level
compared to the other ethnic minorities in destination countries. Self administered
original English questionnaire which also was tested for cross-cultural validity have
been applied for data collection in this study.
A combination of quantitative (structured telephone questionnaire) and qualitative
(follow-up focus groups) methods were employed (2004-05) in the study of Poureslami
et al (397) to assess the effectiveness of informational video clips (that were translated
into Persian) on the Iranian migrants' attitude and intention to use health programmes in
the Vancouver, Canada. The study sample was randomly selected using the Iranian
yellow pages and telephone books. All Iranian adults aged 19 years or over were eligible
to participate in the study. The initial telephone interview was administered in Persian
and from 800 Iranian residents in the greater Vancouver area who were contacted 590
people (mostly women in the age range of 35-64) agreed to participate (participation rate
was 73.75%). In the qualitative stage of the study 98 randomly selected volunteers from
the telephone interview phase were asked to participate in focus group sessions. But
participation rate for this stage and place of focus group discussions were not provided
by the authors.
In the study ofNeale et al (400) Iranian residents aged 18 years or over along with two
other ethnic groups were investigated (October 2003-March 2004) for their knowledge
and use of health services and also satisfaction about the delivered services in Victoria,
Australia. Face to face interview and focus group discussions were the data collection
methods. The study questionnaires for Iranian migrants were translated only verbally
into Persian and the responses were recorded during the interviews. The study
interviewers in relation to the Iranian participants were native bilingual Iranians who
were trained about the study aims and data collection methods. The initial target sample
size for each of the studied ethnic groups (including Iranians) in this study was 50 with
equal gender distribution but only 10 male and 13 female Iranians were managed to be
recruited (46%). Initial recruitment was performed through advertising the study in the
community organisations and radio programmes in appropriate language and snowball
sampling technique was used to extend the sample. Place of interview was not
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mentioned in the study report and the authors referred to a degree of reluctance to sign
the study consent form by the participants in spite of reassurance was given with regard
to the study aims and anonymity of the results.
All Iranian-bom people aged 60-84 years (286 residents) in the township of Kista,
Stockholm in Sweden were invited (the date was not given) by Koochek et al. (401) in
their study on health-related quality of life. The invitation was took place via a letter
written both in Swedish and Persian. The participation rate was reported to be 65%. The
non-respondents also were contacted by the investigators and no difference was seen
between the respondents and non-respondents with regard to gender, education and self-
reported health. The interviews were conducted face to face in Persian but the interview
places were not mentioned in the study report.
These additional studies extended scale of our knowledge about methodology of
research on Iranian Diaspora and indicated variation of the methods and heterogeneity of
the findings in studies on Iranian Diaspora.
3.7 Abstract
Introduction: Iranian migrants are dispersed within the general population in the
destination countries. It is UK policy mandates that we provide equal access to health
and health care for all ethnic minorities. The research evidence on which to base health
care planning and provision decisions for the Iranian Diaspora is, however, very limited.
In order to leam lessons to apply to future planned epidemiological research this study
aimed systematically to review methods used in population-based health research on
Iranians.
Methods: Nine databases along with other electronic resources such as web pages of
ethnicity related organisations or official health organisations of countries known as
having a fair number of Iranians and potentially pertinent Internet sites were searched.
PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses)
guidelines were used to report findings of this systematic review.
Results: From 31 relevant articles, 17 unique studies met the inclusion criteria.
Considerable heterogeneity was seen in the methods and findings. Participation rate was
in the range of 19% to 99% among the eligible studies. Random sampling method to
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recruit Iranian women resulted in participation rate of 21% in one study and 79% in
another. Given the small number of studies on this ethnic minority and the diversity of
methodologies, it was not possible to analyse these results statistically. Overall, the
study findings showed Iranians' cooperation and eagerness to participate in research.
Conclusion: This review as the first study of applied methods in health research on
Iranian migrants showed huge gaps in the evidence base. The findings also indicated that
no single method of recruitment can be considered a gold standard to recruit Iranians
living abroad. Findings of this systematic review helped planning of a pilot UK based
study on the Iranian ethnic group which is discussed in chapter five and six.
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Chapter four: Risk factors of cardiovascular diseases among
Iranians: a systematic review of prevalence
studies
4.1 Introduction
In the previous chapter findings from the systematic review on the methods and
themes of health related research on the Iranian Diaspora were provided. The review has
shown that health related studies on Iranian Diaspora are sparse while there is now a
considerable and growing population of Iranian migrants throughout the World. There
are no such studies in the UK whereas in the interests of equity of health care, and in
response to health policies and legislation promoting equality, research on the health of
all ethnic minorities is mandatory.
We know very little about the prevalence of CVD risk factors in the Iranian migrant
population. There is no comprehensive systematic review of studies on the prevalence of
CVD risk factors ever undertaken among Iranians and for this reason interpretation and
comparison of the results is burdensome.
The recommended structure (PICO: Population, Intervention, Comparison and
Outcome) of Glasziou et al. (290) in systematic reviews of health studies was applied to
frame main question in this systematic review. Estimation of the prevalence of
conventional CVD risk factors (outcome) among Iranians (population) was a major
component of the study question. All efforts were made to identify and assess accuracy
and the quality of the methods used in all eligible studies. This is a basic step to prepare
for new studies on the prevalence of CVD risk factors among Iranian migrants or even
Iran's general population.
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This chapter describes the protocol and findings of this systematic review which was
carried out to answer some of the outstanding questions prior to planning of a prevalence
study on the major CVD risk factors in the Iranian ethnic group living in the UK.
4.2 Background
Cardiovascular disease is a major cause of death and morbidity throughout the world
and ranked as the leading cause of death in many countries. (46) Most of these deaths are
preventable by control of contributing risk factors such as hypertension, diabetes,
smoking, physical inactivity and nutritional behaviours. But due to the widespread
inadequacy of preventive measures, CVD is still the leading public health threat in many
developed and developing countries. (52) A predominant gap between developed and
developing countries and even, among subgroups of population within individual
countries has been reported regarding the CVD related morbidity and mortality. (60)
Such a gap also was suggested to exist among ethnic migrant groups compared to the
indigenous population in the destination countries and population of the country of
origin. (47-51) The discrepancy was indicated to be attributable to the differences in the
associated CVD risk factors among population subgroups. (61) The study of subjects
separated from their original environment and cultural background and adapted to a new
sociocultural environment may provide a tool for assessing cultural, environmental and
genetic factors on occurrence of the disease.
Iran as a transitional country is encountering a rapid change towards industrialisation.
Expanding urbanisation and subsequent alteration in life style (e.g. nutritional habits and
physical activity level) are major consequences of this change that in turn have had
substantial impacts on the occurrence of some major diseases among them CVD is
leading. (410)
As shown in the previous chapter despite increasing numbers of Iranian migrants in
the major destination countries (including the UK), research evidence to base our
knowledge about CVD health status of this ethnic group is scant. In this review present
body of literature about the prevalence of CVD risk factors among Iranian adult
indigenous and migrant population was examined. The ultimate goal was to establish
baseline data about the burden of CVD risk factors among Iranians based on sound
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evidence. Expected findings can inform the process for designing of a future relevant
study and also decisions about how to prioritise resources in favour ofmost needed area.
4.2 Methods
4.2.1 Types of studies
All studies that have measured the prevalence of CVD risk factors among Iranians
were considered eligible provided they focused on Iranians (and not foreign-bom
refugees residing in Iran) living inside or outside of Iran. Any published study was
included in this review if it reported sampling method, sample size, recruitment criteria,
methods and tools of data gathering and CVD risk factors.
4.2.2 Types of data
- Data on the place of study, sampling method and sample size, recruiting
criteria, participation rate, data collection methods, analysis methods and
techniques and quality of the findings report.
- Data on socio-demographic characteristics of subjects in the studies i.e. age,
sex, level of education, occupation and marital status.
Data on physical activity status, cigarette smoking, anthropometric measures,
blood pressure level, level of total cholesterol, high density lipoprotein (HDL-
C) and low density lipoprotein (LDL- C) cholesterol in blood, diabetes and
taking ofmedication for controlling of these risk factors.
4.2.3 Types of outcome sought
- Number of studies having good quality information on the applied
methodologies (sample size, sampling method, sampling frame and recruitment
criteria of subjects, participation rate).
- Number of studies having good reporting quality.
- Prevalence of physical inactivity.
- Prevalence of smoking.
- Prevalence of being overweight, obese or having central obesity based on
anthropometric indices such as Body Mass Index (BMI).
- Prevalence of hypertension based on resting blood pressure.
83
- Prevalence of hyperlipidaemia based on concentration of blood lipoprotein
(LDL-C, HDL-C).
- Prevalence of diabetes.
- Prevalence ofCVD related signs and symptoms.
- Prevalence of CVD related medication taking (to verify detected CVD among
studied subjects).
4.2.4 Search strategy
The free text and MeSH (Medical Subject Headings) indexing terms (Appendix
five) were used to search the following databases that were considered to be most
relevant in terms of objectives of this systematic review:
- AMED (Allied and Complementary Medicine) (1985 to March week 4, 2009).
- CAB Abstracts (1973 to March 2009).
- CINAHL ( Cumulative Index to Nursing & Allied Health Literature) (1982 to
March week 4, 2009).
- EMBASE (1980 to March, 2009).
- Global Health (1973 to March 2009).
- Index to theses (A comprehensive listing of theses with abstracts accepted for
higher degrees by universities in Great Britain and Ireland since 1716) (1716 to
March week 4, 2009).
- International Bibliography of the Social Sciences 1951 to March week 04,
2009).
- MEDLINE(R): 1950 to 1965, 1966 to March week 4, 2009 and In-Process
& Other Non-Indexed Citations (March 31, 2009).
- National Research Register (UK).
Other electronic resources regarded as appropriate such as web pages from Iranian
Ministry of Health and Medical Education (MOHME) or medical universities in Iran for
official information and other potentially relevant internet sites (PubMed, Google) were
also explored to identify any other published or unpublished work.
This review was limited to English or Persian language studies published between
1950 up to March 2009. The titles and abstracts of all retrieved records were screened to
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identify apparently related articles. Articles were only rejected on initial screen if it was
clear from the title and abstract that the article was not a report of a CVD related
prevalence study. When a title/abstract could not be rejected with certainty, the full text
of the article was obtained for further evaluation. As well as the above-mentioned
strategies, references of relevant articles were checked to identify additional studies. It
was also decided to include studies recognised through serendipitous discovery (such as
finding a relevant article when looking for something else) in this review. To reduce the
possible effects of publication bias, experts (Professor M Janghorbani, Dr. F
Khavarpour, Dr. R Kelishadi, Professor H Meyer and Dr. S Momenzadeh,) who were
well known to do work in the area were also contacted for references not identified
through the search process.
4.2.5 Data extraction
Reference Manager Software (version 10) was used to download the citations
identified in electronic search process and to enter those retrieved from other sources
manually.
A data extraction sheet was used for summarising included studies (Appendix six).
These studies were also assessed for their quality according to the internal and external
validity criteria (Appendix seven). Data in the data extraction sheet double checked by
one of the study supervisors (Professor Aziz Sheikh) and disagreements were resolved
by consensus.
Information was extracted for each included study on the following areas: study and
setting, protocols applied for measurement and reporting of variables, control of
confounding factors, use of a representative sample and declaration of participation
rates, proper explanation of the non-participants' characteristics, calculation and
providing of confidence intervals and age adjusted sex specific rates for the reported
prevalence rates.
Due to use of US units in Iran to report level of biochemical factors in blood analysis
the reported quantities in US units (mg/dl) were converted into SI units (mmol/1). To do
so, quantities of triglycerides in US units were multiplied by 0.011 and those of total
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cholesterol, high density lipoprotein and low density lipoprotein multiplied by 0.0259 to
have the quantities in SI unit.
4.2.6 Data analysis
Results of this systematic review were tabulated based on the PRISMA (Preferred
Reporting Items for Systematic Reviews and Meta-Analyses) statement (302, 303). The
retrieved studies were summarised chronologically by title, name of the researcher(s)
and location and presented in descriptive form. Meta-analysis was performed using
Comprehensive Meta Analysis (CMA) software (version 2.2.046) to incorporate data
from eligible studies.
In order to ensure that the reported sex specific prevalence rates of major CVD risk
factors in different studies are comparable, they were standardised by using the latest
Iranian population census data (Appendix eight). Heterogeneity indices were calculated
based on a subgroup analysis and discussed for each group of studies separately when
dealing with the sex specific age adjusted prevalence rates of different CVD risk factors.
Thus Q-value as the test of dispersion of outcome measures and I-squared (I2) to indicate
the amount of variance among the included studies as a proportion of the total variance
(411) were presented separately along with the estimated pooled prevalence rates. Fixed
effect model was used to estimate overall pooled prevalence rates or mean levels of the
studied CVD risk factors when no evidence of heterogeneity was seen among the
included studies. Random effects model was applied when such heterogeneity was
observed according to the test results. (411) Fixed or random effects models in the
subgroup analysis were used to combine data only across those studies that have not
major issue of internal validity (analysis of the data started with a fixed effect model and
if there was a empirical evidence of heterogeneity random effects model was applied).
Where possible, confidence intervals for prevalence rates or age adjusted prevalence
rates have been calculated based on the data provided in the eligible articles. These
measures were discussed considering all limitations that may exist in the meta-analysis
of the methodologically divergent prevalence studies.
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Application of funnel plot as a primary visual tool for the investigation of possible
publication bias and use of a proper numerical approach to show any evidence of
asymmetry was also discussed where appropriate.
4.3 Results
Search of the proposed databases yielded 1470 articles (Figure 4.1). Non-relevant
and duplicate articles were eliminated in two stages and thus 254 potentially applicable
articles remained for further scrutiny. A further 27 candidate articles were also identified
by reviewing other electronic resources (e.g. web pages of Iranian organisations,
PubMed and Google), references of the potentially applicable articles, serendipitous
discovery and contacting of researchers or experts who were known to do work on this
subject (Professor M Janghorbani, Dr H Soori, Dr R Kelishadi and Professor F Azizi
from Iran, Professor HE Meyer from Norway). As a result 281 potentially appropriate
articles were scrutinised and 104 of them met the inclusion criteria. The full texts of
these possibly relevant articles were obtained and inspected. Some studies had been
described in more than one publication. In some cases, additional analyses of a study
were reported. In these cases, it was decided to include the analysis that provided the
most information and avoided duplication of results. A number of publications did not
meet the inclusion criteria and were excluded consequently. Thus from 104 articles,
which met our initial criteria, 63 were multiple publications of the 5 main studies in Iran
and in 13 articles usable information was not provided or format of the provided data
was not applicable for the purpose of this systematic review.
Azizi et al. had 41 publications (412-452) from Tehran Lipid and Glucose Study
(TLGS) reporting prevalence of several CVD risk factors or discussing genetic,
biological, or environmental determinants of CVD in a representative population of
Tehran. Only one main article (416) was selected to be included in this review.
Concurrently from 17 publications (453-469) mainly by Sarraf-Zadegan and (or) her
colleagues in the Isfahan Cardiovascular Research Centre (ICRC) seven publications
(453, 454, 456, 459, 466, 468, 469) were included in this review based on data from
Isfahan Healthy Heart Programme (IHHP). Sarraf-Zadegan et al. (469) in their recent
publication and based on an updated analysis ofpreviously presented data (456) have
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Figure 4.1 The PRISMA flow diagram: number and status of the identified
articles in the systematic review of prevalence studies on the
risk factors of cardiovascular diseases among Iranians
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provided information about the magnitude of CVD risk factors in Iran. Since data about
a number of the CVD risk factors in the former published article were not provided in the
later article both of them were included.
Among eight publications (470-477) of Fakhrzadeh et al. one article (471) which
reported the prevalence of CVD risk factors in a representative population of Tehran was
selected.
One article (478) was included from two publications (478-479) reporting the findings
of a study in Ahwaz (capital city of Khozestan province)..
From a total of five articles (480-486) that represent four different studies in Fars
province (in South West of Iran), three articles (482-484) were included.
Also separate publications that reporting the findings of several studies in different
parts of Iran including city of Islamshahr (located in Tehran province) (485), city of
Rafsanjan (located in Kerman province) (486), city of Bushehr (capital city of Bushehr
province) (487), Khorasan province (488) and Semnan province (489) were also
included.
Among a total of 11 publications (490-500) representing result of national surveys
seven eligible articles (490-493, 496, 497, 499) were included (see Table 4.1 for
excluded publications).
An article by Janghorbani et al. (498) indicating the prevalence of hypertension in Iran
(based on the findings of a national survey on the prevalence of non-communicable
diseases risk factors) was excluded since another article (499) using same database but
reporting the standardised prevalence rate of hypertension was included. Haghdoost et
al. (500) have reported findings of a systematic review on the epidemiology and
heterogeneity of hypertension in Iran. They have included in this systematic review only
those papers which were published between Jan 1996-Dec 2005. International (Medline)
and also national or local databases have been searched in this systematic review to
identify relevant studies. They have included 29 eligible publications in their review but
excluded those reporting studies with sample size less than 300. The authors have
presented the point estimate of the prevalence of hypertension based on the results of a
national survey in different provinces separate from other studies. Unadjusted and non-
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standardised prevalence rates were used in this review to estimate the overall prevalence
rate of the hypertension in Iran. The identified papers were mostly those articles that had
been published in non-indexed medical journals in Iran. Thus, availability bias (selection
of easily accessible publications) could be regarded as a potential source of error in this
systematic review. Based on the analysis of the findings, two point estimates (not sex
specific) for the total prevalence rate of hypertension was reported (22.06% and
12.54%). The authors of this article have incorrectly concluded that the prevalence of
hypertension in Iran is declining since by every one year increase in the articles'
publication date they have noticed a 1.11% reduction in the prevalence of hypertension.
Due to all these technical issues this article was also excluded.
In the article of Hatmi et al. (501) which was on the prevalence of coronary artery
diseases risk factors in a representative sample of adults in Tehran, clear definition or
measurement method for some of the studied variables (diabetes, smoking, physical
activity) was not provided. Therefore, this article was also excluded.
One study from Rasht (capital city of Guillan province in the Northern part of Iran)
which was conducted by Maddah (502) was excluded due to focus of study on the obese
people, their blood lipids and fasting glucose levels.
Bahrami et al. (503), in the analysis of findings from their study on the prevalence of
obesity and hypertension in the Golestan province (North of Iran), have adjusted the
prevalence rates to the U.S standard population in 2000. They have not given crude age
specific prevalence rates of the obesity and hypertension in their published paper so that
a researcher can standardise these rates to an Iranian standard population. In this article
the crude prevalence of self reported alcohol consumption was also presented which is
very rare in the Iranian publications but due to the reason explained above it was decided
to be excluded.
The report of a study by Chehrei et al. (504) which was conducted to clarify
correlation of dyslipidaemia and anthropometric indices in Isfahan was also excluded
since hypertensive and diabetic patients were not included in the studied sample.
In the study of Dastgiri et al. (505) in the North West of Tabriz (capital city of East
Azarbaidjan province) the prevalence of obesity was studied by recruitment of 330
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randomly selected adults. The authors in their report have not provided age-adjusted or
standardised prevalence rate of obesity nor data to be calculated by another researcher.
Therefore this article was also excluded.
Another excluded article was a duplicate publication (in Persian language) of a
previously included article (489) and written by Gorbani R et al. (506).
Another nine reports (305, 391, 507-513) were identified on Iranians living abroad that
met the primary inclusion criteria. Among the identified studies on Iranian migrants, two
were excluded (507, 510) since they had not any data about Iranian migrant population
separately and their data were analysed cumulatively with other migrants. Two studies
were multiple publications (508, 509) of a single study on a group of migrant Iranians
abroad and so only one of them was included. (509) The study of Glans et al. (511) was
on the diabetic patients and in two publications by Koochek et al. (512, 513) findings of
a study on the Iranian elderly population settled in Kista, Stockholm were reported.
Therefore all these three articles were excluded.
Thus from a total of 104 potentially relevant publications, 76 were excluded (Table
4.1) and 28 articles were scrutinised further. In the later group, 25 were original cross-
sectional prevalence studies and three were narrative description of data gathered by an
organisation (490, 493) or summary of studies conducted by others. (491)
4.3.1 Quality of studies
Eligible studies were classified into three groups (Table 4.2) based on a quality
assessment procedure adopted mainly from methods developed by Siegfried et al. (514).
This system included appraisal of studies based on external and internal validity criteria
relevant to biases in the epidemiological studies.
Quality of these studies was independently evaluated by the main investigator and one
of the study supervisors (professor Aziz Sheikh) and disagreements were resolved by
consensus. From 27 included studies indirect method (self report) of observation to
measure a quantitative variable was used in two studies. (305, 478) Results of these
studies are prone to information bias since for instance weight or height measures were
obtained by self report rather than direct measurement. Only in 16 publications (305,
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Associationflipids,ipopro eins,apolipopr teinsndar x naseenzymctivityw hprematurec o aryr rdisea e.Az zFl. 2002
Paperpublishedfromstu y
readyinclude
DeterminantsofserumHDL-Cl velinaT hr nurbapop l tion:e rLi idGluco eSt dy.Az ziFl.2002
Paperpublishedfromstu y
readyinclude
Familialclusteringofbes tyandthroln tr tion:Tehranlipigluc sest y.Mirm raPetal.2002
Paperpublishedfromstu y
readyinclude
Associationfeduca nallevelandm r tast tuswi hdi taryintakec rdiov scularr skfa rT hr ni ndult :ehrLipid andGlucoseSt dy.MirmiranPetl2002
Paperpublishedfromstu y
readyinclude
Coronaryarterdiseasei ssociatedwithth iofap lipopr teinA-I/Bderumcon entrationfap lipopro eiB,bu tw h paraoxonaseenzymactivityiIra iansubjects.R hm iMl.2002
Paperpublishedfromstu y
readyinclude
Coronaryheartdiseaseriskfact sandmenopause:studi1980T hr i nw m n,tT hrLipGlucoSt dy.AziziFl 2003
Paperpublishedfromstudy
readyinclude
Cardiovascularri kf ctorsintheelde y:TehranL pidanGlucoseSt dy.Az ziFt2003
Paperpublishedfromstu y
readyincluded
SerumlipidevelsnanIraniandultspopulation:T hrli ia dgl cosest dy.AziziF.2003
Paperpublishedfromstu y
readyincluded
Issystolicbloodpressuresufficientf rcla ificationfblo dpre surendete m i nfhy er ensioba dJNC-VIi Iranianadultpopulation?Tehrli idandgl cosest y.Az ziFel.2003
Paperpublishedfromstu y
readyinclude
Prevalenceofmetabolicsyndromei urbanpopulation:TehrLi idGl c sStudy.Az ziFt.2003
Paperpublishedfromstudy
readyinclude
Genderdifferencesii taryintak s,a thropom t icalm asurementsdbiochemic lndicnurbadultp ul tion:Tehr LipidanGlucoseStudy.M rmiranPetl2003
Paperpublishedfromstu y
readyinclude
Estimationofenergyrequir me tsf adults:Teh alipidngluc est y.Mirm ranPl.2003
Paperpublishedfromstudy
readyinclude
Predictionofcardiovascularr skfa torsinemalebyseruml v lftriglyceridesnw i tc r umference(Teh aLip dGlu e Study).latiMeal2003
Paperpublishedfromstu y
readyinclude
Obesityandcardiovasculardisea er skfa t rsiTehrandult :population-b sedst y.Az ziFal.2004
Paperpublishedfromstu y
readyinclude
Predictorsofcardiovascularr skfa t rinTeh aniandolescents:hraLip dGlu seStudy.AziziFa .2004
Paperpublishedfromstudy
readyinclude
Waist-to-hipratioibet erscr eningmeasu eforc rdiovascularri ka rsthothen hropometr cindic t rsTeh niad lt men.EsmaillzadehAetl2004
Paperpublishedfromstu y
readyinclude
Bloodpressurem a resanelectroc rdiogram-d finedmy ca ialinf ctionIr ipopulation:T hrLiaG u osst y.P rubl sh df yl dyincl d GhanbarianAetl.2004
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Table4.1Exclud dstu iesbytianreasonofxclusionithsyst maticreviewftpre al cest iesoi kf c r ofcardiovasculardiseasesmongIrani n(c ntinued) TitleofStudy/author(s)/publicationyear
Reasonforexclusion
Tehran(TehranLipidanGlucoseStu y)
Dietarydiversityscoreinadolesc nts-g odindi atorfthnut iti aladequacyfd e s:T h anlipndglucoses ud . MirmiranPetal.2004
Paperpublishedfromstu yalr adyincl ded
Detectionofcardiovascularskfa t rsbyan hropomet icme resiT h ni nadu s:r ceiverp atingcharact ristic(ROC)ve analysis.MirmiranPet l2004
Paperpublishedfromstu yalr adyincl ded
Cardiovascularri kf ctorsinmaleswithhypertriglyc mici t(Tehr nL p dnGlu o eS dy).ol iMl2004
Paperpublishedfromstudyalr a yinclude
Dietarydiversitscoreifa o blyass ciatedwiththmet bolicsynd meT h niana u ts.AzadbakhtL.2005
Paperpublishedfromstu yalr a yincl ded
Generalobesityandcentraladiposityi r present tivesamplefTeh a iandu ts:valencedd t in ts. AzadbakhtLetl.2005
Paperpublishedfromstu yalr a yincl ded
Dairyconsumptioniinverselyssociatedw htheprevalencefmetabolicyndr meiTeh nianadults.Az bakhtLtl2005
Paperpublishedfromstudyalr a yincl de
DietqualitystatusofmoTehr nianad tsn edimproveme t.Az bakhtLl2005
Paperpublishedfromstu yalr a yincl ded
Trendsinoverweight,be i yandc tralf accumulationo gT hrania ltsb twee1998-1999d2001 2002:T h nlipin glucosestudy.AziziFetal.2005
Paperpublishedfromstudyalr a yinclude
Isthereanindep nd ntssociationb twe naist-to-hipr tia dcardiovascularskf t rsi verweightndb ewomen? AziziFetal.2005
Paperpublishedfromstu yalr adyincl ded
Correlatesofunder-andver- eportingfrgyintakeTehranians:bomain xndlifestyle-rela edf cto .AziziFl.2005
Paperpublishedfromstudyalr aincl de
Evaluationofw istcircumferencetpredictcardiovasculariskf t rsinoverweightTehranianp pulation:fin smeh LipidanGlucoseStudy.EsmaillzadehAetl2005
Paperpublishedfromstudyalr a yincl d
Whole-grainconsumptionandthemetabolicsyndrome:fav ra soc ationiTehr n au ts.E maillz dehA.2005
Paperpublishedfromstu yalr a yincl ded
Seasonalvariationofserumlipidsind lt :Teh aiddgluc sest dy.H aeghFtl.2005
Paperpublishedfromstu yalr a yincl ded
Dairyconsumptionndb dmassindex:nver er latio ship.Mi mi anPtl2005
Paperpublishedfromstudyalr a yincl de
Dietaryquality-adherencetohd rguidelinesinTe r n andol sce ts:T hrL p daGl cosStud .Mirmi anPl.2005
Paperpublishedfromstudyalr aincl de
Therelationshipbetweg uc seintolerancandbloop es ure,yma sindexdw i tiptioT hranurba population:TehrLi idanGlucoseSt dy..aadatN tl2005
Paperpublishedfromstu yalr adyincl ded
Highprevalenceofundi gnos ddiabetesandbnormalluc et lerancethIr ianurbpopulation:T hr nL iGl e Study.HadaeghFetal(2008)
Paperpublishedfromstu yalr aincl d d.
Foodintakepatternsmayexplainthhighpreva cefcardiov s ularskfa rsmongIr niw men.EsmaillzadehAtl.(2008)
Paperpublishedfromstu yalr a yincl d d.
PrevalenceofmetabolicsyndromebytheAdu tTre mentP lIII,Internatio alDi b t sF deration,ndWorlH al hOrga isa ion definitionsandtheirssociationwithc ronaryhea tdis asei elderlIra ap pulation.H d eghF.(2009)
Paperpublishedfromstudyalr a yincl d .
Isfahan
Thepreval nceofcoro arya terdis sinu banpopul tionI f h n,ra .Sar af-ZadegaNtl1999
Paperpublishedfromstudyalr a yincl de
LipidprofilesinthIsfahanpulation:nI fcardiov sculard se ekfacts rv y,1994.R fieiMt99
Paperpublishedfromstu yalr a yincl ded
Prevalenceofhypertensiondassociat di kfact rsiIsfah n,l micRepublifI n.Sar f-Zad ganNt1999
Paperpublishedfromstudyalr a yincl de
FoodannutrientintakemongdultfIsf ha ,r n.M h m difardNel2000
Paperpublishedfromstudyalr a yincl de Tablecontinuednextpag
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Table4.1Exclud dst iesbytianreasonofexclusionithsyst maticreviewftprevalen est ieso kf r ofcardiovasculardiseasesmongIrani n(c tinued) TitleofStudy/author(s)/publicationyear
Reasonforexclusion
Isfahan
IsfahanHealthyrtProgr mme:Acomprehensiveintegrat dcommu ity-basedp ogrammef rc rdiovasculardisp ntion control.Design,meth dsaninit alexpe ience.Sarraf-ZadeganNt2003
Paperpublishedfromstu yalr adyincl de
TobaccouseamongIranianm ,womenndad lesc ts.S rr f-Z d ganNl2004
Paperpublishedfromstudyalr a yincl de
Highbloodpressureanssociat dcardiovascularkfa t siIr n:sfa anH lthytP ogr mme.S deg iM.2004
Paperpublishedfromstudyalr a yincl de
Themetabolicsyndromeihypertensiva dnormotensivesu j cts:ThI f hanH al hyrtP gra me.Keli hadiRl.2005
Paperpublishedfromstudyalr a yincl de
Theassociationoflei uret mphysicala tivity,wat hingtelev s on,b sityandl pp ofileIr nipopulation. SaidieMetal.2005
Paperpublishedfromstu yalr adyincl de
Correlationofdyslipidaemiawithisttoheigr t o,waistcircu ference,ndb dymassindexIr ndult . ChehreiAtal.(2007)
Samplingbias.
Therelationbetweetotalda lycaloricint kendblopr ssure.N jafianJt.(2008)
Paperpublishedfromstu yalr adyincl ded.
Tehran(otherstudies)
Comparativestudyoftheeff ctatienteducationt ro ghgroupdi cuss nversusb kl tknowledgedpr c icef patientswithhyperlipidaemia.Lar j niBel.2003
Paperpublishedfromstu ylr adyinclude
Evaluationofprevalencethm t bolicsyndr minhabita tsofTeh anUniver ityM i alScien sP pul tionL b. FakhrzadehHetal.2004
Paperpublishedfromstu yalr adyincl de
Evaluationoft talpl smahomocysteine,f l cacidnvitB12i25-64g dinh bi a tsfTehr nUniv r ityMedical Sciencespopulationlabregion.F khrz dehHtal.2004
Paperpublishedfromstu ylr adyinclude
Therelationohhyperh mocysteinemiaw thimp iredglucoset era cdiab tes(TT ranHomo ystei eSu v y). FakhrzadehHetal.2005
Paperpublishedfromstu yalr adyincl de
Homocysteinelevelsanditcorrelationmetabolics dromei25-64arsldsi tsfthT hranmed alun v rsity populationlab.F khrzadehHeal.2005
Paperpublishedfromstu yalr adyincl de
Plasmahomocysteineconcentr tiona dbl opr ssureiheal hyIr niadults:The ah mocys inerv y(2003-2004). FakhrzadehHetal.2005
Paperpublishedfromstu yalr adyincl de
Plasmahomocysteineconcentr tiona dbl opr ssureiheal hyIr niadults:Theh mocys einev y(2003-2004). FakhrzadehHetal.2005
Paperpublishedfromstu yalr adyinclude





Height,weight,BMIandeight-for-heighofdultsisout rnIran:h wsh uldb itybd fined?Ayat lahiSMT.1993
Usableinformationw snotprovid d.
Ahwaz
Eatingpatternsndrevale ceofb sitymongAr blivAhwaz,I .Sooritl2002
Paperpublishedfromstu ylr adyinclude Tablecontinuednextpag
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Table4.1Exclud dst iesbytianreasonofexclusionithsyst maticreviewfpre ale cest diesoi kfac r ofcardiovasculardiseasesmongIrani n(c tin ed) TitleofStudy/author(s)/publicationyear
Reasonforexclusion
Golestanprovince
Obesityandhypert ioninnIr niacoh rtstud ;Ir iwomenexperiencehig rrat sfb ityandhyp rt nsionhAme ca women.BahramiHet(2006)
Usableinformationw snotprovided.
Rasht
Associationfgendera deducationwi hbloodlip safas ggluc selevelmplefIr anobults. Maddah(2007)
Isnotapopulationbasedt dy.
Semnan
Prevalenceofhypertensionamo gthedultpopulationfS aprovinceG rb i(2009)
Paperpublishedfromstu yalr a yincl d d
Tabriz






Narrativedesc ip onoffind ngsr m publishedandunpublishenationallocal studieswithoutq otingtothe rmet odolo y
Epidemiologyandheterogeneityfhypertensi niIra :systematiceview.H ghdo stAA(2008)
Methodologicalandrep rtingqual tyiss e.
Nationwidesurv yfprevalenceaniskf ctorsfpre-hyp rtensionandhy er e sioiIr iaadults.JanghorbaniM(2009)
Paperpublishedfromstu yalr a yinclud d.
StudiesonIraniansabroad
Morbidityincardiovasculardiseasesimmigr ntsSwed n.G d2003
Usableinformationwernotprovided
Dietaryfatintake,sourcesandcidcompositionserumo gimmigrantwomefrI andT keyc par dh womenofSwedishethn city.DaryaniA2005
Paperpublishedfromstudylr a yincl d
Thetrendofcardiovasculardis a einimmigr ntsSweden.G dM2005
Usableinformationwernotprovid d
ImmigrantsfromtheMiddle-Easthavediff rentf fTyp2b t sco paredwi hSwedi hp ti nts.GlF(2008)
Isnotapopulationbasedstudy.
IsmigrationtoSwedenassociatedwi hincre sprevale cefi kfactorscardiovasculardi se?K kAt(2008)
Isnotapopulationbasedt dy.
Physicalactivityndbodymassindexel erlyIr n ansSwe en:popul tion-basedudy.Ko hekA(2008)
Isnotapopulationbasedt dy.
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391, 416, 453, 454, 456, 459, 466, 468, 471, 478, 483, 493, 497, 499, 509) participation
rate as a criteria of external validity was reported. The rate in five articles (391, 456, 466,
497, 509) was below 80% and therefore they were liable to selection bias; however, only
in one of the related studies (454) non-participants were surveyed to ensure that
comparable differences do not exist between them and those who consented to
participate.
As an index of reporting quality only in nine articles (416, 453, 471, 478, 487, 492,
496, 497, 499) prevalence rate estimates of CVD risk factors were given with their
precision (e.g. 95% confidence interval). Adjusted prevalence rates for major
confounding factors (e.g. age) as another criterion of reporting quality were provided in
11 articles. (387, 391, 416, 453, 468, 471, 485, 496, 497, 499, 509) Thus only in four
studies (416, 453, 471, 499) all intended criteria for internal and external validity were
met. The overall quality of included studies was highly variable. Different methods,
instruments or cut-off points were used in the most of the retrieved articles in relation to
CVD risk factors (the applied methods and cut off points were shown separately for each
of the CVD risk factors as follow). In order to assess these divergences statistically and
to investigate heterogeneity among the studies the Q test was performed (as stated earlier
it is the test of dispersion among studies).
In some cases (471, 492), the authors were contacted to get clarification about
mismatches in the data within the articles or to get additional data to be able to calculate
adjusted prevalence rates. These contacts, however, were not added to the extracted data
from the included studies since corresponding author of one article (471) did not respond
and of the second article has confirmed typo in a part of the article. (492)
4.3.2 Prevalence of CVD risk factors in Iran
4.3.2.1 Physical inactivity
Only in four articles (456, 459, 496, 509) data were provided about physical inactivity
(Table 4.3). In none of the four corresponding studies application of a standard
measurement protocol was mentioned. Only in one of the included articles (456) raw
data were provided so that a researcher can calculate age standardised prevalence rates.
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In this article subjects who did not exercise at all were classified as physically inactive.
One of the Iranian publications (459) neither provided age adjusted prevalence rate of
physical inactivity nor the needed raw data a researcher can calculate it. In the study by
Janghorbani et al. (496) people who have reported to do physical activity at least 30
minutes a week were labelled in the group with regular physical activity level. Daryani
et al. (509) in their study on the Iranian women in Sweden have not provided any
information about their applied definition of low physical activity. With this background
calculation of an overall summary estimate for prevalence of physical activity/inactivity
in the Iranian migrant or indigenous population was not possible.
Table 4.3 Reported prevalence rate of physical inactivity in the studies on Iranian
indigenous and migrant population.
Study/age group/
fieldwork or publication date
Men
Prevalence % (95% CI)
Women
Prevalence % (95% CI)
Studies in Iran
Sadeghi K et al./ > 15 years
1995 (459)
22.1 (19.3-25.1)* 32.4 (29.1-35.9)*
Sarraf-Zadegan N et al./19-70 years
1999 (456)
71.5 (71.1-71.8) ** 89.3 (89.0-89.8)**
Janghorbani M et al./ 25-64 years
2004-05 (496) 64.6 (64.2-65.0) *p 79.7 (79.3-80.1) *p
Studies on Iranians abroad
Daryani A et al./ 35-64 years
1995-96 (509)
NAY 49.3% (95% CI: 38-60.7)*
* Confidence interval was calculated by the author
** Age-standardised rate: standardised to latest Iranian population census data by the author
P Age-adjusted rate y Not applicable
4.3.2.2 Smoking
Ten publications (305, 391, 416, 456, 466, 471, 483, 484, 496, 509) reported data on
cigarette smoking (Table 4.4). Self reported smoking was used in all of the studies to
determine smoking status. Three reports representing studies among Iranians in Norway,
98
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(391) Australia (305) and Sweden (509) had information about smoking. In the Iranian
publications data to calculate standardised prevalence rates were provided in only three
articles. (416, 456, 484) As a result, estimation of an overall smoking rate among
Iranians was performed using the findings of these three studies. In the article of
Glenday et al (391) and Rissel et al. (305) necessary data to calculate age adjusted
smoking prevalence rates were not provided. The study by Daryani et al. (509) was
conducted solely on the Iranian migrant women living in Sweden. Thus, due to all these
limitations calculation of an overall smoking prevalence rate for Iranian male and female
migrants was not possible.
Analysis of the included publications has shown heterogeneity among articles that
reported the prevalence of smoking rate in the Iranian adult male (P< 0.000 and I2=
99.49) and female populations (P= 0.007 and I2= 79.65). Therefore random effects
model was used to calculate overall prevalence estimate of smoking rate based on the
reported findings in the included papers. (Figure 4.2)
Group bv
Subgroup within study
Statistic for each study ' Prevalence rate and 95% confidence interval
FEMALES
Prevalence rate Lower limit Upper limit
MALES
Azizi F et al.
Sarrafzadegan N et al.
Mossavi-Jarrahi A et al.
Female overall
Azizi F et al.
Sarraf-Zadegan N et al.


























• Since entered prevalence rates automatically rounded up by the CMA software to calculate the confidence interval limits you may notice
their very small differences with the given limits in the summary tables.
Figure 4.2 Overall pooled estimates from the standardised prevalence rates of smoking
in studies on the Iranian adult population.
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The calculated point estimates of the prevalence of daily cigarette smoking shows a
considerable difference between Iranian men and women. The age standardised self-
reported smoking rate was considerably lower in the study of Sarraf-Zadegan et al. (456)
among females and in the study of Azizi et al. (416) among males. This caused a wider
confidence interval for the overall point estimates especially in the male subgroup.
Findings of studies on Iranians abroad have shown a higher rate of smoking among
Iranian women compared to the Iranian indigenous women. As a result the observed gap
in the Iranian studies regarding the self reported smoking rate between men and women
seems to be narrower in the Iranian migrants.
4.3.2.3 Hypertension
The prevalence of hypertension or weighted mean level of systolic (SBP) and diastolic
(DBP) blood pressure of Iranian indigenous adult population (416, 453, 454, 456, 466,
469, 471, 493, 496, 499) or Iranian migrants (391, 509) were reported in 12 articles
(Table 4.5). A considerable heterogeneity was seen in the blood pressure measurement
methods of the included studies. Among the seven publications reporting the prevalence
of hypertension in Iran only in three articles (416, 471, 501) age standardised prevalence
rates or raw data to be calculated by other researchers were provided. Only in the article
of Esteghamati et al. (501) the standardised prevalence rates were provided based on the
Iranian standard population. Therefore, only reported or calculated standardised
prevalence rates of hypertension in these eligible articles were used to estimate an
overall prevalence rate for Iranian indigenous males and females.
In the article of Sarraf-Zadegan et al. (456) detailed data about the prevalence of
hypertension in different age groups were only given using a higher cut off points for
SBP and DBP (hypertension was defined as having SBP> 160 mmHg or DBP> 95
mmHg or using anti-hypertensive medication). In most of the other papers (391, 416,
454, 465, 466, 471, 501); however, WHO criteria (SBP> 140 mmHg or DBP> 90 mmHg
or using anti-hypertensive medication) were applied.
Due to the heterogeneity observed among the included studies random effects model
was used to calculate the point estimates of the mean SBP and DBP levels according to
the reported weighted means in the four eligible papers (Table 4.6).
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DaryaniAetal.(320)/ Womenag d35-64 (Sweden-1998-2000)
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Since a recent article of Sarraf-Zadegan et al. (469) was based an updated analysis of the
data published earlier by the author and her colleagues (456) it was decided to use the
information in the recent publications. In order to prevent bias in the calculation of the
overall point estimates the reported findings of the study of Amini et al. (453) also were
excluded due to their focus on people from > 40 age group. With the same token the
study of Sarraf-Zadegan et al. (454) was excluded due to their fieldwork date (which
was in 1993-1994) and inclusion of an updated study from Isfahan. (469)
Table 4.6 Overall pooled estimate of the mean systolic (SBP) and diastolic (DBP) blood
pressure (mmHg) based on the reported weighted means in the included
studies on Iranian indigenous adult population.
Study Mean SBP (95% CI) Mean DBP (95% CI)
Amini M et al. (453)
Male 132.65 (132.52-132.79) * 82.28 (82.23-82.33) *
Female 133.95 (133.83-134.10)* 82.32 (82.26-82.38) *
Sarraf-Zadegan N et al. (454)
Male 131.83(131.49-132.17)* 83.78 (83.60-83.96) *
Female 132.20(131.75-132.65)* 82.88(82.63-83.13 )*
Azizi F et al. (416)
Male 119.48(118.95-120.01) 77.40 (77.07-77.73)
Female 116.12 (115.70-116.57) 76.90 (76.63-77.17)
Sarraf-Zadegan N et al. (469)
Male 115.30(114.71-115.89)* 75.40 (75.01-75.79) *
Female 114.60(114.01-115.19)* 75.20 (74.81-75.59) *
Fakhrzadeh H et al. (471)
Male 128.00(126.41-129.58) 84.00 (82.97-85.03)
Female 127.00 (125.48-128.52) 83.00 (82.11-83.89)
JanghorbaniM et al. (496)
Male 123.30(123.14-123.46)* 78.40 (78.28-78.52) *
Female 121.30(121.14-121.46)* 76.50 (76.38-76.62) *
Overall point estimate **
Male 121.47(117.39-125.55) 78.68 (77.13-80.24)
Female 119.70(115.62-123.79) 77.81 (76.26-79.37)
Test of heterogeneity results
I2=99.65, PO.OOO I2=99.14, PO.OOOMale
Female I2=99.67, PO.OOO I2=98.83, PO.OOO
* Confidence interval calculated by the author.
** Excluding findings of the studies of Amini M et al. (453) and Sarraf-Zadegan N et al. (454)
Pooled point estimate of the prevalence of hypertension was shown in Figure 4.3.
Random effects model has been used in both subgroups (P< 0.000, I2= 99.50 in female
and P< 0.000, I2= 99.41 in the male subgroup of studies) to calculate the overall rates
due to the observed heterogeneity among the included studies. Major disparity was seen
regarding the reported prevalence rate of hypertension among the studies in both sexes.
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For instance studies of Azizi et al. (416) and Fakhrzadeh et al. (471) both were
conducted on a randomly selected sample of adults in almost same age groups (but in
different regions) in Tehran but their findings are extremely different. A lower
prevalence of hypertension among Iranian males and females in Norway (391) and also
very lower prevalence rate of hypertension among Iranian women in Sweden (320)
(while using a lower cut off points) all needs to be clarified.
4.3.2.4 Overweight and obesity
Being overweight as a risk factor for CVD based on the calculated BMI was reported





Statistic for each study * Prevalence rate and 95% confidence interval
Prevalence rate Lower limit Upper limit
MALES
Azizi F et al. 13.70 12.80 14.66
Fakhrzadeh H et al. 37.45 34.39 40.51
Esteghmati A et al. 24.80 24.34 25.26
Female overall 23.92 14.84 36.20
Azizi F et al. 13.97 12.96 15.11
Fakhrzadeh H et al. 41.47 37.67 45.44
Esteghamati A et al. 25.50 25.04 25.96
Male overall 25.33 15.81 38.00
0 23 46
• Since entered prevalence rates automatically rounded up by the CMA software to calculate the confidence interval limits you may notice
their very small differences with the given limits in the summary tables.
Figure 4.3 Overall pooled estimates from the standardised prevalence rates of hypertension
in studies on the Iranian adult population.
Also from 28 included articles in this systematic review, 10 reports had data about the
prevalence of obesity in the Iranian population or Iranian ethnic minorities living abroad
(Table 4.8). (416, 453, 456, 471, 478, 482, 484, 485, 489, 509)
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Measurementsw ret keithhor ovedandtparticipants lightclothing.Theprotocolforheightandweightmeasuremen s wasnotspecified.
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Among these included articles self reported weight and height had been used in two
reports (305, 478) to calculate BMI. In some of the Iranian publications (453, 456, 466,
471, 491) age-adjusted prevalence rates or/and needed data to be able to calculate
standardised prevalence rates were not provided. In the article published by Mostafavi et
al. (484) the provided data were only applicable to calculate standardised prevalence rate
in the Iranian men. Another included paper (485) was only about a group of Iranian
women. Thus for the purpose of this systematic review the data from only five articles
(416, 482, 484, 485, 489) were applied to calculate separately the overall point estimates
of the prevalence of overweight and obesity in the Iranian population. Moreover, the
data about sex specific weighted mean level ofBMI which were provided in six articles
have been applied to calculate pooled point estimate of the mean BMI in the Iranian
population (Table 4.9).
Table 4.9 Overall pooled estimate of the mean body mass index (BMI) based on the
reported weighted means in the included studies on Iranian indigenous adult
population.
Study Male (95% CI) Female (95% CI)
Amini M et al. (453) 25.72 (25.62-25.82) * 26.36 (26.27-26.45) *
Pishdad GR (482) 22.8 (22.6-23.0) * 23.6 (23.3-23.9)*
Sarraf-Zadegan N et al. (456) 24.8 (24.6-25.0) * 27.0 (26.8-27.3) *
Azizi F et al. (416) 25.7 (25.6-25.8) 27.5 (27.4-27.6)
Kelishadi R et al. (468) 25.4 (25.3-25.4)* 27.4 (27.3-27.5) *
Mostafavi H et al. (484) 23.8 (23.6-24.0)* 25.3 (25.2-25.4) *
Fakhrzadeh H et al. (471) 26.0 (25.6-26.4)* 29.0 (28.6-29.4) *
Sotoudeh G et al. (485) NAa 27.5 (27.4-27.6)
Janghorbani M et al. (496) 24.6 (24.56-24.64) * 26.5 (26.46-26.54) *
Overall point estimate p 25.0 (24.5-25.6) 27.2 (26.6-27.7)
Test of heterogeneity results I2=99.25, PcO.OOO I2=99.51, PO.OOO
* Confidence interval calculated by the author.
a Not applicable. (3 Excluding findings of the studies of Amini et al. (453) and Pishdad. (482)
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Thus in order to prevent bias resulting from the inclusion of highly heterogeneous
studies in calculation of the point estimates (regarding the age of studied samples in this
case) the study of Amini et al. (453) was excluded due to their focus on people from >
40 age group. Study of Pishdad (482) also was excluded due to the date of its fieldwork
in about 15 years ago.
In the included reports weight and height measurement methods and also appointed
cut off points were almost identical but the studied age groups were not congruent. The
highest age standardised prevalence of overweight in both males and females was
calculated based on the data provided by Rashidy-Pour et al. (489) from Semnan
province in the central part of Iran and the lowest one based on the data in the article of
Mostafavi et al. (484) from Shiraz in South part of Iran (Table 4.7). Also according to
the study of the Rashidy-Pour et al. (489) the highest age standardised rate of obesity
was seen in their recruited sample in 2005-2006 (Table 4.8). Based on these findings
Iranian women compared to men suffer from a higher rate of obesity. The difference was
evident by higher mean BMI of Iranian women in almost all of the included studies
(Table 4.9). As a result pooled mean BMI also was higher for the Iranian women than
men.
In order to make a robust decision in selecting a proper model for the meta-analysis of
the findings the Q test was conducted to clarify any possible homogeneity or
heterogeneity among the studies' results. The test indicated that a considerable
heterogeneity exists among articles reporting the prevalence of overweight (P= 0.000,
I2= 95.84 in female and P< 0.000, I2< 98.63 in the male subgroups) and obesity (P<
0.000,12= 99.10 in females and P<0.000,12= 98.70 in male subgroups) both in male and
female subgroups. It was based on the findings of this primary analysis that a random
effects model was applied to estimate the prevalence of overweight and obesity in the
Iranian indigenous population.
Subgroup analysis of the calculated age standardised rates revealed that 32.5% (95%
CI: 26.3-39.5) of Iranian women and 32.9% (95% CI: 26.6-39.9) of men were
overweight (Figure 4.4). Also 22.6% (95% CI: 14.2-34.1) of Iranian women and 7.7%
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• Since entered prevalence rates automatically rounded up by the CMA software to calculate the confidence interval limits you may notice
their very small differences with the given limits in the summary tables.
Figure 4.4 Overall pooled estimates from the standardised prevalence rates of overweight
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• Since entered prevalence rates automatically rounded up by the CMA software to calculate the confidence interval limits you may notice their very
small differences with the given limits in the summary tables.
Figure 4.5 Overall pooled estimates from the standardised prevalence rates of obesity
in studies on the Iranian adult population.
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The studies conducted on the Iranian migrants residing in Australia (305), Norway (391)
and Sweden (509) have indicated very different findings regarding the prevalence of
overweight and obesity both in male and female subgroups. Rissel et al. (305) for
instance suggested that 36.04% (95% CI: 30.00-42.50) of Iranian men and 29.26% (95%
CI: 23.20-36.11) of women in Australia are overweight or obese. The study of Glenday
et al. (391); however, has shown that 70.95 % (95% CI: 62.49-80.24) of men and
58.82% (95% CI: 49.48-69.43) of Iranian migrant women in Norway suffer from
overweight or obesity. Moreover, in their study on a group of Iranian women in Sweden
Daryani et al. (509) have revealed that 13.00% (95% CI: 6.80-22.40) of them were
obese.
Probably these differences in the reported prevalence rates stem primarily from the
heterogeneity in the methodology used and also from a real difference between
subgroups of Iranian migrants in different countries. But regarding the reported
unadjusted rates, the observed differences should be interpreted by caution.
4.3.2.5 Dyslipidaemia
From a total of 28 included publications, 11 articles (391, 416, 453, 456, 466, 469,
471, 486, 490, 496, 509) were found to have information about dyslipidaemia based on
the level of total cholesterol (TC), high density lipoprotein (HDL-C), low density
lipoprotein (LDL-C) or triglycerides (TGs) (Table 4.10). Two articles were reporting
dyslipidaemia in a group of Iranian migrant population in Norway (391) and Sweden.
(509) Among the other nine studies which were presenting prevalence of dyslipidaemia
in the Iranian adult population, seven reports (453, 466, 469, 471, 486, 490, 496) did not
provide sex specific age adjusted prevalence rates or/and the data to be able to calculate
standardised prevalence rates (Table 4.11). The applied cut off points to determine
abnormal cases are almost identical in the studies of Sarraf-Zadegan et al. (456), Azizi et
al. (416) and Nadimi et al. (486) but different from other included studies. For instance
the cut off point used to define abnormally high level of triglycerides (> 2.2 mmol/1) in
the study by Fakhrzadeh et al. (471) is 100% lower than the cut offpoints (> 4.4 mmol/1)
that were used by Aziz et al. (416) and Sarraf-Zadegan et al. (456)
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Table4.10Provid dinformationa outthmeasurementeth sfbllipi sninclustudienI nia indigenousa dmigrantdultpopulation. Study/agegroup/location/Giveni formationaboutthmeasureme teth dfieldworkopublicationdate StudiesinIran KimiagarMetal(482)/>0years (National-1990-1992)NP AminiMetal(453)/>0years (Isfahan-1993)Fastingbloodsample(after8hoursve night)wadr wyfteh rclinicalmeasureme ts. RoohafzaHetal.(466)/>20yearsld (Isfahan-1993to1994)Fastingbloodsample(12h urs)wadrawn. Sarraf-ZadeganNetl.(456)/20-70years (Isfahan-publishedi1999)Fastingbloodsample(14h urs)wasdr wn. AziziFetal(416)/>20years (Tehran-1999to2001)Fastingbloodsamples(12-14h ur )wedr wet e7-9inthitposi ion centrifugedwithin30-45minutesofcollection. Sarraf-ZadeganNetl.(469)/>1years (Isfahan-2000to2001)Bloodsampleswertak nafter12hfa i gTGnHDL-Cnalysis. FakhrzadehHetal(471)/25-64years (Tehran-2002)Fastingbloodsample(f rtle st12hoursve night)wadr w . NadimiAEetl(486)/>20years (Rafsanjan-publishedi2004)Fastingbloodsample(14h urs)wasdr we rlym rning7.30-9). JanghorbaniMetal.(496)/>25years (National-2004t 5)Overnightfastingbloodampleswertakanalysis. StudiesonIranianabroad DaryaniAetl.(509) Womenag d35-64 (Sweden-1998to2000)FBS(after12hours)inthbl odsampledrawnm r ingetwee7.15-9. GlendayKtal.(391)/31-60years (Norway-2002)Nonfastingvenousbloodamplewasdraw Notpr vided 115
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Thus the data derived from two publications (416, 456) in Iran were applied to calculate
age standardised prevalence of dyslipidaemia and accordingly to estimate the pooled
prevalence rate (Figure 4.6-4.9). However, data about the weighted sex specific mean
level of the lipids in the studied samples were presented in seven publications (Table
4.12). (416, 456, 469, 471, 486, 490, 496) Based upon the overall point estimates were
calculated separately for mean level of different lipids in the Iranian population.
Group by Statistic for each study * Prevalence rate and 95% confidence interval
Subgroup within study
Prevalence rate Lower limit Upper limit
FEMALES
AziziFetal. 21.78 20.76 22.88
Sarraf-Zadegan N et al. 26.15 21.47 31.33
Female overall 22.03 21.01 23.08
MALES
AziziFetal. 16.17 15.12 17.34
Sarraf-Zadegan N et al. 17.13 11.93 23.91
Male overall 16.23 15.17 17.35
0 16 32
• Since entered prevalence rates automatically rounded up by the CMA software to calculate the confidence interval limits you may notice
their very small differences with the given limits in the summary tables.
Figure 4.6 Overall pooled estimates from the standardised prevalence rates of
hypercholesterolaemia in the eligible studies on Iranian adult
population.
Pooled estimate of the prevalence of hypercholesterolaemia which was calculated
based on the findings of only two studies in Iran (416, 456) suggests that Iranian women
suffer significantly from a higher rate of hypercholesterolaemia than men. Sex specific
weighted mean levels of total cholesterol which were reported in three included
publications (416, 471, 496) also verifies this conclusion. However, pooled estimate of
the mean cholesterol level which was based on the findings of five studies in Iran (416,
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• Since entered prevalence rates automatically rounded up by the CMA software to calculate the confidence interval limits you may notice
their very small differences with the given limits in the summary tables.
Figure 4.7 Overall pooled estimates from the standardised prevalence rates of abnormal
high LDL-C level in the eligible studies on Iranian adult population.
Group bv
Subgroup within study
Statistic for each study * Prevalence rate and 95% confidence interval
Prevalence rate Lower limit Upper limit
FEMALES
Azizi F et al. 13.14
MALES
Sarraf-Zadegan N et al. 42.23
Female overall
Sarraf-Zadegan N et al. 52.67
12.26 13.99
38 76
• Since entered prevalence rates automatically rounded up by the CMA software to calculate the confidence interval limits you may notice
their very small differences with the given limits in the summary tables.
Figure 4.8 Overall pooled estimates from the standardised prevalence rates of abnormal




Azizi F et al.
Statistic for each study * Prevalence rate and 95% confidence interval
Prevalence rate Lower limit Upper limit
MALES
Female overall
Azizi F et al.
2.71
Sarraf-zadegan N et al. 3.89
2.84
Sarraf-zadegan N et al. 10.23
Male overall
2.31 3.15
• Since entered prevalence rates automatically rounded up by the CMA software to calculate the confidence interval limits you may notice
their very small differences with the given limits in the summary tables.
Figure 4.9 Overall pooled estimates from the standardised prevalence rates of
hypertriglyceridaemia in the eligible studies on Iranian adult population.
The overall pooled estimate for mean levels of LDL-C, HDL-C and TGs also did not
indicate statistically significant difference between Iranian men and women. This is
while findings of a number of included studies indicated such a difference with regard to
the mean levels of LDL-C (416, 456, 471), HDL-C. (416, 469, 471) and TGs. (416, 469)
Bringing in mind the methodological heterogeneity was seen among the included studies
and also applied cut off points to define abnormal cases it is recommended that all these
findings to be interpreted by caution since it was not possible entirely to rule out the
probability of measurement and reporting bias among the studies. As an example of
diversity in reporting abnormal cases while Azizi et al. (416) have used > 4.4 mmol/1
level Sarraf-Zadegan et al. (469) have applied > 1.65 mmol/1 level to label people with
hypertriglyceridaemia.
I was discussed earlier that only two articles (391, 509) reporting the prevalence of
dyslipidaemia in the Iranian ethnic minority living abroad had inclusion criteria to be
included in this systematic review. One (391) of these papers reported the prevalence of
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Table 4.12 Overall point estimates by sex for weighted mean levels (mmol/1) of
different lipids reported in the included studies on Iranian indigenous adult
population.
Lipids
Studies TC" LDL-C "" HDL-C r TGn
Mean level, 95% CI °
Amini M et al. (490)
Male 5.53 (5.52-5.54) NA % NA 2.36 (2.35-2.37)
Female 5.75 (5.74-5.76) 2.28 (2.27-2.29)
Sarraf-Zadegan N et al. (456)
Male 5.00(4.88-5.12) 3.11 (3.06-3.16) 1.04(1.03-1.05) 1.49(1.45-1.52)
Female 5.17(5.09-5.25) 3.30 (3.25-3.34) 1.05 (1.04-1.06) 1.46(1.42-1.49)
Azizi F et al. (416)
Male 5.30(5.25-5.31) 3.39 (3.37-3.42) 0.98 (0.97-0.99) 2.02(1.99-2.06)
Female 5.50 (5.46-5.52) 3.50(3.48-3.52) 1.17(1.16-1.17) 1.79(1.77-1.82)
Sarraf-Zadegan N et al. (469)
Male NA NA 1.10(1.09-1.11) 2.01 (1.99-2.12)
Female 1.20(1.19-1.21) 1.8(1.78-1.82)
Fakhrzadeh fi et al. (471)
Male 4.79(4.71-4.88) 2.46 (2.40-2.52) 1.40(1.36-1.43) 2.21 (2.06-2.37)
Female 5.08 (5.00-5.15) 2.62 (2.56-2.68) 1.58(1.55-1.61) 2.00(1.91-2.10)
Nadimi AE et al. (486)
Male 5.20 (5.05-5.35) 2.98 (2.86-3.11) 1.23(1.20-1.27) 2.14(1.98-2.30)
Female 5.06 (4.90-5.22) 2.90 (2.77-3.02) 1.30(1.26-1.35) 2.00(1.86-2.14)
Janghorbani M et al. (496)
Male 5.09 (5.08-5.10) NA NA NA
Female 5.35 (5.33-5.36)
Overall point estimatev
Male 5.1 (5.0-5.2) 3.00 (2.56-3.45) 1.18 (1.06-1.29)x 2.06 (1.99-2.12)x
Female 5.2 (5.1-5.4) 3.06 (2.61-3.51) 1.31 (1.20-1.43)x 1.86 (1.80-1.93)x
Test of heterogeneity results
I2=97.82, PO.OOO I2=99.80, PO.OOO I2=67.55, P=0.026Male I2=99.65, PO.OOO
Female I2=97.44, PO.OOO I2=99.44, PO.OOO I2=99.59, PO.OOO I2=88.54, PO.OOO
* Total cholesterol. ** Low density lipoprotein cholesterol,
t High density lipoprotein cholesterol. ff Triglycerides. J Not applicable,
a Confidence interval calculated by the author.
P Excluding findings of the study ofAmini M et al. (490).
X Excluding findings of the study of Sarraf-Zadegan N et al. (456).
dyslipidaemia in a group of Iranian migrants in Norway and the other one (509)
indicated the rate on a group of Iranian female migrants in Sweden. In the later
corresponding study LDL-C level was not measured. As shown in Table 4.11, different
cut off points had been applied by authors of the two included articles especially in
relation to the TG and HDL-C abnormal levels. The rates presented in the study of
Glenday et al. (391) were adjusted for age but in the study of Daryani et al. (509)
adjustment of reported rates for age has not been mentioned. Thus with such a
heterogeneity in the applied methodology and data reporting it was not possible to pool
the data about Iranian migrants for the purpose of this systematic review.
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4.3.2.6 Diabetes
Crude and age standardised prevalence rates of diabetes in several samples of Iranian
adult population are shown in Table 4.13. Since US unit is in use to report glucose levels
in Iran, quantities of glucose in US units were divided by 18 as a conversion factor into
SI units where appropriate. In two articles (466, 496) age adjusted prevalence rates or
even necessary data to calculate them were not provided. In the papers of Larijani et al.
and Azizi et al. (487, 491) needed data to calculate the standardised prevalence rates
were not included in the published article. The study of Daryani et al. (509) was on a
group of Iranian (n=71) migrant women in Sweden but did not provide age adjusted
prevalence rate of diabetes. Thus only six publications (416, 453, 456, 471, 488, 497)
remained for meta-analysis. To prevent over estimation bias findings of the study of
Amini et al. (453) were excluded from the analysis since it was conducted on subjects
over 40 years old in 1993. As displayed in the table, studied age groups, measurement
protocols and even applied cut off points (based on the World Health Organisation 1985
or 1988 or American Diabetes Association criteria) (515) were somewhat different in the
included articles. Age standardised prevalence rate of diabetes in one national (497) and
one large scale study in Tehran (416) was indicated that Iranian women have a
significantly higher rate of diabetes compared to men. However, findings of other
included studies did not show such a difference. Findings of the study of Fakhrzadeh et
al. (471) which was conducted in one of the almost deprived part of Tehran indicated
significantly higher prevalence rate of diabetes (13%) among studied women compared
to the rate (8.6%) was seen in the study of Azizi et al. (416) in the Eastern region of
Tehran. These differences along with disparities was seen in studies which were
conducted in different part of Iran must be interpreted by caution due to the differences
in the studied age groups and also applied methodology. Even so, the observed
difference between Iranian men and women especially in deprived regions warrant
further scrutiny.
Only one study (509) was found in this systematic review investigating the prevalence
of diabetes in a group of Iranian migrant women in Sweden. Despite application of a
lower cut off point (> 6.1 mmol/1) and inclusion of subjects from the age group of 35-64
123
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years to identify diabetic patients, the findings suggested that only 4.2% of the study
participants are diabetic. But it was not clear from the provided explanations whether the
reported prevalence rate is adjusted for age or not.
The overall point estimate of the age standardised prevalence rate of diabetes in the
Iranian studies did not show any difference between sexes (Figure 4.10). Regarding the
• • • 2
heterogeneity was seen in the subgroup analysis of the included studies (I = 88.98, P<
0.000 in male and I2=96.32, P<0.000 in females subgroups) random effects model was
used to calculate the pooled estimates.
Group by
Subgroup within study
Statistic for each study *
Prevalence rate (%) Lower limit Upper limit
Prevalence rate and 95% confidence interval
FEMALES
MALES
Azizi F et al. 8.60 7.90 9.40
Sarraf-Zadegan N et al. 3.70 2.76 4.93
Fakhrzadeh H et al. 13.00 11.01 15.28
Esteghamati A et al. 8.30 7.98 8.63
Azimi-Nezhad M et al. 3.74 2.98 4.69
Female overall 6.92 5.44 8.75
Azizi F et al. 6.80 6.07 7.61
Sarraf-Zadegan N et al. 4.20 3.12 5.63
Fakhrzadeh H et al. 8.80 6.80 11.31
Esteghamati A et al. 7.10 6.79 7.42
Azimi-Nezhad M et al 4.23 3.40 5.25
Male overall 6.05 4.73 7.70
0 8 16
• Since entered prevalence rates automatically rounded up by the CMA software to calculate the confidence interval limits you may notice
their very small differences with the given limits in the summary tables.
Figure 4.10 Overall pooled estimates from the standardised prevalence rates of diabetes
in the eligible studies on Iranian adult population.
Mean level of fasting blood glucose was reported in four articles (Table 4.14). A
statistically significant difference between Iranian men and women was seen in two
studies (471, 496). One of these studies was a country wide study (496) and the other
one (471) was conducted in Tehran. However, findings of other two studies and also the
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Table 4.14 Overall point estimates by sex for weighted mean levels (mmol/1) of fasting




Mean level, 95% CI *
Azizi F et al. (416) 5.44 (5.39-5.49) 5.44 (5.39-5.49)
Sarraf-Zadegan N et al. (469) 4.60 (4.56-4.64) 4.60 (4.56-4.64)
Fakhrzadeh H et al. (471) 4.40 (4.26-4.54) 4.62 (4.57-4.67)
Janghorbani M et al. (496) 5.34 (5.32-5.37) 5.47 (5.45-5.49)
Overall point estimate 4.95 (4.47-5.43) 5.03 (4.56-5.51)
Test of heterogeneity results I2=99.76, P<0.000 I2=99.86, PO.OOO
* Confidence interval calculated by the author.
estimated pooled mean of FBS did not confirm presence of any difference between men
and women.
4.3.2.7 Results' summary
A summary of the point estimates from the age standardised prevalence rates of the
studied CVD risk factors in Iran are provided in Table 4.15. As seen, major differences
seem to exist between two sexes in the Iranian population with regard to the smoking
and obesity. Due to the reasons like limited number of eligible studies, considerable
amount of heterogeneity in the applied methodology and differences in the study
location or fieldwork date, the calculated confidence limits are wide for the pooled
estimates ofprevalence rates for some of the risk factors.
Due to the sparse number of studies on Iranian migrants it was not possible to pool
data presented in the eligible studies to calculate overall estimates of the CVD risk
factors for this ethnic minority. But in order to have an overall view about the studied
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CVD risk factors and the differences exist in the applied methodology and reported
rates, findings of the identified studies regarding the prevalence of CVD risk factors
among Iranians in different countries of the world were summarised in Table 4.16.
Table 4.15 Pooled point estimates from the sex specific and age standardised prevalence






Smoking 17.65 (10.19-28.82) 1.25 (0.64-2.44)
Hypertension 25.33 (15.81-38.00) 23.92(14.84-36.20)
Overweight f 32.90 (26.62-39.86) 32.53 (26.28-39.48)
Obesity 1t 7.71 (4.50-12.91) 22.64 (14.22-34.05)
Dyslipidaemia
Hypertriglyceridaemia * 7.05 (3.74-12.89) 2.84 (2.47-3.28)
Hypercholesterolemia * 16.23 (15.17-17.35) 22.03 (21.01-23.08)
High LDL-C a 18.91 (12.02-28.46) 27.12 (17.94-38.77)
Low HDL-C p 41.50 (16.16-72.31) 24.8 (8.26-54.90)
Diabetes A 6.05 (4.73-7.70) 6.92 (5.44-8.75)
* Self reported smoking: at least one cigarette a day.
* * SBP> 140 mmHg or DBP> 90 mmHg or using anti-hypertensive medication.
| 25< BMI<30 kg/m2 ff BMI>30 kg/m2 % TGs>4.4 mmol/1
± TC> 6.5 mmol/1 in one study and TC> 6.24 mmol/1 in another one.
a LDL-C>4.14 mmol/1 in one study and LDL-C>4.20 mmol/1 in the another one.
P HDL-C<0.90 mmol/1.
X 2h PG>1 lmmol/1 or FBS> 7 mmol/1 in four studies and FBS >7.8 mmol/1 in one study.
Since these prevalence rates were not adjusted for a standard population they can not
be compared reliably with the standardised prevalence rates calculated for Iranian
indigenous population.
4.4 Discussion
The study findings indicated that there are only a few comprehensive studies on the
prevalence of CVD risk factors in Iran with substantial heterogeneity in the
methodologies used. The observed heterogeneity of the applied study protocols (even
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when studying identical variables) heralds the importance of adherence to a standard
study protocols when doing research on the prevalence ofCVD risk factors.
Table 4.16 Prevalence rate (PR%) of the major CVD risk factors by sex reported
in the studies on Iranian migrant adult population.
PR (95% CI)
Variables Studies
Rissel C et al. (305) " Daryani A et al. (509) ** Glenday Ket al. (391)f
Smoking *
NA *Male 23.9 (18.7-29.9) ± 11.2 (8.3-14.9)±
Female 17.0 (12.3-23.0) ± 21.0 (13.2-32.0)± 10.5 (7.2-15.1)±
Hypertension TT
Male NS** NA 14.0(10.8-17.9) *
Female NS 6.0(2.2-13.6) ± 10.9(7.6-15.5) ±
Overweight °
71.0 (62.5-80.2)* 6Male 36.0 (30-42.5) * NS
Female 29.3 (23.2-36.1) * 58.8 (49.5-69.4)* €
Obesity ^
Male NS NA NS
Female 13.0(6.8-22.4) ±
Hypertriglyceridaemia k
Male NS NA 27.9 (23.5-32.8) ±
Female 25.0(16.7-36.6) ± 18.9(14.4-24.4) ±
Hypercholesterolemia a
Male NS NA 23.7(1.6-28.4) ±
Female 13.0(6.8-22.4) * 13.9 (10-18.8) ±
Low HDL-C *
Male NS NA 20.1 (16.3-24.6) ±
Female 50.0 (39.3-62.0) * 8.8(5.8-13.1) *
Diabetes 0
Male NS NA NS
Female 4.2 (1.4-11.7) ±
* Self reported: at least one cigarette a day. ** Age adjusted rates were not provided,
f Age adjusted prevalence rates were provided: confidence interval calculated by the author.
J Not applicable. ± The confidence interval calculated by the author,
ft SBP> 140 mmHg or DBP> 90 mmHg or using anti-hypertensive medication.
±± Not studied. <X25<BMI<30 kg/m2
€ Reported rate in this article shows the prevalence of overweight and obesity together.
P BMI>30 kg/m2 X TGs>4.4 mmol/1
6 TC > 6.5 mmol/1 in the study of Daryani et al. and TC > 6.2 mmol/1 in the study of Glenday et al.
¥ HDL-C < 1.29 mmol.l in in the study of Daryani et al. and HDL-C < 0.9 and 1 mmol/1 for men and
women in the study of Glenday et al.
$ FBS 6.1 mmol/1.
This heterogeneity in applied methodology also indicates the challenges other
researchers may face in meta-analysis of the findings of these divergent studies.
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Intuitively, differences in the underlying characteristics inherent among descriptive
epidemiological studies (studying different samples chosen from different locations
within the larger community or time lag between studies) may also have proportional
effect on the observed variations. For instance, the observed prevalence rates of different
CVD risk factors in this systematic review considerably were divergent depending on
the date of fieldwork and location of studies.
Reporting bias was one of the other important considerations in this meta-analysis. As
a result, complying with a standard reporting protocol by Iranian researchers may
prevent major biases in the future studies (e.g. under or over reporting of the prevalence
of a CVD risk factor due to use of unconventional cut off points or interpretation of
crude prevalence rates instead of age adjusted or standardised rates). Thus application of
more stringent methods than hitherto for analysis and reporting of data must be regarded
as sine qua non for researchers.
This study is the first comprehensive systematic review of the prevalence studies on
the major CVD risk factors in the Iranian original and migrant populations. Findings of
this systematic review raise major concerns about the prevalence of a number of CVD
risk factors (obesity and low level of HDL-C) in the Iranian population especially with
observed differences between men and women. The overall pooled estimate of the
reported prevalence rates in the Iranian eligible studies revealed that about 23% of
women and only about 8% of men suffer from obesity. The difference may stem from
lower physical activity levels of Iranian women due to a variety of reasons such as their
unequal access to health and fitness clubs in Iran.
Since there are a few empirical data on the Iranian Diaspora with regard to the
prevalence of CVD risk factors, it was not possible to calculate overall summary
prevalence rates in this ethnic group for comparison purposes. There is some evidence
suggesting the change in CVD risks among migrant populations compared to their
country of origin. Limited available evidence (305, 391, 509) indicated that the
prevalence of hypertension in both sexes and obesity in women is considerably lower
and the prevalence of self reported smoking rate among Iranian migrant women is
markedly higher compared to their counterparts of same gender in Iran.
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As discussed before a sizeable number of Iranians are now living in the U.S and
different European countries. Due to our insufficient knowledge about Iranian migrants'
CVD profile, it is practically difficult to judge about their risk status after migration.
Therefore performing of a future population based study on this ethnic group to clarify
their CVD risk status will be informative and strongly recommended.
This review had its own weaknesses and strength. All efforts were made to perform a
comprehensive search of the literature to minimise probability of publication bias.
Unfortunately due to limited number of eligible studies in this review (less than 10 in
each subgroup) it was not possible to analyse the findings for publication bias as a
source of heterogeneity. (514, 516) Only a funnel plot (Figure 4.11) from the
publications reporting the prevalence of diabetes in the Iranian indigenous population is
provided as an example of primary visual tool for the investigation of possible
publication bias in the meta-analysis of prevalence studies.
Figure 4.11 Funnel plot of precision by logit prevalence rate to evaluate publication
bias in the systematic review of studies reporting the prevalence of
diabetes in the Iranian indigenous adult population.
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As shown, there is no indication of major asymmetry and thus no evidence of
publication bias. It is very likely that the observed variations were produced by mainly
divergences in the methodologies, measurement or reporting biases. They also may
represent just regional variations or pattern of change in the prevalence of different CVD
risk factors by time. Due to small number of eligible studies it was not possible to rule
out all these possibilities by certainty. Considering the evidence presented here it is very
important to the Iranian researchers to comply with standard protocols in doing research
on the prevalence of different CVD risk factors. Without such a most needed revision
and with the current amount of methodological heterogeneity in the CVD related
epidemiological studies, reaching to a soundly based and robust conclusion in future
systematic reviews will be very unlikely.
In this review an extensive search had been done to find out all studies, regardless of
their publication place and language (English or Persian) but some limitations of this
review warrant to be addressed. Few authors reported participation rates or explained
characteristics of those refused to participate in their studies. Many of the included
articles had poor reporting quality and in some cases proposed measures were calculated
manually based on the provided raw data.
Every effort was made to track down unpublished study and grey literature but this
research is unable to rule out the possibility of detection bias entirely. To make contact
with researchers or even after contacting them to get a copy of full results from their
presented abstracts in conferences or brief summary of results in informal publications
was not always successful. Therefore, included in this analysis only are those studies
that were accessible and consistent with the inclusion criteria.
Reliance was on the information reported in the articles. In some cases (471, 484)
there was mismatch between numbers in the texts and tables. To resolve these
mismatches authors of the articles were contacted. In one case the response was received
confirming that the mismatch is a typo. (484) In many reports there were not enough
details about applied methodology for data gathering or data analysis.
The strength of the review could be greatly improved if it was possible to have access
to all journals; thesis or unpublished documents had been published in Persian mostly in
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Iran which is not possible currently. This is the result of limitations in having remote
access to the findings of scientific publications in this country due to lack of systematic
data storage and sharing infrastructure within the academic institutions.
Since only few studies were conducted on the Iranian migrant population to
investigate their health status and among them even very few focused on the prevalence
of CVD risk factors in this ethnic group, the data provided in this review may not be
generalisable to all Iranians living abroad. Considering the available data from identified
studies on the Iranian migrants, it was noticeable that except smoking, prevalence of the
other major risk factors was lower among the migrants compared to the Iranian general
population (Table 4.15 and Table 4.16). This could be the consequence of major
differences in the community resources including access to health care services,
supportive legislation and even life style skills in the country of origin with those
structured in the mostly developed destination countries. However; selection and
reporting bias or bias due to use of an unreliable measurement method are other
possibilities. There are strong cultural barriers for instance in Iran with regard to smoking
females. As a result there is a sense of stigma among women which inhibits them to
explore their smoking behaviour to strangers. Thus reliance solely on the self reported
smoking data in the Iranian studies could provoke major bias in the estimated overall
prevalence rate of smoking in this sex group.
This systematic review is a major step in the epidemiological research on the
prevalence ofCVD risk factors in this population. Thus its findings can help researchers
and policy makers to take informed decisions when dealing with the prevalence of major
CVD risk factors in the Iranian original and migrant populations.
4.6 Abstract
Introduction: As explained in the previous chapter, there has been increasing
migration from Iran to countries all over the world in the last three decades. There is no
comprehensive systematic review of studies on the prevalence of CVD risk factors ever
undertaken among Iranians and for this reason interpretation and comparison of the
results is burdensome.
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Methods: Nine data bases along with other appropriate electronic resources were
searched to identify possibly all studies that have measured the prevalence of CVD risk
factors in the Iranian indigenous or migrant populations and their accuracy and quality
were assessed.
Results: From a total of 104 potentially relevant publications, 28 articles were
scrutinised and substantial heterogeneity in the applied methodology were observed.
Based on the overall pooled estimates obesity was prevalent among 22.64% (95% CI:
14.22-34.05) of the women and 7.71% (95% CI: 4.50-12.91) of Iranian men. Self
reported smoking rate was estimated to be 17.65% (95% CI: 10.19-28.82) in men and
only 1.25% (95% CI: 0.64-2.44) in Iranian indigenous women. This is while the lowest
reported prevalence rate of smoking among Iranian migrant women so far is 10.5% (95%
CI: 7.2-15.1).
Conclusion: Findings of this systematic review raise major concerns about the
prevalence of a number of CVD risk factors and also differences between men and
women in the Iranian population. Due to a few empirical data it was not possible to
calculate overall prevalence rates of CVD risk factors for the Iranian Diaspora. A
proposal was set out to do a pilot study on the prevalence of major CVD risk factors
among Iranian ethnic group in Edinburgh as a prerequisite for a UK wide study. This
proposal is described in the next chapter.
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Chapter Five: Methodology of the field work: a pilot study of the
prevalence of established cardiovascular disease
risk factors among Iranians in Edinburgh
5.1 Introduction
In the two previous chapters it was discussed that there is a growing population of
Iranians abroad and so study of determinants of health in this ethnic minority group is
vital. However, it was discussed that there is a huge gap in the evidence and the research
evidence on which to base health care planning and provision decisions for the Iranian
Diaspora is very limited. With dispersion of Iranian migrants within the general
population in the destination countries conducting of population-based studies on this
minority group is challenging. Only a few comprehensive studies exist on the prevalence
of cardiovascular disease (CVD) risk factors in Iran with substantial heterogeneity in the
methodologies used. Also a few empirical data on the Iranian Diaspora were identified
with regard to the prevalence ofCVD risk factors. So it was not possible to calculate an
overall summary prevalence rates in this ethnic group for comparison purposes. This
chapter explain the methodology of a pilot study which was set out to investigate the
prevalence of major CVD risk factors amongst Iranians living in Edinburgh as the first
study of Iranian Diaspora ever undertaken in the UK.
5.2 Outline of research
In the previous chapters (pages 1-5) it was indicated that major variations exist
among ethnic migrant groups compared to the indigenous population in the destination
countries and population of the country of origin regarding the prevalence of
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cardiovascular disease risk factors. But due to our insufficient knowledge about Iranian
migrants' CVD profile it is not possible to have a precise judgement about their risk
status after migration. Therefore, a proposal was set out to conduct a pilot population-
based study on the prevalence of major CVD risk factors amongst Iranians living in
Edinburgh. The ultimate goal was to develop methods, gain experience and to acquire
estimates to inform a full scale future study.
5.2.1 Research proposal
Findings of this study will answer the following questions:
1. Is it possible to construct a sampling frame of Iranians living in Edinburgh?
2. What kinds of concerns have Iranians about answering a study questions through
face-to-face interview or being a subject of physical examination or invasive tests
(e.g. blood sampling)?
3. Are there any special preferences among Iranians to have physical examination or
assessment being undertaken by practitioner of same gender?
4. Can the Scottish Health Survey questionnaires be adapted for the Scottish Iranian
population?
5. What proportion of Iranian subjects in the study of this kind need translated materials
or translation to complete the procedure?
6. What proportion of those invited to participate in a study of this kind give their
consent and actually participates in the study?
7. What is the estimated prevalence ofmajor CVD risk factors among the Iranian living
in Scotland? (This could be used for calculation of sample size in the future population
based CVD studies on Iranians living in Scotland).
8. Are there any major differences between Iranian migrants in Edinburgh with Iran's
indigenous population or Scottish White population regarding the prevalence ofCVD
risk factors?
5.3 Study questionnaires
Since one of the objectives of this study was to compare the status of Iranian
subjects living in Edinburgh with the status of general Scottish White and Iranian
indigenous population with regard to the major CVD risk factors, application of the
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questionnaires and measurement methods that are standard in CVD epidemiology were
considered. Thus Scottish Health Survey (2003) was selected as one of the key surveys
and data collection technique in this study was modelled on that. These questionnaires
were translated into Persian and their face validity was assessed and confirmed by one of
the study supervisors (Dr Farshid Namdaran) who was fluent in academic English and
Persian. The study participants were given choice to choose original English (Appendix
nine) or translated questionnaires (an electronic copy is provided in the attached CD to
the back cover of the thesis) to be completed by face-to-face interview. So another
purpose of the pilot study was to assess face validity of the questionnaires.
5.4 Ethical approval
Research involving the national health system (NHS) staff, patients (alive or
recently dead), data, premises or facilities in the UK must go through an NHS Research
Ethics Committee. (517) Application for the local NHS ethics committee (Lothian
Research Ethics Committee) approval was submitted at 30th November 2005 and a
favourable ethical opinion was received at 18th May 2006 (Appendix ten).
5.4.1 Other approvals (NHS Research and Development Approval, Study
site approval, the University of Edinburgh's Health and Safety
Department approval, Enhanced Disclosure)
In addition to the NHS ethics committee approval every health and social care research
in the UK also needs the local NHS Research and Development Office (R&D) approval
for each of the NHS organisation where the project will take place. (518) The R&D
approval was received for this study at 23rd of May 2006 (Appendix 11). Study site
approval (Wellcome Trust Clinical Research Facility at Edinburgh's Western General
Hospital) also was needed to commence this study which was granted at 13th April 2006
(Appendix 12). The University of Edinburgh's Health and Safety Department approval
also was required to include the investigators and their study participants within the
liability insurance cover held by the university. This approval was achieved on 16th
March 2006 (Appendix 13). To complete the list of needed approvals the requested
enhanced disclosure for the main investigator should also be added. This disclosure was
issued by the Scottish Criminal Record Office on 3rd of February 2006 (Appendix 14).
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Separate application forms were filled out to get all needed approvals before starting the
pilot study.
5.5 Research design
This pilot study was a cross-sectional population-based study on the prevalence of
the major CVD risk factors among Iranian migrants in Edinburgh. As a preliminary
work a systematic review was carried out to provide a comprehensive tabulation of
available data on recruitment methods have been used successfully in studies on the
Iranians living abroad (page 56-80). According to the findings of this review no single
method of recruitment can be considered a gold standard in studies on Iranian migrants
since similar methods in varying circumstances have led to differing results. Therefore
multi-method sampling technique was decided to be used in this study.
Another systematic review was implemented on the prevalence studies of CVD risk
factors amongst Iranians in order to have a reliable estimate on the prevalence of these
risk factors and also to identify reliable Iranian studies (see results in chapter four).
Based on the comment was given by one of the panellists in the annual review session of
my study (Dr Jackie Price) matching design was applied to see whether there are any
major differences between Iranian migrants in Edinburgh with Iranian indigenous and
Scottish White population regarding the prevalence ofCVD risk factors.
Therefore due to the small number of available cases relative to the number of
available controls and in order to improve efficiency of comparisons multiple matched
controls (1:5) were selected where possible otherwise variable numbers of controls
(maximum 5) matched to each case. Thus raw data from a comprehensive study in
Scotland (519) and one from Iran (416) were requested for analysis. Scottish Health
Survey was also selected as one of the key surveys and data collection technique in this
study was modelled on that.
5.5.1 Study Sample
5.5.1.1 Inclusion criteria
Healthy and free-living (not living in institutions) Iranians including people already
diagnosed with a CVD aged 18 years or older were included in the study. Those who
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had at least one of the inclusion criteria but reside in the UK temporarily (not permanent
residents) were excluded from the study. Those students who were resident in Edinburgh
for more than five years also were included in this study.
5.5.1.2 Sample size
One of the objectives of this pilot study was to collect initial data to make possible a
reliable sample size calculation in any future large scale study. Results of a census was
held in Scotland in April 2001 (520) indicated that the number of Iranians who were
born in Iran and reside in Scotland was 1588 (1017 males and 571 females) of whom
388 (257 males and 131 females) were residents of Edinburgh. Among those Iranians
living in Edinburgh 355 (236 males and 119 females) were over 15 years old. A
pragmatic approach was applied to determine the sample size in this pilot study
regarding the feasibility issues (time, cost) (521) Therefore bringing in mind the number
of Iranian males relative to the females in Edinburgh it was decided to include about
(50-100) of them in this pilot study depending on progress in recruitment of eligible
subjects.
5.5.1.3 Sampling method
Since there was not a representative sampling frame of Iranians in Edinburgh and they
were broadly scattered within the larger community it was not possible to easily access
them through other more reliable sampling methods. Consequently, multi-method
sampling strategy including snowball sampling had been used to recruit them into this
pilot study.
5.5.1.4 Publicising study project among Iranians living in Edinburgh
A leaflet was produced in both English (Appendix 15) and Persian version (an
electronic copy is provided in the attached CD to the back cover of the thesis) to
publicise the study among Iranians living in Edinburgh. Several copies of this leaflet
were distributed in places such as local shops (to be known to provide Iranian food stuff
or owned by an Iranian), restaurants (owned and managed by Iranians), Iranian school
(active only in Saturdays to teach Persian to Iranian children) and the Edinburgh's
central mosque. Also several original and translated versions of this leaflet were
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distributed among known Iranians to be redistributed by them among their friends or
family members.
Information about this study and my contact details also were advertised (in English
and Persian) in a quarterly newsletter (Shirin) which was publishing by the Persian
Society of the University of Edinburgh. This study was also advertised in English
through a 10 minutes radio programme from the local Muslim radio station which was
broadcasting in the holy month ofRamadan (Radio Ramadan).
The leaflet also was distributed in different occasions when Iranians informally
gathered together to celebrate e.g. Iranian New Year or to watch an Iranian film
together.
5.5.1.5 Initiating the primary contacts and approaching potential
participants
I explained among the small circle of Iranian friends the study objectives and
procedures I am going to do on the study participants. Advantages ofparticipation in this
study were emphasised and they were requested to introduce this study to their friends or
relatives and give my contact details to whom that show interest for participation. After
receiving contact details of potentially interested people they were contacted by phone
or sending email or text message. At this stage a brief explanation about the study
objectives was given and a convenient appointment time was settled for them. Those
attending the study clinic were also asked to encourage their friends or family members
to participate in the study.
5.5.2 Study variables
Studied variables in this pilot study can be classified in four groups as follow:
Baseline variables: age, sex, self-declared nationality, country of birth, length of stay in
UK, length of stay outside Iran and parents' country of birth.
Variables relating to the study setting and participants' concerns: preferred
language, successful ways of reaching Iranians, willingness to allow their name and
contact details to go on a list of Iranians, willingness to share their family and friends'
contact details, factors affecting their participation (religion, ethnic characteristic, sex,
age or any other aspect of the study researcher or interviewer), preference in relation to
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the gender of practitioner, method of questioning, any other factors affecting their
participation, feeling about study questionnaire and questions (the time questions took,
being easy to understand or too sensitive), self-declared religion, idea about Iranians'
willingness to explore their religion, considering question about religion too sensitive,
suggestions to improve Iranians participation in health studies, data collection method
and place, language of interview, the questionnaire completing method, the
questionnaire completion status, consenting to give blood sample for analysis and
storage, consenting to allow their GP to be informed about participation in this study and
to receive a copy of results from their blood sample analysis.
CVD risk factors: Physical inactivity, unhealthy eating habits, smoking, excessive use
of alcoholic drinks, poor economic condition, low educational status, familial history of
CVD, hypertension, raised level of total cholesterol, LDL-C or triglycerides, low HDL-
C level, general obesity, high waist to hip ratio, diabetes.
Cardiovascular conditions: Angina, heart attack, heart murmur, abnormal heart
rhythm, other heart trouble, stroke, ischaemic heart disease (IHD).
In order to make the results section easy to follow, the applied definition(s) for each of
the studied CVD risk factors is/are provided separately before providing the findings
with regard to every individual risk factor in chapter 7.
5.5.3 Method of data collection
5.5.3.1 Protocol for measurement of anthropometric indices
In order to measure anthropometric indices (weight, height, waist and hip
circumference) accurately the Standard Operating Procedures (SOP) followed by the
practitioners in the Wellcome Trust Clinical Research Facility (WTCRF) were adopted
(Appendix 16: weight measurement, Appendix 17: height measurement, Appendix 18:
waist and hip measurement).
To measure weight a digital scale (SECA 797) was used and all study participants
were asked to remove outdoor clothing, their shoes and any heavy items in pockets.
Then they were requested to stand on scales and instructed to keep still while their
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weight was been measured. Weight was recorded and analysed in kilogram (kg) to the
nearest 0.1 kg in this study.
In order to measure height the study participants were asked to remove their shoes and
stand in an unsupported position with their legs straight, their heels, head and shoulder
blades touching the wall or vertical scale and their feet parallel to each other. In this
position and to have an accurate measurement toes should point forward and soles
should positioned flat on the floor. All participants were also asked to stand as tall as
possible and look straight ahead with head and eyes in Frankfurt plain position (it is an
anatomical position of the human skull referring to a position in which a presumptive
line passing through the inferior margin of the left orbit and the upper margin of each ear
canal is parallel to the surface of earth. This position is recommended at the World
Congress on Anthropology in Frankfurt, Germany in 1884 to be considered in height
measurements). (522) The horizontal measure blade then was brought down to touch the
top of subject's head. All height values were read on the vertical scale to the nearest 0.1
centimetre and recorded in metre.
5.5.3.2 Protocol for measurement of blood pressure
To reduce inter and intra observer variation a digital sphygmomanometer was applied
in this study to measure study participants' blood pressure. Thus calibrated Omron
705IT monitor was used to measure the subjects' blood pressure twice with at least 10
minutes interval. The measurements were done by qualified nurses in the study site
(WTCRF - Edinburgh's Western General Hospital).
Every participant was explained on his/her arrival objectives of the study and also the
measurements procedure. Then they were asked to read the study information sheets and
sign consent forms. A copy of the study information sheet along with signed consent
forms were given to the participant for their future study. They were advised that to have
an accurate blood pressure measurement he/she should sit quietly for five minutes to
rest. They also were requested not to eat or drink during this time and were warned that
during the measurement the cuff will inflate and they may feel some pressure on their
arm during the procedure. All study participants were requested to sit in a comfortable
chair in a private room and a pillow was offered to support their right arm at a level to
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bring their elbow to approximately heart level. Then they were asked to sit in a
comfortable position with legs uncrossed and feet flat on the floor. A standard adult size
cuffwas applied round the upper right arm (about 2 cm above the elbow crease) and left
arm was used only if it was impossible to use the right arm for the measurement. The
cuff was applied neither tightly nor loosely so that it was possible to insert two fingers
between cuff and arm. Blood pressure measurement was repeated after ten minutes for
each participant. Values both for diastolic and systolic blood pressure were recorded on
the data sheet which had been prepared for this purpose. The Standard Operating
Procedure (SOP) for application of Omron 705IT monitor was followed in this study to
measure the participants' blood pressure (Appendix 19).
5.5.3.3 Protocol for blood sampling, processing and storage
Blood samples were obtained by the nurses from those study participants that
consented to give their blood samples for lipids and glucose analysis and also for long
term storage to use in future possible studies. These samples were directly were sent to
the study site laboratory for analysis and those for storage were spun immediately and
then classified and stored in separate boxes temporarily in the study site freezer (-40° C)
and then for long term storage (-80° C) they were transferred to the Queen's Medical
Research Institute at the Royal Infirmary of Edinburgh.
Blood sampling regime for analysis and storage purposes was determined after
consultation with Professor Rudolph Riemersma (senior lecturer in cardiac biochemistry
and professor of medical physiology in Vascular Injury & Cardiology Unit of the
University ofEdinburgh) (Table 5.1).
5.6 Data collection
Data collection stages of the study were planned to take place in the study site.
Those participants who had not time to stay in the study site after anthropometric
measurements and blood sampling there was an opportunity to be interviewed in their
home or any other preferred place. An appointment time between 9 AM - 3 PM was given
during week days to people who showed their interest to participate in the study (e.g. by
telephone call or sending message). Participants were allowed to select the interview
language (Persian, English, Azeri Turkish) of their choice.
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They also were allowed to select the language of consent forms, study information sheet
and interview questionnaires (from an original English or translated Persian versions).
5.6.1 Study questionnaire testing in the pre-pilot phase
To be sure that those potential study participants will understand all questions in the
original and translated versions of the questionnaire and supporting documents they
were checked by one of the study supervisors (Dr Farshid Namdaran) who was fluent in
English and Persian as his mother language. Also the questionnaire and its adjoining
documents were tested before start of the pilot study in pre-pilot phase. Therefore four
questionnaires were filled and based on the respondents feedback very minor changes
were done in the content of questions or open ended answers within the study
questionnaire (e.g. in the alcohol drinking module the number of questions were reduced
and questions were focused on drinking or not drinking of alcoholic beverages and
frequency of drinking rather than the type of drinks).
5.6.2 The interviews, measurements and sampling
Wellcome Trust Clinical Research Facility (WTCRF) based in the Edinburgh's
Western General Hospital was selected as the study site. Officials in the WTCRF
accepted to provide space and instruments and also research nurse staff at a subsidise
rate.
Complete information about the study objectives and the procedure were given to the
study participants on their arrival. They were advised to ask any question(s) they might
have about the study or the procedures. Then they were given consent forms in three
copies with a study information sheet to study and sign (Appendix 20) (an electronic
copy of the Persian version is provided in the attached CD to the back cover of the
thesis). A copy of the signed consent form along with the study information sheet was
given to the participants to keep for future study. Another copy was filed in the study
site and the third copy was kept by the study investigator. The process of studying and
signing consent forms, blood pressure and anthropometric measurements, blood
sampling and interview took between 60-80 minutes.
The study participants were interviewed about their CVD related life style e.g.
physical activity, smoking habit and diet. They also examined for anthropometric indices
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and their blood sample were analysed for certain biochemical factors (TC, HDL, LDL,
and Glucose). Waist and hip circumference of all female participants were measured
twice by a female nurse assistant and of the male participants by me or a nurse assistant
in a private room. Mean values of two measurements were used in the analysis. If the
difference between two measurements was more than 0.5 centimetre a third
measurement was performed and two close values were selected for analysis. Height
was measured to the nearest 1 cm and weight to the nearest 0.1 kg.
For those participants who were not able to attend the study place telephone interview,
postal questionnaire or interview in their homes were offered. Afterwards they were
asked to nominate and facilitate introductions to other people whom they know and who
fulfil the study criteria. In the later phase the introduced nominee was contacted for
participation in the study again with giving detailed information about objectives and
stages of the study.
Based on the participants' permission a copy of their blood sample analysis' results
attached to an information sheet (to describe the meaning of normal and abnormal
values) were sent to their address and another copy to their GPs.
5.6.3 Inter and intra-observer measurement variation
To ensure accuracy of waist and hip measurements and to reduce intra-observer
variation I attended along with other research nurse assistants in a practical training
session which was planned by the WTCRF in the study site. There was opportunity in
this training program to check for measurement variation between different measurers
and to correct measurement method according to the standards.
5.7 Ethical considerations
In this pilot study all participants was given choice to give blood sample only for
lipids and glucose analysis, for storage purposes simultaneously or refuse to give blood
sample at all. Verbal explanation about the study, its objectives and stages of procedures
was provided for all participants on their arrival. But at the same time to ensure rigor and
prevent potential misunderstandings they were given both Persian and English version of
the study information sheet attached to the consent forms. All study participants were
asked to read the study information sheet which was prepared to give information about
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the study, the participants' legal rights if something goes wrong and organisations that
funded the study. It was emphasised that no one will have access to the information they
will provide in this study without their prior permission. No names were written on the
study questionnaires and all participants were allocated a code. So it was not possible to
detect the name of respondents from the questionnaires or examinations result forms. All
names and contact details also were filed separately from the questionnaires and the
participants coding lists. The study participants were offered a cup of tea or coffee with
biscuits after giving blood sample. They also were offered five pounds as compensation
to cover a part of their travel costs to and from the study site.
5.8 Process of data request from Scottish Health Survey 2003 and an
exemplar study from Iran for comparison purposes
To compare findings of this pilot study with the results of exemplar studies in Iran
and also in Scotland data from two major studies were decided to be used for
comparison purposes. Tehran Lipid and Glucose Study (TLGS) from Iran (416) and
Scottish Health Survey 2003 (519) were the selected studies. The process of getting data
of the Iranian study took several months (August-December 2007) and the data from
Scottish Health Survey were obtained from the statistics unit of Scottish Government
about 16 hours after the submission of data inquiry.
5.9 Data analysis
5.9.1 Data coding and extraction
Data coding was mainly adopted from the coding system that was used in the Scottish
Health Survey and thus almost similar codes were applied to label the study variables,
missing values and non-numeric data. SPSS version 14 had been used to created data
extraction sheet and data were manually entered to the extraction sheets.
5.9.2 Data entry
Data entry was performed by me after checking each individual questionnaire for
mismatches and missing. If there was any mismatch in the responses it was corrected by
referring to the related questions or by contacting the respondents for clarification. All
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continuous variables were entered as they were reported (e.g. age) or measured (e.g.
systolic and diastolic blood pressure) and where possible with two digit decimals.
Responses to open ended questions were extracted separately for each question and they
were categorised in different groups and a code was allocated to each group. Thus open-
ended questions were analysed as nominal variables.
5.9.2.1 Quality control of data entry: Visual record verification
check of the data
Visual record verification check of the data was applied to correct any discrepancies in
the electronic file resulting from errors in the initial data entry. Every outlier in the
variables was checked on the original questionnaire and laboratory report sheets and if
they were proved to be true, they were used in the analysis. In the case of missing
information for a single variable of the study, subjects were excluded only from the
analysis of that variable. To increase robustness of analysis and to maximise possibility
of using parametric methods in the analysis, application of imputation technique for
missing values (median imputation) was also decided to be considered if the number of
missing values for each variable exceeds 10%. However; in practice imputation was not
performed since the number of missing values for each variable was not reached to the
10% level.
5.9.2.2 Statistical methods used in data analysis
There is no statistical theory behind analysis of non-random data. But since one of the
objectives of this pilot study was to leam lessons and develop methods to conduct a
future population based study, the study data were analysed statistically assuming that
they were collected randomly. Therefore, application of these methods can be
considered in the future large scale study. With this background basic characteristics of
the studied sample were described by absolute and relative frequencies and no further
statistical analyses were performed on these data. To indicate prevalence of CVD risk
factors and CVD conditions in the study sample and also Iranian exemplar population in
comparison to the baseline population (Scottish general White population) mean, mean
difference and its confidence interval or geometric mean and exponential confidence
interval, exponential geometric mean difference for continuous variables and prevalence
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rate ratio with confidence interval for dichotomous variables were calculated. To see
whether any possible differences between these three samples were statistically
significant straightforward comparison method has been applied primarily by ignoring
matching criteria and thus conventional methods like analysis of variance (Anova) were
applied where possible. To test distribution of continuos quantitative variables for
normality Q-Q plot and if necessary Kolmogorov-Smirnov test (without Lellifors
significance correction) was applied. Also when the assumption of normality in the
original data set was violated, logarithmic or power transformation was used to
overcome the issue where possible.
Conditional logistic regression model was also applied in order to analyse the binary
data in matched groups to see whether its use can change analysis results in practice.
STROBE (The checklist to Strengthen the Reporting of Observational studies in
Epidemiology) (523) statement guideline was applied to report data analysis results.
Multiple test adjustment to correct experimentwise error (ER) (524) (probability of
rejecting at least one of the independent null hypotheses that are conducted in a study
when in fact they are true) was an issue of concern in this pilot study because of the
multiplicity of measured outcomes and thus number of needed hypotheses testing in the
comparison groups. The logic behind the recommended adjustment for multiple testing
is that when performing a significance test at 95% confidence level there is a chance to
observe one coincidental false significant result in every 20 performed test. (525, 526)
Opponents of multiple test adjustment have raised several questions and suggested that
no statistical theory provides answer to their questions. (526) One of the main objection
is that with reducing the chance of making type I error, the chance of making type II
error increases. Increasing of testing confidence level (99%) can reduce ER rate which
also needs a larger sample size. (526) Due to the small sample size of the recruited
Iranians and exploratory nature of this pilot study it was decided to analyse data at 95%
confidence level (without application of multiple test adjustment) and to provide results
of all performed comparisons.
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5.10 Summary
Due to a few empirical data on the Iranian Diaspora with regard to the prevalence
of CVD risk factors, calculation of an overall summary estimate from the reported
prevalence rates of CVD risk factor in this ethnic group is not possible. A proposal was
set out to do a pilot study on the prevalence ofmajor cardiovascular disease (CVD) risk
factors amongst Iranians living in Edinburgh. As the first study on Iranian migrants in
the UK, the results will inform future large scale research.
Multi-method sampling technique was used to recruit healthy and free-living Iranians
aged >18 years into this pilot study. One to many (1:5) matching design was applied to
compare the collected data in this pilot study with the obtained data from two exemplar
studies among Iranian indigenous and Scottish White population regarding the
prevalence of CVD risk factors. Main variables included physical inactivity, smoking,
hypertension, overweight, obesity, hyperlipidaemia and diabetes. Concerns of the
Iranian migrants to participate in a study of this kind also were examined. Mean, mean
difference (95% CI) to describe continuous variables and prevalence rate ratio (95% CI)
for dichotomous variables were applied. Conventional methods (e.g. ANOVA) and also
conditional logistic regression model was used to test the observed differences between
the comparison groups.
Findings of this pilot study are provided in the next two chapters. General characteristics
of the study participants, their concerns to participate in a study of this kind and
prevalence of the CVD risk factors in this ethnic minority group are discussed in chapter
six. In chapter seven CVD risk status of the Iranian migrants compared to Iranian
indigenous and also Scottish general White population are explained.
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Chapter Six: Lessons learnt from the field work: a pilot study of
the prevalence of established cardiovascular
disease risk factors among Iranians in Edinburgh
6.1 Introduction
Methodology of this pilot study was described in the previous chapter (page 135-
150). Findings of the pilot work in relation to the characteristics of the participants, their
views about the study itself and also about the applied questionnaire, language used and
method of questioning are provided in this chapter. The respondents' concerns to
participate in a study of this kind, to give blood for analysis and long term storage and
also their preference with regard to the gender of practitioner who examine them and
reservation to answer questions about religion and economic status are also discussed.
Major focus of this chapter is on issues reflecting possibility of using the applied
methodology in a similar future large scale study on Iranian migrants. Other findings
related to the prevalence ofCVD risk factors all are indicated in the next chapter.
6.2 Demographic and other baseline characteristics of the study
sample
Recruitment stage of this pilot study was started from 29/08/2006 and continued
until 15/06/2007 during which a total of 72 people (49 males and 23 females) aged 18
and over were examined for cardiovascular risk factors. Mean age and age range of the
study participants were shown in Table 6.1 compared with the Scotland 2001 Census
data about Iranians. (520) Numbers of the recruited people in both sexes and in different
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age groups compared to the numbers of Iranians in Edinburgh according to the Scotland
2001census data were also indicated in Table 6.2.
Table 6.1 Mean age and age range of the recruited Iranians aged 18 compared to the
Edinburgh's Iranian population based on the Scotland 2001 census data.
Recruited Iranians Iranians in Edinburgh Mean difference
Sex in this study (Scotland 2001 Census data) 95% CI
n Mean age (age range) n Mean age (age range)
Male 49 47.7 (29-64) 231 41.1(18-71) 6.6 (4.9-8.2)
Female 23 44.2 (30-71) 115 37.8 (18-80) 6.4 (5.6-8.1)
Total 72 46.6 (29-71) 346 40.0 (18-80) 6.6 (5-8.1)
Table 6.2 Age distribution of recruited Iranians in this pilot study and Iranians in
Edinburgh by sex according to the Scotland 2001 census data.
Age groups
Iranians in Edinburgh * Recruited Iranians in this studyScotland 2001 Census data
Number (%)
21 to 30
Male 23 (10.2) 2(4.1)
Female 29 (26.4) 1 (4.3)
Total 52 (15.5) 3 (4.2)
31 to 40
Male 65 (28.9) 8 (16.3)
Female 41 (37.3) 6(26.1)
Total 106 (31.6) 14(19.4)
41 to 50
Male 111 (49.3) 21 (42.9)
Female 24 (21.8) 12 (52.2)
Total 135 (40.3) 33 (45.8)
51 to 60
Male 19(8.5) 16 (32.6)
Female 10(9.1) 3 (13.1)
Total 29 (8.7) 19 (26.4)
61 and over
Male 7(3.1) 2(4.1)
Female 6 (5.4) 1 (4.3)
Total 13 (3.9) 3 (4.2)
Total
Male 225 (100) 49 (100)
Female 110(100) 23 (100)
Total 335 (100) 72(100)
* Identified based on the country of birth.
The findings indicated a higher mean age (46.6) of the recruited sample relative to the
mean age of the Iranian population who were counted during the Scotland 2001 census.
152
As shown the mean age in both male and female subgroups was significantly higher in
the recruited sample compared to the mean age of Iranian men and women in Edinburgh
according to the Scotland 2001 census data. Such a difference might be resulted from a 6
years lag between the Scotland 2001 census data and the date of data collection in this
pilot study (2007).
According to the study results men from the age group of > 50 years and women in the
age group of 40-60 years are over represented but both males and females from younger
age groups are under-represented in the recruited sample.
Country of birth for 71 (98.6%) of the respondents was Iran and only one of the male
participants was born in Britain. Place of birth in the former group based on its
geographical location within different provinces of Iran relative to the provinces
population (527) is provided in Table 6.3.
Table 6.3 Distribution of the recruited study sample by sex and place of birth in
different provinces of Iran-2007.
Province population *
Number (%) ""
Recruited Iranians in this study
Name of the province Male Female Total
Number (%)
Tehran 13,413,348 (19.0), (23.9) 15 (31.2) 5 (21.9) 20 (28.3)
Khozestan 4,274,979 (6.1), (7.7) 9(18.7) 4(17.5) 13 (18.3)
East Azarbaijan 3,603,456 (5.1), (6.5) 5 (10.4) 3 (13.1) 8 (11.3)
Isfahan 4,559,256 (6.5), (8.3) 3 (6.2) 3 (13.1) 6 (8.5)
Razavi Khorasan 5,593,079 (7.9), (10.1) 3 (6.2) 1 (4.3) 4 (5.6)
Gilan 2,404,861 (3.4), (4.4) 1 (2.1) 1 (4.3) 2 (2.8)
Hamadan 1,703,267 (2.4), (3.1) 1 (2.1) 1 (4.3) 2 (2.8)
Markazi 1,349,590 (1.9), (2.5) 2 (4.2) 0 2 (2.8)
Mazandaran 2,920,657 (4.1), (5.3) 1 (2.1) 1 (4.3) 2 (2.8)
Qazvin 1,143,200 (1.6), (2.1) 2 (4.2) 0 2(1.4)
South Khorasan 636,420 (0.9), (1.2) 2 (4.2) 0 2 (2.8)
West Azarbaijan 2,873,459 (4.1) 1(2.1) 1 (4.3) 2 (2.8)
Chaharmahal and Bakhtiari 857,910 (1.2), (1.5) 1(2.1) 0 1 (1.4)
Fars 4,336,878 (6.2), (7.8) 0 1 (4.3) 1 (1.4)
Kerman 2,652,413 (3.8), (4.8) 1 (2.1) 0 1 (1-4)
Kermanshah 1,879,385 (2.7), (3.4) 0 1 (4.3) 1 (1.4)
North Khorasan 811,572(1.2), (1.4) 0 1 (4.3) 1 (1.4)
Qum 1,040,681 (1.5), (1.9) 1 (2.1) 0 1(1.4)
Total 56,054,411 (79.5), (100) 48 (100) 23 (100) 71 (100)
Total population of Iran 70,472,846 (100)
* According to the census 2006.
** Relative to the country population and total population of the representative provinces respectively.
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There are currently 30 provinces in Iran and people from 18 provinces had at least one
representative in the study sample. As seen in the Figure 6.1 (528) the study participants
are originated from different part of Iran but those coming from some of the provinces
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Figure 6.1 Map of Iran and geographical location of its 30 provinces-July 2008
Parents' birthplace was Iran for 65 (90.3%) of the respondents and 7 people did not
answer the question. This shows that most of the study participants were originally
Iranian and that they were probably brought up mostly within an Iranian family in which
Iranian culture and health-related life style was dominant.
The overall mean length of stay in UK for the study participants was 19.13 (years)
(85% CI: 16.63-21.63) with the range of 3-36 years. Average length of stay for Iranian
males was 21.86 (95% CI: 18.98-24.73) in the range of 5.1-36 years and for females it
was 13.32 (95% CI: 9.1-17.54) in the range of 3-36 years. Findings of this study
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revealed that Iranian males have migrated to UK several years earlier than females
(mean difference: 8.54 years, 95% 3.53-13.55) but effect of small sample size in the
interpretation of these results should not be disregarded.
General characteristics of the studied sample were shown in Table 6.4. While 98.6% of
respondents were born in Iran only in 73.6% of cases, self-declared ethnicity was
Iranian. Three options were available to be chosen in the applied questionnaire to
declare the ethnic group. Thus 25% have introduced themselves as mixed British-Iranian
and 1.4% have chosen the "others" option. A number of interviewees from two later
subgroups of informants, while answering the question referred also to the presence of a
degree of scepticism among Iranians in relation to the question and the fact that some
Iranians may respond to this question conservatively due to reasons like fear of
discrimination against ethnic minorities in the host community.
Table 6.4 General characteristics of the studied sample of Iranians living in Edinburgh-2007.
Male Female Total
Baseline variables n= 49 n= 23 n= 72
Number (%)
Self reported racial or ethnic group
Iranian 36 (73.5) 17(73.9) 53 (73.6)
Mixed British-Iranian 13 (26.5) 5 (21.7) 18 (25.0)
Others: British 0 1 (4.4) 1 (1.4)
Country of birth
Iran 48 (98.0) 23(100) 71 (98.6)
UK 1 (2.0) 0 1 (1.4)
Other 0 0 0
Occupation *
Managerial & professional 10(20.4) 1 (4.4) 11 (15.3)
Intermediate 9(18.4) 0 9(12.5)
Small employers & own account workers 5 (10.2) 8 (34.7) 13 (18.1)
Lower supervisory & technical 13 (26.5) 1 (4.4) 14(19.4)
Semi-routine & routine 5 (10.2) 4(17.4) 9(12.5)
Not employed: looking after home & family or retired 7(14.3) 9(39.1) 16 (22.2)
Education
MSc (MA) or PhD 11 (22.5) 3 (13.1) 14 (19.5)
BSc 17(34.7) 6(26.1) 23 (31.9)
College degree/SCE Higher/CSYS/A-Level or diploma 16(32.6) 12 (52.2) 28 (38.9)
Lower grades than SCE/CSYS/A-Level or diploma 1 (2.0) 1 (4.3) 2(2.8)
Other 4 (8.2) 1 (4.3) 5 (6.9)
* Classification was drawn from socio-economic classification in the Scottish Health Survey.
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It was not possible to judge the claim in this pilot study since any discussion needs to be
based on sound evidence which can be achieved for instance through an in-depth
interview.
Self-declared religion of the study respondents was indicated in Table 6.5. Formally
more than 99.4% of Iran's population are Muslim. (529) In this study 16.7% (7 males
and 5 females) of respondents considered questions about religion offensive and 2.8%
made no comment. On the other hand 54.2% of all participants (21 males and 18
females) stated that Iranians generally are not interested to clarify their religion in a
future similar study. When respondents in the later group were asked for the reason of
not being interested to clarify their religion in studies of this kind, 43.6% made no
comment and 56.4% (13 males and 9 females) stated that because of social pressure
against religious minority groups they prefer to respond this question conservatively.
The findings suggest that given answers to a single and direct question about religion
can be potentially misleading in the Iranian community and that such answers should be
interpreted with caution.
Table 6.5 Distribution of the recruited sample of Iranians in Edinburgh by religion
(2007) compared to the Scotland 2001 Census data.
Recruited Iranians in this study Iranians in Edinburgh
Religion Male Female Total (Scotland 2001 Census data)
Number (%)
Muslim 39 (79.6) 17(73.9) 56 (77.8) 254 (65.5)
Zoroastrian 1 (2.0) 0 1(1.4) NP*
Christian 0 1 (4.3) 1 (1.4) 18 (4.6)
Jew 0 0 0 1 (0.3)
Baha'i 1 (2.0) 1 (4.3) 2 (2.8) NP
Other 4 (8.2) 1 (4.3) 5 (6.9) 12(3.1)
None 4 (8.2) 2 (8.7) 6 (8.3) 72(18.5)
Not stated 0 1 (4.3) 1 (1.4) 31 (8.0)
Total 49(100) 23 (100) 72 (100) 388 (100)
* Not provided.
6.3 Participants ideas about the study and questionnaire
Views of studied Iranians about successful ways of reaching Iranians and their
willingness to give their contact details for recording purposes in order to be contacted
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in any future health study were shown in Table 6.6. Word of mouth, advertising in
media, participation in the Iranians' informal gatherings and reaching people through
those friends who already consented to participate in a study were suggested to be the
most suitable way of reaching Iranians. In total 87.5% of all participants were interested
to give their own and 79.2% of their family members' or friends' contact details (with
their permission) to be recorded for invitation in a possible future study.
Table 6.6 Views of Iranian migrants in Edinburgh on the successful ways of reaching
Iranians and their willingness to be recruited in a similar future study-2007.
Male Female Total
Question (open ended) n= 49 E3 II n=72
Number (%)
What do you think would be successful ways
of reaching Iranians in Edinburgh for studies
of this kind? *
Electoral list 0 1 (4.4) 1(1.4)
Local phone books 0 0 0
Iranian well known people 1 (2.0) 0 1 (1.4)
Iranian local shop owners 1 (2.0) 0 1 (1.4)
Word ofmouth 12 (24.5) 3 (13.0) 15 (20.8)
Advertising in media 8 (16.3) 4(17.4) 12(16.7)
Iranian communities 2(4.1) 3 (13.0) 5 (6.9)
Participating in Iranian informal gatherings 10 (20.4) 5 (21.7) 15 (20.8)
Friends 12 (24.5) 3 (13.0) 15 (20.8)
Other 0 2 (8.7) 2 (2.8)
No comment 14(28.6) 7 (30.4) 21 (29.2)
Would you willing to allow your name and
contact details to go on a list of all Iranians in
Scotland for a future health study of this kind?
Yes 42 (85.7) 21 (91.3) 63 (87.5)
No 7(14.3) 2 (8.7) 9(12.5)
Are you willing to share your family and
friends' contact details so they can be invited
to participate in this study?
Yes 38 (77.6) 19 (82.6) 57 (79.2)
No 11 (22.5) 4(17.4) 15 (20.8)
* More than one suggestion was allowed.
The results indicated that construction of a sampling frame of Iranians who live in
Edinburgh is feasible and the list which was prepared through this pilot study can be
applied to recruit Iranians in future health studies after obtaining their formal consent.
157
Recruitment process of Iranians in Edinburgh into this pilot study and the number of
people have actually participated is indicated in Table 6.7. Since a multi-method
approach was utilised in this study to recruit Iranians it was not possible to clarify the
number of people who have actually been reached by the radio programme (which was
broadcasted to publicise this pilot study) and those who have received the study leaflet
or read the advertisement (which was given to invite them for participation). It was also
not possible to clarify how many people have been invited among friends or relatives by
those who themselves have consented to participate and from those invited people how
many refused to participate. Thus it was not possible to calculate participation rate in the
pilot study.





People directly invited by the researcher and:
Consented to participate 14 (77.8) 4 (22.2) 18 (48.6)*
Refused to participate 7 (46.7) 8 (53.3) 15 (40.5)*
Agreed to participate but not attended 3 (75.0) 1 (25.0) 4 (10.8)*
People introduced by study participants or those 35 (64.8) 19 (35.2) 54 (75.0)**
who have been reached by the study
advertisements
* Percent relative to the number of people invited directly by the researcher.
** Percent relative to the total number of the study participants.
As shown in Table 6.7 among the study attendees 54 (75.0%) were friends or relatives of
those who have participated in the study at the earlier stages or those who have seen or
heard the study advertisements. As a limitation to the multi-method sampling approach
among this later group it was not possible to identify referral chain. For instance I could
not identify exactly how many people have been reached by the study advertisements,
how many been contacted by their friends or relatives and overall from those who have
been reached by the study advertisement or invited by their friends or relatives how
many people refused to participate or attended the study site. It was also not possible to
identify connections between the study participants and to clarify who were introduced
by whom and to decide whether these advertisements or other factors such as persuasion
of friends or relatives were main motivation to participate in the study.
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Views of the Iranian migrants in relation to the different choices of applicable
methodologies in a future population based health study were shown in Table 6.8.
Majority of the respondents (76.4%) stated that a face to face interview is their preferred
questioning method. The second most preferred questioning method (12.5%) reported to
be self completion of a paper or an electronic version of the study questionnaire. But
female participants gave equal weight to self completion of a paper or an electronic
questionnaire and also an online interview.
Table 6.8 Preferred choices ofmethodologies by Iranians in Edinburgh to be used in a
future population based health study-2007.
Male Female Total
Question (open ended) n= 49 n= 23 n= 72
Number ("/
Which method of questioning might increase your
participation in similar health studies?
Face to face interview 35 (71.4) 20 (87.0) 55 (76.4)
Self completion paper questionnaire 4 (8.2) 1 (4.3) 5 (6.9)
Self completion electronic questionnaire 3(6.1) 1 (4.3) 4(5.6)
On line internet interview 1 (2.0) 1 (4.3) 2(2.8)
Telephone interview 1 (2.0) 0 1(1.4)
No difference 5 (10.2) 0 5 (6.9)
What is your preference in relation to the gender of
practitioner who examines or assesses you physically?
Same gender in all kinds of examinations 1 (2.0) 4(17.4) 5 (6.9)
Opposite gender in all kinds of examinations 2(4.1) 3 (13.0) 5 (6.9)
Same gender in examinations of private areas 13 (26.5) 8 (34.8) 21 (29.2)
No preferences about gender of practitioner 33 (67.3) 8 (34.8) 41 (56.9)
Would you agree for your blood sample be stored for
further analysis in the future for other CVD risk
factors?
Analysis and storage 45 (91.8) 22 (95.7) 67 (93.1)
Only for analysis 4 (8.2) 1 (4.3) 5 (6.9)
In which language would you prefer the questionnaire
or interview in future similar studies?
Persian 19(38.8) 13 (56.5) 32 (44.4)
English 13 (26.5) 3 (13.0) 16 (22.2)
Persian or English 17 (34.7) 7 (30.4) 24 (33.3)
According to the findings about 28.5% of men and 52.2% of women prefer
practitioner of same gender in all kind of examination or examination of private areas.
So it will be important to provide freedom of choice for Iranians to select practitioners'
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gender in future studies that involve physical examinations (including waist and hip
measurements especially in the female subgroup).
There was a choice in the consent form of this pilot study to show whether every
individual participant agrees to give blood sample for long term storage or not. More
than 93% of the study participants agreed to give extra blood to be used in a CVD
related future study. This rate indicated that most of the Iranians in Edinburgh are
generally cooperative with the health studies and have no special reservation in this
regard. Moreover I realised that most of the study participants especially men have a
positive approach towards blood giving by considering it as a helpful procedure for their
own health.
The participants were also asked about their preferred language of a study
questionnaire or interview in future. Although about a third of them stated that an
original English or translated Persian questionnaire or interview is same for them but
almost 45% told they prefer Persian as the language of interview or a printed
questionnaire. This is while about 22% of the study respondents selected English
language as their preferred language of interview or a printed questionnaire in future.
There were options for the study participants in this pilot study to choose from original
English or translated Persian questionnaire and other study documents and also to be
interviewed in English or in Persian or Azeri Turkish which is the second most spoken
language of the country.
As indicated in Table 6.9 for 93.1% of cases a translated questionnaire was used to ask
about their CVD related life styles. Persian was selected by 40.3% of respondents as the
language of interview, Azeri Turkish by 11.1% of them and English by only 1.4% of the
participants. In 47.2% of cases more than one language (English-Persian, Persian-Azeri
Turkish or English-Azeri Turkish) was used in the interview. Most of the interviews
(95.8%) have taken place in the study site which was an indication of Iranians
willingness to spend time and money from their home or work place to travel to the
study site. Although a £5 banknote was offered to all participants for compensation of
their travel costs but I believe it had not considerable effect on the participants' decision
to attend the study site. Those who were interviewed in their home mostly had young
160
children and so could not spend much time to stay at the study site after clinical
measurements and blood sampling. Due to the limitations in working hours of the study
clinic all measurements and interview sessions were planned from 9am to 3.5pm. There
were contacts from some of the Iranians in Edinburgh to indicate their willingness to
come and participate in the study during weekends or after 5 pm. Also there were
several contacts by Iranians residing in nearby small cities (e.g. Livingstone,
Dunfermline, Dalgety Bay) but since only Iranians in Edinburgh were target group of
this pilot study they were not recruited.
Table 6.9 Preferences and views of the Iranian migrants in Edinburgh about the choices
of languages and place of interview in this pilot study-2007.
Male Female Total
Variables n= 49 n=23 n= 72
Number (%)
Interview language
Persian 15 (30.6) 14(60.9) 29 (40.3)
Azeri Turkish 6 (12.2) 2 (8.7) 8(11.1)
English 1 (2.0) 0 1(1-4)
Mixed of the two or three languages 27 (55.1) 7 (30.4) 34 (47.2)
Language of the questionnaire used
English version 4 (8.2) 1 (4.3) 5 (6.9)
Translated version 45 (91.8) 22 (95.7) 67 (93.1)
Interview place
Study site 48 (98.0) 21 (91.3) 69 (95.8)
Participants home 1 (2.0) 2 (8.7) 3 (4.2)
The average time to explain the study objectives, to sign consent forms, measure
anthropometric indices and blood pressure, blood sampling and interview was about 60
minutes. In relation to the amount of time questions took in the study, majority of the
participants (95.8%) told the time was about right (Table 6.10). Only a few of the study
respondents have reported some of the questions in the questionnaire sensitive (question
about religion, economic status and alcohol drinking) but almost 99% suggested that the
questions were easy to understand.
6.4 Discussion
From the eligible adult Iranian migrants (aged 18 and over) in Edinburgh (346 Iranians
were aged 18 and over based on the available data from Scotland 2001 Census data),
161
20.8% were recruited which included 21.2% of males (n=231) and 20% of females
(n=l 15) (Table 6.1). Recruitment of the study participants took about 9 months which
means in average 2 people were recruited each week during this period of time. The
recruitment process of course interrupted during 2007 January holidays and Iranian New
Year period (18-31 March 2007).
Table 6.10 Views of the Iranian migrants in Edinburgh about the length of study
interview and applied questions-2007.
Male Female Total
Variables n= 49 0II OJ n= 72
Number (%)
How did you feel about the time questions took in this
interview?





























This relatively long recruitment stage of Iranian migrants in this study can probably
justifiable by lack of a sampling frame or limitation in the study site's working hours
(during weekdays). As mentioned earlier there were contacts from some of the Iranians
in Edinburgh to indicate their willingness to come and participate in the study during
weekends or after 5 PM. If such a possibility will be provided in any future study it
could boost recruitment process considerably. The long recruitment stage into this pilot
study can also be an indication to label Iranian migrants a hard-to-reach ethnic group.
Moreover, application of other appropriate recruitment strategies should be considered
simultaneously in future similar studies.
Lack of a sampling frame of Iranian migrants' names or addresses in Edinburgh and
also not having easily identifiable names that are specific for Iranians, made use of
multi-method recruitment strategy inevitable in this pilot study. Thus recruitment
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process was based mainly on snowball and convenience sampling method. All efforts
were made to expand the primary contacts in order to reach every potential eligible
Iranian in Edinburgh to make this sample as inclusive as possible. The recruitment
procedure was also boosted by calling friends and those who participated in the study
earlier to remind them ongoing process of the recruitment. I attended Iranians informal
gatherings and distributed the study leaflets in different occasions. All these attempts I
believe were effective in convincing Iranians to participate. Role of key persons (those
with extended network of friends) to persuade people to participate were also pivotal in
this pilot study.
Prevention of selection bias through inclusion of similar and related cases was one of
the main concerns in this pilot work. The recruited people were older than (about 6
years) the average Iranian migrant population in Edinburgh (according to the 2001
census data). The difference between two populations should be interpreted with
caution due to small sample size in this pilot study and the fact that the test results may
change by increase of sample size. There was also a time lag (6 years) between the date
of data collection in this pilot work at 2007 and the census date at 2001 which should be
considered important in the interpretation of this difference. Our judgement about age
range of the recruited people in this study is based on the number of Iranians were
counted during Scotland Census 2001 according to their stated birth place. However,
one may question reliability of birth place as a proxy question to determine ethnicity of
people in any census including in the Scotland Census 2001. Accordingly for nationals
of other countries who just were born in Iran it is probable to be classified as Iranian.
The only other proxy question applicable to check this assumption in the Scotland 2001
Census questionnaire was question about religion. The available census data (520)
indicated that only 4.6% of respondents that time were Christian (any branch) and only
0.5% of informants were Hindu, Buddhist or Sikh. Unfortunately it was not possible to
judge correctly whether these Christians are nationals of other countries who were born
in Iran or members of Iranian Christian community (about 0.2% of Iranian population
according to the conducted census data in 2006 are Christian). (530) But even if these
Christians were non-Iranian citizens of other countries who just were born in Iran, the
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Scotland 2001 Census data support the idea that most of the people with Iran stated to be
their birth place were originally Iranian and not nationals of other countries.
The overall mean length of stay in UK for the study participants was 19.1 years (95%
CI: 16.63-21.63) with the range of 3-36 years and for about 76.4% of the study
participant it was more than 7 years. These results can verify representativeness of the
study sample from the community of Iranian migrants in Edinburgh however; a robust
decision can only be made upon having access to the original data collected in the
Scotland 2001 Census which were not provided due to the data protection
considerations.
In the age groups of 21-30 and 31-40, number of recruited people was seemingly low
relative to the number of Iranians in these age groups based on the Scotland 2001 census
data. Over-representation of people in the older age groups who know they are in greater
risk or have previous experience of the disease and so are willing to avail themselves to
the calls for participation in a CVD risk factor study is very common. (531, 532) Thus
people who think they are in greater risk of CVD be volunteer for participation. But
lower self perceived threat of the disease in younger people, restrain them from
participation. The assumption was not possible to be scrutinised in this pilot study but
this is generally a common limitation of reliance on convenience sampling method in
population based CVD studies. Recruited sample in this study was not an exemption and
to have a better sample structure in any similar future study it is better to consider
possibility of applying quota sampling to ensure that study sample include enough
number of people from different age and sex groups and is not over-represented by
volunteers of some age groups.
Recruited people in this pilot study were from 18 provinces among 30 provinces of
Iran which indicates acceptable representation of the sample from original population.
But as discussed recruited people from a number of provinces are over represented in the
sample which can be explained by size and the structure of Iranian migrant population in
Edinburgh. To the best ofmy knowledge Iranians coming from Khozestan province are
a major subgroup of Iranian migrants in Edinburgh. They are mainly those students who
were recruited from southern provinces of Iran (including Khozestan) and sent about 40
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years ago to Edinburgh by the Iranian Ports and Maritime Organisation to study marine
engineering. A considerable number of these students stayed or returned to Edinburgh
after graduation for work and now reside in Edinburgh with their extended families. In
relation to the over-representation of migrants from East Azarbaijan probably my own
ethnic background and network of friends I have from Iranian Azeri people in Edinburgh
had some effects in their higher recruitment rate into this study but again with the lack of
access to the structure of total Iranian migrants in Edinburgh with regard to their place of
birth and residence (by province) before migration, it is very difficult to give a robust
explanation for such a over-representation.
Having origin in a special province of Iran may have reflection on the diet and lifestyle
of that individual migrant and his/her family. For instance people from the sea-side
provinces (in North and South part of Iran) generally have sea foods in their daily diet
while people from mountainous area in the North West, West and the central part of the
country rarely have fish or other sea foods in their diet. So it is worth to consider such
background variations in any future study on the health of Iranian migrants.
Iranian males in the study sample had longer length of stay in UK than females which
can be explained by first wave of Iranian male students who have come to Scotland for
study but remained in this country for work and married mostly by one of their
counterparts in Iran and brought her later to Scotland. This pattern of intermarriage
among immigrants in the western countries is common in ethnic minorities. (533-536)
In response to the question about their ethnicity 25% of the respondents have chosen
mixed British-Iranian option while 73.6% introduced themselves an Iranian. A number
of respondents stated that they prefer to introduce themselves British when filling formal
documents because of a degree of discrimination that they feel exist against ethnic
minorities. Such a claim can be a main concern in detecting ethnicity of Iranians who fill
a form or answer a question especially when we know only 26.5% of Iranians answered
questions about ethnicity correctly (have chosen the "Other" option) in the Scotland
2001 Census (21.4% stated that they are White and 50.5% selected the "Other South
Asian" option). (520) Although misunderstanding of the question may have a role in
giving incorrect answers but regarding the observed level of literacy among Iranian
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migrants in Edinburgh misunderstanding must be ruled out as the main reason for
inaccurate answers. So with such a low sensitivity of a single question in detecting
ethnicity of Iranians, it is suggested to avoid application of a unique question as a proxy
for ethnic classification of Iranian migrants in future studies. This inaccuracy also was
seen with question about faith and religion specially when interviewing religious
minority groups. Concerns about presence of an institutionalised discrimination against
people who practice a special religion and the effects this may have on their legal rights
in the host community can prevent people to reveal their faith or religion. Such a
reservation also may stem from migrants' previous experiences in relation to the
declared religion in another country or country of the origin. Study of association
between religion and health related life style is the main purpose of question about
religion in health studies. But findings of this study indicate that at least for Iranian
migrants, answers to the question will not lead to straightforward answers.
Answers were given by the study respondents about the successful ways of reaching
Iranians in Edinburgh to recruit them into health studies reflects challenges researchers
may face in accessing Iranians. Only one of the participants stated the electoral list can
be used to find Iranian names and no one referred to possibility of using local phone
books to identify Iranian names. Lack of a software package to detect Iranian names and
family names in the electoral or phone book data bases can lead us to recommend
informal methods (word of mouth, participating in Iranians informal gatherings etc) to
recruit Iranians into health studies. But use of above mentioned methods can be
considered as alternate especially if such software will develop in the future or if the
number of all names and family names in a single database will be so small that make
hand searching of Iranian names and family names cost effective and feasible.
Face to face interview as the preferred questioning method for most of the informants
in this pilot study is relatively an expensive method of data gathering compare to self
completion of paper or electronic questionnaires. However its use has some advantages
like reliability of answers and possibility of correcting misunderstandings. But regarding
amount of time and money which are needed to set up an interview session this method
might face certain limitations in practice. Thus in planning a population based health
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study to be conducted on Iranian migrants all aspects of data gathering methods
including costs should be considered carefully.
Since about 45% of the study respondents selected Persian as their preferred language
of interview or study questionnaire in a future similar study application of both English
and Persian languages simultaneously in any future large scale study on Iranian migrants
is recommended. The study results also suggest that employment of multi-lingual
interviewers can increase success rate in recruitment and conducting of a population
based study on Iranian ethnic minorities.
Findings of this pilot study indicated that there is no reservation among Iranians in a
scale that inhibits them completely from participation in health studies. So it seems that
a large scale population based study on Iranian migrants is feasible. The results revealed
that the Scottish Health Survey questionnaires can be adapted for the Scottish Iranian
population and with its translation into Persian probability of success in conducting a
large scale study will be increased.
6.5 Abstract
Introduction: A total of 72 people (49 males and 23 females) aged 18 and over were
examined for cardiovascular risk factors in this pilot study. The main objectives were to
assess feasibility of a large scale study on Iranian Diaspora and to estimate variability of
outcomes to help calculation of sample size in the large scale population based CVD
studies.
Results: Recruited people were from 18 provinces among 30 provinces of Iran. Mean
age of the studied sample (46.6 years, range 29-71) was about 6 years higher than the
mean age of Iranian migrants (40.0 years, range 18-80) were counted in the Scotland
2001 census. Almost 56.9% of the study participants had no preference about the gender
of practitioner but 29.2% indicated their preference towards practitioner of same gender
in examinations of private areas in future studies. A translated questionnaire was used in
93.1% of cases to clarify CVD related life styles of the respondents. Persian was
selected by 40.3%, Azeri Turkish by 11.1%, English by only 1.4% of the participants
and in 47.2% of cases more than one language was used as the language of interview.
More than 93% of the study participants agreed to give extra blood to be used in a CVD
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related future study. Majority of the participants (95.8%) told that the amount of time
questions took in the study was about right. Only a few of them have reported that
questions about religion, economic status and alcohol drinking are sensitive. Almost
99% suggested that the questions were easy to understand.
Conclusion: Iranian migrants in Edinburgh did not show any reservation to participate
in a health study in the future. Construction of a sampling frame of Iranians who live in
Edinburgh is feasible and the list which was prepared through this pilot study can be
applied to recruit Iranians in future health studies. The findings also revealed that
Scottish Health Survey questionnaires can be adapted for the Scottish Iranian
population.
In the next chapter results of the pilot work in relation to the prevalence of CVD
conditions and major CVD risk factors among Iranians in Edinburgh compared to the
Edinburgh's general White population and an exemplar Iranian population will be
discussed.
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Chapter Seven: Prevalence of the major cardiovascular disease
risk factors among Iranians in Edinburgh
compared to Iranians in Tehran and
Edinburgh's White population
7.1 Introduction
In the two previous chapters the general applied methodology and findings with
regard to the characteristics of the study participants and their views about the study and
the applied procedures were discussed. In this chapter findings of the pilot study in
relation to the prevalence of major cardiovascular disease risk factors are compared with
two other age and sex matched data sets: one from Scottish Health Survey 2003 and the
other from Tehran Lipid Glucose Study 2002 as an exemplar study from Iran. Main
focus of this chapter is to compare prevalence of the CVD risk factors among Iranian
migrants in Edinburgh with the Edinburgh's White population and also Iranian
indigenous population whenever possible. Planing of an analysis approach for a future
large scale study with same study design is also considered in this chapter. Such a
comparison is for illustrative purposes only and due to differences between the studies,
such comparisons must be interpreted with extreme caution. However, following
discussions can shed light on priorities and the way a future large scale study on the
health of Iranian migrants can be conducted.
7.2 Statistical analysis method
Since the study subjects were recruited based on a non-random sampling method
and bearing in mind that no statistical theory exists for comparisons of the data collected
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from a non-random sample with data of a randomly selected sample, in the first instance
and for the ease of data analysis and presentation it was decided to compare three
comparison groups based on an assumption that the data of this pilot study were
produced through a random sampling procedure. Thus conventional statistical methods
(by ignoring the matching criteria) were used to analyse and discuss possible differences
between the comparison groups.
Mean differences and where appropriate geometric mean differences for quantitative
variables and the prevalence rate ratio (PRR) for the dichotomous variables were
calculated as the parameters of interest in the analysis. Prevalence proportion ratio (PPR)
is another term which applied some times in the literature to refer to PRR. It was
suggested that PRR instead of PPR should not be used since prevalence proportions are
not functions of time and so are not rates. (537, 538) This controversy still remains and
mainly stems from lack of standard epidemiological terminology when there is not a
common consensus on the definition and labelling of the indicators and therefore from
application of a range of terms in the literature to refer to a same measure. PRR was
decided to be used to indicate the difference in the prevalence of CVD risk factors
between the comparison groups.
Prior to the advent of methods for the analysis ofmatched data sets it was common to
ignore the matching criteria. (539) The rationale behind such a decision that time was
that matching might not change explicitly the estimate of outcome measure. But with the
development of statistical methods it was shown that certain conditions should be met to
be able to ignore matching in the analysis of matched sets (stratification variable should
either be independent of disease status given the risk factors or independent of the risk
factors given disease status). Even so, it was also indicated that both types of analyses
may sometimes yield equivalent results if even these conditions are violated in practice.
(539) Thus, the key point to consider in the analysis of matched data sets is that although
there is a gain in power (narrower confidence interval) unmatched analysis may cause
biased results. The direction of such a bias tends towards conservatism (increased
likelihood of type II errors or false negative findings). In the matched analysis due to
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slightly larger standard error the confidence interval estimated for the outcome measure
will be wider compared to the unmatched analysis.
To see how analysis of the data based on the matching criteria will change the analysis
result conditional logistic regression model (fitted via Cox regression model) was used
to analyse a part of the study data which were collected about variables with
dichotomous exposure based on one to many matched design (Dr Anderson N was
consulted as statistician to choose the proper analysis method based on software
availability and my training background).
Disputes in the literature about different alternatives to analyse cross-sectional data
using PRR have not yet proposed a robust conclusion. (540, 541) Cox's proportional
hazards model (Cox regression) was originally introduced for the estimation of the
conditional hazard ratio in the complete or censured longitudinal data with varying
follow-up time. (542) Breslow (543) indicated that by assuming constant risk period the
conditional hazard ratio estimated by Cox model is equal to the PRR for cross sectional
data. Barros and Hirakata (540) and other authors (538) have confirmed that application
of Cox regression can produce directly a correct point estimate of PRR in the cross
sectional studies but they also commented that the underlying distribution of the
response using this model is Poisson while prevalence data in a cross sectional study
follow a binomial distribution. Thus they concluded that the variance of the coefficients
tends to be overestimated and so resulting in wider confidence intervals (less precision)
compared to those based on the binomial distribution. Such a problem especially when
the prevalence of the disease was high could be a major concern.
Some authors by considering available software rather than the estimator commented
that using Cox model for binary outcomes is inappropriate because the model is created
for survival data. (544) Complication of preparing data for analysis using Cox model
(which is computationally simple) also have led some authors to conclude incorrectly
that the method is invalid for calculation of PRR. (545)
The Robust Poisson method (applicable in SAS using PROC GENMOD syntax) (546)
and log-binomial method are other introduced alternatives to analyse cross-sectional
data using PRR. (541) However findings of this and another study (540) revealed that
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point estimates obtained with Cox, Poisson and log-binomial models are very close to
the Mantel-Haenszel prevalence ratio (MHPR) which has been introduced as an alternate
indicator in the analysis of the matched data resulting from studies with one case to
variable number of controls design. (539, 547) My own experience in calculating MHPR
manually based on the methods explained by Breslow and Day (539) for matched data in
the study design with one case to variable number of controls produced almost same
point estimates with Cox regression method. As an interim approach, when using such a
design in a future random based sample, application of a proper analysis strategy
considering developments in the statistical methods to analyse matched data sets (with
one case to variable many controls) should be contemplated whenever possible.
7.3 General characteristics of the three studied populations
Educational and occupational status of the three sample populations which were
used to compare prevalence ofCVD risk factors in this pilot study are indicated in Table
7.1.
Based on the findings a higher proportion of Iranian migrants in Edinburgh possess an
academic qualification (having a BSc, MSc, MD or PhD) than the general White
population and also Iranians in Tehran.
In relation to the occupational status a trivial difference (PRR=1.0, 95% CI: 0.9-1.2)
was seen between the Iranian men and the Edinburgh's White men regarding the
employment rate. Notwithstanding employment rate among the Iranian migrant women
was about 15% lower than the Edinburgh's White women (PRR=0.8, 95% CI: 05-1.1).
Lower employment rate among Iranian women in Edinburgh comparing to the
Edinburgh's White women can be explained by a considerably higher rate of Iranian
women (43.5% vs. 14.6%) reported to look after their family instead ofworking outside.
Having a managerial role in job (e.g. being a director, manager, supervisor or foreman,
self employed with at least one employee in small or large establishments) among those
who reported to be in paid employment was more prevalent among Iranian men than the
Edinburgh's White men (PRR= 1.2, 95% CI: 0.8-1.6). In the female subgroup even a
higher proportion of Iranians reported to have a managerial role in their jobs (PRR= 2.1,
95% CI: 1.2-3.9). None of Iranian migrants in Edinburgh reported to be unemployed.
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7.4 Current or past history of cardiovascular disease
7.4.1 Applied definitions
The prevalence rates of major cardiovascular conditions among the study participants
were calculated through asking direct questions about current or past history of having
angina, heart attack, stroke or surgery due to a heart problem. For the purpose of this
study, respondents were classified to have any one of the mentioned conditions only if
they confirmed that the diagnosis was made by a doctor. In addition to direct questioning
about angina and heart attack, Rose Angina Questionnaire (548) was also applied to
estimate the prevalence of predicting symptoms of these conditions. Thus based on
presence of pain on the sternum, the left arm or left anterior chest, informants were
classified to have grade 1 angina if they reported to have this pain only when walking
fast or uphill so that make them to stop or reduce speed. Those subjects who reported to
have pain even when walking at an ordinary pace on the level was classified to have
grade 2 angina. The respondents who reported to have a very severe pain across the front
of their chest lasting for half an hour or more irrespective of medical diagnosis were
classified to have possible myocardial infarction. Since needed data from the Iranian
exemplar study were not provided, status of Edinburgh Iranian sample population in
relation to the symptoms of angina or possible myocardial infarction was compared only
with the age matched sample of Edinburgh white population.
7.4.2 Prevalence of current or past history of cardiovascular disease
As indicated in Table 7.2 some variations were observed between Edinburgh Iranians
and Edinburgh White population regarding the prevalence of CVD. Due to the small
number of cases who reported to have symptoms of angina grade 1 or 2, the subjects in
these two groups were combined and classified in one groups as those who reported
symptoms of angina grade 1 or 2. According to the findings, symptoms of angina grade
1 or 2 and possible myocardial infarction were more prevalent among Edinburgh's
White men and women compared to the Iranian migrants. Although 95% confidence
interval of the observed differences includes 1 (except in comparison of females who
have reported symptom of possible myocardial infarction), such a result should be
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interpreted with caution due to the small sample size in the pilot study. A higher
proportion of Iranian male and female in Edinburgh have reported chest pain on their
sternum, left arm or left anterior chest than the Edinburgh White matched cases. But
since they did not mention that the pain made them to either stop or reduce their speed,
they were not classified as having angina grade 1 or 2.
In Table 7.3 the prevalence of doctor-diagnosed CVD conditions is shown. Overall,
Iranians in Edinburgh indicated a lower rate of CVD conditions than their matched
Edinburgh White men and women. Only in the female subgroup more Iranians reported
to have a history of heart attack or surgery due to a heart problem than Edinburgh's
White women. Surgery due to a heart problem was about two times more prevalent
among Iranian women than the Edinburgh's White women however; the effect of small
sample size should be considered in interpreting the 95% confidence interval of the
prevalence rate ratio which includes 1.
Ischaemic heart disease (IHD) defined as ever having a doctor diagnosed angina or a
heart attack (549) also was less prevalent among Iranian migrants in Edinburgh
compared to the Edinburgh White population. The difference especially in the male




Physical activity levels were defined based on four main groups of activities which are
home-based activities (e.g. housework, gardening, and building work including Do-It-
Yourself (DIY) activities), walking, sports and exercise and finally activity at work. The
recommended physical activity level which was applied in the Scottish Health Survey
2003 (550) used in this pilot study to classify people in two distinct groups: those who
have at least a kind of moderate or vigorous physical activity on at lest five days of the
week and those who are inactive or have less physical activity then the recommended
level. The cut-off point has been used in this pilot study to classify people as being
inactive was 15 minutes or less for all discussed activities within recent four weeks.
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7.5.1 Prevalence of physical inactivity
As indicated in Table 7.4 while Iranian male respondents reported to have more
sedentary life style but Iranian women in Edinburgh have indicated almost similar
physically activity level with their age and sex matched controls. A higher proportion of
Iranian women reported to do sport than Edinburgh White women and thus to have a
better physical activity profile than their age matched controls. Among those who
reported to be in employment about 44% of Iranian men and 93% of women told they
are fairly or very physically active in their job. These rates were considerably higher
than the rates were calculated for the Edinburgh White population.
7.6 Unhealthy dietary habits
7.6.1 Applied definitions
A modified and short version of the dietary questionnaire which was used in the
Scottish Health Survey (550) and adopted from the Dietary Instrument of Nutrition
Education (DINE) (551) was applied in this pilot study. Main focus of the questionnaire
was to assess dietary habits of the respondents' and their usual intake of a balanced or
imbalanced range of foods which may have role in the healthy maintenance of the body
physiology or important negative side effects.
7.6.2 Prevalence of unhealthy dietary habits
The summarised data about the dietary habits of the study participants are shown in
Table 7.5 and compared to the Scottish White representative population where possible.
Some of the unhealthy dietary behaviours such as eating crisps, biscuits or chocolates
once a day or more and also eating sweets, cakes, pastries or ice cream two or more
times a week and use of full fat spread on bread, sandwiches or toast were less prevalent
among Iranian migrants in Edinburgh. This is while other unhealthy behaviours such as
drinking soft drinks once a day or more, eating red meat two or more times a week were
reported in a higher rate compared to the Edinburgh's White population. According to
the findings Iranian migrants had a higher consumption rate of red meat and poultry in
their diet. Fish consumption (any kind) once a week or more was seen in a higher rate in
the Edinburgh's Iranian women compared to the Edinburgh's White woman.
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but the rate was similar in the male subgroups. A lesser consumption rate of skimmed or
semi skimmed milk or sufficient portions of fruits and vegetables (five times or more a
day) in the daily diet was evident among the Iranian migrants compared to the
Edinburgh White population.
Usual adding of salt to food at the table was more prevalent among Edinburgh's White
men and women than the Iranian migrants.
Questions about drinking of alcoholic beverages in this pilot study were mainly included
to clarify alcohol drinking behaviour of the respondents and also to see how informants
answer questions related to their alcohol drinking habits or their willingness to answer
the questions at all. This concern was raised due to the illegality of drinking alcoholic
beverages in public places in any quantity in Iran according to the current laws and that
Muslims are forbidden from drinking alcoholic drinks according to the Islamic rules.
The study results (shown in Table 7.5) indicated that at least 75.5% of the Iranian men




Self reported smoking was used to determine smoking behaviour of the respondents.
People who reported to smoke currently at least one cigarette a day was classified as
being smoker.
7.7.2 Prevalence of self-reported smoking
Self reported daily smoking rate among Iranian men and women settled in
Edinburgh was high compared to Iranians in Tehran and the difference especially in the
female subgroup was noteworthy (Table 7.6). Smoking rate also among Iranian migrant
men was higher than the rate observed for the Edinburgh's White men. But notably the
calculated rate for Iranian migrant women was about 40% of the rate calculated for
Edinburgh's White women.
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7.8 Hypertension
7.8.1 Applied definitions, instruments and procedures
As a limitation to the comparison of mean blood pressure levels between the
comparison groups it is important to note that a digital sphygmomanometer for blood
pressure measurement was used in this pilot study (Omron 705IT) and also Scottish
Health Survey 2003 (Omron HEM 907) but in the Iranian study mercury
sphygmomanometers (it's model and brand not provided) were applied. The systolic
(SBP) and diastolic (DBP) blood pressure measures provided from the Iranian study all
were rounded up to the nearest whole number. The average differences between the
Omron 705IT device and mercury sphygmomanometer readings for SBP and DBP were
reported to be -0.2 mmHg (standard deviation = 4.5) and -2.0 mmHg (standard deviation
= 4.8) respectively which fulfils the recommended criteria of the international protocol
of the European Society of Hypertension. (552) If there was technically an available
method to convert measures in the three separate studies into a standard set of
measurements according to the results of previously performed calibration studies, the
comparison of SBP and DBP measures in the three populations would be more reliable.
But in the lack of needed regression equations, variations in the measurement methods
were ignored and mean values of both systolic and diastolic blood pressure in the three
populations were applied for interpretation.
7.8.2 Prevalence of hypertension
Mean levels of systolic (SBP) and diastolic (DBP) blood pressure for all three
comparison groups are indicated in Table 7.7. The findings revealed that Iranian men
and women in Tehran had a lower mean level of systolic and diastolic blood pressure
than the Iranians in Edinburgh. The difference in the mean systolic blood pressure of
Iranians in Edinburgh compared to the Edinburgh White population was trivial but
Iranian men had a higher level of diastolic blood pressure compared to their age matched
White men.
In Table 7.8 the prevalence of hypertension based on the measured or reported systolic
and diastolic blood pressure in the comparison groups are shown. Also findings
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regarding the self reported current or past history of hypertension or being under
treatment for hypertension are provided in this table. According to the results, Iranian
men and women in Edinburgh indicated a higher prevalence of hypertension compared
to the Iranian men in Tehran. The prevalence rate of hypertension among Iranian women
in Edinburgh was lower than the Edinburgh White women. Rate of current or past
history of hypertension was reported to be almost same in the Edinburgh Iranian and
White men. But none of the Iranian women in Edinburgh was reported a current or past
history of hypertension while about 13% of them were hypertensive based on their
measured systolic and diastolic blood pressure level. About 50% of Iranian and White
men in Edinburgh who reported to have a current or past history of hypertension but
only about 15.6% of White women reported to be under treatment for hypertension.
7.9 Overweight and obesity
7.9.1 Applied definition
Body mass index (BMI) which is defined as the weight in kilograms divided by the
square of the height in metres (kg/m2) was used to determine the prevalence of
overweight and obesity in the comparison groups. A BMI > 25 kg/m2 but < 30 kg/m2
was considered as the marker of overweight and a BMI > 30 kg/m2 as the marker of
obesity.
7.9.2 Prevalence of overweight and obesity
Findings of this study indicated no major difference in the body mass index of all three
comparison groups (Table 7.9). Iranian women in Edinburgh however, indicated a
slightly lower BMI and also mean weight compared to their age matched counterparts in
Iran and also Edinburgh White women. Such a difference was not concurrent with
regard to their hight since they had a higher mean hight level compared to the Iranian
women in Tehran. Iranian women in Edinburgh also had a lower waist to hip ratio than
their counterparts in Iran. The difference in the waist circumference was especially
remarkable between Iranian women in Edinburgh and Tehran. Thus it seems that Iranian
migrant women in Edinburgh have a better anthropometric profile compared to the
women in Iran. Iranian men in Edinburgh in average were about 3 centimetres taller than
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the men in Tehran but since they also had a higher mean weight compared to their
matched controls in Iran the calculated BMI did not indicate any major difference
between these two groups. Iranian men and women in Edinburgh had slightly higher
waist to hip ratio compared to Scottish control group but the difference seems not to be
significant.
The prevalence of overweight among Iranian men and women in Edinburgh was
higher than both Scottish White and Iranian indigenous population (Table 7.10). Also
prevalence of the obesity among Iranian men in Edinburgh was higher than their
counterparts in Iran but lower than the Edinburgh White men. Most notably the
prevalence of obesity among Iranian women resident in Edinburgh was lower compared
to their age matched controls in Tehran and Edinburgh. None of these differences were
statistically significant but effect of small sample size in the test results should not be
disregarded and these differences warrant to be investigated in a future large scale study.
7.10 Hyperlipidaemia
7.10.1 Applied definitions and procedures
It was not possible to compare the applied laboratory and analysis technique of blood
lipids in the three studies since they were conducted in different time frames and more
importantly full details of measurement protocols of blood lipids were not given in the
studies. According to the provided information, HDLc analysis was carried out in the
Scottish Health Survey 2003 by the direct method (no precipitation) (550) while in the
Tehran Lipid and Glucose Study the measurement was carried out after precipitation of
apo-B lipoprotein. (553) It was suggested that use of direct method may bias the result
with overestimation of low HDLc concentration (554, 555) however use of the direct
method is more convenient and possibility of errors such as misidentification or loss of
the sample (during centrifugation) is much lower than the conventional method. So
considering all these limitations, it was not possible to adjust available data for possible
variations in the laboratory methods. Thus the data were applied for blood lipids
comparison by ignoring possible bias divergent applied laboratory techniques in three
studies may pose on the findings.
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7.10.2 Prevalence of hyperlipidaemia
Total and high density lipoprotein level (TC, HDLc), level of low density lipoprotein
(LDLc), triglycerides along with TC/HDLc ratio for informants in three populations are
indicated in Table 7.11. Iranian migrants have shown a lower level of total cholesterol
and HDLc compared to the Edinburgh White population however, there was not a major
difference in TC/HDLc ratio between two populations. This is while Iranian men and
women in Edinburgh indicated a better HDL-C profile than the Iranian in Tehran which
also leaded to an improved TC/HDL-C ratio in this group. Mean triglycerides level also
was lower among both Iranian men and women in Edinburgh compared to their
counterparts in Iran. It was not possible to compare Iranian' status in Edinburgh with the
Edinburgh White population regarding the triglycerides level since it was not measured
in the Scottish Health Survey 2003. The overall impression is that Iranians in Edinburgh
have an improved lipid profile than their age matched controls in Iran but their HDL-C
level was slightly lower than the level in the Edinburgh White population.
7.11 Diabetes
7.11.1 Applied definition
Respondents are classified to have diabetes in this study only if the stated that diabetes
was diagnosed by a doctor. Since fasting blood sugar was not measured in the Scottish
Health Survey 2003 and the data for Tehran Lipid and Glucose Study were not provided
it was not possible to compare fasting blood sugar levels in three comparison groups.
Thus distinct judgment about the prevalence of diabetes among Iranians in Edinburgh
and Scottish White population was only made based on respondents' reports from their
previously diagnosed diabetes.
7.11.2 Prevalence of diabetes
Mean fasting glucose level was 5.0 mmol/l (95% CI: 4.4, 5.6) for men and 4.1 (95%
CI: 2.9, 5.4) for women among Edinburgh Iranian population. According to the World
Health Oraganisation's criteria (515) about 2.1% ofmen (95% CI: 0.4, 10.9) and none of
the Iranian women in Edinburgh had diabetes (Plasma fasting blood sugar > 7 mmol/l).
Presence of impaired fasting glycaemia (IFG: 6.1 mmol/l<FBS< 7 mmol/l) (515) was
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Table 7.12 Doctor diagnosed diabetes in the age and sex matched Edinburgh White and Iranian
migrant population: prevalence rate and prevalence rate ratio (PRR).
Population: PR (95% CI) PRR (95% CI)
Edinburgh White Edinburgh Iranian Edinburgh Iranian
Variable n= 257 n=72 /
(Male= 162, Female= 96) (Male= 49, Female= 23) Edinburgh White
Diabetes *
Male 4.3 (2.1,8.7) 4.1 (1.1, 13.7) 0.9 (0.1,5.0)
Female 1.0 (0.2,5.7) 0 0
Total 3.1 (1.6, 6.0) 2.8(0.8, 9.6) 0.9 (0.1,4.5)
* Presence of a doctor diagnosed
also evident among 6.3% of men (95% CI: 2.2, 16.8) and about 4.5% of women (95%
CI: 0.8, 21.8) based on the blood samples analysis.
Prevalence of the self reported diabetes among Iranian migrants and Edinburgh's
White population is indicated in Table 7.12. The findings may imply that Iranian
migrants in Edinburgh are not in added risk of diabetes compared to the Scottish White
population but obviously a robust judgement will only be possible when a randomly
selected population of Iranian migrants will be investigated.
7.12 Comparison of analysis result based on unmatched and
matched design
To assess effect of analysis method on the results of data collected based on a
matched design, the analysis result compared when data were pooled and matching
criteria was ignored with the results of data analysis based on matched design (one
control to many variable controls). The findings are provided in Table 7.13 and as seen
in most cases the point estimates are exactly same but there are very trivial differences in
their confidence intervals. These findings indicate that matched analysis of data
collected in a matched design using conditional logistic regression model (fitted via Cox
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regression model) versus unmatched analysis will direct findings towards more
conservatism with providing a slightly wider confidence intervals.
7.13 Summary of results
Findings of this study regrading the prevalence of CVD risk factors in three
comparison groups are shown in Figure 7.1. Only those risk factors were indicated in the
figure that there were available data for all three groups in order to give an overview
about the observed differences. Smoking with overweight and obesity are the most
prevalent CVD risk factors among Iranian migrants that need to be focused in future







































I I Edinburgh White [ZZ3 Edinburgh Iranian Iranian in Tehran
* At least one cigarette a day ** Systolic blood pressure > 140 mmHg and/or diastolic blood pressure > 90 mmHg (WHO criteria)
t Body Mass Index & 25 ft TC/HDL-C ratio >4.5 ± HDL-C<1 mmol/1
in males and HDL-C <1.2 mmol/1 in females
Figure 7.1 Prevalence rate (95% CI) of a selected number ofCVD risk factors in the age
matched populations of Edinburgh White, Edinburgh Iranian and Iranians in
Tehran.
A high level of hypertension among Iranian migrant men and women in Edinburgh
compared to their counterparts also warrant to be investigated further. Iranian migrants
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in Edinburgh while had an apparent improved lipid profile compared to their age
matched controls in Tehran but still a high level of TC/HDL-C ratio especially among
Iranian migrant women needs to be addressed.
7.14 Discussion
Based on the findings a higher proportion of Iranian migrants in Edinburgh
possess an academic qualification than the general White population and also Iranian in
Tehran. Notwithstanding employment rate among the Iranian migrant women was about
15% lower than the Edinburgh's White women. Based on the study findings it was also
evident that a higher proportion of Iranian men in Edinburgh have a managerial role in
their job than the Edinburgh's White men. In the female subgroup proportion of people
who reported to have a managerial role was even higher compared to their age matched
controls in Edinburgh.
In the interpretation of this findings possibility of bias in the recruitment phase of the
study sample should not be disregarded. For instance it is probable that mostly educated
people made themselves available to participate in this pilot study due to a better
knowledge about consequences of cardiovascular diseases. While every effort was made
to prevent selection bias in the recruitment stage but as a limitation of non-random
sampling method, possibility of such a bias should not be ruled out completely. Effect of
small sample size especially in the female subgroup also should not be disregarded in
the interpretation of the results.
The observed difference in the level of education is concordant with the result of
previous studies (298, 299, 304, 306, 307) in relation to the better educational profile of
Iranian migrants who left the country due to the special circumstances like war and
economic constraints in the home country. Lower employment rate among Iranian
women in Edinburgh comparing to the Edinburgh's White women can be explained by a
considerably higher rate of Iranian women (43.5% vs. 14.6%) reported to look after their
family instead ofworking outside.
In addition to possibility of sample selection bias which was inevitable due to the
explained limitations in accessing Iranians in Edinburgh this results also can reflect in
part selective placement of Iranian educated and wealthy migrants in Edinburgh (such as
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the pattern exist in Beverly Hills in the western part of the Los Angeles County in
California, United States) since this city is one of the relatively expensive cities to live
compared to other neighbouring cities in Scotland or other major cities in the UK.
Another hypothesis could be participation of mostly wealthy Iranians in this pilot study
due to the importance and priority of health in their value system. Based on this
assumption less wealthy or deprived Iranian refrained from participation in the study due
to the low self perceived threat of the disease or simply because they have not received
the invitation messages for participation. Thus under-representation of those with limited
social contacts, low education level and knowledge about CVD in this pilot study is
possible.
In relation to the prevalence of CVD conditions and symptoms while a higher
proportion of Iranian men and women in Edinburgh reported to have a chest pain
compared to Edinburgh White controls but since their pain did not make them to either
stop or reduce their speed, they were not classified as having angina grade 1 or 2. In the
lack of other diagnostic evidences it is very difficult to have a robust judgement about
the observed difference however; variable level of perceived threat and sensitivity to the
disease and also awareness about the symptoms of myocardial infarction and also
subjective variations in the stated severity of chest pain probably had more important
role in the observed differences. Healthy migrant effect and sample selection bias should
also not be disregarded as the possible contributing factors for the observed higher
prevalence of the other doctor diagnosed CVD conditions among Edinburgh's White
men and women compared to the Iranian migrants in Edinburgh.
The study findings revealed that a noticeably lower proportion of Iranian men in
Edinburgh had adequate physical activity level compared to Edinburgh White men. But
moderate or vigorous physical activity level was seen among Iranian women in an
almost similar rate with the Edinburgh White controls. Such a result was not supported
by the results of previously conducted studies (456, 459, 496) that indicated higher level
of physical inactivity among Iranian women in Iran. Thus ifwe can ignore possibility of
selection bias in this pilot study, the findings imply that Iranian migrant women have a
considerably improved physical activity level compared to their age matched
199
counterparts in Iran. Thus while even a considerably higher proportion of Iranian women
reported to do sport (compared to Iranian men and Edinburgh White women) but
probably most of them do not adhere to the recommended moderate or vigorous activity
level on at lest five days of the week. The findings also suggest that Iranian men in
Edinburgh might be more at risk of the consequences of the sedentary unhealthy life
style compared to Iranian women and also their age matched controls in Edinburgh.
Iranian migrants in this pilot study reported a higher consumption rate of meat
products and lower consumption of fruits and vegetables in their daily diet. Such an
imbalance in diet could potentially have major side effects on their health especially
with the observed level of physical inactivity among them.
In relation to alcohol drinking behaviour about 76% of Iranian men and 52% of
women in Edinburgh reported to drink alcoholic beverages occasionally or on a regular
basis. These rates are still lower than the reported alcohol drinking rate in the age
matched Edinburgh White men and women. There is a strong sense of stigma with
alcohol use among some of the Iranians in Iran and those who drink alcoholic beverages
are very conservative in talking about their drinking behaviour for strangers particularly
for one of their counterparts. Consequently self reported data about drinking of alcoholic
beverages should be considered carefully specially for women since such stigma for
female drinkers is much stronger than the male drinkers. Under-reporting therefore is
probable when asking question about Iranians drinking behaviour especially with regard
to the frequency and quantity of alcohol use. For instance in the only published article in
recent years (503) which included alcohol consumption, the rate (unstandardised) was
7.2% for men and 0.1% for women in the Golestan province of Iran.
Iranian men and women in Edinburgh indicated a higher rate of smoking compared to
their counterparts. The difference in the women subgroup was substantial (13% versus
0.9%). Presence of a same stigma for smoking women in the Iranian community which
exist for alcohol drinking warrants consideration of measurement bias in the
interpretation of the results. Smoking for Iranian women is considered to be a Western
behaviour and so is not a social norm within the Iranian community. It should be
accepted however, that the observed smoking rate among Iranian women in Tehran
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(about 1%, 95% CI: 0.2-4.9%) which is concurrent with the pooled estimated of
smoking rate for Iranian women (1.25%, 95% CI: 0.6-2.4%) (see chapter four) might
reflect a degree of conservatism in responding questions about smoking behaviour. Thus
use of self-reported smoking data may cause a major bias in the research findings. But
even with confirming presence of such conservatism, the observed difference is
considerable and should not be interpreted solely based on the probability of under¬
reporting. It is not possible however, to judge about magnitude of this stigma on the
observed difference until a reliable method is used to identify smokers in the Iranian
studies. Higher self reported smoking rate of Iranian men compared to Edinburgh White
men also needs to be addressed and investigated further using more reliable methods to
detect smokers from absolutely non-smokers. The difference can also be explained by
the presence of selection bias in the recruitment stage of this pilot study where people
with higher rate of smoking made themselves volunteer to participate because of their
prior knowledge about relationship between smoking and cardiovascular diseases. This
study was unable to confirm or reject any of these hypotheses.
Iranian migrants in Edinburgh indicated higher mean levels of systolic and diastolic
blood pressure and also prevalence rate of hypertension compared to their counterparts
in Iran. Mean SBP level of Iranians especially in the male subgroup was higher than the
estimated pooled mean of SBP using the data from Iranian studies (see chapter four). In
the female subgroup the observed mean SBP was almost similar to the pooled estimate
of the reported SBP in the Iranian eligible studies (see chapter four). Prevalence of
hypertension among Iranian women in Edinburgh was notably lower than their age
matched controls in Edinburgh. Bias due to use of different BP monitors in different
studies is an important probability and variations in the results due to use of divergent
measurement methods should not be completely ruled out. In any large scale future
study issue of selection bias and mentioned limitation needs to be considered carefully
and use of identical BP monitors or calibration of the new devices must be programmed
in advance. Other hypothesis like diet change including a higher rate of alcohol
consumption and smoking rate especially among Iranian migrant men may also explain
their increased level of SBP compared to their counterparts in Iran.
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In relation to the anthropometric indices Edinburgh's Iranian and White men were
taller than the Iranian men in Tehran but at the same time they had higher mean weight
level. Thus the excess weight affected their anthropometric profile. Such pattern was not
observed among females since Iranian women in Edinburgh had lower weight than their
counterparts in Iran and also than the Edinburgh's White women. Mean height of Iranian
female migrant in Edinburgh also was higher than the mean height of Iranian women in
Iran. Thus it can be concluded that Iranian female migrants in Edinburgh benefited
significantly with their migration in relation to their weight however healthy migrant
effect could be another important contributing factor.
The difference between hip and waist circumference of Iranian women in Edinburgh
and two other comparison groups was statistically significant while waist to hip ratio did
not show any meaningful variation. Iranian women in Edinburgh had narrower waist and
hip circumference from both White women in Edinburgh and Iranian women in Iran.
Iranian men in Edinburgh were not very different from their counterparts in relation to
the waist and hip circumference but their hip circumference was significantly narrower
than the Edinburgh's White men. Accordingly since larger hip circumference has
protective effect on CVD (556) it is predicted that Iranian migrant men in Edinburgh
might be in a higher risk ofCVD especially with their lower level ofphysical activity.
HDLc level in Tehran population was lower than the level of HDL-C in Edinburgh
Iranian population. Accordingly it can be suggested that Iranians' HDL-C level
increases with migration especially in women due to the factors like better access to
physical fitness facilities and change in diet. A higher triglycerides level and TC/HDLc
ratio among Iranian in Tehran may also confirm this hypothesis. Having a healthier diet
and as indicated more physical activity by Iranian men and women probably are the
most important influential factors in improving lipid profile of the Iranian migrants in
Edinburgh. Being target of health education programmes and social pressure to be fit
and healthy can also be other contributing factors. Iranian migrants in Edinburgh have a
very similar lipid profile with the Edinburgh' White population which indicate that they
are not at added risk ofhyperlipidaemia.
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Analysis of fasting blood glucose was indicated that about 2% of Iranian men and
none of women in Edinburgh were diabetic. Also none of Iranian women reported to
have doctor diagnosed diabetes. Presence of impaired fasting glycaemia was also seen
among 6.3% of men and about 4.5% of women. Although these later figures should be
confirmed by the 2 hours post glucose load test but since doing of this test was not
proposed in this pilot study in any future study it should be applied to make precise
judgement possible. If these findings were true then we can conclude that Iranian male
migrants are in higher risk of diabetes when compared to Iranian women. Previously
calculated overall prevalence of diabetes in Iran (about 6.0% in men and 7.0% in
women) does not confirm such a difference (see chapter four). Effect of selection bias in
the observed and reported rate of diabetes in the female subgroup and most importantly
effect of small sample size should not be disregarded. Adjustment of results to some of
the baseline confounding factors such as BMI or waist circumference can provide a
better view of diabetes in the Iranian migrant population in future large scale study.
It was indicated that the analysis of data collected based on matching criteria using
conventional methods with ignoring matching did not change the prevalence estimates
considerably compared to use of matching techniques. Thus one potential application of
the data collected in this pilot study in line with the progress in the matched analysis of
the data collected in the cross-sectional studies with one case to many variable controls
design could be comparison of the different analysis model on the point estimates of
PRR and their 95% confidence intervals.
In this study for the first time CVD risk profile of Iranian migrants was investigated in
the UK and their status was compared with age and sex matched controls from
Edinburgh White and Iranian indigenous population. Such a comparison was not
conducted before and its findings can give us an insight about priorities in health care
provision and research field. Major limitation of this study was use of non-randomly
selected sample of Iranians in Edinburgh for which there was not other choice due to
lack of a reliable sampling frame. Thus it is probable that these results were affected by
the selection bias. Small sample size of the recruited Iranians in this study was also
made the findings and comparisons less precise.
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With observed higher educational and occupational profile in the Iranian migrant
group it was expected that they also have a better CVD profile compared to the
indigenous White population. But this pilot study was unable to confirm such a
difference. Thus it is probable that the Iranian general migrant population even have a
worse CVD risk status than the currently identified levels.
To have a better view about health status of Iranians in UK and other countries of the
world findings of this pilot study should be applied to plan and conduct a future large
scale study on a representative sample of Iranians. According to the results of this pilot
study while Iranian migrants have a better profile regarding some of the CVD risk
factors compared to their counterparts in Iran but are in a added risk with regard to a
number of CVD risk factors compared to Edinburgh indigenous White population. But
their pattern of life style change and also CVD risk after migration need to be clarified
further. In the next chapter an extensive overview about the main findings of this pilot
study is given in relation to the health of Iranian migrant population and implications of
these results on the ways any future large scale study can be conducted.
7.15 Abstract
Introduction: In this chapter findings of the conducted pilot study in relation to the
prevalence of major cardiovascular disease risk factors were compared with two other
age and sex matched data sets: one from Scottish Health Survey 2003 and the other from
Tehran Lipid Glucose Study 2002 as an exemplar study from Iran. Such a comparison
and following discussions can shed light on priorities and the way a future large scale
study on the health of Iranian migrants can be conducted.
Methods: Conventional statistical methods (by ignoring the matching criteria) were
used to analyse and discuss possible differences between the comparison groups. Mean
difference and where appropriate geometric mean difference for quantitative variables
and the prevalence rate ratio (PRR) for the dichotomous variables were calculated. To
see how analysis of the matched data based on the matching techniques will change the
analysis result conditional logistic regression model (fitted via Cox regression model)
was also applied to analyse data of a number of variables with dichotomous exposure.
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Results: A higher proportion of Iranian migrants in Edinburgh possess an academic
qualification than the general White population and also Iranian in Tehran. A trivial
difference was seen between the Iranian men and the Edinburgh's White men regarding
the employment rate. Notwithstanding employment rate among the Iranian migrant
women was about 15% lower than the Edinburgh's White women. While Iranian
migrants indicated a better profile regarding some of the CVD risk factors (lipids,
physical activity) compared to their counterparts in Iran but prevalence of hypertension,
overweight or obesity and smoking was high among Iranian men in Edinburgh
compared to their counterparts in Iran and also matched White controls.
Conclusion: The findings provided a better view about health status of Iranians in UK
and other countries of the world. But many unanswered questions like a higher smoking
rate and hypertension among Iranian women in Edinburgh compared to their age
matched controls in Tehran remained to be answered. This study results can be used to
plan and conduct a future study on a representative sample of Iranians.
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Chapter Eight: Overview of the key findings from the two
systematic reviews and pilot study on the
prevalence of the cardiovascular disease
risk factors among Iranians in Edinburgh
8.1 Introduction
The rationale behind choosing this study topic, its aims and objectives,
methodologies used and results of the data analysis were provided separately based on a
comprehensive review of the relevant literature in the previous chapters. The study
findings also were discussed generally in chapter six and in relation to the CVD risk
factors in chapter seven. This chapter gives an extensive overview about what this study
added to the scientific literature in relation to the health of Iranian ethnic minorities
throughout the world and also about implications this study may have on the ways any
future large scale study on Iranian migrants can be conducted. Limitations in
implementing population-based health studies across the Iranian communities abroad
and major methodological issues researchers may consider in their work on Iranian
migrants are also discussed in this chapter.
8.2 Main findings of the systematic reviews and pilot study
8.2.1 Findings related to the research methods on Iranian migrants
Two systematic reviews and a pilot prevalence study were conducted to gain
experience and learn lessons to inform a future large scale study on Iranian Diaspora. In
the systematic review of the methods and themes of health-related research on the
Iranian Diaspora few studies were found but considerable heterogeneity in the
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methodologies used. (297) The results also revealed that different recruitment methods
in varying circumstances may lead to differing results. Distaste of Iranian migrants for
written surveys and their suspicion of strangers asking questions were reported in some
studies. (299, 313) But findings of this systematic review indicated that Iranians in
general are cooperative with researchers and they are not characteristically reluctant to
participate in health studies. However, the limited number of health related studies on
Iranian migrants (297) implies inadequacy of our knowledge to have an explicit analysis
about health status of this ethnic minority group. Therefore, with the growing population
of Iranian migrants throughout the world, it is vital to move beyond boundaries of our
current understandings about the health status of this ethnic minority.
Results of the second systematic review on the prevalence studies of cardiovascular
risk factors among Iranians indicated a major heterogeneity in the methodologies used
and divergent reporting quality. Also there was only limited number of studies on the
prevalence of CVD risk factors among Iranian migrants. Thus, reliance solely on the
results of these meagre and divergent researches to judge about CVD risk status of
Iranians in Iran or abroad can be misleading. Without disregarding this limitation, the
calculated pooled prevalence rates for some of the conventional CVD risk factors (e.g.
obesity in women and abnormally low level of HDL-C in men) suggested that
conducting of future precise studies both in Iranian indigenous and migrant populations
can be enlightening.
With this background and to prepare for a large scale study on the prevalence ofCVD
risk factors among Iranian migrants in UK or other European countries a pilot study was
conducted. According to the findings major reservation to participate in a health study
was not found among Iranians in Edinburgh. In this study 87.5% of the respondents
consented to give their own and 79.2% their family members' or friends' contact details
(with their permission) to be recorded for invitation in a possible future study. While a
majority of recruited Iranians in this pilot study indicated their willingness to cooperate
in future health studies, but concerns of at least a fraction of Iranian migrants need to be
investigated. The overall judgement is that conducting a future large scale population-
based study on Iranian migrants is feasible. But in order to do such a study, creating a
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list from names and contact details of Iranians residing in the major cities of the
Scotland or whole UK will be pivotal. Even so, lack of a sampling frame of Iranian
migrants' names or addresses in destination communities and also not having easily
identifiable names that are specific for Iranians can make conducting of research on
Iranian Diaspora challenging. Despite reported lack of engagement by some of the
Iranians in earlier health studies, (299, 313) findings of this pilot work may readdress the
assumption that such a hesitation probably stem from applied methodology or study
limitations per se rather than a characteristic reluctance of Iranians to be recruited into
health studies. These limitations in line with the restriction in the opening hours of the
study clinic were probably influential in the relatively long recruitment stage of the
Iranians into this pilot study. All these restraints however, may also be regarded as
indications to label Iranian migrants a hard-to-reach ethnic group.
A number of respondents stated that they prefer to introduce themselves British when
filling formal documents because of a degree of discrimination that they feel exist
against ethnic minorities. Such a constraint can be a main concern in identifying Iranian
migrants who will be questioned through indirect methods (e.g. postal questionnaire or
electronic questionnaire) in future studies. This is especially important when we already
know that about 72% of Iranian migrants in Edinburgh stated their ethnicity as "White"
or "Other South Asian" during the Scotland Census 2001. (520) Therefore it is
suggested to avoid application of a unique question as a proxy for ethnic classification of
Iranian migrants in future studies. Such an inaccuracy also was seen with question about
faith and religion when interviewing Iranian minority groups. The study findings
indicated that at least for Iranian migrants, answers to the posed question about ethnicity
or religion may not lead to straightforward answers. Not different from other population-
based studies on ethnic minorities (557-559) results of this pilot study also revealed that
preference for a same gender practitioner in all kind of examinations or examination of
private area (including waist and hip measurement) should be regarded as a potential
cultural barrier against participation of Iranian migrants in health studies.
The study results indicated that most of the Scottish Health Survey questionnaires can
be adapted for the Scottish Iranian population. About 45% of the study informants stated
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that they prefer a Persian questionnaire or an interview in Persian language in a future
health study. While both optional original English and a translated version of the study
questionnaire were available for study participants but regarding cross-cultural
conceptual matters which is generally arise (560) when using directly translated version
of questionnaires planned in English language, validation of the translated questions
should be considered seriously for future studies.
Further research is needed to develop culturally sensitive methods to study Iranian
migrants but before this happens involving of native multilingual Iranian researchers
who are familiar with culturally sensitive issues and are oriented to Iranian customs, and
also approaching key persons (those with extended network of friends) can be important
in recruitment of Iranian subjects into health studies. Appealing to urgency of some
health issues among Iranian communities abroad and that Iranians were not generally
included like other ethnic minorities in studies which investigated prevalence of serious
health problems (297) may also positively affect recruitment of Iranians into health
studies.
8.2.2 Findings related to the prevalence of CVD risk factors among
Iranians in general and Iranian migrants in particular
Cardiovascular diseases are the main cause of death in the UK and account for
about 208,000 deaths annually. (561) Despite reduction of death rates from CVD in the
UK since the early 1970s among more developed countries after Ireland and Finland the
deaths rates in UK still is highest and this country has a top position among developed
countries mortality league table. (562) This is while even within the UK there are
regional differences regarding the prevalence of CVD and CHD and their consequences
with Scotland having the highest death rate from CHD. (561) In addition to the regional
differences ethnic variations are also reported in relation to the CVD related deaths in
UK. South Asians including Indians, Pakistanis and Sri Lankans for instance have been
indicated to suffer from a higher premature death rate of CHD than average population
but those from Caribbean and West Africa reported to have much lower death rates than
the average. (561)
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Due to lack of empirical evidence about the CVD risk of Iranians in UK it is not
possible to compare their status with general White or other ethnic populations.
However, findings of the study can give us an overall view and in part be potentially
applied for such a comparison. It should be noted that the statistical comparisons applied
in this pilot study were for illustrative purposes only and due to differences between the
studies, such comparisons must be interpreted with extreme caution.
According to the study results Iranian males in Edinburgh had an overall worse CVD
risk factors profile than the Edinburgh White men. While for instance prevalence rate of
hypertension, overweight or obesity and TC/HDL-C ratio were more or less same in the
two comparison groups but regarding smoking rate and low HDL-C level Iranian men
had a worse prevalence rate compared to Edinburgh White men (see Figure 7.1). In the
female subgroup Iranians with regard to the prevalence of smoking, hypertension and
overweight or obesity rate had a better status but a worse condition regarding the high
TC/HDL-C ratio and low HDL-C level.
Iranian males except for high TC/HDL-C ratio and low HDL-C level also showed a
worst CVD risk factors profile than their age matched counterparts in Iran. This is while
in the Edinburgh Iranian women in addition to a better TC/HDL-C ratio and HDL-C
level, prevalence of overweight and obesity was also lower compared to age matched
Iranian women in Tehran (see chapter seven).
The probability of bias towards over-representation of educated and high risk people
cannot be ruled out due to non-random selection of the respondents. But putting all this
information together and considering the UK and Scotland's worse CVD profile
compared to most other developed countries we can conclude that Iranian migrants are
probably a high risk group for at least some of the important CVD risk factors.
8.3 Strength and weaknesses of the conducted studies
8.3.1 Strength and weaknesses of the systematic reviews
The systematic review of recruitment methods in health studies of Iranian
Diaspora was a major initiative to understand the factors that persuade or inhibit Iranians
living abroad to participate in a health study.
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In this systematic review literature written in English or Persian language was searched
while a sizeable number of Iranians are living in countries where other languages are
used. Therefore articles or reports that may be published in local languages (France,
Denmark, Germany, Norway and Sweden) were probably missed. Thus researchers
should try to expand the search domain to the non-English/Persian language in any
future similar study.
Findings of the second systematic review which was on all the CVD risk factor studies
ever undertaken on the Iranian indigenous population or all Iranian migrants (see pages
81-134) should be interpreted with caution due to observed heterogeneity of applied
methods. However, the findings can be considerably informative as a major prerequisite
for planning a future epidemiological research on the prevalence of CVD risk factors
among Iranian migrants or even Iran's indigenous population. The results indicated only
a few comprehensive studies on the prevalence of CVD risk factors in Iran with
substantial heterogeneity in the methodologies applied. Also only few studies were
identified to investigate health status of Iranian migrant population and among them even
very few focused on the prevalence of CVD risk factors in this ethnic group. With this
background findings of this review may not generalise to Iranian population or all
Iranians living abroad but nonetheless they provide a consistent overall picture about the
extent of research had been performed on Iranians with regard to CVD risk factors and
their potential credibility in giving a reliable impression about the CVD risk status of
Iranians in Iran and abroad.
An extensive search had been done in this review to find out possibly all relevant
studies, regardless of their publication place and language (English or Persian) but some
limitations warrant to be addressed. Unfortunately due to limited number of eligible
studies in the review it was not possible to analyse the findings for publication bias. But
with observed heterogeneity in the applied methodology it is very likely that the
observed variations in the findings were produced by these divergences in the
methodologies rather than a chance. Thus in order to have reliable pooled estimates from
the prevalence of CVD risk factors, it will be crucial for future researchers to comply
with a standard protocol in doing research on the prevalence of CVD risk factors
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especially in Iran. Few authors reported participation rates or explained characteristics of
those refused to participate in a study. Many of the included articles had poor reporting
quality. Every effort was made to track down unpublished studies and grey literature but
this research is unable to rule out the possibility of publication bias entirely. Having
access to a copy of full results from presented abstracts in conferences or brief summary
of results in informal publications was not always successful. The strength of the review
could be greatly improved if it was possible to have remote access to all journals or
thesis had been published in Persian mostly in Iran (or to the databases of studies' title or
abstracts) which is not possible currently due to lack of infrastructure to have access to
the published works in this country electronically.
8.3.2 Strength and weaknesses of the pilot study
Findings of the above mentioned systematic reviews were used to plan a pilot study on
the prevalence of CVD risk factors among Iranians in Edinburgh. This pilot work
according to the best of current knowledge is the first study of its kind on Iranian
Diaspora in the UK and is unique regarding the type and number of CVD risk factors
studied. The study results represent extent of the prevalence of CVD risk factors in the
Iranian Diaspora and important methodological issues that must be considered in future
research on this ethnic group.
Use of non-random sampling method for recruitment of the study participants was a
major limitation in this study. But the study results indicated no major difference
between age structure of the recruited people with the age structure of Edinburgh's
Iranians based on the Scotland 2001 Census data. Since a multi-method sampling
approach was used to recruit people into the pilot study calculation of participation rate
among those who received or saw the study flyer or those who heard about the study
from their relatives or friends was not possible. Thus it is not possible to completely rule
out probability of selection bias in the recruited sample.
For the first time the questionnaires had been used in the Scottish Health Survey 2003
were translated into Persian to provide freedom of choice for the study participants.
Although face validity of the translated questionnaires was checked by one of the study
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supervisors but cross-cultural validity of the applied questionnaires should be scrutinised
in any future large scale study.
Recruitment stage of this pilot study started at 29/08/2006 and continued until
15/06/2007. There is some evidence supporting seasonal variations of selected
biomarkers of CVD including lipid profiles. (120-124) Nevertheless, due to the small
sample size and uneven availability of the study participants to attend the study clinic it
was not possible to control effect of this possible confounding factor in this study.
Every effort was made to relax people before starting blood pressure measurements (by
explaining advantages of participation in the study or taking about general topics like
whether or sport events...) but probability of "white coat effect" (72) can not be ruled
out in the blood pressure measures. A digital sphygmomanometer was used in this study
to measure blood pressure. Results of this pilot study were compared with the findings
of an exemplar study from Iran (416) for comparison purposes. In the Iranian study a
conventional mercury sphygmomanometer was used to measure blood pressure but since
its model was not provided in the study report it was not possible to validate blood
pressure measures from two studies before comparison.
Owing to the presence of a kind of stigma in the Iranian community in relation to
smoking among women, the applied self-report method in this study probably did not
provided accurate data and so more reliable methods (e.g. measuring amount of carbon
monoxide in breath with a portable monitor) (76) must be approached to identify reliably
smoking Iranian women in future studies.
Another limitation for this pilot work was impracticability of comparison between the
applied laboratory and analysis technique of blood lipids in the three studies. Since the
analyses were conducted in different time frames and more importantly details of
measurement protocols were not completely similar in the identified studies it is highly
probable that different lipid analysis methods have given us divergent results for same
level of lipid profile.
Some of the discussed limitations were in part inevitable due to proposed study design
and comparison of the findings from three different studies in which no single standard
protocol was followed for the variables measurements. But where possible researchers
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should be aware of these limitations and try to avoid or control their effect in future
large scale studies through applying standard measurement protocols or adjusting the
measures by the appropriate equivalence scale.
8.4 Results of the study in relation to the scientific literature
This study indicated that Iranian migrants are under-represented in health studies as
there are sizeable groups of Iranians in some of major destination countries. The issue of
exclusion of ethnic minorities from health research has also been highlighted in the
study ofBartlett et al. (563) They have suggested that under-representation of population
subgroups in research are associated with differences in underlying factors and risk
levels including socio-demographic status. They also have concluded that the issue of
diversity in inclusion or exclusion of ethnic minorities in health studies is not very clear
among researchers and for this reason it is generally ignored. Ranganathan and Bhopal
(564) in their study on 72 North American and European cardiovascular cohort studies
also have shown that the process of inclusion/exclusion of ethnic minority groups
generally was not emphasised in these studies. Hussain-Gambles at al. (565) have
argued that exclusion of ethnic minorities from health-related research can affect
external validity of the findings. The ongoing discussions about importance of different
contributing factors in inclusion or exclusion of ethnic minorities in health studies, gives
the overall impression (565-570) that migrants in general share common challenges
while some challenges may be amplified amongst certain groups. Factors like age,
language, social class, feeling of not belonging/mistrust, culture and religion are
suggested to be key points in recruitment of ethnic groups into health studies. (571)
Researchers' perceptions of these factors are also suggested to be consequential in their
success to recruit ethnic minorities. (568) Wendler et al. (570) have found small
differences in the willingness of different minorities to participate in health studies and
hence, they have recommended to focus on equal access to health research for all groups
rather than concentrating on one group and their attitudes toward participation in health
studies.
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Under-representation of ethnic minorities in research created debates about the causes
and patterns of variations in cardiovascular disease and its contributing risk factors in
different countries. Nonetheless, the conducted works have generated a large scientific
literature with many interesting findings. (47, 48, 67, 239, 572-581) For instance, Lip et
al. (572) suggested that epidemiologic profile of CVD among African Americans do not
explain pattern of CVD morbidity and mortality among black Africans and black
Caribbeans, both in Britain and in their native African countries. Forouhi et al. (573)
have reported ethnic differences in levels of visceral adiposity, insulin resistance, and
also other risk markers such as C-reactive protein (CRP), adiponectin and plasma
homocysteine. Agyemang and Bhopal (574) have indicated heterogeneity of blood
pressure level in the South Asian groups residing in the UK. Lemic-Stojcevic et al. (575)
also reported a higher prevalence of hypertension in Black Caribbeans but a lower level
of HDL-C and TGs compared to Whites in the UK. The observed CVD variations and
similarities across ethnic groups may stem from genetic or environmental factors and
their precise exploration can provide valuable information for planning interventional
programmes.
Due to the discussed limitations CVD prevalence rates calculated in this pilot study
were not directly and exactly comparable with the rates reported for Iranians by other
investigators or with the figures reported for other ethnic minorities in UK. But pending
a comparable definitive study and to give an overall picture of the status of CVD risk
factors among Iranian migrants in Edinburgh, such a limitation has been set aside, albeit
with extreme caution.
As discussed in chapter 3 and 4 health studies on the Iranian Diaspora are scarce. Due
to the heterogeneity of published research calculation of an overall summary estimate
for prevalence of different CVD risk factors was not possible. Therefore comparisons of
findings from this pilot study are with results of other single studies.
The prevalence of abnormal high fasting blood glucose level (FBS > 6.1 mmol/1) as an
indication of impaired fasting glycaemia or even probable diabetes among female
Iranians in this pilot study (4.5%) is almost similar with the findings reported (4.0%) for
Iranian women in Sweden by Daryani et al. (320) However, there are differences in the
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age range of two studied groups (30-71 in Edinburgh pilot study and 35-64 in the study
of Daryani et al.). Also there is a time lag between the two studies (fieldwork of the
Edinburgh pilot study was conducted in 2007 while in the study of Daryani et al. data
gathering took place before 2005). (320) Direct or indirect standardisation of these rates
is not possible due to lack of needed data about number of recruited women in different
age groups in the study of Daryani et al or having a standard structure of Iranian
migrants population. Thus our judgement is based on non-standardised prevalence rates.
Same problems exist for comparison of the obesity prevalence rates in two studied
groups, but crude rate for both Iranian women in Edinburgh and Sweden (Uppsala) was
13.0%. (320)
Self-reported smoking rate of Iranian men in Australia according to the study of Rissel
et al. (305) was lower than their counterparts in Edinburgh (24.0% versus 30.6%) but in
female subgroup it was higher (17.0% versus 13.0%). Such a difference should be
interpreted with caution since the age range of target group was over 18 years old for
both males and females in the study of Rissel et al. while in Edinburgh study it was 29-
64 for males and 30-71 for females. Eligher smoking rate of Iranian men in Edinburgh
can be attributed to baseline factors responsible for a high smoking rate of indigenous
population in Scotland. But this assertion should be investigated further regarding all
problems which potentially may occur when comparing none standardised prevalence
rates.
The prevalence of hypertension (according to the World Health Organisation criteria)
among Iranian men in Edinburgh reported to be higher than Iranian men in Oslo,
Norway (391) (22.5% versus 14.0%) however, the observed difference in the prevalence
of hypertension among Iranian women in Edinburgh compared to the Iranian migrant
women in Oslo (13.0% versus 11.0%) seems to be insignificant. The mean age, age
standard deviation and age range of Iranian women studied in Oslo was 41.7 years, 7.2,
31-60 but for Iranian women in Edinburgh it was 44.2 years, 8.98, 30-71 respectively. A
higher mean age of Iranian female subgroup in Edinburgh may explain the observed
difference in the prevalence of hypertension but more robust interpretation needs to be
based on further scrutiny.
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Considering all limitations in calculating standardised prevalence rates, available data
suggest that Iranian men in Edinburgh have the worst smoking rate (31%) after
Bangladeshi men (40%) residing in England (561) and that smoking rate among Iranian
women in Edinburgh is higher than the South Asian females. Obesity rate among Iranian
men also was higher than the South Asian men living in England but lower among
Iranian women in Edinburgh compared to the South Asian women. Prevalence of
hypertension and diabetes however seems to be lower among Iranian migrants of both
sexes in Edinburgh compared to South Asians and in a similar level with Edinburgh
White and also England general population. (561) To be able to discuss these differences
precisely, use of data from a randomly selected sample of Iranians abroad and
application of standardised prevalence rates are suggested in future studies.
Findings of this pilot study herald the immense importance of a future large scale
study to investigate health status of Iranian Diaspora. Two conducted systematic reviews
indicated how sparse are our knowledge about Iranian migrants and how important are
use of reliable methodologies in providing an accurate picture from the health status of
Iranians abroad and also Iranians in Iran. Probability of selection bias towards inclusion
of highly educated people was a major concern in this pilot work. Thus logically the
higher educational level among recruited Iranians must indicate its impact on their better
CVD risk profile. But even if we assume the studied sample as a relatively
representative sample of Iranian Diaspora in UK (or even in Europe) it was evident that
while CVD risk factor profile for Iranian men improves regarding some of the risk
factors (HDL-C level and TC/HDL-C ratio) after migration, but it also gets worse
simultaneously in relation to some other important risk factors such as smoking and
hypertension. To be able to verify such a claim a large scale study on a randomly
selected sample of Iranians abroad will be needed in the future.
8.5 Conclusions and recommendations
Findings of this pilot study indicate that there is no reservation among Iranians in a
scale that prevents them from participation in health studies. So a large scale population-
based study on Iranian migrants seems to be feasible. The study results also suggest that
Scottish Health Survey questionnaires can be adapted for the Scottish Iranian
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population. Due to the stated preference for Persian language as the questionnaires or
interview language (by 44.4% of respondents), in any future study it is recommended
that application of translated documents and also employment of multilingual
interviewers can potentially increase success rate in recruitment and conducting of a
population-based study on Iranian ethnic minorities. Therefore, validation of the
translated questionnaires will be a top priority before application of these translated
versions in any future study.
The results also revealed challenges researchers may face in recruiting Iranians into
health studies. For instance informal methods e.g. word of mouth, contacting people
through their friends and participating in Iranians gatherings to invite them for
participation are suggested more frequently by the respondents than the formal methods
(e.g. advertising in the media) for increasing participation rate.
The study findings indicated that application of a single and direct proxy question to
identify Iranians' ethnicity in future studies may lead to incorrect answers. So use of a
group of questions like birth place, mother language, religion and number of years
stayed in the country may give a better view about ethnicity of Iranian migrants.
The study findings highlighted importance of providing freedom of choice to select
gender of practitioner when examination of the study participants is going to be
performed in any future study on Iranian migrants.
This pilot study shed light on the pattern of the prevalence of a number of major CVD
risk factors among Iranians settled in Edinburgh. Comparison of the collected data with
the acquired data from an Iranian exemplar study in Iran and Scotland gave further
information to assess patterns of changes in lifestyle and so in the prevalence of CVD
risk factors after migration in this ethnic group. There are however, still debates about
reliability and accountability of different CVD risk factors in the prognosis of CVD
(112-119, 225, 228, 233, 234, 240, 244, 252, 255, 582-585). More than 93% of the study
participants consented to give extra blood sample to be stored for further analysis of
other CVD risk factors in the future. Therefore analyses of these frozen samples for
some of the other recommended CVD risk factors (e.g. C-reactive protein, adiponectin
or C-peptide) will be potentially informative in uncovering pattern of CVD risk among
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Iranian migrants. Findings of such analyses can help researchers to base their decisions
about priority of study variables on sound evidence in any future large scale research.
About 87% of the respondents in this pilot study were willing to allow their name and
almost 79% of them consented to give their family members' or friends'contact details
to go on a list of all Iranians in Scotland for a future health study of this kind. The results
indicated that construction of a sampling frame of Iranians who reside in Edinburgh is
feasible and the list which was prepared through this pilot study can be applied in future
health studies after obtaining their formal consent.
Since number of available cases in this pilot study was small relative to the number of
available controls, in order to increase relative efficiency of the comparison multiple
matched control (1:5) design were applied where possible (otherwise variable numbers
of controls (maximum 5) matched to each case). Primary analyses of the study data were
performed using conventional method by ignoring matching criteria. Then analyses were
repeated based on matching design for some of the quantitative variables using
Conditional Logistic Regression (fitted via Cox Regression model) to see how the
analysis model can affect the study results. These findings indicated that matched
analysis of data collected in a matched design versus unmatched analysis will direct
findings towards more conservatism (wider confidence intervals). Thus one potential
application of the data collected in this pilot study in line with the progress in the
analysis of the data gathered based on one case to many variable controls design could
be comparison of the different analysis model on the point estimates of prevalence rate
ratio (PRR) and their 95% confidence intervals in future.
8.6 Summary
The limited number of health related studies on Iranian migrants implies inadequacy
of our knowledge to have an explicit analysis about health status of this ethnic minority
group. Two systematic reviews and a pilot prevalence study were conducted to gain
experience and learn lessons to inform a future large scale study on Iranian Diaspora.
A considerable heterogeneity was seen in the methodologies used within studies on
Iranian Diaspora. Application of a multi-method recruitment approach; translation of the
study questionnaire and declaration of consent in the respondents' language were
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suggested to be helpful to increase participation of Iranians in population-based studies.
A few comprehensive studies were identified on the prevalence of CVD risk factors in
Iran with substantial heterogeneity in the methodologies applied. Only few studies were
identified to investigate health status of Iranian migrant population and among them
very few focused on the prevalence ofCVD risk factors.
In the pilot study of the prevalence of CVD risk factors among Iranians in Edinburgh
the questionnaires had been used in the Scottish Health Survey 2003 were translated and
used to collect data. Blood pressure and anthropometric indices were measured and
blood samples were analysed for lipids and fasting glucose levels. Iranian males in
Edinburgh indicated an overall worst CVD risk factors profile than the Edinburgh White
men. Smoking rate and low HDL-C level among Iranian men was worst than the
Edinburgh White men. This is while Iranian males in Edinburgh had shown also a worst
CVD risk factors profile than their age matched counterparts in Iran. In the female
subgroup Iranians in Edinburgh had a better profile regarding the rate of smoking,
hypertension and overweight or obesity but a worst condition with regard to the high
TC/HDL-C ratio and low HDL-C level compared to Edinburgh White women. They also
had a better TC/HDL-C ratio and HDL-C level compared to age matched Iranian women
in Tehran with a sharp decline in the prevalence of overweight and obesity.
Without disregarding probability of selection bias we can conclude that Iranian migrants
are probably a high risk group for at least some of the important CVD risk factors. The
study results represent extent of the prevalence of CVD risk factors in the Iranian
Diaspora and important methodological issues that must be considered in any future
health related studies. The questionnaires had been used in the Scottish Health Survey
2003 can be adapted for the Scottish Iranian population. But regarding cross-cultural
conceptual matters, validation of the translated questions should be considered in any
future large scale study which is needed to resolve the remained uncertainties.
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ABSTRACT
There is an increasing Middle Eastern diaspora, of considerable diversity in the questions posed,
which Iranian migrants are a major group. They are methodologies used and findings of these included
dispersed within the general population in the articles. The topics included dental health, cardio-
destination countries; this, together with the fact vascular risk factors, sex roles, cultural identity and
that many are political migrants, makes conducting research methods. The study sample sizes ranged
population-based studies on this minority group from 10 to 413 participants. Participation rate with
challenging. UK policy mandates that we provide snowball sampling ranged from 19% (postal ques-
equal access to health and healthcare for them. tionnaires) to 99% (telephone interview); with con-
The research evidence on which to base healthcare venience sampling from 33% to 57%; and using
planning and provision decisions for the Iranian random sampling from 21% to 68%. Responders
diaspora is, however, very limited. tended to be of higher socio-economic status than
This study aimed systematically to review methods non-responders. Commonly, information on trans-
used in population-based health research on lation and cross-cultural validity of questionnaires
Iranians to learn lessons to apply to future planned was not reported.
epidemiological research. Nine databases were sys- This is the first systematic review of methods in
tematically searched and the references of relevant health studies of Iranians living abroad. We found
articleswere scrutinised. Researchers known to have only a few studies and considerable heterogeneity in
particular expertise of working with Iranians were the methods and findings of these included studies,
contacted to help locate additional unpublished Although there is a growing population of Iranians
work and research in progress. Quantitative and abroad and study of determinants of health in this
qualitative studies on Iranians living abroad, but ethnic minority group is vital, this review shows
not in institutions, published in English or Persian, huge gaps in the evidence base,
that reported recruitment strategy, sampling and
data-gathering technique were eligible for in- Keywords: ethnic group, healthcare, Iran, migrant,
elusion. research, sampling, studies
From 30 potentially eligible articles, 13 unique
studies satisfied our inclusion criteria/There was
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Introduction
In studying ethnic groups as discrete communities,
researchers are endeavouring to contribute to improv¬
ing health and reducing health inequalities. However,
they often encounter difficulties, particularly in
identifying and recruiting the planned number of
participants. There are many potential explanations
for this, including lack of knowledge about the socio-
cultural features of each individual ethnic group. A
rigorous look at recruitment strategies and socio-
cultural attributes ofpotential participants is therefore
extremely important in the planning phase of research
on ethnic minority groups. Research on Iranian popu¬
lations living abroad provides one example of the
difficulties that researchers may experience, and forms
the subject of this article.
There has been increasing migration from Iran in
the last three decades, and Iranians now form one of
the largest groups in a growing Middle-Eastern diaspora.
Iranian migration accelerated with the Iranian revol¬
ution in 1979 and was given added impetus by an
eight-year war between Iraq and Iran, which began in
1980. Those who left Iran were generally wealthy and
educated people compared to both the remainder of
the population and the existing minorities, such as
African-Caribbeans, Bangladeshis and Pakistanis, in
the countries to which they weremigrating. According
to the statistics given by official resources (Migration
Policy Institute, 2004), 135 383 Iranians migrated to
the US, Canada, Germany, Netherlands, UK, Sweden
and Australia during 1996—2000. However, the actual
number of migrants of Iranian origin is likely to be
higher than these official reports suggest. Although
sizeable Iranian communities are now to be found
in many western European countries, the number of
population-based health studies on Iranians abroad is
small, possibly because they are dispersed within the
general population in the destination countries and
have no easily identifiable forenames or surnames.
Iran itself is a multi-ethnic and multicultural country
and this background diversity is reflected in the language,
lifestyle and living conditions of Iranian migrants over¬
seas. Conducting population-based studies on this min¬
ority group is therefore challenging. The lack of
studies on the Iranian migrant population is believed
by some researchers, including the first author, to
reflect a lack of willingness on the part of some
Iranians, particularly political migrants, to participate
in research for reasons that include fear of being
identified. There is, however, no reliable summary of
the empirical literature to substantiate this assertion.
This article presents a review of those population-
based studies that have been conducted about Iranians
living abroad, in order to ascertain what lessons can be
learned and to aid the planning and implementation
of future research. The review focuses on sample size
and recruitment strategies and also assesses the range
of topics covered, and hence both the range of themes
already studied and those that remain unstudied. The
main question of this review is how other researchers
have reached and recruited Iranian migrants into
population-based health studies. Ultimately the review
aims to help treat Iranian origin minorities equally in
relation to research and access to health and health¬
care. As far as we are aware, it is the first systematic
study of this subject in this population of its kind.
Methods
Types of studies
We used the MOOSE (Meta Analysis ofObservational
Studies in Epidemiology) guidelines to do this system¬
atic review (Stroup et al, 2000). All epidemiological
studies or qualitative studies or social surveys on I ranians
living permanently abroad, thus excluding students
and those living in institutions, were eligible if they
were published in English or Persian and reported
sample recruitment strategy, sample size and data
gathering technique.
Systematic reviews of observational studies usually
exclude qualitative studies. Although qualitative studies
may not contribute to synthesis of quantitative epi¬
demiological studies, in view ofthe suggestion that the
lack of studies on the Iranian migrant population may
reflect a lack of willingness on the part of Iranians to
participate in research for reasons including fear of
being identified, particularly among political migrants,
we judged that qualitative studies on Iranians could
be a rich source of understanding about their possible
reluctance to participate in research, and highlight
methodological barriers to recruiting Iranians overseas
into population-based studies. Therefore, we included
such studies. Further details about the types of data,
outcomes and our search strategy are shown in Boxes
1-3.
Box 1 Types of data
The types of collected data included:
• demographic characteristics of studied sample
(age, sex, status of residency and current place
of living)
• sampling approaches in the eligible studies
(sample size and recruitment strategy, sam¬
pling methods, sampling frame)
• study features (researcher, study subject and
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Box 2 Types of outcome sought
Topics covered by studies were:
• number of studies on Iranians living abroad
by country
• number of studies having good-quality infor¬
mation on methods (sample size, sampling
method, sampling frame and recruitment cri¬
teria of subjects)
• type of recruitment strategies
• response rates
• main lessons from eligible studies that may
help planning of future studies on Iranians
abroad
■ t -v -.7 j. -
Selecting studies
The review was limited to English and Persian
language studies published between 1950 up to week
1, April 2006. Abdolreza Shaghaghi checked the titles
and abstracts of all retrieved records to distinguish
relevant articles. Articles were excluded on initial
screening if the title and the abstract showed that
they were not reporting population-based studies on
Iranians. When a title or abstract could not be rejected
with certainty, the full text of the article was acquired
for further assessment. For those studies that were
potentially relevant, full papers were secured. Refer¬
ences of relevant articles were inspected. We also
included studies recognised through serendipitous
discovery. Researchers (Dr Sirous Momenzadeh, Dr
Freidoon Khavarpour and Professor Haakon Meyer)
well known to undertake research on Iranian popu¬
lations were contacted for possible additional refer¬
ences. Reference Manager software was utilised, and
duplicate entries were deleted. Studies were assessed
for quality. A data-extraction sheet was used for
summarising included studies (see Box 4).
Data extraction
The data were extracted into a customised data-
extraction form. Descriptions of the problems en¬
countered by the researchers in recruiting the study
sample or recommendations to increase participation
rate were also extracted.
Data presentation
Data were tabulated chronologically by country ofstudy
and presented in descriptive form. Response rate was
calculated as a percentage of participants in the study
in relation to the number required by the researcher.
Box 3 Search strategy
The following databases were searched:
• AMED (Allied and Complementary Medicine): 1985 to April 2006
• CINAHL (Cumulative Index to Nursing and Allied Health Literature): 1982 to week 5, March 2006
• EMBASE: 1980 to week 13. 2006
• Ovid MEDLINE(It):
- 1950 to 1965
- 1966 to 7 April 2006
- in-process and other non-indexed citations, 6 April 2006
• CAB Abstracts: 1973 to March 2006
• Global Health: 1973 to March 2006
• Index to Theses (a comprehensive listing of theses with abstracts accepted for higher degrees by
universities in Great Britain and Ireland since 1716): 1716 to 6 March 2006
• National Research Register (UK)
• International Bibliography of the Social Sciences: 1951 to week 1, April 2006.
The free texts and MeSH indexing terms were:
Iran or Iranian or Persian or ParsiS or Farsi? or Tehran? or Isfahan? or Shiraz? or "Fars province" or
Ardabil? orUromia? or Qazvin? or Tabriz? orMashad? orMashhad? or Khorasan? or Kerman? orYazd? or
Kermanshah? or Kordestan? or Zahedan? or Lorestan? or "Chaharmahal and Bakhtiari" or "Kohkiloieh va
Boier Ahmad?" or Gilan? or Mazandaran? or Zanjan? or Ahwaz? or Khozestan? or Sistan? or Bandarabbas?
or Hormozgan? or Bushehr? or Golestan? or SemnanS or Markazi? or HamadanS or Qom? or Qazvin? or
Ilam?) AND "ethnic groups" or ethnology or "Emigration and Immigration" or "Transients and Migrants"
or "minority groups" or refugee? or abroad or "foreign country" or overseas.
Other electronic resources such as web pages of ethnicity-related organisations or official health
organisations of countries known as having a fair number of Iranians and potentially pertinent internet
sites (Google) were searched for unpublished materials.
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Box 4 Quality criteria for assessment of
internal and external validity
• Precise definition of study sample
• Clarity of data-gathering technique (e.g. ap¬
plication of original or translated question¬
naires, language used in interviews)
• Referring to the location of data collection
from study participants (e.g. home, office)
• Age, sex, state and length of residency in the
host community
• Use of a representative sample of target group
in the study
• Giving response rate for study
Results
The process by which 13 studies were included is
shown in Figure 1 and described briefly below. Three-
hundred and ten studies (including duplicates) were
identified mainly from CINAHL (11 articles), EMBASE
(83 articles), MEDLINE (109 articles), CAB (CAB
abstracts database; 35 articles), Global Health (29
articles) and International Bibliography of the Social
Sciences (42 articles). Review of the titles of these
identified 70 potentially pertinent articles. Review of
the abstracts led to 24 studies which apparently met
the inclusion criteria, but the full texts showed 20
studies met the initial inclusion criteria.
A further 56 candidate articles were identified by
reviewing the references of these 20 articles, and nine
had potential for inclusion. One study resulted from
serendipitous discovery of unpublished work presented
in the Sixth International Conference on Preventive
Cardiology (Meyer and Kumar, 2005). An internal
report from the Institute for Social Anthropology in
the University of Bergen, Norway (Kamalkhani, 1998)
was not obtainable although the request was sent to
the email address given on the Institute website. There
was considerable diversity in both methodology and
reported data in the potentially eligible articles. To
learn every lesson about application ofdifferent methods
in recruiting Iranian ethnic groups, we decided to
exclude only those studies in which Iranians were not
regarded as a separate group in the data analysis and
reporting of the findings. We also excluded those
studies in which it was not clear from explained
methodology of the article whether the studied group
Figure 1 Study identification and selection process in the systematic review of the methods and themes of
health related research on the Iranian diaspora
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of Iranians settled in a permanent base in the host
community. Furthermore, we considered the quality
of included studies based on above-mentioned quality
criteria in the results section.
In six studies (Meleis et al, 1992; Lindstrom et al,
2001; Lindstrom and Sundquist, 2001, 2002; Dawson
et al, 2005; Lindstrom, 2005), Iranians were a part of
the study sample, but as part ofa group of'immigrants
from other countries', and were therefore not analysed
separately. One article (Ghaffarian, 1987) was on college
students but since it was not clear from the full text
whether these Iranian students were spending a length
of time at their place of study or had grown up in the
host country, it was excluded (see Appendix 1).
Correspondence with other researchers did not add
to the list of relevant studies. Of the 22 articles that
met our criteria, seven (Hjern and Grindefjord, 2000;
Sundquist et al, 2000; Bayard-Burfield et al, 2001;
Hjern, 2001; Hjern et al, 2001; Wandell et al, 2004;
Wiking et al, 2004) were publications from the Im¬
migrant Survey of Living Conditions in fourminority
groups of Sweden. Two studies from Australia
(Khavarpour and Rissel, 1997; Rissel and Khavarpour,
1997), two from the Netherlands (Gerritsen et al, 2004,
2006) and two from Norway (Holvik etal, 2005; Meyer
and Kumar, 2005) were publications based on data
from one study. Since methodologies for sampling,
recruiting and participation rate in different publi¬
cations from same study are identical, we decided to
include one sample study from each study. Thus, 13
studies, including three qualitative studies (Momenzadeh
and Posner, 2003; Higgins, 2004; Barnes and Almasy,
2005), were the focus of this review (see Table 1).
Studies reporting data
The topics included dental health, cardiovascular risk
factors, sex roles, cultural identity and acculturation,
healthy behaviour, mental health, vitamin deficiency
and research methods. Eight studies (Hanassab, 1991;
Chaichian, 1997; Rissel and Khavarpour, 1997; Mahdi,
2001; Momenzadeh and Posner, 2003; Yavari et al,
2005; Barnes and Almasy, 2005; Daryani et al, 2005)
were implemented by authors with Iranian names.
The studies took place in six countries: Australia with
two (15.4%), Canada with one (7.7%), Netherlands
with one (7.7%), Norway with one (7.7%), Sweden
with two (15.4%) and US with six (46.1%). In the
Canadian study, methods for creating a list of Iranians
through linking specific surnames and given names
were described. Sample size among the other 12 studies
was in the range of 10—413 participants. Convenience
sampling (Hanassab, 1991; Chaichian, 1997; Higgins,
2004), snowball sampling method (Lipson, 1992; Rissel
and Khavarpour, 1997; Momenzadeh and Posner,
2003; Barnes and Almasy, 2005), inclusive sampling
(Holvik etal, 2005) and random sampling (Hjern and
Grindefjord, 2000; Mahdi, 2001; Daryani et al, 2005;
Gerritsen et al, 2006) methods were used. Participation
rates in studies that used snowball sampling ranged
from 19% with postal questionnaires to 99% with
telephone interview. Participation rates were 33.3-
57% in studies that used convenience sampling
methods, 21.3-68.1% in studies with random sam¬
pling methods and 38.8% where inclusive sampling
was used (Holvik et al, 2005).
The data-gathering technique, study site, use of
translated or original questionnaires and language in
the interview are provided in Table 2.
Postal questionnaire and face-to-face interview
were used simultaneously in three studies (Hanassab,
1991; Lipson, 1992; Chaichian, 1997; 25%). In five
studies (41.7%) only face-to-face interviews were used
(Hjern and Grindefjord, 2000; Momenzadeh and
Posner, 2003; Higgins, 2004; Barnes and Almasy,
2005; Gerritsen et al, 2006). Telephone interviews
were used in one study (Rissel and Khavarpour,
1997; 8.3%). Self-administered questionnaires along
with clinical examination and para-clinical tests were
applied in two studies (Daryani etal, 2005; Holvik etal,
2005; 16.7%). In one study (8.3%), only a postal
questionnaire (Mahdi, 2001) was used.
The place for data gathering, among eight studies
using face-to-face interview, was not reported in two
(25%) articles (Lipson, 1992; Chaichian, 1997), it was
the participants' homes in four studies (50%) (Hjern
and Grindefjord, 2000; Momenzadeh and Posner,
2003; Barnes and Almasy, 2005; Gerritsen et al, 2006);
while in two studies (25%) both participants' homes
and researchers' offices were used (Hanassab, 1991;
Higgins 2004).
In two studies (16.7%), clinical data were collected
(Daryani et al, 2005; Holvik et al, 2005). Ofsix studies
(50%) where postal or self-administered question¬
naire were used (Hanassab, 1991; Lipson, 1992;
Chaichian, 1997; Mahdi, 2001; Daryani et al, 2005;
Holvik et al, 2005), three (50%) did not refer to
translated questionnaires (Hanassab, 1991; Chaichian,
1997; Mahdi, 2001). In the remaining three studies
(Lipson, 1992; Daryani etal, 2005; Holvic etal, 2005)
translated questionnaires were used.
Telephone or face-to-face interviewwas reported in
nine (75%) studies (specifically or in combination
with other methods). In three (33%) studies (Lipson,
1992; Hjem and Grindefjord, 2000; Higgins, 2004) both
original and translated set of questions (optional) were
used; and in one (Momenzadeh and Posner, 2003; 11%)
only an English version of a questionnaire was used
during interviews. To answer interview questions, inter¬
viewees in one (11.1%) study used Persian (Momenzadeh
and Posner, 2003), in four (44.4%) Persian and English
(Lipson, 1992; Rissel and Khavarpour, 1997; Higgins,
2004; Barnes and Almasi, 2005), in one (11.1%) Persian
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and Dutch (Gerritsen et al, 2006) and in one (11.1%)
Persian and Swedish (Hjern and Grindefjord, 2000). In
two (22.2%) studies (Hanassab, 1991; Chaichian, 1997)
authors did not refer to the language of interview.
Studies on research methods on
Iranians
Three studies (Rissel and Khavarpour, 1997; Higgins,
2004; Yavari et al, 2005) discussed methodological
aspects of doing research on Iranians abroad, as
summarised in Table 3. Rissel and Khavarpour
(1997) referred to obstacles to using more reliable
sampling methods among Iranian migrants, such as
being a small dispersed community within the original
population, not having easily identifiable names or
surnames, and the sensitivity of the study subject such
as sexual behaviour or illegal drug use. They recruited
four bilingual interviewers born in Iran representing
different subgroups of Iranians. These interviewers
then contacted eligible persons via the telephone to
encourage them to answer study questions and to give
telephone numbers of up to four adult friends or
relatives, not immediate family members, with a
parent born in Iran. To avoid selection bias the
number of contacts each participant could suggest
was limited. The project was also publicised through
the local Iranian radio station. The response rate was
99% (417/428). Interviews took place in Persian in
90% and the remainder in English. The sample was
similar with regard to sex and age to that of residents
born in Iran in the 1991 census of the Sydney Statisti¬
cal Area. The snowball sampling method generated a
more educated and wealthy sample than the popu¬
lation ofmigrants from Iran to Australia.
Higgins' (2004) review referred to studies that
indicate high educational and economic status of
Iranian migrants. She stated that residing in the same
area does not guarantee researchers contact with
Iranians and that the offer of paying people for their
time is unlikely to increase participation. She reported
that Iranians were suspicious of strangers asking
questions and that only those with strong ties to the
community can be successful in research on this ethnic
group. She referred to studies that reflected partici¬
pants' co-operation and eagerness to participate. Fac¬
tors like appeals to national or ethnic pride, choice of
language and place of interview were helpful in con¬
vincing Iranians to participate. She reported finding
only one study where a formal informed consent
procedure was followed. In several studies a tendency
among Iranian migrants to present oneself, one's
family and one's community in the best possible light
had been observed.
Higgins used a list of Iranian families' names, phone
numbers and addresses provided by school adminis¬
trators or Iranian networks to send a letter or make a
telephone call to recruit Iranians. She gained consent
from 101 families who agreed to participate, which
was only one-third of the eligible families. She per¬
mitted the study participant to choose the language of
interview and between a non-Iranian and an Iranian
interviewer. Most interviews were in the family home,
but the interviewer's office, participants' place ofwork
and coffee shops were also used. Participation rate was
reported to be one-third of eligible families. Higgins
concluded that Iranians were not over-sensitive, scep¬
tical or cynical, and were typical of the Iranian com¬
munity in the area. The commonest reason for refusal
was lack of time. She recommended that personal
contacts and snowball sampling were the most effec¬
tive ways of recruiting Iranian migrants.
Yavari et al (2005) identified Iranians in British
Columbia (BC), Canada. They listed common Iranian
surnames and given names from a local residential
telephone book and the Screening Mammography
Program of BC database. They linked this list with
the BC Cancer Agency to identify Iranians who had
been diagnosed with cancer. Sensitivity of this ap¬
proach to detect Iranians was reported to be up to 97%
for surnames.
Population-based studies on Iranian
minority group: additional key points
from identified papers
In three studies (30%), only females were included
(Hanassab, 1991; Mahdi, 2001; Daryani et al, 2005).
Two studies (20%) were conducted among Iranian
refugees and asylum seekers (Barnes and Almasy,
2005; Gerritsen et al, 2006). Iranians were combined
in five studies with other migrants in a collective
sample (Hjern and Grindlefjord, 2000; Barnes and
Almasy, 2005; Daryani et al, 2005; Holvik et al, 2005;
Gerritsen et al, 2006).
Hanassab's (1991) study on Iranian women in Los
Angeles, US, used a postal questionnaire. There was
selection of better educated persons from higher
socio-economic backgrounds. Socio-economic differ¬
ence between respondents and non-respondents was
also found be a methodological limitation of the
research byWandell etal(2004). Hjern and Grindefjord
(2000) reported that Iranians had the highest level of
education among migrants. They identified the higher
dropout rate in the minority sample as one of their
study's limitations.
Iranian migrants residing around Iowa City, US,
were sent a postal questionnaire or interviewed in a
study byChaichian (1997). The response rate to postal
questionnaires was 57% and for interview was 17%.
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compared to the larger urban concentrations of
Iranians.
Mahdi (2001) mailed a questionnaire with 113
questions to a number of Iranian families residing in
41 states of the US. The study target group included
Iranian females randomly drawn from address lists of
one cultural and two scholarly associations in the US.
The response rate in this study was 21% (excluding
returned questionnaires due to incorrect addresses).
The sample was biased towards a more educated and
professional sample. Barnes and Almasy (2005) stud¬
ied refugees' perceptions of healthy behaviours. Over¬
all participation rate for the study sample (including
Iranians) was reported as 91%. They suggested not
including refugees from various parts of the world in
one sample without separating the data according to
the similarities and differences between groups.
In a qualitative study by Momenzadeh and Posner
(2003), snowball sampling was used to recruit Iranians
from different socio-economic backgrounds in Australia.
An English version of the questionnaire was used but
interviewees were asked to respond to questions in
Persian. They concluded that snowball sampling can
be effectively applied with Iranian minority groups in
countries like Australia to locate potential study par¬
ticipants. They argued that the focus group method
among Iranian migrants is a useful tool for data
gathering if the interviewer builds up a good relation¬
ship with participants and knows how to manage social
interactions existing in relationships in Iranian culture.
Lipson (1992) sent English and Persian (translated
and back-translated) versions of a standard question¬
naire to 200 selected Iranians of whom only 19%
responded. She suggested that this poor response
rate could have resulted from distaste for written
surveys, a preference for face-to-face interview or
mistrust of research among Iranians in the San
Francisco area.
Discussion
This is the first systematic review of recruitment
methods in health research of Iranians living abroad.
We found relatively few studies, but considerable
heterogeneity in the methodologies used. We found
30 relevant articles, of which 13 unique studies met
our inclusion criteria. One reported linking two
databases of names and surnames to find Iranians
(Yavari et al, 2005). In four articles there was missing
information about important aspects of the method¬
ology. Place ofdata collection (Lipson, 1992; Chaichian,
1997) application of translated versus original ques¬
tionnaires (Hanassab, 1991; Chaichian, 1997; Mahdi,
2001) and language of the interviews (Hanassab, 1991;
Chaichian, 1997) had often not been declared.
The wide range of participation rates from 19% to
99% in these studies probably represents differences
in both recruitment and study methods. No single
method of recruitment can be considered a gold
standard. Similar methods in varying circumstances
lead to differing results. For example, a random sam¬
pling method to recruit Iranian women resulted in
participation rates of 21% in one study (Mahdi, 2001)
and 79% in another (Daryani, 2005). Snowball sam¬
pling was reported to be a successful way to recruit
Iranians. To avoid selection bias where marginalised
people are less likely to be nominated, researchers
should limit the number of contacts each participant
could introduce. Snowball sampling generated a more
educated and wealthy sample than the general popu¬
lation of Iranian migrants in a number of studies.
Participation rates where snowball sampling was used
to recruit Iranian males and females (Lipson, 1992) were
reported to be as low as 19% and as high as 99% (Rissel
and Khavarpour, 1997). In the study by Hjern and
Grindefjord (2000) the face-to-face interview method
in the participants' home resulted in a participation rate
of 68.1%, but in the study by Gerritsen et al (2006) the
participation rate was 53%. Factors at play in these
variations include time and place of study (country,
city, district etc), migration status, level of education,
subject of the research and measurements made in each
individual study.
It is vital to understand the factors persuading or
prohibiting participation by Iranians living abroad.
Given the small number of studies on this ethnic
minority and the diversity of methodologies, it is not
possible to analyse these results statistically. However,
we can conclude that Iranians have high levels of
education and economic status in comparison with
the other ethnic minority groups, that those partici¬
pating have higher socio-economic status than those
not doing so, and that useful studies are achievable for
a variety of settings, countries and topics.
To increase participation by Iranians the sugges¬
tions discovered from this literature included: appli¬
cation of a multi-method approach to recruit Iranians;
translation of the study questionnaire, brochure and
consent form in the respondents' language; empha¬
sising anonymity; choice of interviewer, language,
time and place of interview; contacting of respondents
by letter and in person; using an oral informed consent
procedure; publicising the study through the local
Iranian radio station; and giving financial incentives.
There was discussion in the literature about distaste
for written surveys, strong suspicion of strangers
asking questions among Iranian migrants and that
only those with strong ties to the community can be
successful in research on this ethnic group. One study
avoided distributing a formal consent form to prevent
participants being reminded of earlier confrontations
with legal authorities, but in most studies no problems
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were seen among Iranian migrants in giving consent.
Overall, however, there was evidence reflecting Iranians'
co-operation and eagerness to participate in research.
Lack of engagement on the part of Iranians is thus
unlikely to be a barrier to research; institutional
barriers are likely to be far more important. Social
networks and political processes in the host countries
could also mediate Iranians' perceptions about ulti¬
mate objectives of health researches and their willing¬
ness to participate in such studies.
The limited data available suggest that the majority
of Iranian migrants will speak the language of their
adopted countries and relatively few will require
translation services.
In this review we searched literature written in
English or Persian language, but a sizeable number
of Iranians are living in countries where other languages
are used and articles or reports may be published in
local languages (France, Denmark, Germany, Norway
and Sweden). For this reason we probably missed
>ome articles or reports from these countries. We
limited ourselves to the websites written in English
or Persian, while there are many other websites (non-
English) in which one could find potentially relevant
articles. In future, researchers should try to expand
the search domain to include languages other than
English and Persian.
There is now a considerable and growing popu¬
lation of Iranian migrants throughout the world; the
revolution in 1979 and the eight-year war between
Iraq and Iran were particular drivers for emigration
to Europe, North America and Australia by mostly
affluent Iranians. It is important to research the health
of this migrant group and the quality and quantity
of healthcare they require. An appreciable body of
knowledge has been accumulated in recent years
through conducting research about the health status
ofmajor ethnic groups in Europe and North America.
This knowledge has helped us to achieve a better
understanding about the population health needs in
our societies, and accordingly to plan comprehensive
public health programmes to try to address the needs
of various subgroups of the population. This review
shows that although clearly needed and feasible, such
studies are uncommon on Iranians (none in the UK,
for example). Our review shows that a wide span of
topics can be studied. Heart disease, stroke, diabetes,
cancer and mental illness are a few of the major health
problems of Iranians overseas (and in Iran). We found
no studies on diabetes, stroke and cancer, and meagre
work on the other topics. In the interests of equity of
healthcare, and in response to health policies and
legislation promoting equality, research is mandatory.
Thus, we call on the research community to take heed
of the needs and opportunities identified here.
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Appendix two
The free text and MeSH (Medical Subject Headings) indexing terms were used in
the systematic review of the methods and themes of health-related research on the
Iranian Diaspora:
(Iran or Iranian or Persian or Parsi$ or Farsi$ or Tehran$ or Isfahan$ or Shiraz$ or
"Fars province" or Ardabil$ or Uromia$ or Qazvin$ or Tabriz$ or Mashad$ or
Mashhad$ or Khorasan$ or Kerman$ or Yazd$ or Kermanshah$ or Kurdistan$ or
Zahedan$ or Lorestan$ or "Chaharmahal and Bakhtiari" or "Kohgiluyeh va Boyer
Ahmad$" or Guilan$ or Mazandaran$ or Zanjan$ or Ahwaz$ or Khuzestan$ or Sistan$
Baluchestan$ or Bandarabbas$ or Hormozgan$ or Bushehr$ or Golestan$ or Semnan$ or
Markazi$ or HamadanS or Qom$ or QazvinS or Ilam$) AND ("ethnic groups" or
ethnology or "Emigration and Immigration" or "Transients and Migrants" or "minority
groups" or refugee$ or abroad or "foreign country" or overseas).
278
Appendix three
A systematic review of the methods and themes of health-related research











Objective(s): Q Clearly stated Q Not clearly stated














Method: Q Survey of individuals Q Data bases Q Other studies




Validity of assessment/measurement instrument:
Analysis











A systematic review of the methods and themes of health-related research
on the Iranian Diaspora: massive needs and opportunities
Quality criteria for assessment of internal and external validity of relevant included
studies:
□ Precise definition of study sample
□ Clarity of data gathering technique (e.g. application of original or translated
questionnaires, language used in interviews)
□ Referring to the location of data collection from study participants (e.g. home,
office...)
□ Age, sex and state and length of residency in the host community
□ Use of a representative sample of target group in the study
□ Giving response rate for study.
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Appendix five
The free text and MeSH (Medical Subject Headings) indexing terms were used in
the risk factors of cardiovascular diseases among Iranians: a systematic review of
prevalence studies:
(Iran or Iranian or Persian or Parsi$ or Farsi$ or Tehran$ or Isfahan$ or ShirazS or
"Fars province" or ArdabilS or Uromia$ or QazvinS or Tabriz$ or MashadS or
Mashhad$ or Khorasan$ or KermanS or Yazd$ or Kermanshah$ or Kordestan$ or
Zahedan$ or Lorestan$ or "Chaharmahal and Bakhtiari" or "Kohkiloieh va Boier
Ahmad$" or Gilan$ or Mazandaran$ or Zanjan$ or Ahwaz$ or Khozestan$ or SistanS or
BandarabbasS or HormozganS or Bushehr$ or Golestan$ or SemnanS or MarkaziS or
HamadanS or Qom$ or Qazvin$ or Ilam$) AND ("cardiovascular diseases" or "coronary
arteriosclerosis" or "coronary disease" or arteriosclerosis or hypertension or
hyperlipidemia or obese or obesity or overweight or "body mass index" or anthropomet$
or smoking or smoker or "physical activity" or "physical inactivity" or exercise or
"diabetes mellitus" or lifestyle or "Metabolic Syndrome X").
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Appendix six
Risk factors of cardiovascular diseases among Iranians: A systematic
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Gender: | | Male (n= ) I I Female (n- )
Data gathering:
Method: EZI Survey of individuals ED Data bases EU Other studies











Main outcome measures: (Prevalence rates/confidence interval %)
Males Females
Diabetes ( / - ) ( / - )
Physical inactivity ( / - ) ( / - )
284
CLverweight ( ••••■/■••■• ■
Obesity ^ • • •■*/••/■ ■■■•_ *■»* *
Dyslipidaemia
High total cholesterol ( / - ) ( / - )
High triglycerides ( / - ) ( / - )
High LDL-C ( • •***l**'l••••• — ••••••)
Low LiDL~(S ^ • • •»»/••••• — ■•••••^ ^ ■»•/••••• — J
Smoking ( •«•••/••••• ■ • • • • • ( •• •••/••••• ■ ••••••)
Hypertension ( / - ) ( / - )
Quality ofreporting outcome measures
Prevalence rate(s) with confidence interval □ Yes □ No




Overall quality: |ED A EH B EEIC
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Appendix eight




n % n % n %
0-4 2801568 7.81 2662410 7/69 5463978 7.75
5-9 2820524 7.86 2688533 7.76 5509057 7.81
10-14 3441245 9.59 3267349 9.44 6708594 9.52
15-19 4442901 12.39 4283860 12.37 8726761 12.38
20-24 4511851 12.58 4499571 12.99 9011422 12.78
25-29 3660167 10.21 3564785 10.29 7224952 10.25
30-34 2837969 7.91 2715562 7.84 5553531 7.88
35-39 2511545 7.00 2409579 6.96 4921124 6.98
40-44 2081679 5.80 2007479 5.80 4089158 5.80
45-49 1792481 5.00 1730280 5.00 3522761 5.00
50-54 1386063 3.86 1369357 3.95 2755420 3.91
55-59 923536 2.57 964445 2.79 1887981 2.68
60-64 726449 2/03 738003 2.13 1464452 2.08
65-69 622470 1.74 575080 1.66 1197550 1.70
70-74 598231 1.67 521087 1.50 1119318 1.59
75-79 372570 1.04 321552 0.93 694122 0.98
80 and over 335113 0.93 310488 0.90 645601 0.92
Total 35866362 100.00 34629420 100.00 70495782 100.00
Source: Statistical Centre of Iran (Available from: http://amar.sci.org.ir/)
287
Appendix nine : the study questionnaire (English version)
A pilot study of the prevalence of cardiovascular disease risk
factors among Iranians in Edinburgh
1.1 Can I just check, your age is?
□□ (Range: 18-120)
1.2 Can I just check, your sex is?
Male | | Female | 1
1.3 Can I just check, what is your date of birth?
(Enter Day ofmonth in numbers, Name ofmonth in words (first three letters), Year in numbers) (You
can write your birth date according to the either Christine or Iranian calendar)
The Christian Calendar: Day| 11 | MonthQP] P] Year| | ] j J [ _ J
The Iranian Calendar: DayP] [P] Month [P] P] P] Yearp; 11 j [_ 1
1.4 To which of the following groups do you consider you belong?
1 Iranian [ j
2 Mixed British-Iranian □
3 Other | | 4 How wouldyou describe the racial or ethnic group to which you
belong? □
1.5 In which country were you born?
1 IranP 2 in the city of □
3 UK□ 4 in the city of. [ j
5 Other country □ 6 in the city of □
1.6 How long have you been living in the UK?
j |P Months and [ j 1 j years
1.7 How long have you been living outside of Iran?
I 11 I Months and Q p years




3 I don't know my mother's country of birth Q
4 I don't know my father's country of birth |
2. Cardiovascular disease and use of services
2.11 am now going to ask you some questions mainly about symptoms of the chest.
Have you ever had any pain or discomfort in your chest?
1 YesQ
2 No Q Ifno go to the question 2.10
2.2 Do you get it when you walk uphill or hurry?
1 Yes Q
2 No Q Ifno go to the question 2.4
3 Never walks uphill or hurries j j
4 (Cannot walk) □
2.3 Does this happen:
1 On most occasions O
2 Sometimes/Occasionally □
2.4 Do you get it when you walk at an ordinary pace on the level?
1 Yes □
2 No Q Ifno go to the question 2.10
3 Never walk at an ordinary pace on the level j_ J
4 (Cannot walk) [ j
2.5 Does this happen:
1 On most occasions [ J
2 Sometimes/Occasionally [
2.6 What do you do if you get it while you are walking? Do you stop, slow down or




2 Slow down □
3 Carry on □
2.7 If you stand still does the pain go away or not?
IF RESPONDENT UNSURE, PROBE: What happens to the pain on most
occasions?
1 Pain goes away j ]
2 Pain doesn't go away □
2.8 How soon does the pain go away? Does it go in:
1 ... 10 minutes or less □
2 or more than 10 minutes □
2.9 Will you show me where you get this pain or discomfort?
INTERVIEWER: USE SHOW CARD A TO HELP CODE POSITION OF PAIN
OR DISCOMFORT. CODE ALL THAT APPLY. PROBE: Where else?
1 Sternum (upper or middle) Q j
2 Sternum lower □
3 Left anterior chest □
4 Left arm □
5 Right anterior chest □
6 Right arm □
7 (Somewhere else) □
2.10 Have you ever had a severe pain across the front ofyour chest lasting for half
an hour or more?
1 Yes □
2 No Q Ifno go to the question 2.13
2.11 Did you see a doctor because of this pain?
1 Yes □
2 No □
2.12 What did the doctor say it was? (CODE ALL THAT APPLY)
1 Angina □
2 Heart attacks \ ]
3 Did not say [ j
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4 Other ! |
INTERVIEWER READ OUT: You have already talked to me aboutyour health, and now Iwould
like to go on and talk in more detail about some particular conditions. (They may include some
of the things you have already mentioned.)
2.13 Do you now have, or have you ever had, high blood pressure (sometimes called
hypertension)?
1 YesQ
2 No Q] Ifno go to the question 2.19




(Ifmale go to the question 2.18)
2.15 Can I just check, were you pregnant when you were told that you had high
blood pressure?
1 YesQ
2 No Q Ifmale enter code 9
2.16 Have you ever had high blood pressure apart from when you were pregnant?
1 YesQ
2 No Q Ifno go to the question 2.20 (Ifmale enter code 9)
2.17Apartfrom whenyou werepregnant, approximately how old were you when you
were first told by a (doctor/nurse) that you had high blood pressure?
□□□ (ENTER AGE IN YEARS) (Range: 0..110)
2.18 What other treatment or advice are you currently receiving because ofyour
high blood pressure? (PROBE: What else? CODEALL THATAPPLY)
1 Blood pressure monitored by GP/nurse □
2 Advice or treatment to lose weight □
3 Blood tests □
4 Change diet □
5 Stop smoking □
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6 Reduce stress u
7 Other [] 8 □
9 I don't receive other treatment or advice □
2.19 Have you ever had angina?
1 Yes □
2 No Q Ifno go to the question 2.22




2.21 Approximately how old were you when you were first told by a doctor that you
had angina?
□□ Years old (TYPE INAGE IN YEARS. Range: 0..110)
2.22 Have you ever had a heart attack (including myocardial infarction or coronary
thrombosis)?
1 Yes n
2 No O Ifno go to the question 2.24
2.23 Approximately how old were you when you were first told by a doctor that you
had a heart attack (including myocardial infarction and coronary thrombosis)?
□□ Years old (TYPE INAGE IN YEARS) (Range: 0..110)
2.24 Have you ever had a stroke?
1 Yes □
2 No Ifno go to the question 2.26
2.25 Approximately how old were you when you were first told by a doctor that you
had a stroke?
□□□ (TYPE IN AGE IN YEARS) (Range: 0..110)









2.28 Can I just check, are you currently on a waiting list for any such surgery or
operation?
1 Yes | j
2 No □
2.29 What (other) treatment or advice are you currently receiving because of your
(heart condition or stroke)? (PROBE: What else? CODE ALL THAT APPLY)
1 Special diet [ ]
2 Regular check-up with GP/hospital/clinic |
3 Other□ 4 PLEASE SPECIFY □
5 I don't receive other treatment or advice [ j
2.30 Do you now have, or have you ever had diabetes?
1 Yes □
2 No Q] Ifno go to the question 3.1
(Ifmale go to the question 2.34)
2.31 Can I just check, were you pregnant when you were told that you had
diabetes?
1 YesQ
2 No Q (Ifmale enter code 9)
2.32 Have you ever had diabetes apart from when you were pregnant?
1 YesQ
2 No Q Ifno go to the question 2.34 (If male enter code 9)
2.33 Apart from when you were pregnant, (approximately) how old were you when
you were first told by a doctor that you had diabetes?
□□□ (ENTER AGE IN YEARS) (Range: 0..110)
2.34 Do you currently inject insulin for diabetes?
1 YesQ
2 No □





2.36 What (other non pharmacologic) treatment or advice are you currently
receiving for diabetes?
1 Dietary restriction
2 Regular check-up with GP/hospital/clinic Q J
3 Other□ 4 PLEASE SPECIFY □
5 I don't receive other treatment or advice j
3. Adult physical activity module
3.1 I'd like to ask you about some of the things you have done in the past four
weeks that involve physical activity, this could be atwork (school/college) or in
your free time. (Can I just check) were you in paid employment or self-employed in
the past four weeks?
1 YesQ
2 No Q Ifno go to the question 3.3
3.2 Thinking about your job in general would you say that you are ...READ OUT..
1 ...very physically active □
2 ...fairly physically active □
3 ...not very physically active □
4 ...or, not at all physically active in your job □
3.3 I'd like you to think about the physical activities you have done in the last few
weeks (when you were not doingyourpaidjob.) Have you done any housework in









3.5 Some kinds of housework are heavier than others. This card gives some
examples of heavy housework. It does not include everything, these are just
examples. Was any of the housework you did in the last four weeks this kind of
heavy housework? OO
1 Yes Q On how many days have you done it? (Range: 1..28
2 No n
SHOW CARD D




3.7 Have you done any gardening, DIY or building work from this other card, or
any similar heavy manual work?
1 YesQ
2 No Q Ifno go to the question 3.10
3.8 During the past 4 weeks on how many days have you done this kind of heavy
manual gardening or DIY? (Range: 1..28)
□□ Day(s)
3.9 On the days you did heavy manual gardening or DIY, how long did you usually
spend?
(RECORD HOURS AND MINUTES SPENT. ENTER 0 IF LESS THAN 1
HOUR)
3.10 I'd like you to think about all the walking you have done in the past 4 weeks
either locally or away from here. Please include any country walks, walking to and
from work and any other walks that you have done. In the past four weeks, that is
since (datefour weeks ago), have you done a continuous walk that lasted at least 5
minutes?
1 Yes □
2 No Q If no go to the question 3.13
3 Can't walk at all ED If can't walk go to the question 3.13
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3.11 In the past four weeks, have you done a continuous walk that lasted at least 15
minutes? (That is since (datefour weeks ago))
1 Yes \^\ On how many days? QO (Range: 1..28)
2 No □
3.12 Which of the following best describes your usual walking pace:
1 ...a slow pace □
2 ...a steady average pace □
3 ...a fairly brisk pace j ]
4 .. .or, a fast pace - at least 4 mph □
5 (none of these) □
SHOW CARD F
3.13 Can you tell me if you have done any activities on this card during the last 4
weeks that is since (date four weeks ago)! Include teaching, coaching, training and
practice sessions.
1 Yes □
2 No O Ifno go to the question 3.13




3 Workout at a gym/Exercise bike/ Weight training □
4 Aerobics/Keep fit/Gymnastics/ Dance for fitness [





10 Exercises (e.g. press-ups, sit ups) □
11 Others i J
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3.15 Can you tell me on how many separate days did you do (name ofactivity) for at
least 15 minutes a time during the past four weeks, that is since (datefour weeks
ago)?
| J i J (IF ONLY DONE FOR LESS THAN 15 MINUTES ENTER 0). (Range: 0..28)
3.16 During the past four weeks, was the effort of (name ofactivity) usually enough
to make you out of breath or sweaty?
1 YesQ
2 No □
3.17 When you're at work are you mainly sitting down, standing up or walking
about?
(CODE ONE ONLY)
1 Sitting down □
2 Standing up
3 Walking about □
4 Equal time spent doing 2 or more of these [ 1
3.18 Does your work involve you moving between floors?
1 Yes □
2 No □
3.19 Do you mainly take the lift or climb the stairs?
1 Lift □
2 Stairs I
3 Lift up/stairs down □




3.21 So overall, would you say that in terms of physical effort your work is...(READ
OUT...)
1 ... very demanding j ]
2 fairly demanding □
3 or not very demanding j j
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4. Eating habits module
4.1 What type of spread do you usually use on bread, sandwiches, toast, potatoes or
vegetables?
1 Butter or margarine j j
2 Low fat or reduced fat spread, or half-fat butter Q i
3 Spread not on coding list □
SPONTANEOUS:
4 Does not have usual type ! j
5 Does not use fat spread □
6 What other kind of spread do you usually eat? [ |
SHOW CARD G
4.2 When you have fried foods at home, what kind of fat or oil are the foods usually
cooked in? Please look at SHOW CARD G and tell me which type of fat or oil is
used most often?
1 Solid cooking fat (including butter, dripping lard, ghee, white cap, cookeen) [_ j
2 Half-fat butter Q
3 Polyunsaturated, sunflower or olive margarine
4 Other hard or soft margarine or dairy blend, (including Flora, Clover, Willow)
5 Low fat spreads □
6 Vegetable oil (including olive, sunflower, soya, corn, peanut, rapeseed ! j
7 Some other kind of fat/oil Q
8 What is the other fat or oil your food is usually fried in?
9 (Does not eat fried food) □
4.3 What kind of milk do you usually use for drinks, in tea or coffee and on cereals?
Is it
READ OUT...
1 whole milk, j j
2 semi-skimmed (INCL DRIED SEMI-SKIMMED), Q]
3 skimmed (INCL DRIED SKIMMED, BOOTS DRIED POWDER, CO-OP □
POWDER),
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4 or, some other kind of milk? Text: Maximum 15 characters
5 Evaporated/Condensed milk [ j
6 Soya/Veg-based milk j J
SPONTANEOUS:
7 Does not have usual type □
8 Does not drink milk j J
4.4 Do you usually have sugar in your tea or coffee?
1 Yes, usually has sugar (DO NOT INCLUDE SWEETENERS) [~ j
2 NO □
3 I generally use sweetener instead of sugar □
4 Does not drink tea j
5 Does not drink coffee [ j
4.5 At the table do you ...READ OUT...
1 usually add salt to your food without tasting it first, [
2 taste the food, but then generally add salt, □
3 taste the food, but only occasionally add salt, j ]
4 rarely, or never, add salt at the table? j ]
SHOW CARD H
4.6 Can you tell me how often on average you eat fresh fruits by choosing
answer from this card?
1 6 or more times a day [ j
2 4 or 5 times a day □
3 2 or 3 times a day j J
4 Once a day □
5 5 or 6 times a week □
6 2 to 4 times a week □
7 Once a week
8 1 to 3 times per month □
9 Less often or never i j
SHOW CARD H
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4.7 How often do you eat fried food, including fried fish, chips, cooked breakfast,
samosas?
1 6 or more times a day □
2 4 or 5 times a day □
3 2 or 3 times a day □
4 Once a day □
5 5 or 6 times a week □
6 2 to 4 times a week □
7 Once a week □
8 1 to 3 times per month □
9 Less often of never □
SHOW CARD H
SHOW CARD H
4.8 How often do you eat raw vegetables, or salad?
INCLUDE TOMATOES. DO NOT INCLUDE SALAD IN A SANDWICH
1 6 or more times a day □
2 4 or 5 times a day □
3 2 or 3 times a day □
4 Once a day □
5 5 or 6 times a week □
6 2 to 4 times a week □
7 Once a week □
8 1 to 3 times per month □
9 Less often or never □
SHOW CARD H
4.9 How often do you eat MEAT, SUCH AS beef, lamb ETC?
INCLUDE BEEFBURGERS, SAUSAGE, BACON, MEAT PIES, MINCE AND PROCESSED
MEAT. (DO NOT INCLUDE POULTRY)
1 6 or more times a day □
2 4 or 5 times a day □
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3 2 or 3 times a day □
4 Once a day □
5 5 or 6 times a week □
6 2 to 4 times a week □
7 Once a week □
8 1 to 3 times per month □
9 Less often or never □
SHOW CARD H
4.10 How often do you eat poultry, such as chicken or turkey?
INCLUDE CHICKEN OR TURKEY IN BURGERS, SAUSAGES, MEAT PIES,
MINCE AND PROCESSED MEAT
1 6 or more times a day □
2 4 or 5 times a day □
3 2 or 3 times a day □
4 Once a day □
5 5 or 6 times a week □
6 2 to 4 times a week □
7 Once a week □
8 1 to 3 times per month □
9 Less often or never □
SHOW CARD H
4.11 How often do you eat white fish, such as cod, haddock, whiting, sole or plaice?
INCLUDE FRESH, FROZEN OR CANNED
1 6 or more times a day □
2 4 or 5 times a day □
3 2 or 3 times a day □
4 Once a day □
5 5 or 6 times a week □
6 2 to 4 times a week □
7 Once a week □
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8 1 to 3 times per month
9 Less often or never
SHOW CARD H
4.12 How often do you eat other types of fish, such as herring, tuna, mackerel,
salmon or kippers? (INCLUDE FRESH, FROZEN OR CANNED)
1 6 or more times a day □
2 4 or 5 times a day □
3 2 or 3 times a day □
4 Once a day □
5 5 or 6 times a week j
6 2 to 4 times a week i !
7 Once a week □
8 1 to 3 times per month
9 Less often or never □
SHOW CARD H
4.13 How often do you eat chocolates, crisps or biscuits, including savoury biscuits
such as cream crackers?
1 6 or more times a day □
2 4 or 5 times a day □
3 2 or 3 times a day □
4 Once a day □
5 5 or 6 times a week □
6 2 to 4 times a week □
7 Once a week □
8 1 to 3 times per month
9 Less often or never
SHOW CARD H
4.14 How often do you eat sweets, cakes, pastries or ice-cream?
1 6 or more times a day □
2 4 or 5 times a day □
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3 2 or 3 times a day □
4 Once a day □
5 5 or 6 times a week □
6 2 to 4 times a week □
7 Once a week □
8 1 to 3 times per month □
9 Less often or never □
SHOW CARD H
4.15 How often do you drink soft drinks, not including diet or low-calorie drinks?
INCLUDE SQUASHES AND FIZZY DRINKS. INCLUDE CANS, BOTTLES AND MIXERS.
DO NOT INCLUDE FRESH FRUIT JUICE
1 6 or more times a day □
2 4 or 5 times a day □
3 2 or 3 times a day □
4 Once a day □
5 5 or 6 times a week □
6 2 to 4 times a week □
7 Once a week □
8 1 to 3 times per month □
9 Less often or never □
5. Smoking module
5.1 May I just check, have you ever smoked a cigarette, cigar or pipe?
1 Yes □
2 No □ Ifno go to the question 5.13
5.2 Do you smoke cigarettes or cigar at all nowadays?
1 Yes Q
2 No □ Ifno got to the question 5.13
5.3 About how many cigarettes or cigar a day do you usually smoke on weekdays?
INTERVIEWER: IF LESS THAN ONE A DAY, ENTER 0. IF RANGE GIVEN AND CAN'T
ESTIMATE,
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ENTER MID POINT. IF RESPONDENT SMOKES ROLL UPS AND CANNOT GIVE NUMBER OF
CIGARETTES, CODE 97.
□□ Range: 0..97
5.4 And about how many cigarettes or cigar a day do you usually smoke at
weekends?
INTERVIEWER: IF RANGE GIVEN AND CAN'T ESTIMATE, ENTER MID POINT. IF
RESPONDENT
SMOKES ROLL UPS AND CANNOT GIVE NUMBER OF CIGARETTES, CODE 97.
□□ (Range: 0..97)
5.5 Do you smoke a pipe at all nowadays?
1 Yes Q
2 No O Ifno got to the question 5.8
5.6 How much tobacco do you usually smoke on weekdays?
CODE HERE WHETHER AMOUNT IS TO BE CODED IN GRAMS OR OUNCES. ENTER THE
AMOUNT NEXT.
1 Grams □ 2 ENTER AMOUNT IN GRAMS (Range: 0..100) O O
3 OuncesO 4 Computed: estimated tobacco consumption in ounces (Range: 1..97) □□
(For analysis purposes ounces or grams oftobacco are converted to number ofcigarettes and stored in
the variable DlySmoke)
5.7 How much tobacco do you usually smoke on weekends?
CODE HERE WHETHER AMOUNT IS TO BE CODED IN GRAMS OR OUNCES. ENTER THE
AMOUNT AT THE NEXT QUESTION.
1 Grams □ ENTER AMOUNT IN GRAMS (Range: 0..100) □□
2 Ounces O Computed: estimated tobacco consumption in ounces (Range: 1..97) [
(For analysispurposes ounces or grams oftobacco are converted to number of
cigarettes and stored in the variable WkndSmoke.)
5.8 And for approximately how many years did you smoke regularly?
INTERVIEWER: IF LESS THAN ONE YEAR, CODE 0.
OO Range: 0..97
5.9 How old were you when you started to smoke cigarettes regularly?
INTERVIEWER: IF Never smoked regularly CODE 97
OO Range: 1..97
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(IF (Sex =Male) OR (Female aged >49years go to the question 5.13)
5.10 Can I check, are you pregnant now or have you been pregnant in the last
twelve months?
1 Yes □
2 No □ Ifno go to the question 5.17
5.11 Have you smoked at all since you've known you've been pregnant?
IF YES, PROBE: All the time or just some of the time?
1 Yes, all the time j I
2 Yes, some of the time □
3 No, not at all □
5.12 Did you stop smoking specifically because ofyour pregnancy, or for some
other reason?
1 Because ofpregnancy □
2 For some other reason □
5.13 May I just check, have you ever smoked a Hubble bubble?
1 Yes □
2 No [^] Ifno go to the question 5.17
5.14 Do you smoke Hubble bubble at all nowadays?
1 Yes □
2 No □ Ifno go to the question 5.17
5.15 Do you smoke Hubble bubble regularly that is at least one Hubble bubble a
month, or do you smoke it only occasionally?
1 Smoke at least one Hubble bubble a month □
2 Smoke it only occasionally^] Ifoccasionally go to the question 5.22
5.16 About how many Hubble bubble do you usually smoke in a week?
ENTERNUMBER SMOKED A WEEK. IF CAN ONLY GIVE RANGE, TAKE MID¬
POINT. IF LESS THAN ONE A WEEK CODE 0.
□□ Range: 0... 997
IF not Smoking now OR have not ever smoked THEN:
SHOW CARD J
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5.17 Are you regularly exposed to other people's tobacco smoke in any of these
places? PROBE: Where else?
CODE ALL THAT APPLY
1 At own home □
2 At work □
3 In other people's homes □
4 On public transport □
5 In pubs □
6 In other public places □
7 No, none of these □
6. Alcohol drinking module j
IF (Age ofRespondent is 20 years or over)
6.11 am now going to ask you a few questions about what you drink - that is ifyou
drink. Do you ever drink alcohol nowadays, including drinks you brew or make at
home?
1 Yes Q Ifyes go to the question 6.4
2 No □
6.2 Could I just check, does that mean you never have an alcoholic drink
nowadays, or do you have an alcoholic drink very occasionally, perhaps for
medicinal purposes or on special occasions like Christmas and New Year?
1 Very occasionally Q Go to the question 6.5
2 Never O
6.3 Did you stop drinking because of a particular health condition that you had at
the time? INTERVIEWER: IF RESPONDENT SAYS PREGNANCY, CODE YES.
1 Yes □
2 No Q Go to the question 6.6
(If drinks alcohols nowadays otherwise go to the question 6.7)
6.4 How much alcoholic drink have you usually drunk on any one day?
306
INTERVIEWER: CODE MEASURES THAT YOU ARE GOING TO USE.
1 Halfpints j j
2 Singles T !
3 Glasses j ]
4 Bottles | |
5 Other Maximum 12 characters □
SHOW CARD K
6.5 How often have you had an alcoholic drink in the last 12 months?
1 Almost every day □
2 Five or six days a week □
3 Three or four days a week □
4 Once or twice a week |
5 Once or twice a month I j
6 Once every couple ofmonths □
7 Once or twice a year □
8 Not at all in the last 12 months Q




7. Economic Activity module
SHOW CARD L
7.1 Which of these descriptions applies to what you were doing last week, that is in
the seven days ending (date last Sunday)?
(CODE FIRST TO APPLY)
1. Going to school or college full-time (including on vacation) [ j
2. In paid employment or self-employment (or away temporarily) □
3. Waiting to take up paid work already obtained! I VsoS° to the question 7.2
4. Looking for work □
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5. Intending to look for work but prevented by temporary sickness or injury
(CHECK 28 DAYS OR LESS) □
6. Permanently unable to work because of long-term sickness or disability (USE
ONLY FOR MENAGED 16-64 OR WOMENAGED 16-59) □
7. Retired (FOR WOMEN CHECK AGE STOPPED WORK AND USE THIS
CODE ONLY IF STOPPED WHEN 50 OR OVER) | j
8. Looking after the home or family
9. Doing something else (SPECIFY) 10 | j
If in employment ask otherwise go to the question 7.3
7.2 I'd like to ask you some details about the job you were doing last week (your
most recentjob/the main jobyou had/the jobyou are waiting to take up). What is
(was/will be) the name or title of the job?
(IF 2+ JOBS, ASK ABOUT MAIN JOB)
Text: Maximum 50 characters
7.3 How many members in your family are economically dependent on you?
□□ Members
8. Education module
8.1 At what age did you finish your continuous full-time education at school or
college?
1 Not yet finished □
2 Never went to school □









11 28 and above □
8.2 Please tell me whether you have any of the qualifications listed below. Look
down the list and tell me the first one you come to that you have got. (CODE FIRST
TO APPLY.)
1 PhD (doctorate degree) j j
2 MSc or MA (master degree) □
3 BSc (bachelor degree) [ j
4 College degree (in Iran) [ |
5 SCE Higher/CSYS (Certificate of Sixth Year Studies)/ A-Level or diploma in
Iran EH
6 Lower grades than SCE/CSYS/A-Level/Iranian diploma EJ
7 Other academic qualification [^] 8 Specify |
9. Family history module
9.1 Is your natural mother still alive?
1 Yes □
2 No EH Ifno go to the question 9.4
9.2 How old is your natural mother?
□□□ (Range: 1..120)
9.3 Does your mother has or ever had from any of the following conditions?
1 High blood pressure (sometimes called hypertension) Qj
2 AnginaQ]
3 Heart attack (including myocardial infarction and coronary thrombosis) EH
4 Stroke [ I




7 None of the above conditions Q
Ifyour mother still alive go to the question 9.6
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9.4 Did your mother die from any of the following conditions?
1. Yes at age| || || | from:
a High blood pressure (sometimes called hypertension)
b AnginaQj
c Heart attack (including myocardial infarction and coronary thrombosis)
d Stroke [ j




2 None of the above conditions □
9.5 How old was your natural mother when she died?
□□□ (Range: 1..120)
9.6 Is your natural father still alive?
1 Yes □
2 No □ Ifno go to the question 9.9
9.7 How old is your natural father?
□□□ (Range: 10.. 120)
9.8 Does your father has or ever had from any of the following conditions?
1 High blood pressure (sometimes called hypertension)
2 Angina QJ
3 Heart attack (including myocardial infarction and coronary thrombosis) [[J
4 Stroke Q j




7 None of the above conditions J
Ifyourfather still alive go to the question 9.11
9.9 Did your father die from any of the following conditions?
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1. Yes at ageP jj jj j from:
a High blood pressure (sometimes called hypertension) Q ]
b Angina Q j
c Heart attack (including myocardial infarction and coronary thrombosis) Q j
d Stroke j




2 None of the above conditions □
9.10 How old was your natural father when he died?
□□□ (Range: 10.. 120)
9.11 Have you or ever had a natural sibling?
1. Yes QQ sibling(s) (Range: 1-15)
2. No □ Ifno go to the question 10.1
9.12 Does/do your sibling(s) has/have or ever had from any of the following
conditions?
1 High blood pressure (sometimes called hypertension)| | in f 1 | of them
2 AnginaQ inQQ] of them
3 Heart attack (including myocardial infarction and coronary thrombosis)^ in□□
of
them
4 Stroke | j in^D of them
5 Other heart trouble (inch heart murmur, damaged heart valves, tachycardia or
rapid
heart) | | in | || | of them
6 DiabetesQ in | jj ~| of them
7 None of the above conditions j
9.13 Did one of your sibling(s) die from any of the following conditions?
1 LlO of them from high blood pressure (sometimes called hypertension)
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2 of them from angina
3On °f them heart attack (including myocardial infarction and coronary
thrombosis)
4 | [[ | of them from stroke
5 | || | of them from other heart trouble (inch heart murmur, damaged heart
valves,
tachycardia or rapid heart)
of them from diabetes
7 None of the above conditions□
10. General Household module
Now, I'd like to get some general information about your household.
10.1 Does your household own or rent this accommodation?
(PROBE FOR DETAILS.)
1 Owns with mortgage/loan □
2 Owns outright □
3 Rents from council □
4 Rents - privately, unfurnished □
5 Rents - privately, furnished □
6 Rents from employer □
7 Rents - other with payment □
8 Rent free □




10.3 May I check with you the post code of your home address?




PREAMBLE: I would now like to measure your height/weight/waist and hip. There is interest in
how people's weight/waist/hip, given their height, is associated with their health.
lUHeighonnon cm (Range: 120-240)
11.2 Height measurement result:
1 Height measured □
2 Height refused Q 3 Reason: j j
4 Height attempted, not obtained Q 5 Reason: |
6 Height not attempted Q 7 Reason: ; I
INTERVIEWER CODE ONE ONLY
11.3 During height measurement was any problem experienced?
1 No problems experienced reliable height measurement obtained [_ J
Problems experienced - measurement likely to be:
2 Reliable : j
3 Unreliable !_ j
11.4 WHAT CAUSED THE HEIGHT MEASUREMENT TO BE UNRELIABLE?
1 Hairstyle or wig □
2 Turban or other religious headgear □
3 Respondent stooped □
4 Respondent wore shoes □
5 Other, please specify □6 □
□
7 Difficulty standing
ii.swrightnnm.riK. (Range: 45.0-244.0 kg)
11.6 Weight measurement result:
1 Weight obtained (subject on own) j ~j
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2 Weight refused Q 3 Reason: I j
4 Weight attempted, not obtained □ 5 Reason: □
6 Weight not attempted □ 7 Reason: | j
INTERVIEWER CODE ONE ONLY.
11.7 During weight measurement was any problem experienced?
1 No problems experienced, reliable weight measurement obtained Q j
Problems experienced - measurement likely to be:
2 Reliable Q
3 Unreliable Q
11.8 Waist: First measurement| 11 11 | ,| | cm Second measurement] || || | J |
cm
11.9 Waist measurement result:
1 Waist obtained j_J
2 Waist refused □ 3 Reason: □
4 Waist attempted, not obtained Q 5 Reason: j j
6 Waist not attempted Q 7 Reason: T ]
INTERVIEWER CODE ONE ONLY.
11.10 During waist measurement was any problem experienced?
1 No problems experienced, reliable waist measurement obtained ] J






11.11 Hip: First measurement! || || | J | cm Second measurement
cm
11.12 Hip measurement result:
1 Hip obtained □
2 Hip refused □ 3 Reason:
4 Hip attempted, not obtained Q 5 Reason:
6 Hip not attempted Q 7 Reason:
INTERVIEWER CODE ONE ONLY.
11.13 During hip measurement was any problem experienced?
1 No problems experienced, reliable hip measurement obtained
Problems experienced - measurement likely to be:
2 Reliable \ j
3 Unreliable □
11.14 Blood pressure
First measurement: | |[ || |.[ || | MmHg (Systolic)
MmHg (Diastolic)
Second measurement: .[ |[ | MmHg (Systolic)
MmHg (Diastolic)
11.15 Blood pressure measurement result:
1 BP obtained [ I
2 BP refused Q 3 Reason:
4 BP attempted, not obtained Q 5 Reason:
6 BP not attempted Q 7 Reason:
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INTERVIEWER CODE ONE ONLY.
11.16 During blood pressure measurement was any problem experienced?
1 No problems experienced, reliable blood pressure measurement obtained□






3 LDL □□. □□ Mmol/1
4 Glucose QQ QQ Mmol/1
11.18 Blood sample taking result:
1 Blood sample obtained □
2 Blood sample taking refused Q 3 Reason:
4 Blood sample taking attempted, not obtained | | 5 Reason:
6 Blood sample taking not attempted Q 7 Reason:
11.19 During blood sample taking was any problem experienced?
1 No problems experienced, reliable blood sample obtained f j
Problems experienced - sample likely to be:
2 Reliable Q
3 Unreliable □
12. Study setting and participants' concerns module








3. Azeri Turkish □
4. Other □
12.2 What do you think would be successful ways of reaching Iranians in
Edinburgh for studies of this kind?
□
12.3 Would you willing to allow your name and contact details to go on a list of all
Iranians in Scotland for a future health study of this kind?
1. Yes □
2. No □ 3 Why? □
12.4 Are you willing to share your family and friends' contact details so they can be
invited to participate in this study?
lYes □ 2 Why? j ]
3 No □ 4 Why? Q
12.5 Does the religion of a study researcher or interviewer affect your participation
in such health studies?
l.YesQ 2 Why? □
3. No □
12.6 Does the ethnic characteristic of a study researcher or interviewer affect your
participation in such health studies?
1. Yes □ 2 Why? □
3. No □
12.7 Does the sex of a study researcher or interviewer affect your participation in
such health studies?
1. Yes □ 2 Why? Q
3. No □
12.8 Does the age of a study researcher or interviewer affect your participation in
such health studies?
l.YesQ 2 Why? Q
3. No □
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12.9 Are there any other aspects related to the study researcher or interviewer
which could affect your participation in such health studies?






12.10 What is your preference in relation to the gender of practitioner who
examines or
assesses you physically?
1 I prefer to be examined by a practitioner of the same gender in all kinds of
examinations including hip and waist measurements
2 I prefer to be examined by practitioner of opposite gender in all kinds of
examinations
3 I only prefer to be examined by practitioner of same gender in examinations ofmy
private areas
4 I have no preferences about gender of practitioner
12.11 Which method of questioning might increase your participation in similar
health studies?
1. Face to face interview j
2. Self completion paper questionnaire Q j
3. Telephone interview
4. On line internet interviewQ
5. Self completion electronic questionnaire | j








Ifblood sample not obtained go to the question 12.14
12.13 Would you agree for your blood sample be stored for further analysis in the
future for other CVD risk factors?
lYes □ 2 Why? []
3 No □ 4 Why? |
12.14 How did you feel about the time questions took in this interview?
1 Too long/taking long time to answer □
2 About right j
3 Too short □
12.15 Did you find the questions in this interview easy to understand?
1. Yes □







12.16 Did you find any questions in this interview too sensitive to you?
1. Yes Q





12.17 What religion, religious denomination or body do you belong to?
1 Muslim □
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2 Zoroastrian i |
3 Christian □
4 Jew | |
5 Baha'i !_ j
6 None J j
7 Others □ 8 Clarify □
12.18 Do you think Iranians living in Edinburgh would bewilling to let their
religion or faith be known to an interviewer in future health studies?
1. Yes □
2. No Q 3 Specify reason □
12.19 Did you find the question about religion in this study sensitive?
1. Yes □
2. No □
12.20 Have you any suggestion to improve participation of Iranians in future health
studies?
1. Yes □ 2 Clarify □
3. No □
12.21 INTERVIEWER: Record how the respondent answered questions:
1. Face to face interview □
2. Postal questionnaire □
3. Electronic questionnaire (through email) □
4. Telephone interview [ |
12.22 INTERVIEWER: Record where this interview and measurements took
place:
1 In the study site j
2 Any other place Q 3 Specify Q
12.23 INTERVIEWER: Record whether questions in the questionnaire were fully
answered?
1. Fully completed □
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2. Partially completed [_ J
3. Not completed Q 4 Reason
12.24 INTERVIEWER: Record whether the questionnaire was completed:
1. Independently [ j
2. With interviewer assistance □
3. With other family member assistance □
4. By interviewer □
12.25 INTERVIEWER: In which language the interview was taken place?
1. Completely Persian □
2. Completely Azeri Turkish □
3. Completely English □
4. Mostly Persian with some English explanations □
5. Mostly Azeri Turkish with some English explanations Q j
6. Mostly Azeri Turkish with some Persian explanations Qj
7. Mostly English with some Persian explanations □
8. Mostly Persian with some Azeri Turkish explanations [:
9. Mostly English with some Azeri Turkish explanations
12.26 INTERVIEWER: Record has this participant given his/her consent to:
1 Give blood sample for analysis about mentioned CVD risk factors
2 Allow his/her GP to be informed about participation in this study
3 Allow his/her GP to receive a copy of the analysis of cardiovascular risk status
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5 Washing floors and paint work
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SHS 98 P 1731
CARD C
HEAVY HOUSEWORK
1 Moving heavy furniture
2 Spring cleaning
3 Walking with heavy shopping (for more than 5 minutes)
4 Cleaning windows
5 Scrubbing floors with a scrubbing brush
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SHS 98 P 1731
CARD D
GARDENING, DIY AND BUILDING WORK
1 Hoeing, weeding, pruning
2 Mowing with a power mower
3 Planting flowers/seeds
4 Decorating
5 Minor household repairs
6 Car washing and polishing
7 Car repairs and maintenance
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CARD E
HEAVY MANUAL WORK
1 Digging, clearing rough ground
2 Building in stone/bricklaying
3 Mowing large areas with a hand mower
4 Felling trees, chopping wood
5 Mixing/laying concrete
6 Moving heavy loads
7 Refitting a kitchen or bathroom
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3 Workout at a gym / Exercise bike / Weight training.
4 Aerobics / Keep fit / Gymnastics / Dance for fitness.
5 Any other type of dancing.
6 Running / Jogging.
7 Football / Rugby.
8 Badminton / Tennis.
9 Squash.
10 Exercises (e.g. press-ups, sit-ups)





1 Solid cooking fat ((including butter, dripping, lard, ghee,
white cap, cookeen)
2 Half-fat butter
3 Polyunsaturated, sunflower or olive margarine
4 Other hard or soft margarine or dairy blend (including
Flora, Clover, Willow)
5 Low-fat spreads
6 Vegetable oil (including olive, sunflower, soya, corn,
peanut, rapeseed)




1 6 or more times a day
2 4 or 5 times a day
3 2 or 3 times a day
4 Once a day
5 5 or 6 times a week
6 2 to 4 times a week
7 Once a week
8 1 to 3 times per month









6. Shortness of breath
7. Other respiratory problems (incl. asthma)
8. Cold/flu/virus
9. Pregnancy
10. Ulcer or other gastrointestinal problem
11. Diabetes




1. At own home
2. At work
3. In other people's homes
4. On public transport
5. In pubs




1 Almost every day
2 Five or six days a week
3 Three or four days a week
4 Once or twice a week
5 Once or twice a month
6 Once every couple of months
7 Once or twice a year
8 Not at all in the last twelve months
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CARD L
1. Going to school or college full-time (including on
vacation)
2. In paid employment or self-employed (or away
temporarily)
3. Waiting to take up paid work already obtained
4. Looking for work
5. Intending to look for work but prevented by temporary
sickness
6. Permanently unable to work because of long term
sickness or disability
7. Retired
8. Looking after the home or family
9. Doing something else (PLEASE SPECIFY)
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Telephone 01 31 536 9000








Telephone: 0131 536 9022




Public Health Sciences, Department of Community Health Sciences
The University of Edinburgh, Medical School,
Teviot place, Edinburgh, UK
EH8 9 AG
Dear Mr Shaghaghi
Full title of study: A pilot study of the prevalence of established
cardiovascular disease risk factors among Iranians in
Edinburgh
REC reference number: 05/S1101/49
Thank you for your letter of 09 May 2006, responding to the Committee's request for further
information on the above research and submitting revised documentation.
The further information was considered by the Chair on behalf of LREC 1.
Confirmation of ethical opinion
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the
above research on the basis described in the application form, protocol and supporting
documentation as revised.
Conditions of approval
The favourable opinion is given provided that you comply with the conditions set out in the
attached document. You are advised to study the conditions carefully.
Approved documents

























Participant Information Sheet: PIS
j Participant Consent Form: Consent Form 1| Participant Consent Form: Consent Form 2 for possible
future research









Response to Request for Further Information




The study should not commence at any NHS site until the local Principal Investigator has
obtained final research governance approval from the R&D Department for the relevant NHS
care organisation.
Statement of compliance
The Committee is constituted in accordance with the Governance Arrangements for
Research Ethics Committees (July 2001) and complies fully with the Standard Operating
Procedures for Research Ethics Committees in the UK.
| 05/S1101/49 Please quote this number on all correspondence
With the Committee's best wishes for the success of this project
Yours sincerely
^Chair
^ V Email: joyce.clearie@lhb.scot.nhs.uk
Enclosures:
Standard approval conditions [SL-AC1 for CTIMPs, SL-AC2 for other
studies]
Site approval form
Copy to: The University of Edinburgh
College of Medicine and Veterinary Medicine
The University of Edinburgh
The Chancellor's Building, 49 Little France Crescent,Edinburgh
[R&D Department for NHS care organisation at lead site]
SF1 list of approved sites
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Appendix 11
NHS Research and Development Office (R&D) approval
University Hospitals Division
Queen's Medical Research Institute














R&D ID No: 2006/R/CAR/08
Title of Research A pilot study of the prevalence of established cardiovascular
disease risk factors among Iranians in Edinburgh
Protocol No/Acronym: N/A
The above project has undergone an assessment of risk to the Division and review of
resource and financial implications, I am satisfied that all the necessary arrangements have
been set in place and that all Departments contributing to the project have been informed.
As this project involves healthy volunteers, I note that the University of Edinburgh will act as
Sponsor of the study.
Use of Tissue or Samples
♦ The study involves the use of patient tissue or samples. You must be familiar with
NHS Lothian's Tissue Policy and abide by its conditions and also with all
regulations in place at the time. Approval is subject to the prevailing legal
requirements.
♦ Approval for the use of tissue is restricted to the protocol associated with this
application, but may include additional collaborators within University of
Edinburgh. Collaborators who are not named in the original protocol require to be
notified to local REC.
♦ If material is to be transferred to academic collaborators outwith University of
Edinburgh or to any commercial entity then a material transfer agreement must
be obtained from the R&D Office and signed by all relevant parties prior to







Tel: 0131 242 3330






























♦ I note that additional samples will be taken for the study and that this will be done
with the patient's explicit consent.
On behalf of the Chief executive and Medical Director, I am happy to grant management
approval from NHS Lothian - University Hospitals Division to allow the project to commence,
subject to the approval of the appropriate Research Ethics Committee(s) having also been
obtained. You should note that any substantial amendments must be notified to the relevant
Research Ethics Committee and to R&D Management with approval being granted from
both before the amendments are made.
Please note that under Section A, Q35, NHS Lothian provides indemnity for negligence for
NHS and Honorary clinical staff for research associated with their clinical duties. It is not
empowered to provide non-negligent indemnity cover for patients. Lothian University
Hospitals Division does not provide indemnity against negligence for healthy volunteer
studies. This is the personal responsibility of both NHS and honorary employees and is
usually arranged with a medical defence organisation or through the University of
Edinburgh.
This letter of approval is your assurance that the Division is satisfied with your study. As
Chief Investigator or local Principal Investigator, you should be fully committed to your
responsibilities within the Research Governance Framework for Health and Community
Care, an extract of which is attached to this letter.
Yours sincerely




Tissue Policy (if applicable)
MTA (if applicable)
c/(to be signed and returned)
n/(to be signed and returned)
□ (to be signed and returned)
Administrators, Research Ethics Committee
Fiona McArdte, Clinical Research facility, RIE
Professor Raj Bhopal, Public Health Sciences, Medical School, Teviot Place
337
NHS LOTHIAN ■ UNIVERSITY HOSPITALS DIVISION
Research & Development Office, Royal Infirmary of Edinburgh
Project ID: 2006/R/CAR/08
Project Title: A pilot study of the prevalence of established cardiovascular disease risk factors
among Iranians in Edinburgh.
RECRef: 05/S1101/49
Prinicpal Investigator: Mr Abdolreza Shaghagi
RESEARCH GOVERNANCE FRAMEWORK (RGF) FOR HEALTH & COMMUNITY CARE
The framework is of direct relevance to all those who host, conduct, participate in, fund and manage health and




■ Defines mechanisms to deliver standards
• Requires monitoring and assessment
■ Improves research quality & safeguards the public
Responsibilities and Accountabilities of Principal Investigator (PI)
The PI must take responsibility for the conduct of the research and is accountable for this to their employer, and, through them, to
the sponsor of the research and to the care organisation(s) within which the research takes place or through which participants,
their organs, tissue or data are accessed. The PI must have adequate qualifications and experience to take on these
responsibilities.
In brief, they must ensure that:
• The dignity, rights, safety and well being of participants are given priority at all times by the research team.
■ Ethical and management approval is obtained BEFORE study commences.
■ Care professionals involved with patients are informed of study and its protocols.
■ Study complies with all legal and ethical requirements e.g. data protection, informed consent & with RGF.
■ Each member of the research team is qualified to discharge their role in study and that students are adequately supervised.
■ When a study involves participants under the care of a doctor, nurse or other worker for the condition in which the study
relates, those care professionals are informed that their patients or users are being invited to participate and agree to retain
overall responsibility for their care.
■ If any information relevant to the care of a patient arises through research, the patients care professional must be notified.
Unless, the patient or the relevant research ethics committee request otherwise.
■ Reporting all adverse events, including adverse drug reactions through the appropriate systems.
• Controlled trials are registered.
■ Research follows an approved protocol - any proposed changes or amendments to protocol are notified to the appropriate
research ethics committee, sponsor and research host.
• Findings open to critical review through accepted scientific and professional channels and disseminated promptly.
■ Key role in detecting and preventing scientific misconduct, by adopting role of guarantor on published outputs.
• Arrangements in place for financial management of the study and any Intellectual FToperty arising from it
• All data are stored appropriately at end of study and are available for audit
• Procedures are in place to ensure quality data are collected, processed, analysed, stored and archived
■ Progress reports are sent to sponsors promptly and are of an acceptable standard
For further information and access to the complete Research Governance document visit: -
http://www.show.scot.nhs.uk/cso
Date: 27/05/2006 1 Signature:
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LOTHIAN HEALTH BOARD
RESEARCH & DEVELOPMENT OFFICE
POLICY ON USE OF PATIENT TISSUE AND SAMPLES
i. 'Tissue and samples' includes biopsy samples, bodily fluids, autopsy specimens/organs, resection
material and anything derived from such (e.g. nucleic acids).
ii. 'Non-diagnostic use' includes, for example, all biomedical research, product and process
development, and any use of tissue by a third party, excluding teaching and diagnostic testing at
another centre.
iii. Lothian Health Board ("the Board") is the Guardian of all tissue and samples taken from patients of
the Board, including those taken from the recently deceased, unless the Crown takes possession (in
the case of forensic tissue).
iv. The Board is uniquely placed to supply tissue and samples that have the potential to advance bio¬
medical knowledge and understanding. However, the over-arching principal to the use of patients'
tissue and samples for non-diagnostic purposes is that such use must not compromise the diagnosis
or subsequent care of the patients involved. Therefore all relevant aspects of governance must be
adhered to.
v. The Board, through the R&D Office, requires to be notified and give its approval of all research
involving patients, patient samples, access to records and names of past and present NHS patients
and the use of NHS premises or facilities.
vi. In addition to the approval indicated in point v. above, all research involving patients, patient samples,
access to records, names of past and present NHS patients must have received a favourable ethical
opinion from a relevant research ethics committee.
vii. If tissue or samples are to be removed for diagnostic purposes, and a portion of this tissue or sample
is to be retained for non-diagnostic use (including research), all sub-sampling should be conducted
following a protocol that meets the requirements of the person with delegated authority from the
Guardian1.
viii. The non-diagnostic use of excess diagnostic specimens can only proceed with prior discussion and
approval from the person with appropriate authority delegated by the Guardian1.
ix. Any additional tissue or samples taken from patients for non-diagnostic purposes must be taken with
the patient's explicit consent. The need to take additional tissue and samples must be made clear in
the Patient Information Sheet.
x. Non-diagnostic use of any tissue or sample removed from a patient which is not required for
diagnosis can only proceed provided the appropriate permissions are obtained.
xi. Material already taken for therapeutic purposes which then becomes unsuitable or superfluous may
be used for research, provided the appropriate consent has been obtained at the time of collection.
xii. Any further proposed investigations using tissue and samples stored since the fulfilment of their
original purpose, require permission from the Guardian with appropriate ethical approval, subject to
prevailing legal requirements. Where it is not practicable to contact patients to seek consent, the
1 Person with authority delegated by the Guardian: Prof David Harrison (Pathology), deputy Dr William Wallace (Pathology)
© Lothian Health Board 2005 Lothian Health Board v1: May 2005
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proposed use may still be possible provided the Guardian gives its approval and appropriate ethical
approval is obtained.
xiii. The Patient Information Sheet (PIS), which accompanies the patient consent form, must be full and
complete, including being specific about where the sample goes, where the sample ends up and the
timing of its disposal. When patient tissue or samples are shared with third parties, this information
must be made explicit in the PIS.
xiv. Where a patient sample is to be used in a test which is still undergoing development or validation,
which may have diagnostic or therapeutic significance, whether this test is conducted in a laboratory
within NHS Lothian or that of third party, the patient should be fully aware of the research nature of
the test if they are to be told the result.
xv. Any tissue or samples, which remain unused at the end of a study or the collaboration, remain under
the Guardianship of the Board.
xvi. The Board is moving towards a single managed system for the storage and use of tissue and
samples stored within NHS Lothian, irrespective of where the tissue or sample originated. All tissue
and samples will be assimilated into this collection, to ensure it is stored in a secure, safe and
supervised environment, preferably on more than one site (to insure against losses). The collection
will have an appropriate Management Committee to ensure that the bank is well managed and
governed: this committee will be accountable to the Guardian. Tissues or samples cannot be
released from this collection to any third party2 without the permission of the Management Committee,
the Board and with appropriate ethical approval consistent with prevailing legal requirements.
xvii. In terms of the NHS (Scotland) Act 1978 (as amended), the Scottish Ministers delegate authority to
treat patients to NHS Boards. Accordingly doctors and other professional staff within hospitals are
only entitled to have patient contact by virtue of their status as Board employees. Therefore it is the
Board as their employer (whether honorary employer or not) who would be liable if a claim arose as a
result of such treatment. The Central Legal Office therefore advises that it is vital that the Board is a
party to any Agreement whereby the staff member is to carry out clinical research on patients.
xviil. Any tissue or sample transferred from the Board to an academic or commercial organisation (outwith
the University of Edinburgh) for non-diagnostic purposes (including commercial or academic
research) must be transferred under an appropriate Material Transfer Agreement (MTA). Any tissue
or samples transferred under such agreements will remain under the Guardianship of the Board.
xix. The sale of tissue or samples is not permitted but where there is a commercial research partner, the
Board will recover the administrative and other processing costs. An appropriate Material Transfer
Agreement must be in place and supporting clinical, radiological, demographic and laboratory
information archived in a manner that protects patient confidentiality. For prospective samples, it is
essential that the research is not prejudicial to clinical care and that there are no pressures to obtain a
specific number of samples.
xx. The 2005 MRC Operational and Ethical Guidelines - Human Tissue and Biological Samples for use
in Research provide well balanced guidelines which the Board will adopt as far as possible and until
further guidance for Scotland is available.
2 The University of Edinburgh is excluded from this provision provided the activity has an identified clinical
investigator.
© Lothian Health Board 2005 Lothian Health Board v1: May 2005
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Appendix 12
Study site approval (Wellcome Trust Clinical Research Facility
at Edinburgh's Western General Hospital)
Dr Abdolreza Shaghaghi
Public Health Sciences
Division of Community Health Sciences




1 3th April 2006
OUTCOME: PROJECT FEASIBILITY REVIEW - NEW Application (Full)
Protocol Title: A pilot study of the prevalence of cardiovascular disease risk factors among
Iranians in Edinburgh.
Ethics No: 05/S1101/49
R&D No: not yet known
CRF No: E06341
Date of OMC Approval: 5ln April 2006
Dear Dr Shaghaghi,
I am pleased to inform you that the CRF Operational Management Committee (OMC) has
approved your study to be carried out at the Wellcome Trust Clinical Research Facility.
Approval is granted on the following basis:
(1) This approval is subject to evidence of both Ethical approval and Trust R&D Management
approval. This study will not start until we have received specific and explicit approval
documentation for all aspects of your protocol.
(2) Please be advised that it remains the responsibility of the Investigator to ensure that the
appropriate Ethics and R&D management approvals are in place.
(3) From the feasibility review undertaken we intend to raise a charge of £137.50 for clinical
supplies and general support costs.
(4) The use of the CRF resources as agreed at feasibility review —
Duration of study: 12 months
Number of subjects: 75
Number of visits per subject: 1
Scheduling plan: 5 — 15 per week
Staff: A nurse is required to assist with this study for venepuncture and some measurements.
Space: Access is requested to a clinic room for study interviews. The treatment
room/additional clinic room would also be required for venepuncture and measurements of
skin-fold thickness.
If there are any significant resource variations during the study these may be subject to further




(5) The use of the CRF equipment, if requested. Please note - if you intend to use your own
equipment this should be discussed with Gordon Hill and is subject to CRF Policy (available on
request).
(6) All staff working in the CRF will be required to attend a brief induction prior to commencing
work in the facility.
(7) Studies undertaken in the CRF require all participating researchers and their assistants to
adhere to CRF Policy as well as appropriate Standard Operating Procedures (SOPs). Policy
documents are available on request.
(8) All users are required to inform the Clinical Research Facility of publications and/or
presentations arising from research studies involving CRF resources. Investigators are
required to acknowledge the CRF in all relevant publications.
(9) Continued support is dependant on satisfactory study progression and availability of CRF
resources against competing service demands.
(10) The Principal Investigator retains responsibility for the safe and ethical conduct of their
study and for reporting any adverse events. All source material remains the responsibility of
the Principal Investigator.
With best wishes for a successful study.
Yours sincerely,
CRF Administration'Manager
Copy: Gordon Hill, WTCRF Nurse Manager
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Appendix 13
The University of Edinburgh's Health and Safety Department
approval
COLLEGE of
MEDICINE and VETERINARY MEDICINE OFFICE
Room E1.06
16 March 2006 The Queen's Medical Research Institute
University of Edinburgh













0S/S1101/49 - A pilot study of the prevalence of cardiovascular risk factors among Iranians.
Thank you for forwarding copies of the protocol and ethics application relating to the above study.
I can now confirm that this research will come within the liability insurance cover held by the
University.
I would be grateful if you could send me a copy of the LREC approval when you receive this.
Yours sincerely
Marise Brown
College of Medicine and Veterinary Medicine Office
The University of Edinburgh
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Appendix 14
Scottish Criminal Record Office approval
STRICTLY PRIVATE AND CONFIDENTIAL
D sclosure
MR ABDOIREZA SHAGHAGHI















SCOTTISH CRIMINAL RECORD OFFICE
ENHANCED DISCLOSURE
APPLICANT COPY
Disclosure Number: 120100033 168150
Date of Issue: 03/02/2006
page 01 of 01
A cop/ of this Disclosure has also been sent to:
MIS STEFANIA PANKOWIAK
UNIVERSITY OF EDINBURGH COLLEGE OF MEDIC
COLLEGE OF MEDICINE AND VETERINARY MEDIC




Position Applied For: CHILDCARE RESEARCHER
Name of Employer: UNIVERSITY OF EDINBURGH
Countersignature Details
Registered Body: UNIVERSITY OF EDINBURGH COLLEG
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Appendix 16
The standard Operating Procedure (SOP) followed to measure body weight of the
study participants: Wellcome Trust Clinical Research Facility (WTCRF)
document.
Document Number: CRF/2005/N&C/V1/B008
Title: Performing a body weight measure (using SECA 797 and SECA 761scales)
Version: 1
Author: Jo-Anne Robertson
Effective from: 18 Nov 2005
Valid to: 17 Nov 2008
Superseded Version Number & Date (if applicable) N/A
Revision History
Comments: New Standard Operating Procedure
Written by: Jo-Anne Robertson
Date: 17 Nov 2005







This Standard Operating Procedure (SOP) describes the correct procedure for
performing body weight using the SECA 797 and the SECA 761 weighing scales.
2.0 Scope




It is the responsibility of the CRF staff performing a body weight to have read this
SOP and be familiar with this equipment.
4.0 Procedure
Before body weight is measured on the scales the volunteer should remove outdoor
clothing, their shoes and any heavy items in pockets.
4.1 To measure body weight using the SECA 797 scales:
4.1.3 The scales are automatically zeroed and ready to use
4.1.4 If required the weight display can be changed, see section 4.2
4.1.5 Subject should then stand on scales and be instructed to keep still
4.1.6 The result appears on the digital display
4.1.7 If a load of 160 kilograms or 350 pounds (the maximum threshold) is placed on the
4.1.8 To switch off the scales press the start key again
4.1.9 The scales automatically switch off after 3 minutes
4.2 To switch the weight display:
The weight display can be switched between kilograms (kgs) and pounds (lbs)
4.2.1 Switch on the scales using the start key
4.2.2 Weight will be displayed on the last setting selected
4.1.1 Press the start key
4.2.4 The kgs or lbs display lights up and the switch can now be made
4.3 Maintenance
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4.3.1 Surfaces can be cleaned using a domestic cleaning agent or commercially available
disinfectant. Always follow instructions for use when cleaning
4.3.2 No abrasive or acid cleaners, white spirit, benzene or similar should be
used as this can damage the surfaces
4.3.3 Calibration should be undertaken annually by an approved company
4.4 Changing Batteries
llW L LOLL
4.4.1 When or appears on the display, batteries should be
changed
4.4.2 Turn over scales so that the base is easily accessible
4.4.3 Push the battery compartment closure towards batterie and hold open
the cover
4.4.4 Take out the holder and the batteries
4.4.5 Remove the used batteries and insert new ones
4.4.6 Place the holder and batteries in the battery compartment
4.4.7 Close the cover
4.4.8 Turn the scale back the right way
5.0 To measure body weight using the SECA 761 scales:
5.1.1. Subject instructed to stand on scales
5.1.2. Subject to stay completely still when on the scales
5.1.3 Reading can be read in either kilograms (kgs) or pounds (lbs), (lbs on the outer
circle, kgs on the inner circle)
6.0 Related documents
• Seca 797 & 761 Instructions For Use
7.0 References
• Seca 797 & 761 Instructions For Use





Signature: Date: 17 Nov 2005
Approved by (either Core Manager or CRM):
Name: Gordon Hill
Position: Nurse Manager
Signature: Date: 18 Nov 2005
Name: Geraldine Cummings
Position: Charge Nurse
Signature: Date: 18 Nov 2005
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Appendix 17
The standard Operating Procedure (SOP) followed to measure body height of the
study participants: Wellcome Trust Clinical Research Facility (WTCRF)
document.
Document Number: CRF/2005/N&C/V1/B006
Title: Measurement of Standing Height
Version 1
Author: Barbara McLaren
Effective from: 18 Nov 05
Valid to: 17 Nov 08
Superseded Version Number & Date (if applicable) N/A
Revision History
Comments: New Standard Operating Procedure
Written by Barbara McLaren
Date: 07 Nov 2005
Next review due: 01 Jul 2006
Signature(s):
Comments: Added numbering in section 4. Change of text in item 4.2.
Reviewed by: Gerry Cummings and Gordon Hill
Next review due: 01 Jul 2006
Signature(s)
3.0 Purpose
The purpose of this Standard Operating Procedure (SOP) is to ensure accurate,
repeatable measurements.
4.0 Scope
This SOP applies to all staff undertaking the measurement of standing height within the
Clinical Research Facility (CRF)
3.0 Responsibilities
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It is the responsibility of all staff performing the measurement to familiarise themselves
with this SOP and any equipment used.
4.0 Procedure
4.1 The subjects should be asked to remove their shoes
4.2 The subject should be able to stand unsupported with their legs straight, their
heels, head and shoulder blades should be touching the wall or vertical scale.
4.3 Ensure that the subject is standing with their feet parallel to each other, toes
pointing forward and the soles flat on the floor or as per diagram on the
measuring base.
4.4 The subject should stand as tall as possible looking straight ahead.
4.5The horizontal measure should be brought down to rest on the top of their
head.
4.6 Read the measurement on the vertical scale to the nearest millimetre.
4.7 Record the measurement on the relevant source data sheet.
5.0 Related documents N/A
6.0 References N/A
7.0 Approval and sign off
Author:
Name: Barbara McLaren
Position: Senior Research Nurse
Signature: Date:









The standard Operating Procedure (SOP) followed to measure waist and hip of the
study participants: Wellcome Trust Clinical Research Facility (WTCRF)
document.
Document Number: CRF/2005/N&C/V2/B015
Title: Measurement of waist circumference and waist to hip ratio
Version 3
Author: Dawn Lyle
Effective from: 25 Jan 2006
Valid to: 24 JAN 2009
Superseded Version Number & Date (if applicable) Version 2
Revision History
Comments: Significant changes to section 4.0








The purpose of this Standard Operating Procedure (SOP) is to ensure accurate,
repeatable measurements, whilst maintaining patient safety and dignity.
6.0 Scope
This SOP refers to the measurement and recording of a subject's waist circumference
and waist to hip ratio, for studies undertaken within the CRF.
7.0 Responsibilities
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It is the responsibility of the CRF nurse performing the measurement to ensure subject
comfort and safety throughout the procedure.
8.0 Procedure
4.1 Explain the procedure to the patient/subject.
4.2 Ask them to remove necessary clothing to enable the measurement to be made
directly on the skin surface. Ensure patient/subject dignity is maintained.
4.3 Ask them to stand in a comfortable position with their feet about 30 cm (1 foot)
apart and parallel to each other. They should stand with their weight equally
distributed to both feet and with their arms folded across their thorax.
4.4 To determine the waist measurement, locate the lower rib margin on one side of
the patient/subject using a gentle upward motion. Mark this location at the mid
axillary line using a water-soluble ink pen.
4.5 Using the lengths of your fingers locate the bony prominence above the hip (iliac
crest) top of the upper hip bone using a gentle downward motion. Mark this
location at the mid axillary line.
4.6 The measurement is taken at the narrowest point between the lower costal
border (10th rib) border and the iliac crest. If there is no obvious narrowing the
measurement is taken at the midpoint between these two landmarks.
4.7 To ascertain the midpoint measure the distance between the lower costal border
and the iliac crest, marking the skin with a water soluble ink pen. If preferred this
may also be done if the narrowest point is obvious.
4.8 Standing behind the patient/subject wrap the measuring tape around them, place
the measuring tape over the middle marks at the mid axilliary line. The
measuring tape should be horizontal and not be too tight or too loose.
4.9 Ask the patient/subject to lower their arms to a relaxed position and breathe in
and out normally. As they breathe out take the waist measurement. Record this
measurement on the study documentation. To ensure accuracy of the
measurement repeat step 4.9. Do not remove the tape from around the
patients'/subjects waist.
4.10 To determine the hip measurement ask the patient/subject to assume a relaxed
standing position with their feet together and gluteal muscles relaxed. Arms
should be folded across their thorax.
4.11 Stand at the side of the subject and pass the tape around the buttocks with the left
hand then grasping it with the right hand. Lower or raise the tape until the
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maximum circumference is located. This usually correspond to the level of the
symphysis pubis. The tape should fit comfortably and not be too tight or too
loose. Ensure the tape is kept horizontal
4.12 Ask the patient/subject to relax and breathe in and out slowly. As they breathe
out take the hip measurement. Record this measurement on the study
documentation. To ensure accuracy of the measurement repeat step 4.11. Do not
remove the tape from around the patients'/subjects hips.
4.13 To determine the waist to hip ratio divide the waist circumference by the hip




ISAK Anthropometric Methodologies (International Society for the Advancement of
Kinathropometry) Sara SmithBSc RD level 3 ISAK Anthropometrist.




Signature: Date: 18 Jul 2006









The Standard Operating Procedure (SOP) for application ofOmron 705IT monitor
to measure blood pressure of the study participants: Wellcome Trust Clinical
Research Facility (WTCRF) document.
Document Number: CRF/2006/N&C/V1/B026
Title: Blood Pressure & Heart Rate Measurement using Omron 705IT monitor
Version 2
Author: Lesley Breen
Effective from: 31 Jan 2006
Valid to: 30 Jan 2009
Superseded Version Number & Date (if applicable) Version 1
30 Jan 2006
Revision History
Comments Converted to new template from SOP B3.10 by Dawn Lyle
10th Jan 2006.
Reviewed by: Sharon Cameron and Geraldine Cummings
Minor changes to 4.5. Addition of 4.31, 4.6
Date: 31 Jan 2006







This Standard Operating Procedure (SOP) describes the correct procedure for the
operation of the Omron 705IT monitor ensuring that the results are accurate.
10.0 Scope
355
This SOP applies to the correct operation and maintenance of the Omron 705IT monitor
within the Clinical Research Facility (CRF).
11.0 Responsibilities
3.1 Use of this equipment is the responsibility of the CRF staff using the Omron
705IT monitor
3.2 All staff using this equipment should receive relevant training on its use prior
to commencing the study
3.3 It is the responsibility of the CRF staff using the Omron 705IT monitor to
have read this SOP
4.0 Procedure
4.1 Positioning of subject/patient
4.1.1 Explain procedure to patient/subject, and inform them of the minor
discomfort that may be felt and the number of recordings required
4.1.2 Position the person sitting, lying or standing as per study protocol (sitting or
lying makes no difference to blood pressure (BP) readings provided the arm
is in correct position as below)
4.1.3 3 minutes lying or sitting, or one minute standing is recommended prior to
initiating a recording
4.1.4 The subject should be in a warm environment. Tight or restrictive clothing
should be removed from the forearm
4.1.4 Position and support the patient's arm horizontally on a level with the mid-
sternum
4.2 Application of the cuff
4.2.1 Only cuffs approved by OMRON must be used with this monitor
4.2.2 The standard sized cuff is designed for an arm circumference of 22-32 cm.
(An extra large cuff for arm circumference of 32cm-42cm is also available)
4.2.3 The cuff may be fitted over thin clothing but, please ensure that the clothing
does not constrict blood flow
4.2.4 Fit the cuff around the patients arm so the green mark is located over the
brachial artery and 2-3 cm above the antecubital fossa. The tube should run
down the centre of the arm.
4.3 Preparation of the monitor
4.3.1 Check the date and time recorded on the monitor is accurate. If not
adjust using the 'SET' and 'ADJUST' keys on the top right of the
monitor.
4.3.2 Connect the air tube to the air inlet port (on the left side of the device)
4.3.3 Press the on/off button (O/I); all the symbols on the display will light up. All
the symbols go out and the deflate symbol starts to flash (▼).
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4.3.4 When the preparations for measurement are complete, the 'ready to measure'
symbol (V) appears on the display
4.4 Measurement
4.4.1 Press start button. As the cuff inflates the monitor will automatically
determine the ideal inflation level.
4.4.2 The air will then automatically be released and the reading on the display
drops. As soon as the patients pulse has been detected the (V) symbol begins
to flash and, at the same time the monitor bleeps
4.4.3 When measurement has finished, the systolic and diastolic blood
pressures and heart rate are displayed on the screen
4.4.4 The pressure drop symbol (T) indicates that the remainder of the air in
the cuff is deflating. When all air has escaped the (V) symbol appears on the
display and the BP and pulse are displayed. The results are now transcribed
into the study source data, stored in memory or printed as per study protocol
4.4.5 Press the (O/I) to turn the monitor off. The monitor will automatically
turn itself off after 5 minutes if not turned off.
4.5 Storing the measurements
4.5.1 The monitor can store 28 sets of readings in the memory. Each time a
measurement is complete it will automatically be stored in the memory
4.5.2. To recall a measurement, turn the monitor on by pressing (O/I).
4.5.2 Press the (M) button to recall the stored readings.
4.5.3 To delete all the stored readings press the (M) and (O/I) button
simultaneously (Note: you can not partially delete stored readings).
4.6 Printing the measurements
4.5.4 Attach the Omron printer using the attached USB cable to the USB port on
the right hand side of the device.
4.5.5 Press 'DATA/STOP' to print the most recent measurement
4.5.6 Press 'ALL DATA' to print out all stored readings and the mean of those
readings
4.5.7 The month and date are displayed in the top left corner of the print out.
The time is displayed in the top right corner.
4.5.8 The printout should be signed and dated by the CRF nurse or investigator.
Attach printout to study documentation as per flowsheet/ protocol.
4.5.9 Measurement print outs must be photocopied and stored/archived as source
data as the printout is not suitable for long term storage (>1 year), as it will
degrade over time.
4.7 Maintenance and Servicing
4.7.1 Only use a soft slightly moist cloth for cleaning the monitor. Stains on the
cuff can be carefully removed by using a soapy cloth. It should not be
washed or immersed in water.
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4.7.2 Annual maintenance of the monitor should be undertaken by the
Medical Physics Department to ensure it is functioning correctly and
accurately.
4.7.3 Refer to instruction manual for further information if required. The Omron





6.1 Omron 705IT instruction manual
6.2 Omron printer instruction manual
6.3 British Hypertension Society website www.bhsoc.org
7.0 Approval and sign off
Author:
Name: Lesley Breen
Position: Senior Research Nurse
Signature: Date: 27 Jan 2006
Approved by (either Core Manager or CRM):
Name: Sharon Cameron
Position: Nurse Manager
Signature: Date: 31 Jan 2006
Name: Geraldine Cummings
Position: Charge Nurse
Signature: Date: 31 Jan 2006
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Appendix 20
Participants' information sheet and consent forms in the pilot study of the
prevalence of cardiovascular disease risk factors among Iranians living in
Edinburgh.
A pilot study of the prevalence of cardiovascular disease risk factors among
Iranians living in Edinburgh
Studyparticipants' information sheet and consentform
You are being invited to take part in this research study. Before you decide it is
important for you to understand why the research is being done and what it will involve?
Please take time to read the following information carefully and ask us if there is
anything that is not clear or if you would like more information. Take time to decide
whether or not you wish to take part.
1. What is the purpose of this study?
Cardiovascular disease (disease of heart and its nourishing arteries) is a major
cause of death and illness throughout the world. Unhealthy diet, physical inactivity and
tobacco smoke are known to be serious risk factors for narrowing and blockage of blood
vessels which nourish heart.
There are few studies investigating the prevalence of cardiovascular disease and its
risk factors in Iran and despite increasing migration from Iran to other countries fewer
still among Iranians living abroad.
Results of this research will be used to plan a bigger study which will lead to
identify Iranian profile of CVD risk factors and consequently to control the disease
amongst Iranians living in the UK and similar European countries. This will also be
influential in planning appropriately tailored preventive programmes within NHS
359
(National Health System) to the needs of Iranians. Successful implementation of this
study will lead to PhD degree for the study main researcher.
2. Who could participate in this study?
All Iranians aged 18 and over who permanently reside in the UK may participate in
this study.
3. Do I have to take part in this study?
It is up to you to decide whether or not to take part. If you decide to participate,
you will be given this information sheet to keep and be asked to sign a consent form. If
you decide to take part you are still free to withdraw at any time and without giving a
reason. A decision to withdraw at any time, or a decision not to take part, will not affect
the standard of health care you will receive in the future.
4. What will happen to me if I participate in the study?
To participate in this study you may call the study main researcher for an
appointment. Consequently, you will be invited to come to the Wellcome Trust Clinical
Research Facility Centre (WTCRFC) in the Edinburgh Western General Hospital
(WGH) for which compensation to cover travel expenses will be available. You will be
asked a number of questions in relation to your risks of cardiovascular disease and your
blood sample will be taken for analysis of your blood lipids (fats) and glucose although
you could refrain from giving blood. All of this interview and sample taking will be
done within 90 minutes. You will be requested to fast for at least 10 hours for taking
accurate blood sample (This will not requested if you already have diabetes).
Participation in this study will not affect your other daily routines such as activities or
medications. Results of your CVD risk analysis will be sent to you or your GP if you
permit. All questions will be asked from you in this study are related to risks of CVD
but, nonetheless, you will have the choice to decide whether or not to answer a question
or number of questions.
5. What will happen to my blood sample if I take part in the study?
A part of your blood sample will be used for analysis of the blood lipids (fats) and
glucose and if you permit remaining will be stored in a freezer at the University of
Edinburgh for future research on CVD by only a member of the current research team.
The samples will not be used for DNA purposes.
6. What are the side effects or disadvantages for those who participate in the study?
There are no known side effects or disadvantages for the study participant, aside
from slight pain during blood sample taking.
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7. What are the possible benefits of taking part?
Through participation in this study, you will receive results of your blood sample
analysis for glucose and lipids and be aware of your cardiovascular disease risks. We
hope this information will help you to adopt a healthier lifestyle. The information we
will get from this study may help us to understand the pattern of cardiovascular diseases
risk factors among Iranians living in the UK and to plan a large-scale study in the future.
This could lead to more effective plan of preventive measures and to attract attentions to
the health issues of Iranian ethnic group. This study will be a part ofmy research activity
leading to PhD degree.
8. What if something goes wrong?
To the best of our knowledge there is no harm to you in taking part in this study so
there are no special compensation arrangements. If you wish to complain or have any
concerns the normal National Health Service complaints mechanisms will be available
to you. The University of Edinburgh is responsible for compensation of injuries that
results from procedures carried out in accordance with the protocol for this study. The
University of Edinburgh will not compensate you where such injury results from any
procedure carried out which is not in accordance with the protocol of the study. Your
right at law to claim compensation for injury where you can prove negligence is not
affected.
9. Will my taking part in this study be kept confidential?
All information that is collected about you during the course of the research will be
kept strictly confidential. Any information about your health will have your name and
address removed so that you cannot be recognized from it. Your information will be
inspected by the researcher and by the responsible supervisors for analysing the results.
Your name however, will not be disclosed outside the hospital (WGH).Your GP will be
notified of your participation in this study and a copy of the results from analysis of your
cardiovascular risk status will be send to your GP. If you don't want your GP to be
informed about your participation in this study or your cardiovascular risks please tick
appropriate box in the consent form.
10. What will happen to the results of the research study?
This study will be published in the PhD thesis of main researcher. The results may
be published in medical journals and an abstracted copy of the study results will be sent
to study participants on request. But you will not be identified in any report or
publication.
11. Who is organising and funding the research?
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This study is funded partly by the Iranian Ministry of Health and Medical
education (MOHME) and other expenses possibly will be funded by another funding
organisation within the UK. (At any circumstances, no personal data will be passed on to
organisation outside the university). The study is organised within the University of
Edinburgh and is under full supervision of highly qualified researchers in the university
(Professor Raj S. Bhopal, Professor Aziz Sheikh, and Dr Farshid Namdaran). The study
researcher will not be paid for including you in this study.
12. Who has reviewed the study?
The NHS Research Ethics Committee had reviewed this study proposal and
approved it.
12. Contact for further information:
A.Reza Shaghaghi
Public Health Sciences
Department ofCommunity Health Sciences
The University ofEdinburgh





Thank you for your participation and cooperation in this study.
You will be given a copy of this information sheet and signed consent form to keep.
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Consent Form (1)
Title of Study: A pilot study oftheprevalence ofestablished cardiovascular
disease riskfactors among Iranians living in Edinburgh.
Name of the researcher: Abdolreza Shaghaghi
1.1 confirm that I have read and understood the information sheet
dated 9th, May, 2006 (version 06-03) for the above study and
have had the opportunity to ask questions.
2.1 understand that my participation is voluntary and that I am free to
withdraw at any time, without giving any reason, without my medical
care or legal rights being affected.
3.1 agree to take part in the above study. □
4.1 agree that my GP be informed about my participation in this study. f j




Name ofparticipants Date Signature
Name of person taking consent Date Signature
(If different from researcher)
Name of researcher Date Signature
A.Reza Shaghaghi




(Consent for possible future research)
Research on the future cardiovascular riskfactors such as level ofC-reactive,
urea and creatinine, homocysteine and its essential metabolic cofactors such as
cobalamin (vitamin B12), folate, and vitamin Be ■■■)
Title of the main Study: A pilot study oftheprevalence ofestablished
cardiovascular disease riskfactors among Iranians living in Edinburgh.
Name of the researcher: Abdolreza Shaghaghi
1.1 confirm that I have read and understood the information sheet
dated 9th, May, 2006 (version 06-03) for the above study and
have had the opportunity to ask questions.
2.1 understand that my participation is voluntary and that I am free to
withdraw at any time, without giving any reason, without my medical
care or legal rights being affected.
3.1 agree to allow my blood samples to be stored for use within future other
cardiovascular risk factor studies (samples will only be used by a member
of the current research team but not for DNA purposes). (This will require




Name of participants Date Signature
Name of person taking consent Date Signature
(If different from researcher)
Name of researcher Date Signature
A.Reza Shaghaghi
1 for participant; 1 for researcher; 1 to be kept with individual flies in the research organisation
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